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Synthesis of Modified Thymidine and Intrastrand Cross-Linked DNA 
Probes to Investigate Repair by O
6
-Alkylguanine DNA Alkyltransferases 
and Bypass by Human DNA Polymerase η 
 
Derek K. O’Flaherty, Ph.D. 
Concordia University, 2016 
O
6
-Alkylguanine-DNA alkyltransferases (AGTs) are responsible for genomic maintenance 
by repairing O
6
-alkyl-2’-deoxyguanosine (O6-alkyl-dG) and O4-alkyl-thymidine (O4-alkyl-dT) 
adducts. AGT-mediated repair was investigated against DNA intrastrand cross-links (IaCL). A 
variety of cross-linked dimers linking the O
6
-atom of dG or O
4
-atom of dT were prepared 
synthetically to produce precursors for IaCL DNA that either lack or containing an intradimer 





-dG flexible IaCL DNA (lacking the phosphodiester linkage) were efficiently 
repaired by hAGT. Repair of the model IaCL DNA occurred more efficiently in comparison to 




-dG IaCL DNA containing the intradimer 
phosphodiester were moderately repaired by hAGT. Efficiency of the hAGT-mediated repair was 
contingent on the presence of the intradimer phosphate, which suggest conformational flexibility 




-dT IaCL DNA evaded 




-dG were efficiently 




-dT was not proficiently repaired by 
hAGT supporting the importance of the 3'-phosphate group of the target dG nucleotide. 4) 
Flexible IaCL can be employed to generate DNA-protein cross-links (DPCs), with good 











hAGT. The use of such cross-linking experiments may be useful for elucidating substrate 
discrimination across AGTs by X-ray crystallography.   
Translesion synthesis (TLS) may be activated by the cell as a coping mechanism when 
DNA damage evades repair or remains otherwise irreparable by repair mechanisms. Human 
DNA polymerase η (hPol η) is a key TLS Pol involved in the bypass of certain UV-induced 
DNA damage, and lesions formed by platinum-containing chemotherapeutics. Bypass 
experiments were conducted to determine if conformational freedom of the lesion impacted hPol 
η processivity. Towards this end, bicyclic pyrimidines linking the C5-atom to the O4-atom, by an 
ethylene or a propylene bridge, were synthesized as conformationally locked mimics of the 









-EtdT), respectively. Bypass studies revealed that: 1) The conformationally locked pyrimidyl 
analogues described above were bypassed by hPol η with different profiles, relative to O4-MedT 
and O
4
-EtdT. All thymidinyl modifications evoked an error-prone behavior from hPol η, with 





-dG containing the intradimer phosphodiester group behaved 
significantly different relative to those IaCL lacking it. hPol η inserted the correct nucleotide 
(dCMP) across the 3'-dG residue for all IaCL studied, whereas an error-prone behavior was 
observed across the 5'-dG residue. While the lack of the intradimer phosphodiester caused 
frameshift adduct formation across the 5'-dG, hPol η inserted the incorrect dTMP across the 5'-
dG of the canonical IaCL DNA. More studies are required to elucidate whether this dependence 
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1.1  Preamble 
2’-Deoxynucleic acid (DNA) is the medium of genetic information storage for all 
organisms. It is used by organisms to encode ribonucleic acids (RNA), which will ultimately be 
translated in the biosynthesis of functional proteins. Another important biological function of 
DNA is to serve as the template to generate daughter DNA strands, a process known as DNA 
replication carried out by DNA polymerase enzymes. The preservation of the chemical integrity 
of this macromolecule is paramount and any chemical alteration may lead to detrimental events 
felt at the DNA replication and transcription levels. These insults can consequently be translated 
to the protein level and disrupt cellular processes.  
The chemical structure of the DNA macromolecule is composed of four smaller subunits 
known as nucleotides. Each nucleotide is in turn composed of a phosphate group, a 2’-
deoxyribose sugar and a nucleobase. 2’-deoxyadenosine (dA) and 2’-deoxyguanosine (dG), also 
known as purines, pair with their pyrimidine partners, thymidine (dT) and 2’-deoxycytidine (dC) 
respectively. Generally, two complementary DNA polymers assemble into a double-helix where 
the strands are anti-parallel to one another.  
DNA is susceptible to chemical alterations by endogenous and / or exogenous agents. 
Activity of proteins towards the DNA macromolecule may be impaired by the altered DNA 
structure, consequently resulting in a variety of undesirable cellular consequences such as 
mutations, chromosomal instability, teratogenic effects and cellular apoptosis. These 
consequences are dependent on a multitude of parameters such as the chemical composition of 
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the lesion, the location of the lesion on the DNA scaffold, and the protein interacting with the 
DNA, to name a few.  
Certain cancer chemotherapeutic regimens target cellular DNA in order to eradicate the 
malignant neoplasm. Of these, the DNA alkylating agents functionalize one or multiple sites on 
the DNA duplex, disrupting vital processes involved in DNA replication. Small appendages such 
as methyl groups transferred to DNA are sufficient to result in significant toxicity. Bifunctional 
alkylating drugs, which by definition have two reaction centers, have the added facet of 
generating covalent linkages between nucleotides on the same strand (intrastrand cross-link) and 
to the complementary strand (interstrand cross-link).  
Organisms have evolved a range of different mechanisms to cope with the constant 
formation of DNA insults in the cell. These repair pathways have the objective to eliminate or 
bypass the DNA damage, or have an intricate role in activating other cellular mechanisms such 
as apoptosis. The activation of a given repair pathway is dependent on the type of DNA damage 
and together these cellular repair mechanisms have been shown to reverse a wide variety of 
DNA damage. Conversely, cellular repair mechanisms have been associated with resistance to 
certain therapeutic drugs which act directly on DNA, such as alkylating agents of the anti-cancer 
armamentarium. This dichotomy highlights the importance of studying repair pathways involved 
in cell survival for both healthy and cancerous cells. 
1.2 DNA Alkylation Damage 
1.2.1 Sources of DNA chemical modifications 
Estimations of cellular DNA modifications can be on the order of one million events per 
day per cell.
1
 DNA damage can be defined as a DNA chemical modification, harmful to the 
organism, which can generally arise from either radiation or chemical sources. For instance, 
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chemical moieties in the DNA can undergo excitation when exposed to specific radiation, and in 
the process, can react with another chemical moiety in proximity such as (other) DNA 
nucleotides and proteins to name a few. Common examples include cyclobutane pyrimidine 
dimers (CPDs) and pyrimidine (6-4) pyrimidone photoproducts (Figure 1.1) which are produced 
by ultraviolet (UV) radiation. This is particularly important given that solar UV light contains the 
appropriate wavelength range to induce such DNA lesions. High-frequency radiation such as X-
rays and γ-rays are capable of causing ionization, thus producing a free-radical on the DNA 
scaffold.
2–4
 The production of such radicals can lead to the formation of various DNA 
modifications such as DNA strand breaks, nucleobase covalent attachment and oxidation 
products. Similar lesions can be produced from metabolism by-products as these can also 
generate free-radicals.
5
   
 
Figure 1.1: Selected example of DNA modifications from (A, B) UV radiation and (C) ionizing 
radiation. These were selected on the basis of the probes synthesized herein. Modifications are 
shown in blue.   
 
The thesis is centered on alkylation of the DNA, which constitutes the installment of one or 
more alkyl appendages on the DNA strand. For the sake of this document, the term “alkylation” 
will encompass well-defined coordination of a metal to DNA, such as cross-link modifications 
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introduced by the chemotherapeutic agent cisplatin (cis-diamminedichloroplatinum(II)). 
Numerous cases of other chemical modifications have been documented,
6
 such as spontaneous 
hydrolysis of the nucleobase or oxidation adducts, yet only prevalent types and those relevant to 
the chapters below will be discussed in this document. 
     One of the most common types of DNA modification is depurination and 
depyrimidation, with the former occurring more frequently compared to the latter.
7
 These lesions 
are estimated on the order of 10
4
 events per cell per day. The adverse effects of such a lesion are 
not surprising given that DNA nucleobases are utilized for encoding biological information (e.g. 
protein recognition and cellular instructions). However, the rate of nucleobase hydrolysis is quite 
slow in physiological conditions (t1/2 ~ 730 years and t1/2 ~ 14700 years for purines and 
pyrimidines respectively) but can be accelerated by a number of factors such as DNA 
alkylation.
8–10
 Another frequent type of modification results from oxidation damage events, such 
as those that produce 8-oxo-7,8-dihydroguanine (Figure 1.2). These lesions are a result of 
aerobic respiration generating reactive oxygen species (ROS) which can act on DNA. Like alkyl 
groups, the introduction of oxygen atoms on the DNA chemical entity changes the steric and 
electronic properties of the DNA, ultimately disrupting vital processes like DNA replication and 
transcription.   
 
Figure 1.2: Chemical structures of 2'-deoxyguanosine (dG; left structure) and 8-oxo-7,8-






1.2.2 DNA Damage by Alkylation 
Historically, it was at the end of World War I, that the chemical bis(2-chloroethyl)sulphide 
(so-called “mustard gas”) was recognized as an agent capable of generating long-term systemic 
malfunction, in addition to immediate acute damage.
11
 This would later be attributed, at least in 
part, to its ability to act on the genetic material DNA.
12,13
 Since then, a number of environmental 
agents both produced endogenously and / or exogenously have been discovered that assault the 
chemical identity of DNA. For instance, S-adenosine methionine (SAM) is produced 
endogenously and utilized as a cosubstrate for many methyl group transfer reactions. In vitro 
experiments have shown the methylation of DNA when exposed to SAM, and it has been 
estimated that the SAM produces over 4500 DNA lesions in a 24h time period per cell.
14
 Lipid 
peroxidation metabolites are also a source of endogenous alkylating agents.
15,16
 On the other 
hand, exogenous agents such as N-nitroso-N-methylurea (NMU) and methyl methanesulfonate 
(MMS) have been investigated for their ability to transfer an alkyl group to DNA.
17
 Interestingly, 
agents targeting DNA displayed potent anti-mitotic (cell division) properties, a valuable attribute 
for treating groups of malignant cells. Yet, the elevated systemic toxicity prevented any viable 
use of such compounds in the clinic, and consequently prompted research on the development of 
optimized compounds that would retain anti-mitotic potency, while having reduced toxicity. 
Among the first chemotherapeutic drugs were chlorambucil and busulfan (Figure 1.3).
11





Figure 1.3: Selected alkylating agents. Busulfan and hepsulfam are particulaly relevant to the 
thesis. 
 
Compounds capable of causing DNA lesions impede important cellular processes such as 
DNA replication and transcription. It should be noted that alkylating agents are capable of 
causing harmful damage to other biomolecules like RNA and proteins, however these topics 
exceed the scope of this thesis. Only lesions directly involving DNA will be discussed. 
Alkylating agents can be categorized further by the number of reactive moiety inherent to the 
compound. Monofunctional alkylating agents have one reactive center, whereas bifunctional 
alkylating agents have two reactive centers. The former class is limited to producing mono-
adducts on the DNA scaffold (see Scheme 1.1 for mono-alkylation by nitrosourea compounds). 
These added appendages can disrupt the physical and chemical properties important to DNA 
structure and function.
18
 These include disruption of base stacking interactions, base pairing 









-MedT) lesions change the tautomeric 
state of the nucleobase (Figure 1.4), hence causing discrepancies in base pairing preferences.
19,20
 
This is particularly problematic given that DNA polymerases (Pol) generally incorporate the 









 The presence of a methyl group, albeit small in size, can also severely hinder the 
DNA Pol kinetics (i.e. DNA Pol blockage).   
 
Figure 1.4: Base pairing discrepancies observed for O
6
-MedG (B and C) and O
4
-MedT (E and 
F) relative to dG (A) and dT (D), respectively. To be noted is the wobble type base pairing 
present with the alkylated nucleobase and its correct base pairing partner (B and E), which is not 
observed for its mismatch (O
6
-MedG•dT in panel C and O4-MedT•dG in panel (F).It should also 
be noted the tautomeric differences between O
6







Scheme 1.1: Mono-adduct formation by nitrosourea compounds (scheme adapted from the 
following reference).
27
 In this example the O
6
-position of dG is alkylated. Many 
chemotherapeutics utilize the nitrosourea moiety (1 3-bis(2-chloroethyl)-1-nitrosourea (BCNU), 
1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU), and 1-(2-chloroethyl)-3-(4-amino-2-





In addition to mono-alkylation, the bifunctional alkylating agents are capable of generating 
more-pronounced types of DNA damage such as DNA cross-links.
28,29
 These include intrastrand 
cross-links (IaCL) which attaches two sites on the same DNA strand, interstrand cross-links 
(ICL) where alkylation events occur on complementary strand, and DNA-protein cross-links 
(DPC) which attaches a protein molecule to the DNA strand (Figure 1.5). The heightened 
potency of bifunctional compounds is largely attributed to these types of lesions and will be 
discussed in further detail below.    
 
Figure 1.5: Selected reaction fates for bifunctional alkylating agents.
30
 Note that the first 
reaction event is shown only with DNA, whereas the DNA protein cross-link could have been 
generated by a first reaction with the protein followed by a second with DNA. The same could be 






1.2.3 Adverse Effects of  O4-Alkyl-dT and O6-Alkyl-dG Mono-Adducts and 
Various Cross-Links 
 Depending upon their chemical structure, DNA lesions may lead to a number of adverse 
cellular effects.
31,32
 The DNA damage may significantly slow DNA replication and / or 
transcription by interfering with the activity of polymerases. Downstream effects could lead to 
slowing of cell division and chromosomal instability. If capable of bypassing the damaged site, 
DNA polymerases could cause nucleotide misinsertions in the newly synthesized (daughter) 
DNA strand, consequently generating mutagenesis.
31
 Certain DNA adducts are chemically 
unstable, which upon degradation increases the probability of aberrant global DNA lesions such 
as DNA strand breaks.
31
 The understanding of DNA damage and its biological consequences has 
greatly advanced from tracing the chemical structure of a DNA adduct to the critical cellular 
event it causes.  
With the exception of intercalators, DNA alkylators generally possess electrophilic centers. 
Nucleophilic sites found within the DNA can thus attack the electrophiles following the course 
of a single replacement reaction (substitution). Research using benchmark DNA alkylators have 
revealed that the distribution of alkylation sites on the DNA molecule depends on a variety of 
factors such as the nature of the nucleophile and electrophile.
33,34
 In vitro and in vivo studies 
demonstrated that electrophilic alkylators, such as NMU and MMS, largely target the N7-atom 
of dG. This atom is the most susceptible site of alkylation given it has the highest negative 
electrostatic potential (hence being most nucleophilic) compared to other atoms found within the 
DNA nucleobases.
35
 N7-alkyl-dG lesions larger than an ethyl group are detrimental to cellular 
activity.
8
 Interestingly, N7-methyl-dG and N7-ethyl-dG are well-tolerated by cells, perhaps 





these adducts are prone to chemical degradation and can lead to various products harmful to the 
cell, such as abasic sites and formamidopyrimidine (Fapy) lesions.
8
 An aspect to be highlighted 
is that N7-alkyl-dG lesions are particularly difficult to investigate in biochemical assays due to 
their tendency to degrade.  
Potency of a given alkylating agent is governed by more than the number of lesions 
generated on the DNA per dose. Rather, the cytotoxicity heavily depends on the types of lesions 
that amass on the DNA (e.g. sites of alkylation), and the persistence of such DNA adducts. 




-alkyl-dT are produced in relatively low levels, with the 
former occurring more frequently compared to the latter. For instance, subjecting DNA to NMU 
(in vitro) generates 6.3 % of O
6




 Albeit being 
minor sites of DNA alkylation, these types of damage are chemically stable, and if left 
unattended disrupt cellular activity. It has been estimated that approximately 6600 O
6
-MedG 
lesions are sufficient to cause cell death in repair-deficient mammalian tumor cell lines.
37
 









-MedT lesions, on the other hand, are inefficiently processed by mammalian cells compared to 
O
6
-MedG. As a result, this lesion is considered more cytotoxic when present.
41
  




-alkyl-dT are largely a results of DNA Pol 
interference during DNA replication, in both prokaryotes and eukaryotes. For instance, O
6
-MedG 
is capable of blocking a number of DNA Pol such as eukaryote DNA Pol α,42 β,43 δ,44,45 
Escherichia coli (E. coli) Klenow fragment,
46
 and T7 bacteriophage DNA polymerase.
42
 Even 
specialized DNA polymerases from the translesion synthesis (TLS) pathway (human DNA Pol η, 
κ, ι, for instance) also suffer from enzymatic rate reduction when faced with O6-MedG.45 The 
latter DNA Pol, particularly Pol η, will be discussed in greater detail below. Likewise, O4-MedT 
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stalls a variety of different DNA polymerases (both standard and TLS Pol).
22,47
 Perhaps more-
importantly, both of these alkylation sites cause significant misinsertions by DNA polymerase if 
acted upon.
48
 This mutagenesis can have profound effects on the organism given that newly 
synthesized genetic information may be compromised, thus enabling deleterious events at any 
point downstream. 
Organisms have, fortunately, evolved a wide variety of mechanisms to cope with the 
constant attack on DNA. Yet, a somewhat paradoxical event is triggered upon activation of the 






 The MMR 
machinery is capable of detecting mismatches incorporated into the primer strand (i.e. the one 
being grown). Upon excision of a DNA fragment containing the mismatch, DNA polymerases 
are capable of re-synthesis enabling the installment of the correct sequence identity. In the case 
where the lesion is found in the primer strand, the MMR pathway is capable of correcting the 
damage. In contrast, a lesion-containing template strand (i.e. the one being read by the 
replication machinery) will be detected and efforts to repair the DNA damage are futile. MMR 
recognizes the damage but its attempts at repair are only focused on the primer strand, allowing 
the lesion to remain unaffected in the template strand. This process is known as a futile excision-









of dG and dT, respectively, has been overviewed. However, bifunctional alkylating agents have 
the capability of extending the DNA damage profile, from simple mono-adducts, to an 
assortment of cross-links (ICL, IaCL and DPC illustrated in Figure 1.5). Historically, much 
focus has been bestowed to ICL lesions given their exceptional potency.
54
 It is estimated that 
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only 40 ICL lesions are required to cause cell death in repair deficient mammalian cells, and 
single ICL lesion is required to kill bacterial cell.
55,56
 This type of damage is exerted from 
compromising both DNA strands, and preventing DNA strand separation required for DNA 
replication and transcription, hence severely stalling proper cellular activity.
57
 The introduction 
of ICL in the DNA duplex can have profound, or minimal, effects on the global structure of the 
duplex. Higher levels of structure distortion normally correlate with higher levels of detection 
and repair.
57–59
 ICL are generated from a variety of agents including psoralens, mitomycin C, 
platinum compounds, nitrogen mustards and nitrosoureas, many of which have found use in the 
clinic.
57
 ICL are also generated by furocoumarins, which are produced naturally in certain 
plants.
60
 More recently, it was discovered that the presence of abasic sites in DNA can lead to the 
production of ICL lesions.
61–63
 Part of the reason why ICL have been extensively investigated is 
due to their poorly understood cellular repair.
54,57
 ICL DNA lesions are not repaired by only one 
pathway, but rather, the cell makes use of a combination of several repair mechanisms to restore 
the damaged DNA. Pathways such as nucleotide excision repair (NER), TLS, homologous 
recombination (HR), MMR, and Fanconi anemia (FA)-proteins have all been associated with 
ICL repair, which partly accounts for the high toxicity of ICL.
54
 Our group revealed the possible 
involvement of the direct repair pathway in the repair of ICL DNA linking the O
6
-atoms of two 
2'-deoxyguanosine residues, either in a directly opposing fashion or in a GNC motif.
64,65
 
In comparison, the genetic information of only one strand is compromised for IaCL-
containing DNA and certain of these lesions, like UV-induced CPDs, are readily removed by the 
NER machinery.
66–68
 IaCL lesions are produced from bifunctional agents, much like ICL lesions, 
but with the connectivity within one DNA strand (Figure 1.5). These are produced from cross-











 As shown in Scheme 1.1, the nitrosourea can form DNA mono-adducts via a 
reactive 1-hydroxy-2-alkyldiazene intermediate. If the alkyl(ene)-modification contains a second 
good leaving group (terminal chloro group, for instance), another nucleophile may attack the 
mono-adduct generating a cross-link (IaCL, for instance). The mechanism is slightly different in 
the case of the alkyl sulphone busulfan (Scheme 1.2A) or cisplatin (Scheme 1.2B). The N7-
position of dG is the preferred site of alkylation in these examples and, as mentioned above, the 
N7-alkylene-dG appendages are short lived (t1/2 = 1h for N7-dG alkylene ICLs).
73
 In contrast, the 
Pt-adduct are not prone to depurination.
54,74







 all of which are important and 




Scheme 1.2: Proposed mechanisms of IaCL production from (A) busulfan and (B) cisplatin.
69,80
 
Note that other mechanisms are possible and these constitute potential pathways to generate 
IaCL DNA. 
 
Examples of IaCL have demonstrated in vivo toxicity in repair-deficient cells.
81,82
 
Although NER is thought to readily remove most IaCL lesions,
67
 examples of IaCL adducts 
(certain cisplatin-induced, for instance) have shown to be shielded from the NER machinery by 
eliciting proteins containing high-mobility group (HMG) domains, both in vitro and in vivo.
83–85
 
NER displayed little to no capacity of repair because of binding of the protein to the damaged 
DNA.
86–88
 As a result, the biological consequences of IaCL warrants further investigation. The 
focus of CHAPTERS III-VI revolve around the study of IaCL lesions.   
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The bifunctional nature of the IaCL adduct within one DNA strand, generally leads to 
global structural distortions in the DNA duplex. In the case of UV-induced CPD lesions, the 





Similar trends are observed with the (6-4) pyrimidine-pyrimidone photodimer (chemical 
structure shown in Figure 1.1), which drastically influences both the local and global duplex 
structure.
90,91
 The cis-diammineplatinum(II) IaCL between adjacent dG residues, at their N7-
atoms, causes unwinding of the DNA at the platinated site and a considerable bend of the DNA 
towards the major groove, due to the adduct.
92
 In this example, it has been argued that the 
platinum(II)-mediated impact facilitates binding of proteins containing a HMG by opening up 
the minor groove of the duplex.
92
 Molecular dynamics simulations of the oxidatively generated 
dG[8,5-Me]dT IaCL have suggested bends of approximately 20
o
 with respect to the helical 
axis.
93
 More-recent, investigation has shown, however, that the dG[8,5-Me]dT IaCL may adopt a 
more favorable conformation, where the dT moiety is flipped out of the DNA duplex, rendering 
the overall structure more conical-like.
94
 To be noted is the aforementioned IaCL are all 
composed of rigid systems (minimal flexibility inherent to the cross-link linkage). The structural 
distortions induced by the IaCL can drastically interfere with the biological events as bending of 
DNA plays a critical role in tuning protein-DNA interactions.
95
 By the same token, it is these 
helix deformations that can alert the cellular repair response mechanisms.
59,96
 One example of a 
compound that generates flexible DNA lesions is BBR3464 (triplatin tetranitrate), which has 
undergone clinical trials.
97
 This drug generates long range (1,5) IaCL, in addition to (1,4) ICL, 
due to its two flexible alkylene linkers and proves to be very potent.
98,99
 Computational 
approaches suggest minimal global structural perturbations induced by this adduct and may 
account for, in part at least, its elevated toxicity.
98
 These bifunctional adducts can also interfere 
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with replication and transcription by blocking and inducing DNA Pol misinsertions. It may be 
that the bridge between the two nucleotides, residing on the same DNA strand, prevents 
malleability of the individual nucleotide units. This malleability may be necessary for proper 
activity of Pols (both kinetics and reading of the genetic information).  
Another example of deleterious cross-links are DPCs.
100
 DPCs are naturally occurring 
during biological processes and they are thought to be transient when enzymatically catalyzed. 
However, topoisomerases 1 and 2 (TOP1 and TOP2) are examples that can remain trapped as a 
DPC species.
101
 In this case, the enzyme nicks the DNA phosphodiester backbone, generating the 
DPC (between the Tyr and the 3’-phosphate group) and a single-strand break (SSB) containing a 
5’-hydroxyl. The free DNA can thus unwind for other biological process (like DNA replication), 
and after doing so, TOP1 ligates the SSB DNA, returning it back to its original state. Inhibition 
of the ligation steps, from DNA damage for instance,
102
 stalls the TOP1-mediated event to a 
stable DPC and a SSB. Formation of DPC can also arise from non-enzymatic sources such as 
bifunctional alkylating agents. One very simple example is formaldehyde, which can be 
produced endogenously.
103
 Although this compound may not normally be considered 
bifunctional in nature, it can undergo Schiff base formation with an initial amino group (from 
either the protein or DNA). This intermediate is the target of another nucleophile, such as 
another amino group, to produce a DPC bridged by a single methylene group. This process is so 
efficient that it has found applications in chemical biology to identify DNA-protein 
interactions.
104
 As with other type of DNA damage, dG seems to be the most reactive cross-
linking residue in DNA.
105
 Many amino acids have been identified as part of the cross-link, with 
Lys and Cys being the most prevalent.
105





 are also capable of generating DPC adducts. 
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Interestingly, ionizing radiation is efficient at generating DPCs in hypoxic conditions, relative to 
other types of damage like double strand breaks (DSB).
108
 DPCs are particularly cytotoxic 
because of their large size. They thus efficiently inhibit replication and transcription.
109
 
Depending on its site of attachment, their presence can interfere with unwinding of the DNA by 
stalling DNA helicase.
110,111




1.3 Direct repair and O
6
-Alkylguanine DNA Alkyltransferase 
1.3.1 General repair mechanisms 
 There exist a plethora of types of DNA lesions, with only a selected few examples briefly 
discussed above. While repair processes can be sophisticated, no single repair pathway can 
process all the forms of DNA damage. Rather, organisms have evolved a multitude of 
interwoven DNA repair systems. These can deal with most of the assaults inflicted on the genetic 
material. The focus of the thesis is on two such repair systems. The first is direct repair (also 
known as direct reversal) and the second is translesion synthesis. Other repair mechanisms, such 
as base excision repair (BER), NER, MMR, HR, and nonhomologous end joining (NHEJ) may 
be highlighted briefly (mostly for comparison). These repair pathways have been reviewed 




1.3.2 Direct repair 
 Direct repair is unique since it does not involve a re-synthesis step, as observed for other 
repair pathways. The proteins act directly on the DNA scaffold to remove the aberrant chemical 
bonds of additional appendages. Other than photolyases, all known direct DNA repair proteins 
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are involved in the removal of DNA alkylation.
125
 Photolyases, which have not been identified 
and are most-likely lacking in humans,
126
 utilize visible light to restore UV-induced DNA 
damage like TT CPD.
127,128
 These CPD photolyase enzymes function by clamping the DNA at 
the site of damage, inducing a gross conformational change. Using light of wavelength 350-450 
nm, the enzyme can undergo excitation and transfers the energy to the fully reduced flavin 
adenine dinucleotide (FADH
-
) cofactor. The excited co-factor in turn reacts with the CPD, 
ultimately causing a collapse of the CPD into its respective canonical pyrimidyl nucleobases.
127
    
 The AlkB protein family is another set of repair enzymes of the direct repair pathway.
129–
131
 These proteins make use of mononuclear Fe(II) as a cofactor, and α-ketoglutarate as a 
cosubstrate to repair alkyl lesions found on various DNA heteroatoms such as N1-methyl- and 
N1-ethyl-2'-deoxyadenosine (N1MedA and N1EtdA), etheno-2'-deoxyadenosine (εdA), and N3-
methyl-2'-deoxycytidine (N3-MedC).
130
 By using molecular oxygen as the second cosubstrate, 
alkyl lesions are oxidized to a hydroxyalkyl intermediate, which undergo spontaneous 
dealkylation (forming the corresponding aldehyde by-product). Interestingly, one of the sources 
for intracellular formaldehyde is this pathway given that formaldehyde can generate DPCs.  
1.3.3 O6-Alkylguanine DNA Alkyltransferase 
 O
6
-alkylguanine-DNA alkyltransferases (AGTs) are suicide repair proteins that require 
no co-factor, or co-substrate, to remove DNA alkyl lesions at the O
6





 This class of proteins irreversibly transfer the alkyl group from the DNA onto the 
thiolate of an activated Cys residue found in the active site, and in doing so inactivates the 
protein (Figure 1.6). The stoichiometric reaction proceeds via nucleophilic attack onto the α-
carbon of the alkyl lesion. Once alkylated, the protein is rapidly degraded by the ubiquitin 
pathway.
135
 The AGT proteins have a critical role in maintaining genomic integrity and span 
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over all kingdoms of life except plants.
132
 All proteins have a conserved -PCHRV- motif (Figure 
1.7) part of the active site (C denotes the position of the reactive Cys-residue).
136
 They share an 
Asn-hinge used to the induce flippling of the damaged nucleotide into the active site. Lastly, 
there is absolutely conserved helix-turn-helix (HTH) DNA binding motif consisting of -
RAV(A/G)- residues.   
 
Figure 1.6: Proposed mechanism of repair by hAGT. The network is similar to the catalytic triad 
of serine proteases, which deprotonates the active site Cys145. Cys145 gets deprotonated by 
water-mediated His146, to allow for the dealkylation reaction.
137





Figure 1.7: Sequence alignment of active site, asparagine hinge and recognition helix of AGT 




1.3.4 AGT homologues of interest 
 Different AGT homologues have evolved to act on a number of different substrates. Their 
substrate specificity is of interest to correlate a certain type of DNA damage to a, or many, repair 
pathway(s). This may eventually lead to the development of better chemotherapeutic regimens. 
Identifying a particular repair pathway responsible for restoring DNA damage that was induced 
by a specific drug can guide the next generation of drugs, or combination therapies. This has 
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been accomplished previously using O
6




 Historically, the first AGT to be identified and characterized was the E. coli adaptive-
reponse protein (Ada).
140,141
 The Ada protein was found to protect E. coli from methylating agent 
N-methyl-N-nitroso-N′-nitroguanidine (MNNG)142 and highly inducible.143 Ada has two distinct 
domains responsible for removal of alkyl lesions. The first, the N-domain, can act on the 
phosphodiester backbone to remove the methyl group of Sp-methyl-phosphotriester and is in 
charge of regulating expression (adaptive response).
144,145
 The C-terminal domain (also known as 
Ada-C) is capable of removing alkyl groups at the O
6
-position of dG (Me and Et) and O
4
-
position of dT (Me and Et).
146–148
 As of now, larger alkyl groups at these positions have shown 
no reaction in the presence of Ada-C.
65,146,149–151
     
 Later, it was discovered that E. coli possesses another AGT (OGT). Unlike Ada, this 
protein was not inducible and served as a frontline defense against DNA alkylation.
152
 It 
accommodates a wider scope of substrates in comparison to Ada, as shown by our group.
150
 




-MedG with approximately the same efficiency.
153
 
Interestingly, larger adducts at the O
4





hydroxyheptyl-dT, can undergo repair by OGT, whereas Ada-C and human AGT are 
inactive.
149,150




















-heptylene-dG nucleoside cross-linked with an O
6
-dG nucleotide part of 
an oligonucleotide.
143,150,154–156
 Recent work by McManus and Wilds showed that OGT had 




-alkyl-dU) compared to the dT 
series.
149
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 The human variant, hAGT, is the most-widely characterized AGT. One reason stems 





 (BCNU for instance).
132
 
hAGT, like OGT, is not inducible in the cell. To date, this AGT variant has the largest library of 
known substrates (Figure 1.8). It displays activity towards O
6
-alkyl-dG mono-adducted 
analogues, whereas it is limited to only O
4
-MedT for the pyrimidine series. It can repair cyclic 
anologues that link the O
6
-atom with the N1-atom by an ethylene bridge (eX in Figure 1.8). In 
doing so, the product is a stable DNA-hAGT DPC. The attachement to the N1-position prevents 
another hAGT molecule from reacting.
160
 The DPC species was later crystallized and played an 
integral part of the current understanding of the hAGT repair mechanism. Our group has shown 






 In contrast, this substrate generates an 
DPC linked at the O
6
-atom of dG after the first reaction, which in turn, is a substrate for a second 
repair event by another hAGT molecule. The final products are a hAGT-hAGT cross-link and 
the completely repaired DNA strands.  
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  Figure 1.8: Current substrate scope of hAGT (adapted from following reference).
132
  
1.3.5 AGT repair mechanism 
 One aspect that has remained elusive, despite structural investigation, is the exceptional 
rate of repair of DNA containing O
6






 for Ada-C, for instance) to 
overcome the energy barrier of severing the ether bond of O
6
-MedG, without the help of 
cofactors.
161
 The AGT-mediated repair mechanism was first devised using structural 
investigation on Ada-C, given that this protein was the first to be crystallized (manuscript 
published in 1994).
162
 It demonstrated that the reactive Cys residue was buried into the active site 
and that the protein would have to undergo a conformational rearrangement upon binding to its 
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DNA target. In doing so the activated thiolate would be situated in close proximity to the lesion 
allowing for a SN2-type attack. One challenge in using the Ada-C protein as the representative to 
illuminate the properties of the entire AGT family stems from the limited substrate range of Ada-
C relative to OGT and hAGT. There is currently no crystal structures of E. coli OGT and in the 
year 2000 two separate studies were reported on hAGT crystal structures.
163,164
 The structure of 
the alkylated version of hAGT provided insights on how the protein releases the repaired DNA 
substrate, and is subsequently destabilized to promote protein degradation (via ubiquitination).
164
 
It should be noted that crystal structures of the different AGT proteins have similarity despite 
having low sequence identity.
132
 Taking a closer look at hAGT, the protein is divided into two 
major domains. The C-terminal domain hosts the active site and the HTH motif. Through 
biochemical analyses, the N-terminal domain fosters the structural aspects that are crucial for the 
repair activity of hAGT.
165
 Deleting this domain from the protein removes activity. Interestingly, 
the N-terminal of hAGT contains a Zn binding site, which is not essential for repair to occur, but 
its presence increases the rate of repair.
166
 
 A study by Daniels et al. published in 2004, revealed many important aspects concerning 
the hAGT repair mechanism since previous crystal structures were of the native protein, or the 
protein (alkylated) product (i.e. post-repair).
137
 The report described two crystal structures 
involving hAGT complexes with DNA containing modifications, which provided insights on the 
potential intermediate states of repair. The first structure was a non-covalent complex between 
the impotent C145S hAGT variant and DNA containing an O
6
-MedG insert, and the second was 
a covalent DPC complex generated from the repair of DNA containing eX (Figure 1.8).
137
 These 
structures revealed that the mode of binding of hAGT with the alkylated DNA was through the 
minor groove, as opposed to the major groove, via the HTH motif. This observation was unique 
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in proteins containing a HTH that bind B-form DNA.
137
 Upon binding, the protein undergoes a 
minor conformational rearrangement, with one of the helicies from the HTH buried deep in the 
minor groove of the DNA (Figure 1.9). The binding widens the minor groove and allows for an 
arginine (Arg 128) to enter the DNA helix. Arg128 interacts with the base pair containing the 
damaged nucleotide to promote flipping of the alkylated nucleotide into the active site of the 
protein, where extrahelical repair may take place. Nucleotide flipping is aided by a tyrosine 
(Tyr114) residue which interacts with the 3’-phosphate of the damaged nucleotide. hAGT 
variants with this residue mutated to a phenylalanine (Y114F) or alanine (Y114A) have shown a 
reduction in repair rates by 30- and 600-fold, respectively.
167
 Computational studies have 
suggested that the Tyr114 interaction may have electrostatic character,
168
 as opposed to solely a 
steric contribution hypothesized by Daniels et al.
137
 Once flipped into the active stie of the 
protein, the extrahelical base is oriented inside the active site by a number of amino acids (shown 
Figure 1.9C and D). The lowering of the C145 pKa, and thus increase in reactivity, is attributed 
to the catalytic triad (Glu-His-water-Cys) hydrogen bond network.
136,137,164
  
 Understanding the mechanism of detection continues to be of interest for AGT. AGTs are 
capable of binding both single stranded and double stranded DNA, in a cooperative fashion.
169
 
This may serve as a type of recruitment mechanism to scan for specific regions of DNA that 
have undergone DNA alkylation. One hypothesis of DNA damage recognition is AGTs binding 
to the DNA and scanning via one-dimensional sliding.
125,137
 Alternatively, AGTs may be 
scanning DNA by a three-dimensional hopping mechanism.
137
 It is however, unclear how this 






Figure 1.9: (A) Binding mode of hAGT to DNA by the HTH motif. Note the minor groove 
binding. (B) Arg finger (Arg128) that protrudes the DNA helix and H-binds with orphaned 
nucleobase (dC in this case). DNA backbone is illustrated as as a yellow tube. (C)  Cutaway 
view C145S–O6-MedG active site. (D) Cutaway view hAGT– N1,O6-ethanoxanthine active site. 




1.3.6 Cytotoxic effects of hAGT 
 hAGT can have aberrant cellular effects, despite having a critical role in genomic 
maintenance. In the presence of bifunctional alkylating agents, it can follow a series of pathways 
to generate other types of DNA damage like DPCs and abasic sites.
132
 A general pathway is 







be produced at various positions on the DNA scaffold. More importantly, these products may be 
difficult to identify and isolate in biological settings, as these are most-likely transient (degraded 
by the cell). Procedures to generate chemically stable DNA-hAGT DPC species is thus of value. 
One approach was developed by McManus and coworkers from our laboratory using ICL 
DNA.
151
   
 
Scheme 1.3: Formation of DNA-AGT cross-links in the presence of bis-electrophiles (where X 
and Y represent the reaction centers and / or leaving groups). The chemical reacts with either the 
DNA or the protein first and subsequently reacts a second time with its counterpart to generate 
the DPC species. Since hAGT contains two Cys residues, two general DPC can be generated. 
Depending on the location of the linkage onto the DNA, multiple degradation pathways can 
occur if the DPC is chemically unstable. For instance, the linkage at the N7-atom leads to abasic 
site formation and hAGT functionalized with a guanine nucleobase.
170
 Mono-adduct formation 
would arise from hydrolysis of one of the electrophilic centers. 
1.3.7 Application of hAGT in Biotechnology 
 Because hAGT is capable of repairing a wide scope of substrates, including the free 
guanine nucleobase, more-recent developments have allowed for the generation of hAGT 
proteins fused with functional groups. O
6





derivatives functionalized at the para-position have shown to be well-tolerated by hAGT.
172
 This 
allows for the specific tagging of hAGT with virtually any para-functionalized benzyl adduct, 
which has found biotechnological applications and is known as the SNAP-tag.
172–178
 In essence, 
an hAGT (or hAGT variant) is fused to a target protein and subsequent reaction with a labeled 
O
6
-benzylguanine derivative supplies a final labeled covalent complex. This technology offers a 
variety of benefits including low off-target effects and exceptional orthogonality given that O
6
-
benzylguanine derivates are specific to hAGT.     
1.4 Translesion Synthesis (TLS) and DNA Polymerase η 
1.4.1 DNA Pols and replication 
DNA polymerases catalyze the duplication of DNA by incorporating portions of reactive 
building blocks known as 2’-deoxyribonucleoside triphosphates (dNTPs, Figure 1.10) into a 
growing (primer) DNA strand. It discriminates which nucleotide to incorporate in the primer 
strand by reading the template strand. There are currently 17 known human DNA Pols. Of these 
only five are involved in the standard genomic and mitochondrial DNA replication (Pol α, δ, ε, 
and γ and telomerase).179 DNA Pols heavily involved in DNA replication, also known as 
replicative DNA Pols, have exceptional kinetics and fidelity associated with their activity.
180
 
Moreover, these Pols are extremely diligent in incorporating the correct nucleotide in the primer 
strand, meaning they have high fidelity.
181,182
 In the case of Pol δ for instance, the fidelity is 
approximately 1 error for every 10
5
 nucleotides read. In addition, this polymerase (and others) 
possesses an exonuclease domain that can excise the misinserted nucleotide and allow for 
correction by the Pol (and contributes another 10-60 fold increase in fidelity).
181,182
    In spite of 
their high fidelity, these Pols have an extreme intolerance for modification to the DNA. Even 




-atom of dG and dT, 
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respectively, for instance) can severely stall DNA replication. TLS is activated when repair 
mechanisms are unable to act on certain DNA damage, or when the damage evades these repair 
pathways. It had been hypothesized that the cell had to have coping mechanisms to 
accommodate irreparable DNA damage, yet, it was only within the past two decades that 
specialized DNA Pol were characterized as playing an integral part via TLS.
183,184
 This specific 
pathway does not repair the damage per se, but rather, bypasses it in order to alleviate the 
replication stall. Organisms from all kingdoms of life have evolved many Pols capable of 
carrying out TLS and part of the focus of this dissertation is on one Y-family DNA Pol (Pol 
η).185 Currently, four known Y-family DNA Pols have been identified in humans; Pol η, Pol ι, 
Pol κ, and Rev1. Pols from the Y-family are characterized as having low fidelity and processivity 
(nucleotide incorporation rates) for unmodified DNA. In addition, these proteins lack a 
proofreading domain, which contributes to their lowered fidelity. Their active sites are generally 
larger and is one of the contributors as to why they can accept a wider range of substrates during 
catalysis. Once thought to be “jacks-of-all-trades”, evidence suggests that these proteins have 
specifically evolved to cope with defined types of DNA damage.
186
 This remains an ongoing 




Figure 1.10: (A) The general chemical structure of dNTPs is shown, as well as a non-
hydrolyzable analogue dNMPNPP. The latter has an (α-β) imido moiety which prevents cleavage 
of this bond by DNA Pols. These analogues have found applications in X-ray crystallography of 
ternary complexes.
187
 (B) Simplified illustration of DNA primer extension from a DNA 
polymerase reading the template strand. In this case, the polymerase would have to incorporate 
dC mono-phosphate into the primer for the correct insertion. For simplicity, no general base and 
acid are shown although they play a critical role in the catalysis. Note the bond severing of the α- 
and β-phosphate group, as the 3’-OH attacks the α-phosphate group. The reactant is a dNTP, the 
2'-deoxynucleoside monophosphate (dNMP) gets incorporated into the primer strand.  
 
DNA Pols have three ubiquitous subdomains; the thumb, palm, and finger. The first 
crystal structure of these proteins, Klenow fragment of E. coli, was reported in 1985.
188
 Since 
then many crystal structures have been reported and, despite varying sequence identity, there are 
strikingly common structural features across all cases.
189,190
 They all share a similar catalytic 
domain architecture, resembling that of a right hand. Subdomains were named accordingly 
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(thumb, palm and finger domains).
191
 Each of these has specific roles in catalyzing DNA 
extension. Briefly, the DNA lies in the palm domain, where the chemical bond formation occurs. 
Any of the four nucleotides can bind to the binary complex. Yet, it is with the finger domain that 
the correct or wrong dNTP is detected. If incorrect, the polymerase will remain in an open form 
and allow for dissociation and re-association of another dNTP. There are a number of structural 
reasons as to why the DNA polymerase remains in the open form, such as interference with the 
optimal geometry of the template or primer strands, wobble base pairing, or fraying of the DNA 
at the insertion site.
192,193
 If the selection is detected as correct, the polymerase rearranges into a 
“closed” form.194 The closed state generates the binding site in the palm domain for the newly-
formed base pair with the incoming nucleotide and the template nucleotide. This allows for the 
subsequent chemical bond formation. 
Catalysis is dependent on the binding of two divalent metal ions (normally Mg
2+
, but 
others have been shown to work like Mn
2+
, but not Ca
2+
). The chemistry occurs on the primer 
DNA via a nucleotidyl-transfer reaction. A new bond is formed between the 3’-OH of the primer 
DNA and the α-phosphate of the dNTP, whereby the phosphodiester bond between the α- and β-
phosphates is cleaved (Figure 1.10B). The reaction is assumed to go through a pentavalent 
phosphate intermediate via an addition-elimination mechanism.
195 DNA and RNA polymerases 
and many nucleases seem to follow this two-metal-ion-dependent mechanism.
196
 Kinetic 
measurements, computational, and structural studies have all guided the understanding of the 
mechanism involved in DNA chain extension. That is, crystal structures of ternary complexes (E 
• Dn • dNTP; Figure 1.11) in the presence of Ca
2+
 (which prevents efficient activity by DNA 
Pols) have illustrated the geometric configuration of the active site prior to the reaction. Kinetic 
studies, such as the pre-steady-state, suggest that gross conformational rearrangement occurs by 
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substrate binding, followed by the rate limiting step which is a second conformational change in 
the active site.
193,197,198
 It was only until recent that the process of DNA replication was 
visualized via multiple static snapshot images during bond formation.
198
 This study was 
accomplished using DNA Pol η, the model Y-family translesion synthesis Pol described in this 
thesis (CHAPTERS II and VI), and its mechanism of bypass will be described in greater detail 
below.   
 The mechanism by which DNA gets extended is an assembly of six or more steps 
(Figure 1.11).
193,199
 Referring to Figure 1.11, the first step is complexation of the enzyme with 
the DNA duplex. The binding occurs in a given directionality such that the shorter DNA 
fragment is oriented for 5’→3’ extension catalysis. The binding of the dNTP generates the 
ternary complex (step 2), which entices the finger domain to close if the geometric and energetic 
“price-is-right”. The enzyme reaches an excited state (step 3), where the chemistry occurs 
generating an extension of the DNA primer by one unit and pyrophosphate (step 4). The ternary 
complex then relaxes to ground state (step 5) followed by release of the pyrophosphate by-
product. The cycle can halt by releasing of the DNA (step 7), or enter a second round of catalysis 
(step 8). Step 8 can only be achieved after movement of the polymerase along the 





Figure 1.11: General catalytic mechanism for DNA polymerases. The figure illustrates a 
minimal mechanism required for DNA polymerization. E, Dn, and dNTP represent the enzyme, 
DNA and 2’-deoxynucleoside triphosphate, respectively. E* stands for the excited state and 
figure was adapted from the following reference.
199
 Note that the each intermediate can have a 
conformational rearrangement associated with it or possess another state that is inactive. One 





1.4.2 Y-family DNA Pols  
The basic mechanism of TLS is illustrated in Figure 1.12. The first step is a stall 
occurring in face of a replicative DNA Pol. The TLS pathway is activated and the current Pol is 
removed and replaced by a TLS Pol. This stall-rescue mechanism allows the TLS Pol to add 
directly across the modified template nucleotide, or slightly past the damaged site. The activity 
of TLS Pol will be error-free or error-prone (i.e. high or low fidelity, respectively) depending on 
the type of DNA damage and the specific TLS Pol activated. Note that a second TLS Pol may be 
called upon after the extension from an initial Pol. Once canonical DNA is restored past the 
damage site, the original replicative Pol is reactivated.
200
 The are numerous proposed interactions 
between different DNA Pols within cellular context and this remains an ongoing investigation.
199
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The Y-family DNA Pols have the largest class of TLS Pols. There are two members of 
the Y-family DNA polymerase in Saccharomyces cerevisia (yeast; yRev1 and yPol η). As 
mentioned above, human Y-family Pols have four current members (Rev1, hPol ι, hPol κ, and 
hPol η), each having their own substrate profile. Rev1 is said to be unique across all Pols given 
its exceptional capability of incorporating dC across dG templates.
201





 and N2-dG adducts.
203
 It was later discovered that the preference for dC was a feature 
specific to REV1 since this protein flipped out the template nucleotide and used its own active 
site (Arg residue) as the reading template, which was true for both yRev1 and human Rev1.
204,205
 
Pol ι is capable of correctly incorporating dT across dA and is also capable of extending across 
N2-dG adducts.
200,206
 However, this Pol has difficulty in extending templates containing dT 
stretches, which was attributed to its mechanism of extension.
206
 It turns out Pol ι utilizes the 
Hoogsteen face of the nucleobase, as opposed to the Watson-Crick face, to read the template. In 
this manner, it is capable of proficient extension across dA nucleotides (dAMP).
206
 Pol κ has 
shown to generate frameshift adduct formation (skipping a template nucleotide, generating a 
product that is n-1 in length), when carrying out DNA replication and is also capable of 
extending across N2-dG adducts.
200
 Moreover, hPol κ is capable of extending past the damaged 
site with fidelity (e.g. once the nucleotides have been incorporated directly across the damage).  
1.4.3 Human DNA Pol η 
The most widely studied TLS Pol is DNA Pol η, primarily because improper function of 
the POLH gene leads to the disease xeroderma pigmentosum variant (XPV).
207
 These patients 
suffer from sunlight hypersensitivity and higher incidents of cancer, particularly of the skin.
207,208
 
Interestingly, the XPV cells are NER-proficient, whereas conventional xeroderma pigmentosum 
(XP) is characterized by having dysfunctional NER machinery. XPV are especially sensitive to 
UV radiation, which epitomized the importance of the hPol η in the protection against UV-
induced DNA damage. In 2004, it was identified that hPol η was capable of bypassing the cis-syn 
TT CPD (Figure 1.1), which accounted for experimental evidence of hPol η's involvement in 
TLS against UV-induced insults.
209
 It was only later, in 2010, the first crystal structure of hPol η 
was reported in the presence of non-hydrolyzable dNMPNPP (Figure 1.10), undamaged DNA or 
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DNA containing a cis-syn TT CPD insert.
187
 It was noted that, like all other Y-family DNA Pol, 
hPol η contained an additional domain called the little finger (LF).187 The structure revealed that 
the protein acts as a splint, by enforcing an almost-canonical B-form structure on the DNA 
duplex containing the CPD damage. Alone, the CPD-containing duplexes have gross structural 
perturbations.
89
 Moreover, other structures of repair protein complexed with DNA containing the 
TT CPD also didn't force the duplex back into canonical shape.
210,211
 The larger active site of the 
protein allows for the entire CPD to be present and enables selectivity for the correct incoming 
nucleotide to undergo catalysis. Residues Gln38 and Arg61, uniquely conserved across all Pol η 
homologues, were found to have a crucial role in guiding the incoming nucleotide.
187
 The bypass 
mechanism was extrapolated from four crystal structures with DNA containing modifications in 
varying positions along the template strand (Table 1.1), along with an unmodified duplex. This 
enabled static snapshots at different "simulated" stages of insertion (e.g. before the first insertion, 
at the first insertion, second insertion, and post insertion) (Figure 1.13). From TT1 and TT2, the 
study revealed that both nucleotides of CPD retained H-bonding with the incoming nucleotide, 
which was different from a replicative Pol (bacterial T7) complexes with DNA containing a CPD 
insert.
187,212
 In the latter case, only one nucleotide part of the IaCL was H-bonding. Both cross-
linked residues are interacting with Gln38 via the O2-atoms. The importance of Gln38 was 
verified using the Q38A variant, which lowered overall catalytic efficiency and promoted stall of 
the enzyme at the stage equivalent to TT3. In TT3, Gln38 aids the template base to stack with the 
CPD, consequently allowing for proper alignment necessary for primer extension. The Arg61 
residue, on the other hand, seems to coordinate the incoming nucleotide by interacting with the 
N7-atom of dG (or dA) and the phosphate groups of the triphosphate moiety. Polymerase 
efficacy was also reduced for the R61A variant, and this variant caused purine misinsertion into 
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the primer (dG compared to dA) across the TT CPD. All crystal structures revealed that hPol η 
keeps the DNA aligned and rigid because of a positively charged surface in contact with a span 
of four nucleotides upstream (towards the 5'-end) of the active site. The little finger domain 
possesses a β-strand, which runs along the DNA template and heavily interacts with it via H-
bonding of the protein amide backbone, in addition to side chain interactions with the sugar-
phosphate DNA backbone.   
Table 1.1: Structure name, protein, DNA sequence and incoming nucleotide studied by 
Biertümpfel et al.
187
 The DNA sequence displays the varying positions of the modification (TT 
in red). 
Structure name DNA sequence Incoming non-hydrolyzable dNTP 
Nrm 3' - TCGCAGTATTACT- 5' 
5'- TAGCGTCAT 
dAMPNPP 
TT1 3' - TCGCAGTATTAC- 5' 
5'- TAGCGTCAT 
dAMPNPP 
TT2 3' - CGCAGTATTCAAT- 5' 
5'- TGCGTCATA 
dAMPNPP 
TT3 3' - CGCAGTATTCAAT- 5' 
5'-  ACGTCATAA 
dGMPNPP 
TT4 3' - CGAGCATTACTAC- 5' 






Figure 1.13: (a) Crystal structure overlay of TT1, TT2, TT3 and TT4 DNA with the DNA in 
Nrm (undamaged). The CPD modifications are shown as red sticks. Spheres are Mg
2+
 ions. (b–
d) The replicating base pairs in the four ternary complexes hPol η residues (note Q38 and R61) 
that contact nucleobase and incoming dNMPNPP. H-bonds are shown as dashed lines. The 





Since its discovery, a multitude of different DNA lesions have been tested against bypass 
by hPol η. Studies are normally carried out using in vitro DNA primer extension as a 
representative model. The identification of plausible substrates is difficult to predict and, more 
often than not, is carried out by trial and error.        
1.4.4 Bypass of O6-alkyl-dG, O4-alkyl-dT and IaCL 
The objective of this section is to briefly review a few key studies that have been reported 





dT and IaCL since CHAPTERS II and V focus on O
4





-dG IaCL, respectively. This will allow to situate these two studies in the context of 
the current literature. Although literature directly pertaining to these studies are reviewed in each 
individual chapter, this section will elaborate further.  
A thorough investigation of O
6
-alkyl-dG mono-adducts bypass by hPol η, hPol κ, and 
hPol ι  was reported in 2006 by the Choi et al.45  The study focussed on the effect of bulk at the 
O
6
-atom of dG by using three adducts; the Me, benzyl (Bn) and 4-oxo-4-(3-pyridyl)butyl (Pob) 




-BndG could be bypassed by 
replicative bacterial DNA Pols, whereas the O
6
-PobdG stalled the enzymes.
213
 Moreover, the O
6
-
PobdG is a well-known tobacco-derived carcinogen.
214–216
 hPol κ and ι mainly produced 




-BndG insert in the template. 
These two TLS Pols were both blocked by the O
6
-PobdG modification, suggesting that steric 
bulk influences the activity of hPol κ and ι. Yet, hPol η was capable of bypassing all three 
modifications with varying efficiencies (all reduced compared to unmodified DNA). Steady-state 
analysis revealed hPol η and κ inserted the pyrimidines (the correct dC (dCMP) and incorrect dT 
(dTMP) nucleotides) across the O
6
-alkyl-dG adducts, while hPol ι exclusively misinserted 
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dTMP. hPol η caused frameshift adduct formation (-1) in the case of O6-PobdG, and in doing so 
stalled after adding across the subsequent template nucleotide.  
In terms of O
4









 by various Pols including some 
from the Y-family. The O
4
-MedT cause blockage of the yPol η and hPol κ, and upon bypass, 
both enzymes caused dG nucleotide (dGMP) misinsertions across the modification. A similar 
profile was observed for O
4
-EtdT, tested against hPol η, hPol κ, and hPol ι with an error-prone 
behavior for all three Pols (dGMP preferantial misinsertion). It was noted that hPol ι was capable 
replicating one nucleotide across the O
4
-EtdT modification but was stalled subsequently. hPol κ 
proved inefficient in bypassing the O
4
-EtdT, whereas hPol η was capable of bypassing and 
extending past the lesion. Together, these results support the mutagenicity O
4
-alkyl-dT lesions 
despite action by TLS Pols. It is unclear however, how this effect was exerted by such small 
lesions.      
hPol η is proficient in bypassing the UV-induced d(TT) CPD IaCL, but is also capable of 
efficiently bypassing other CPD adducts d(TU)
218
 CPD and other derivatives.
219
 The d(CT) and 
d(TC) CPDs are chemically unstable and undergo deamination to generate the 2'-deoxyuridine 
(dU) analogue.
220
 A CPD of dT and N
4
-methyl-dC is chemically stable but induces misinsertions 
by hPol η and prevents fully extended products past the misinsertion.221 Strikingly, hPol η is 
incapable of pyrimidine (6-4) pyrimidone IaCL adduct bypass.
82
 For DNA containing the 
d(G[8,5-Me]T) IaCL, hPol η performed mostly error-free DNA replication, with more difficulty 
across the dG portion of the IaCL.
222,223
 Evidence suggests that the inverted IaCL, d(T[5-
Me,8]G), is more problematic for DNA replication machinery in vivo.
222
 Studies using yPol η 
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demonstrated capability of bypass of the d(G[8,5]C) IaCL with error-prone profiles for the dG 
portion, as with the d(G[8,5-Me]T) IaCL.
78
 
 Another noteworthy aspect of hPol η is its potential role in chemotherapeutic resistance 
by efficiently bypassing lesions generated from drugs in the clinic, such as cisplatin and 
oxaliplatin.
71
 hPol η is capable of bypassing the most-abundant Pt-dGG lesion adduct, but 
inefficient at extending past the lesion site.
224–227
 Structural investigation of the ternary complex 
revealed that the enzyme conformationally rearranges the DNA backbone of the template to 
catalyze efficient insertion opposite the modification, much like the d(TT) CPD IaCL.
227
 The 
conformation of the Pt-dGG lesions in the active site is different from the CPD, most-likely due 
to its larger size. The short loop R61-M63 is shifted to accommodate the entire IaCL dimer. The 
5'-dG part of the lesion is held in a syn conformation about the glycosidic bond during insertion 
across the 3'-dG. This is primarily due to the steric constraints imposed by the Pt-lesion (≈30° 
roll angle). During the second insertion, this roll is forced onto the 3′-dG part of the lesion, 
allowing proper geometry of the 5'-dG residue to H-bond with the incoming nucleotide. Once 
insertion across both nucleotides part of the IaCL is carried out, the lesion protrudes the major 
groove of the DNA causing an entire shift of the LF domain. The molecular splint imparted from 
the protein is thus compromised and severely hinders Pol activity by allowing the damaged 
nucleotides to clash with the incoming dNMPNPP. The enzyme remains capable of inserting one 
nucleotide past the damage site, but is then stalled.
227
 




 A major objective of the thesis was the synthesis of DNA containing site-specific 
modifications, on scales and purities amenable to structural and biochemical investigation. The 
DNA probes were utilized to shed light on different cellular response mechanisms such as AGT-
mediated repair and bypass by hPol η. Moreover, certain probes were designed to efficiently 
generate DPC between DNA and AGTs, which may find applications in structural biology or 
chemical biology. 
 There are two general methodologies that can be used in the production of DNA 
modifications. In one approach, unmodified DNA can be treated with certain exogenous 
chemicals that will generate the desired lesion on the DNA. This approach has been fruitful in 
identifying a number of different adducts that have formed at specific sites of alkylation (IaCL 
formed at the N7-atom of neighbouring dG residues,
69
 for instance). However, this methodology 
is inefficient in producing large quantities of a desired site-specific modification, particularly for 
adducts part of the minor products, given that a number of unwanted side products are formed 
simultaneously in the DNA. Moreover, isolating the desired product from by-products may be 
virtually impossible in high yield and purity with current separation techniques. The second 
methodology, used by a number of research groups including ours, employs a combination of 
solution and solid-phase synthesis (SPS) to generate DNA with site-specific and well-defined 
modifications. This avenue is particularly effective given that the DNA strand is specifically 
tailored using chemical synthesis entirely. 
 The O
4
-alkyl-dT series have been investigated to a lesser extent compared to their O
6
-
alkyl-dG counterpart families. Previous studies, from our group and others, have established that 
AGTs can efficiently discriminate against these two types of alkylation damage. More-recently, 
evidence using a conformationally-locked analogue of O
6
-alkyl-dG has suggested that the 
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orientation of the alkyl group affects repair efficiency by hAGT.
228
 Interestingly, the latter 
analogue locked the α-carbon (where nucleophilic attack occurs) in an anti conformation with 
respect to N1-atom, and was a poor substrate of hAGT. In contrast, the eX  modification (Figure 
1.8), which locks the α-carbon in syn conformation with respect to the N1-atom, was efficiently 
repaired by hAGT.
137,160
 The repair of DNA containing eX by hAGT generated the DPC, which 
was later crystallized and the X-ray crystal structure was determined.
137
 We initially developed 
analogous constructs for the O
4
-alkyl-dT series to further probe repair by various AGTs. To our 
dismay, these novel constructs remained inert to AGT-mediated repair (mentioned in 
CHAPTER IV). This was not surprising for hAGT given that O
4
-MedT is poorly processed by 
this protein. It is also known that O
4
-alkyl-dT are poor substrates of mammalian repair pathways 









 using recombinant translesion DNA Pols. However, no 
structural insights have elucidated why these lesions cause certain DNA Pols to miscode. In 
addition, our conformationally locked analogues (bicyclic systems) could offer insights on the 
impact of the lesion restriction on the bypass by DNA Pol η. The latter protein was utilized as the 
model translesion DNA Pol.     
 The occurrence of IaCL damage has been identified and sources for their production have 
been well-established and characterized. There has been growing evidence, however, that 
attributing their repair solely to the NER machinery may not have been unequivocally accurate. 
As mentioned above, translesion synthesis, particularly by Pol η, plays a pivotal role in genomic 
maintenance against DNA damage (including IaCL DNA) in eukaryotes.
186
 It would thus appear 
that exact cellular processing mechanism of IaCL DNA is not fully elucidated and most-likely 
depends on the nature of the IaCL DNA and perhaps the frequency of occurrence. Our group has 
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suggested a potential role for AGTs in the repair of ICL DNA
64,65,150,151
 and this may hold true as 
well for similar adducts, in an IaCL motif. This was a recurring objective in CHAPTERS III, 
IV, and VI.  
 Moreover, the strategy we devised to introduce IaCL in DNA allowed for the production 
of two sets of similar adducts; one lacking the phosphodiester linkage between the cross-linked 
residues, and another set containing this linkage. The former set of IaCL DNA would be 
inherently more-flexible. We could then probe the influence of the phosphodiester linkage on the 
AGT-mediated repair of IaCL DNA (CHAPTER IV). A similar approach was taken to identify 
the influence of the phosphodiester group on the bypass of IaCL DNA by hPol η (CHAPTER 
V).  
 Using the conclusions drawn from CHAPTER III and VI, and the substrate specificity 
of various AGTs, novel IaCL DNA probes were designed, prepared, and tested against AGTs 
(CHAPTER VI). As hypothesized, new DNA-hAGT conjugates were prepared with excellent 
conversions and increased versatility compared to previously developed ICL probes.
151
 
1.5.2 Arrangement of the thesis 
CHAPTER I 
 This chapter supplies highlights concerning DNA damage and the consequences of such 
damage on cellular activity. DNA alkylation is briefly overviewed with selected examples. The 




-alkyl-dT is highlighted. The biological 
consequences of ICL, IaCL, and DPC lesions are briefly described. The direct repair pathway is 
overviewed with a focus of AGT-mediated repair. Finally, TLS by Y-family DNA Pols is 









-EtdT. These adducts link the C5-atom of the pyrimidine ring with the O
4
-atom by an 
ethylene or an n-propylene bridge. Once incorporated into DNA oligomers, biophysical studies 
demonstrated minor differences between the open-chain analogues, with respect to those that 
were conformationally constrained. Bypass studies using DNA Pol η on the templates containing 
the adducts demonstrated a clear variance between all the modifications. Crystal structures of 
ternary complexes of hPol η, incoming dA or dG nucleotide, and DNA containing O4MedT or 
O
4
EtdT supplied additional insights concerning the error-prone behavior of hPol η towards these 
adducts. That is, the structures involving DNA containing O
4
MedT revealed an unprecedented 
conformational geometry of the nucleobase in the active site of hPol η. 
CHAPTER III 




-dG IaCL mimics, lacking the phosphodiester 
linkage the cross-linked site, were synthesized and AGT activity towards them was evaluated. 
The biophysical studies demonstrated a reduction in the thermal stability due to the presence of 
the IaCL, while retaining the overall B-form duplex DNA. Finally, hAGT was capable of 
efficiently repairing the model IaCL DNA, with greater efficacy towards the heptylene IaCL 
DNA. This demonstrated the potential capability of hAGT-mediated repair of IaCL DNA 
CHAPTER IV 




-dG IaCL containing the phosphodiester 
backbone were prepared synthetically. Duplexes containing the IaCL DNA demonstrated a 
decrease in thermal stability compared to the unmodified duplex. Interestingly, the thermal 
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profiles were in agreement with the identical IaCL lacking the phosphodiester linkage. The 
global DNA structure was not substantially affected, as assessed by circular dichroism. Repair 
assays of these IaCL demonstrated only moderate repair by hAGT, with  much lower efficiency 
compared to the model IaCL lacking the phosphodiester group, which suggested that repair may 
be dependent on the lesion's orientation and/or flexibility. This chapter also reported the efficient 
repair of the single-stranded IaCL DNA mimic synthesized in CHAPTER III.  
CHAPTER V  
 The IaCL DNA prepared in the previous two chapters were evaluated for bypass 
processivity by hPol η. The bypass profiles were significantly different for IaCL containing the 
phosphodiester backbone linkage (GpG4 and GpG7), in comparison to those lacking it (GG4 
and GG7). Steady-state kinetic evaluation revealed blockage of hPol η by the presence of the 
IaCL in all cases, relative to the unmodified control. The enzyme incorporated the correct dCMP 
across the first adducted O
6
-alkylene-dG nucleotide (3'-dG) but demonstrated error-prone 
behavior across the second O
6
-alkylene-dG (5'-dG). Frameshift adduct (-1) formation was a 
major product observed in the replication of the 5'-dG of GG4 and GG7, whereas dTMP was 
incorporated at the highest frequency for GpG4 and GpG7. An increase in IaCL linker size, 
from butylene to heptylene, resulted in an increase in the rate of misinsertions by hPol η.  
CHAPTER VI  
Efficient production of site-specific DPC species may find use for a variety of different 
biotechnological applications. Towards this end, DNA linking two thymidine residues, or linking 
a thymidine residue to a 2’-deoxyguanosine residue (either in a 5’→3’ or 3’→5’ fashion), 
lacking a phosphodiester linkage at the cross-linked site, were synthetically prepared. In light of 
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the results acquired throughout the previous chapters, we anticipated efficient repair by AGTs 
towards the newly prepared IaCL. All IaCL DNA displayed similar UV thermal denaturation 
profiles, with a decrease in thermal stability relative to the unmodified duplex DNA. Circular 
dichroism signatures revealed little global structural distortions induced in the duplex by the 




-thymdine (TT4 and TT7) and the 
(5’→3’)  O6-2’-deoxyguanosine-alkylene-O4-thymdine (GT4 and GT7)  IaCL DNA adducts 
were inert against any of the AGT tested (hAGT, OGT, and Ada-C). The (5’→3’)  O4-thymdine-
alkylene-O
6
-2’-deoxyguanosine (TG4 and TG7) IaCL DNA containing butylene or heptylene 
tethers were efficiently repaired by the human variant, whereas Ada-C was capable of modestly 
repairing the heptylene IaCL adduct. The IaCL DNA were utilized to conjugate hAGT to the 3’-
end of the DNA strand in excellent yields with short reaction times using single stranded TG4 
and TG7, as well as GG4 and GG7 (single-strand repair of GG4 and GG7 by hAGT was first 
reported in CHAPTER IV). DPC products were characterized by SDS-PAGE and LC-MS.  
These IaCL expand the toolbox of strategies to site-specifically conjugate hAGT with DNA. 
hAGT was functionalized with a fluorescently-labelled DNA IaCL sequence as an example to 
show the feasibility of this method. 
CHAPTER VII 
This final chapter summarizes the results and general conclusions resulting from 
CHAPTER II - CHAPTER VI, as well as suggestions for future directions concerning the 
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DNA lesions that elude repair may undergo translesion synthesis catalyzed by Y-family DNA 
polymerases. O
4
-Alkylthymidines, persistent adducts that can result from carcinogenic agents, 
may encounter DNA polymerases. The influence of lesion orientation around the C4-O
4
 bond on 





-ethylthymidine, and analogs restricting the O
4
-methylene group in an 
anti-orientation. Primer extension assays revealed that the O
4
-alkyl orientation influences hPol  
bypass. Crystal structures of hPol •DNA•dNTP ternary complexes with O4-methyl- or O4-
ethylthymidine in the template strand showed the nucleobase of the former lodged near the 
ceiling of the active site, with the syn-O
4
-methyl group engaged in extensive hydrophobic 
interactions. This unique arrangement for O
4
-methylthymidine with hPol , inaccessible for the 
other analogs due to steric/conformational restriction, is consistent with differences observed for 
nucleotide incorporation and supports the concept that lesion conformation influences extension 















DNA alkylation results from a variety of endogenous and/or exogenous agents that can 
interfere with vital cellular processes, i.e. replication and transcription.
31
 The addition of alkyl 
appendages on the DNA scaffold can have adverse consequences such as DNA polymerase (Pol) 
blockage, nucleotide misincorporation, chromosomal instability, and activation of the cellular 
apoptotic pathway.
18,31
 However, organisms have various repair pathways to restore damaged 
DNA. In the event that a lesion evades the process of DNA repair, translesion synthesis (TLS) by 
Y-family DNA Pols can occur, allowing bypass of the DNA lesion in an error-free or error-prone 
manner.
200
 Y-family DNA Pols are described as more "promiscuous" given their larger active 
sites when compared with replicative DNA Pols, which accounts for their ability to bypass 
damaged nucleotides that induce blockage. DNA Pol η in humans (hPol η) plays a pivotal role in 
the bypass of certain UV-induced DNA damage, which impedes DNA replication.
209
 hPol η 
activity has also been correlated with chemotherapeutic resistance to platinum-based agents such 






-position of thymidine is susceptible to alkylation by agents such as N-nitroso 
alkylamines, in certain foods, water, air, and particularly tobacco products.
231,232
 Albeit a minor 
















-EtdT hinder high fidelity replicative DNA Pol activity, resulting 
in misinsertion of dGTP in the daughter DNA strands.
21,22,234
 Correlations between the 
mutagenicity of O
4
-MedT and cancer have been established,
20,40
 highlighting the importance of 
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investigating the structural properties and biological outcomes associated with this type of DNA 
damage.  
The current understanding of the mechanism of Y-family DNA Pol misincorporation 
during TLS depends on a number of factors, including the nature of the DNA damage, the DNA 
Pol and the incoming nucleoside triphosphate. The geometrical array of the ternary complex 
formed (involving DNA, protein and nucleoside triphosphate) is the key characteristic that 
governs efficient bypass of a DNA lesion. Structural investigation by NMR and X-ray 
crystallography of duplexes containing an O
4
-MedT insert has revealed that the methyl group 
preferentially adopts a syn conformation around the C4-O
4
 bond (Figure 2.1).
25,235
 We 
hypothesized that the conformation of the O
4
-alkyl lesion could affect the base pair geometry 
during the primer extension reaction catalyzed by DNA Pol η. To address this possibility, we 
probed hPol η processivity with thymidine analogs that link the C5 and O4 atoms by a 
dimethylene or trimethylene group, which limits the O
4
-lesion to adopt an anti-conformation 
(Figure 2.1) to relate the structural features of O
4
-alkylated dT with the bypass activity of hPol 
η.  
We investigated bypass profiles opposite all four lesions by hPol  (steady-state single 
nucleotide incorporation and LC-MS/MS analysis of full-length extension products). Crystal 





-EtdT reveal a distinct orientation of the former lesion that stacks atop 
a tryptophan residue near the ceiling of the active site instead of pairing with the incoming 
nucleotide. Conversely, O
4
-EtdT pairs with both incoming A and G via bifurcated H-bonds in the 
insertion complexes and displays the same configuration opposite primer dG in the crystal 
structure of an extension complex adjacent to the nascent dG:dCTP pair. The structures provide a 
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-EtdT lesions in hPol -





2.2.1 Synthesis and characterization of modified oligonucleotides 




-EtdT and the modified pyrimidyl nucleosides 3-(2´-
deoxypentofuranosyl)-5,6-dihydrofuro[2,3-d]pyrimidin-2(3H)-one (DFP) and 3-(2´-
deoxypentofuranosyl)-3,5,6,7-tetrahydro-2H-pyrano[2,3-d]pyrimidin-2-one (TPP) are shown in 
Figure 2.1 (methods describing the preparation of nucleosides and oligonucleotides can be found 
in the section 2.6). UV thermal denaturation studies of duplexes containing single inserts of the 





with complementary strands containing adenine or any mismatched base pairing partner (Figure 
S2.6).  Circular dichroism spectra of duplexes containing the DFP or TPP inserts revealed little 
deviation from a B-form structure (see Figure S2.7). 
2.2.2 Steady-state kinetics 





-EtdT, DFP, TPP and unmodified dT were carried out with the catalytic core construct of hPol 
η (amino acids 1-432). In all cases, these pyrimidyl modifications blocked DNA synthesis by the 
polymerase relative to the unmodified control (Figure 2.2a, values shown in Table S2.1). 
Incorporation of the correct dAMP nucleotide by hPol η opposite to O4-MedT, O4-EtdT, DFP, 
and TPP was reduced approximately 6.5-, 12-, 4.5-, and 5-fold, respectively, relative to dT (see 








-EtdT, (d) DFP and 
(e) TPP adducts.  In bold are the bonds between the atoms shown to have a syn (b and c) 
or anti (d and e) orientation around the O
4
-C4 bond. Full primer extension assays for the control 




-EtdT, DFP, and TPP-bearing substrates with hPol η. 
The template strand sequence is 3’-AGCATTCGCAGTAXTACT-5’ where X denotes the 
modification and the 5’-FAM labeled primer strand sequence is 5’-TCGTAAGCGUCAT-3’. 
 
hPol η incorporated dCMP and dTMP opposite all the pyrimidyl modifications and dT 
with similar catalytic efficiencies (ranging from approximately 0.002-0.015 μM-1 s-1). However, 
a strong preference for either dAMP or dGMP incorporation opposite the modified pyrimidines 
was observed. Other than O
4
-MedT, hPol η preferentially incorporated the correct dAMP 
nucleotide opposite all the pyrimidyl modifications. The significant incorporation of dGMP 
when hPol η encountered these pyrimidyl modifications, compared to the unmodified control, 





MedT, dGMP was slightly preferred as the nucleotide incorporated by hPol η (0.19  ± 0.01 vs. 
0.18  ± 0.03 μM-1 s-1 for dGMP and dAMP, respectively). 
2.2.3 LC-MS/MS Analysis of Full-length Extension Products Produced by 
hPol η 
 Analysis of single insertions by a DNA polymerase is useful for kinetic evaluation but 
may not reflect incorporation fidelity in the presence of all four dNTP across the damage and 
beyond this site.  The fidelity of hPol η and its processivity past the damage site was addressed 
by the use of a full extension assay coupled with LC-MS/MS analysis.
45,229,236
  
The optimal reaction times to observe the full extension products from the template 
strands containing the modifications and the unmodified control were evaluated (Figure 2.1). 
Full extension was achieved for the unmodified control at 30 min, whereas templates containing 
the modifications required longer reaction times (60-90 min). The time course assay revealed 
that hPol η had difficulty in extending past O4-MedT and O4-EtdT and displayed a significant 
“S+1” band at reaction times of 30 and 60 min. UPLC separation of the cleaved products and 
mass spectrometry analysis of their sequence identities revealed that dGMP was incorporated 










and TPP by hPol η with individual dNTPs. (b) Incorporation frequencies based on ESI-MS/MS 




-EtdT, DFP, and TPP 
containing templates ("_" indicates frameshift adduct formation. Tabulated fragments identified 
by LC-MS/MS analysis of full-length extension products can be found in Appendix II). 
 




-EtdT, DFP, and TPP for the full 
extension products was evaluated (see Figure 2.2b and Table S2.2).  The presence of O
4
-MedT 
increased the level of frameshift formation by hPol η relative to the control (9.5 vs. 3.5%). 
Comparable levels of frameshifts were observed opposite O
4
-EtdT and the dT control. However, 
the templates containing the bicyclic pyrimidine adducts did not induce a similar increase in 
frameshift formation with levels that were approximately one-half, relative to the control. The 
correct dAMP nucleotide was incorporated by hPol η at a frequency of approximately 30, 24, 22, 




-EtdT, DFP, TPP, and dT, respectively. Out of the lesions 
investigated, hPol η exhibited the highest fidelity opposite O4-MedT and lowest opposite the 
TPP. Incorporation of dGMP was observed to occur in the extension products with overall 




-EtdT, DFP, TPP, and dT, 
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respectively. The accuracy of bypass varied for the O
4
-alkylthymidine modifications by 
approximately 2:1 in favor of dGMP opposite O
4
-MedT to 5:1 in favor of dGMP opposite TPP. 




-EtdT and DFP to TPP, resulted in a 10% increase 
of dGMP misinsertion at the expense of a 10% decrease of the correct dAMP incorporation. 
Similarly, the conformationally restrained analogues (DFP and TPP) induced an increase in 
dGMP misinsertion (10%) by hPol η compared to O4-MedT and O4-EtdT, respectively. 





-EtdT at the Insertion Stage 




-EtdT lesions at the active site of hPol trapped at the 
insertion stage, we determined four crystal structures of ternary complexes with the Pol bound to 
a 12mer template strand with the incorporated lesion and paired to an 8mer primer and incoming 
purine nucleoside triphosphate. For details regarding the crystallization, data collection and 
structure determination and refinement procedures please see the section 2.6. Selected crystal 
data, data collection and refinement parameters and examples of the quality of the final electron 
density for all structures are summarized and depicted in the Table S2.3. The two complexes 
with O
4
-MedT-containing templates and incoming dATP or dGMPNPP reveal similar 
orientations of the lesion (Figure 2.3, PDB ID codes 5DLF and 5DLG, respectively). Instead of 
pairing with the incoming nucleotide, O
4
-MedT is lodged near the ceiling of the active site. Thus, 
its base portion is nestled against Trp-64 (base stacking interaction), Met-63 and Ser-62 
(hydrophobic contacts between O
4
-Me and both C and C(=O) from the two residues) from a 
loop region in the finger domain and Gly-46 from an adjacent -strand that together form the 




-MedT and the amino group of Asn-
38 are H-bonded (Figure 2.3b,d). This position of the O
4
-MedT lesion at the entrance of the 
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Figure 2.3: Detached arrangement of incoming purine nucleotide triphosphate and O
4
-MedT in 
two hPol  insertion-stage complexes. (a), Active site conformation in the complex with dATP 
opposite O
4
-MedT viewed into the DNA major groove, and (b), rotated by 90° and viewed 
perpendicular to the adenine plane. (c), Active site conformation in the complex with dGMPNPP 
opposite O
4
-MedT, viewed into the DNA major groove, and (d), rotated by 90° and viewed 
perpendicular to the guanine plane. Carbon atoms of O
4
-MedT, the incoming nucleotide 





 ions are cyan and pink spheres, respectively, and selected 
H-bonds are shown as dashed lines.  
 
Closer inspection of the positions of the incoming nucleotides shows that adenine stacks 
on the adjacent t(emplate)A:p(rimer)T pair, with the side chain of Arg-61 from the finger domain 
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hovering closely above the adenine plane and engaged in H-bonds to the - and -phosphates of 
dATP via its guanidino moiety (Figure 2.3b). By comparison, guanine is shifted into the minor 
groove and the stacking interaction with the adjacent tA:pT pair is slightly less favorable. The 
shift is likely a consequence of the altered orientation of the Arg-61 side chain that is extended in 
the structure of the complex with dGMPNPP, resulting in formation of H-bonds between its 
guanidino moiety and guanine O
6
 and N7 (Figure 2.3d). The particular orientation of the 
incoming dG brings it closer to Asn-38 from the finger domain, but the distance of 3.64 Å 
between N2 of the former and the O1 oxygen of asparagine is slightly too long for formation of 
a H-bond.  
A surface rendering of the hPol  active site in the O4-MedT insertion-stage complex 
with the incoming dATP indicates that the nucleobase moiety of the lesion fits snugly into the 
gap between Trp-64 and Ser-62 (Figure S2.16). It is clear that O
4
-EtdT (with the ethyl group in 
the syn conformation) cannot be accommodated in the same fashion, as the longer substituent 
would clash with residues from the finger domain. Instead, the O
4
-EtdT lesion has been pulled 
inside the active site and pairs with incoming dAMPNPP or dGMPNPP via bifurcated H-bonds 
in the two crystal structures of insertion-stage complexes with this lesion (Figure 2.4a-d, PDB 
ID codes 5DQG and 5DQH, respectively). As in the complexes with O
4





-EtdT in the minor groove. However, unlike in the O
4
-MedT complex with 
incoming dGMPNPP, the side chain of Arg-61 in the corresponding complex with O
4
-EtdT does 
not adopt an extended conformation to contact the major groove edge of guanine. As can be seen 
in Figure 2.4, Arg-61 is directed toward the triphosphate moiety and forms a salt bridge with the 
-phosphate group in both insertion-stage complexes. The methylene group (C1) of the O4 
substituent in O
4
-EtdT adopts an anti conformation in the complex with dAMPNPP (torsion 
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angle C1-O4-C4-N3 = -142°) and a syn conformation in the complex with dGMPNPP (torsion 
angle C1-O4-C4-N3 = +62°). This is a clear difference to the structures of complexes with O
4
-
MedT, both of which show the lesion adopting a syn conformation (torsion angles C1-O4-C4-N3 





-EtdT complexes is constituted by the orientations of template 
nucleotides 5-adjacent to the lesions. In the former, A2 and T3 form a stack with Trp-42 outside 
the active site (Figure 2.2). In the O
4
-EtdT complexes, A2 is located outside the active site and 
forms a stacking interaction with Trp-42. However, T3 sits inside the active site and stacks onto 
O
4
-EtdT (dAMPNPP complex; Figure 2.4a). In the complex with dGMPNPP, T3 juts into the 
major groove (Figure 2.4c). Thus, neither orientation adopted by T3 in these complexes 
resembles that of O
4
-MedT, lodged near the ceiling of the active site and stacked onto Trp-64.  
2.2.5 Crystal Structure of a Ternary hPol •DNA•dCTP Extension-Stage 
Complex with O
4
-EtdT Paired Opposite Primer dA 
 The structure of a complex with O
4
-EtdT paired to dA at the -1 position followed by 
template dG opposite incoming dCTP was determined at 2.05 Å resolution (Figure 2.4e,f, PDB 
ID codes 5DQI). The geometry of the O
4
-EtdT:dA pair replicates that seen in the insertion 
complex with O
4
-EtdT opposite incoming dAMPNPP (Figure 2.4a,b and 2.4e,f). As in the case 
of the latter, the ethyl group has moved outside the thymine plane and adopts an anti orientation 
(torsion angle C1-O4-C4-N3 = -135°). The base pair itself adopts a Watson-Crick like geometry 
with formation of a single H-bond; the adjacent dG:dCTP pair displays a standard geometry with 
three H-bonds. Arg-61 is directed toward the phosphate moieties of the incoming nucleotide and 
forms two salt bridges with the - and -phosphate groups, and Asn-38 is engaged in two H-





Figure 2.4: Pairing between incoming purine nucleotide triphosphate and O
4
-EtdT in two 
hPol insertion-stage complexes (a - d). (a), Major groove view of the Watson-Crick pair 
between dAMPNPP and O
4
-EtdT with formation of bifurcated H-bonds. (b), The active site 
rotated by 90° relative to A, with the base pair viewed perpendicular to the adenine plane. (c), 
Major groove view of the sheared configuration between dGMPNPP and O
4
-EtdT, with 
formation of bifurcated H-bonds. (d), The active site rotated by 90° relative to C, with the base 
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pair viewed perpendicular to the guanine plane. Carbon atoms of O
4
-EtdT, the incoming 
nucleotide triphosphate, and selected hPol amino acid side chains are colored in maroon, 
orange and magenta, respectively. Mg
2+
 ions are cyan spheres and selected H-bonds are shown 
as dashed lines. Active site configuration in a ternary hPol  extension-step complex with O4-
EtdT opposite primer dA, followed by template dG opposite incoming dCTP (e - f). (e), Major 
groove view of the active site, with carbon atoms of O
4
-EtdT and the paired dA colored in 
maroon and light blue, respectively. Carbon atoms of the nascent dG:dCTP pair are colored in 
orange, carbon atoms of selected hPolamino acid side chains are colored in magenta, and those 
of the 3’-terminal primer dC are colored in purple. (f), The active site rotated by 180° relative 
to A and viewed into the minor groove. 
 
The most unusual feature of the extension-stage structure is the presence of an additional 
nucleotide at the 3-end of the primer (Figure 2.4f). Because the crystallization solutions 
contained dCTP and the residual electron density is consistent with a pyrimidine, we extended 
the primer by dC (Figure S2.17). We suspect that hPol  possesses weak catalytic activity with 
Ca
2+
 as the cofactor or that traces of Mg
2+
 present in the crystallizations led to primer extension 
in situ (even a very low activity could result in extension by a single nucleotide over the course 
of two weeks). We showed earlier that the translesion DNA polymerase Dpo4 from Sulfolobus 
solfataricus is able to catalyze nucleotide insertion with Ca
2+
, although the activity is far below 
that seen with Mg
2+
 as the prosthetic group.
237
 The additional dC stacks against the backbone of 
the template strand in the minor groove and its position is further stabilized by two H-bonds 
between N3 and O2 and the guanidino moiety of Arg-111 (Figure 2.4f).  
2.3 Discussion 
The known toxicity of alkylated adducts at the O
4
-position of thymidine prompted us to 
explore the influence of restricting orientation of the alkyl group around the C4-O
4
 bond to an 
anti conformation in translesion synthesis catalyzed by hPol η. In these studies, the bicyclic 
pyrimidine analogs DFP and TTP, which link the C5 and O
4
 atoms with a di- or trimethylene 
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linker, were evaluated in addition to O
4
-MedT and the bulkier O
4
-EtdT lesion. Conformationally 
locked analogs of damage that can occur at the nucleobase have been previously synthesized and 
employed in studies which have provided insights into the requirements for DNA repair 
processes.
137,228
 In addition, DNA containing DFP and TPP were evaluated for AGT-mediated 
repair and experiments revealed no activity towards these modifications (data shown in 
CHAPTER VI, Figure S4.17).  
UV thermal denaturation studies of oligomers containing DFP and TTP revealed similar 










-EtdT.  NMR studies of a duplex containing an O
4
-MedT•dG pair 
revealed, in addition to the O
4
-methyl group adopting a syn-conformation, that the base formed a 
Watson-Crick “like” pairing with a single hydrogen bond.26 In this structure, the syn-orientation 
of the O
4
-Me group influences the hydrogen bond between the imino proton of dG and the N3 
atom of O
4




 atoms of dG and O
4
-MedT, 
respectively. Limiting the orientation of the methylene group at the O
4
-atom to the anti-
conformation, in the case of the DFP and TTP modifications, appears to have a minimal impact 
on the interaction with dG and duplex stability.  In pairing with dA, a similar drop in duplex 





DFP, and TTP modifications.  The NMR structure of a duplex containing a O
4
-MedT•dA pair 
indicated that the O
4
-Me group is syn and that the bases adopt a wobble alignment with one 
hydrogen bond formed between the imino nitrogen of O
4
-MedT and the amino group of dA.
25
 
The restricted anti-orientation of the methylene group for DFP or TPP modifications does not 







Steady-state kinetics of individual nucleotide incorporation opposite the DFP and TTP 
modifications by hPol η demonstrated preferred insertion of purine nucleotides relative to the 




-EtdT. The efficiency of nucleotide insertion (kcat/Km) 





-EtdT.  For dGMP, a similar efficiency of nucleotide insertion occurred for DFP, TPP, and 
O
4
-MedT whereas a drop was observed for O
4
-EtdT. In agreement with studies involving 
Saccharomyces cerevisiae DNA polymerase η (yPol η), a reduction in incorporation efficiency 
due to the presence of an O
4
-MedT insert was observed.
47
 However, whereas the yeast homolog 
revealed a significant preference for dGMP, which was incorporated approximately 80 times 
more efficiently than dAMP,
47
 hPol η displayed almost equal selectivity at incorporating dAMP 
(f = 0.94) as dGMP opposite O
4
-MedT. A comparable 80-fold preference for dGMP over dAMP 
was exhibited by yPol η for the bulkier O4-carboxymethylthymidine lesion.238 The rationale for 
the preferred incorporation of dGMP opposite O
4
-MedT by yPol η was attributed to a dG•O4-
MedT wobble base pairing. Differences observed for nucleotide incorporation opposite O
4
-MedT 
by the yeast and human homologs of Pol η may be influenced in part by different sequence 
contexts, as previously observed.
229,239
 In addition, homologs of Pol η have exhibited differences 
in nucleotide incorporation across some types of DNA damage. For example, yPol η accurately 
inserts dCMP across 8-oxodG whereas hPol η is less accurate inserting some dAMP across this 
lesion as well.
229,240
 Interestingly, similar misinsertion profiles have been observed in bypass 
experiments of hPol η and yPol η with O6MedG, a lesion which also protrudes in the major 
groove of the DNA duplex.
241
  
For the bulkier O
4
-EtdT and conformationally restricted analogs DFP and TTP, a 
preference for nucleotide incorporation of dAMP over dGMP was observed. For O
4
-EtdT, hPol η 
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, respectively. These values are approximately two-fold lower compared to those 
observed for the O
4
-MedT-containing template, but can be rationalized by the increased bulk of 
the ethyl group, which may influence dNTP incorporation in the hPol η active site. Ethylation of 
the O
4
-position of dT has been shown to stall the human Y-family DNA polymerases hPol κ and 





 Bypass of O
4
-EtdT by hPol η revealed dGMP misincorporation at 55 % 
compared to 19 % for dAMP insertion, in agreement with our data despite different sequence 
contexts. 
For the conformationally restricted DFP and TPP modifications, incorporation efficiency 




, respectively) and 
comparable for dGMP relative to O
4
-MedT.  These results demonstrate that hPol η is more 
proficient at incorporating both the correct (dAMP) and incorrect (dGMP) nucleotides across 
from these more conformationally restricted lesions. In addition, the increase in steric bulk from 
the DFP to TPP slightly decreases incorporation efficiency. Exposure of the hydrogen bonding 
face of the DFP or TPP modifications may have a greater influence on stabilizing the wobble 
alignment geometry that has been suggested for the O
4
-MedT•dA pairing. The conformational 
restriction of the alkyl group to an anti-orientation around the C4-O
4
 bond, as in the DFP and 
TPP modifications, would direct the O
4
-methylene group away from the amino group of dA, 
which could account for the enhancement of incorporation of the correct nucleotide (dAMP) 
compared to O
4
-MedT. Incorporation of dGMP may not be as influenced by orientation of the 
alkyl group around the C4-O
4
 bond as the proposed hydrogen bonding interaction, based on the 
NMR structure of the duplex containing the O
4
-MedT•dG, which occurs between the amino 
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 In the case of O
4
-EtdT, the combination of the syn-
orientation and the size of the ethyl group may both contribute to the reduced efficiency of 
nucleotide insertion of dAMP and dGMP in this series. 





-EtdT, DFP, and TTP modifications demonstrated that hPol η was proficient at 





EtdT exhibited a greater accumulation of non-full length oligonucleotide products at reduced 
reaction times (30 and 60 min), which was not observed for bicyclic DFP or TPP analogs.  The 
LC-MS/MS analyses of the extension products from the in vitro primer bypass studies revealed 
that dGMP incorporation across the lesion was preferred over dAMP in all cases except the 
control (dT). The ratio of dGMP:dAMP incorporation by hPol η, assessed from the extension 
products, was found to decrease in the series TPP (4.6:1) > DFP (3.3:1) ≈ O4-EtdT (3.2:1) > O4-
MedT (2.1:1).  The presence of the larger alkyl group for O
4
-EtdT or the analogs with the O
4
-
methylene group in an anti-conformation (TPP and DFP) clearly promotes dGMP 
misincorporation in the presence of all four nucleotides. In addition, the DFP and TPP 
modification were not found to induce a significant amount of frameshifts in the products 
compared to O
4
-MedT.  Differences in fidelity observed between the steady-state kinetic and 
LC-MS/MS full-length experiments have been observed previously.
45,47
 The variance may be 
attributed to accommodation of the incoming dGTP relative to dATP for these modifications, 
highlighting that adduct size and the conformation of the O
4
-methylene group can influence 
interactions in the active site of hPol η.  In the case of the analogs investigated, hPol η continued 
extension of the primer in an error-free manner after incorporation of dATP or dGTP across from 
the damaged site on the template.   
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Several observations based on nucleotide incorporation profiles attest to the distinct 
effects on hPol  bypass synthesis exerted by the O4-MedT and O4-EtdT lesions. These concern 
(i) the more error-prone bypass caused by O
4
-MedT, i.e. dGTP is favored relative to dATP 
(Figure 2.2a), (ii) increased accumulation of the +1 product in the full-length extension reaction 
for O
4
-MedT (Figure 2.1), and (iii) significantly more frameshift products caused by the O
4
-
MedT lesion (Figure 2.2b). Interestingly, the structural data for insertion-stage hPol  




-EtdT in the template strand reveal starkly different 
orientations of the two adducted nucleotides at the active site. O
4
-MedT is trapped in an 
orientation that keeps it at a considerable distance from the incoming purine nucleotide 
triphosphates. Conversely, O
4
-EtdT pairs opposite both dATP and dGTP with formation of 
bifurcated H-bonds (whereby the latter pair features a sheared orientation of the two partners, 
with G being pushed toward the minor groove). The increased proclivity for insertion of dG 
opposite O
4
-MedT compared to O
4
-EtdT is not surprising if one considers the strict preference 
by the O
4
-methyl substituent for a syn conformation. The syn conformation precludes adoption of 
an O
4
-MedT:dA pair with standard Watson-Crick geometry, but the sheared pairing mode seen 
in the case of O
4
-EtdT:dG(MPNPP) (Figure 2.4c,d), also presumably adopted by the O
4
-
MedT:dG pair, is compatible with a syn conformation of the substituent. This conclusion is borne 
out by the observations that the ethyl moiety in the O
4
-EtdT:dA(MPNPP) pairs assumes an anti 
conformation (Figs. 2.4a,b,e,f), whereas its conformation is syn in the O
4
-EtdT:dGMPNPP pair. 
Furthermore, the TPP adduct opposite dGMPNPP was modeled from the O
4
-EtdT:dG(MPNPP) 
ternary crystal structure coordinates. The configuration of the adduct seen in the model is 
consistent with the enhanced incorporation of dG observed in the primer extension experiments 
since the constrained anti conformation of the bicyclic system does not hinder the guanine 
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nucleobase from shifting towards the major groove and potentially form two H-bonds with TPP 
(Figure S2.18).    





-EtdT is consistent with the structural data that show the former is not engaged opposite the 
incoming nucleotide but trapped adjacent to the ‘entrance’ of the active site. Perhaps the more 
pronounced accumulation of the +1 product in the case of the full-length extension reactions 
opposite O
4
-MedT compared to the other O
4
 adducts tested here are the result of non-templated 
insertion. Thus, purine nucleoside triphosphates would be favored and their incorporation would 
not be affected by the particular conformation of the O
4
-methyl group, syn or anti. This scenario 
is certainly not inconsistent with the structural data that reveal no interaction between the O
4
-
MedT lesion and the incoming dATP or dGMPNPP. Clearly, it is intriguing that both activity 




-EtdT lesions for bypass 
by hPol . However, it is important to note that the position of the O4-MedT lesion at the active 
site, unique among all crystal structures of hPol  complexes analyzed to date, represents one 
state during bypass. Perhaps other orientations and interactions of the adducted nucleotide occur 
during bypass, which precludes all steps involved in the mechanism of O
4
-alkyl bypass synthesis 
by hPol Yet, we have provided intriguing insights on a potentially different bypass mechanism 
of O
4
-MedT in comparison to the larger O
4
-EtdT adduct.   
2.4 Conclusions 
Oligonucleotides containing DFP and TPP, designed as analogs of O
4
-alkylated 
thymidine, were synthesized to explore the influence of limiting the O
4
-alkyl lesion to an anti-
orientation on nucleotide incorporation by hPol η. These modifications were shown to destabilize 
the DNA duplex, based on UV thermal denaturation studies, regardless of the base-pairing 
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-EtdT. Primer extension assays demonstrated 
that these pyrimidyl modifications hindered nucleotide incorporation by hPol η. Single 
nucleotide incorporation studies revealed increased selectivity towards dAMP over dGMP that 
followed the order O
4
-EtdT > DFP ≈ TPP. A slight preference for dGMP over dAMP 
incorporation was observed for O
4
-MedT. LC-MS/MS analysis of primer extension studies (in 
the presence of all four dNTP) revealed that hPol η incorporated dGMP over dAMP across the 
lesions in the order TPP > DFP ≈ O4-EtdT  > O4-MedT. These trends suggest that limiting the 
orientation of the O
4
-alkylene group enhances the proficiency of dNTP incorporation by hPol η 
across O
4
-alkylated dT damage.  In the presence of all four dNTP, error-prone nucleotide 
incorporation by hPol η is enhanced by restricting the O4-lesion to an anti-orientation. This study 
exemplifies how restricting a lesion's conformational freedom impacts bypass profile by hPol η. 
Moreover, our results supply mechanistic insights on the mutagenicity of the biologically 





2.5  Acknowledgements 
 We thank the Natural Sciences and Engineering Research Council of Canada (Grant No. 
299384-2011 to C.J.W.), the Canada Research Chair Program (Grant No. 950-213807 to C.J.W.) 
and the US NIH for financial support (Grants No. ES010375 to F.P.G. and M.E., Grant No. 
CA160032 to M.E., and ES010546 to F.P.G.). D.K.O. thanks NSERC for a Canada Graduate 
Scholarship (CGS) and Michael Smith Foreign Study Supplement Scholarship, and the NSERC 
CREATE Program in Bionanomachines for support of an exchange with Vanderbilt University. 
Vanderbilt University is a member institution of the Life Sciences Collaborative Access Team at 
sector 21 of the Advanced Photon Source, Argonne, IL. Use of the Advanced Photon Source at 
69 
 
Argonne National Laboratory was supported by the United States Department of Energy, Office 
of Basic Energy Sciences (grant DE-AC02-06CH11357).  
2.6 Supporting information 
2.6.1 Supplementary Discussion 
2.6.1.1 Synthesis and characterization of nucleosides. 




-EtdT in DNA oligomers has been described 
previously.
242
 The chemical synthesis for phosphoramidites 2.6a and 2.6b is shown in Scheme 
S2.1. Precursors 2.1a and 2.1b were prepared according to published procedures.
243–247
 Modified 
heterocycles 2.2a and 2.2b were obtained by a base-catalyzed intramolecular reaction under 
protic conditions.
244,245
  Attachment of heterocycles 2.2a or 2.2b to commercially available 1-
(α)-chloro-3,5-di-O-(p-toluoyl)-2-deoxy-D-ribose (Berry and Associates) by an uncatalyzed 
Vorbrüggen-type coupling yielded compounds 2.3a and 2.3b in moderate yields.
248
 Resolution of 
the mixture of anomers for the latter coupling was challenging.  Column chromatography 
using solvent systems such as CH3OH:CH2Cl2, EtOAc:hexanes, and CH3CN:CH2Cl2 with 
shallow gradients afforded low, if any, resolution of the anomeric mixture.  The desired β-
anomer was resolved by recrystallization from boiling EtOAc (1:1 EtOAc:hexanes, v/v for 2.3a 
and 100% EtOAc for 2.3b). Resolution of the anomers could also be accomplished by first 
protecting the free alcohol functionality with a tert-butyldimethylsilyl (TBS) group, followed by 
column chromatography (EtOAc:hexanes mobile phase) to separate the anomers. Subsequent 
removal of the TBS group supplied pure 2.3a and 2.3b. The bicyclic pyrimidines 2.4a and 2.4b 
were synthesized by first mesylating the terminal hydroxyl group followed by intramolecular 
cyclization in dilute basic conditions under reflux. A saturated solution of ammonia in methanol 
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removed the toluoyl groups followed by protection of the 5´-hydroxyl group with DMTr to yield 
mono-protected nucleosides 2.5a and 2.5b, which were then phosphitylated with N,N 
diisopropylaminocyanoethylphosphonamidic chloride in the presence of diisopropylethylamine 
to produce phosphoramidites 2.6a and 2.6b. 
31
P NMR signals were observed at 148.27, 148.11 
ppm for 2.6a and 148.30, 148.03 ppm for 2.6b, indicating the presence of the non-hydrolyzed 
phosphoramidite group.   
2.6.1.2 Synthesis of DNA containing single modification inserts.   
 The solid-phase syntheses of DFP and TPP containing oligonucleotide sequences were 
performed on a 1.5 μmol scale using either phosphoramidite 2.6a or 2.6b, respectively. Given the 





deprotecting”  3´-O-2´-deoxyphosphoramidites were employed (dissolved to a concentration of 
0.1 M in anhydrous acetonitrile) with phenoxyacetic anhydride used as the capping agent to 
prevent an undesired N-acetylation reaction that could occur with acetic anhydride.
249
 
Phosphoramidites 2.6a or 2.6b were dissolved in acetonitrile to a concentration of 0.12 M with a 
coupling time of 600 s (as opposed to 120 s) to ensure optimal production of the desired full-
length oligonucleotides. 





 These conditions employed treatment of the support bound 
oligonucleotide with a 0.05M solution of K2CO3 in anhydrous CH3OH for 3.5 h at room 
temperature in the dark. The resulting crude DNA solution was neutralized with acetic acid to 
prevent oligonucleotide damage during the evaporation of the solvent in the centrifugal 
concentrator. The resulting pellet was taken up in NaOAc (0.1M), desalted, and reconcentrated. 
The DNA sequences were purified by SAX-HPLC (see Figure S2.1 for the HPLC 
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chromatographs) and subsequently desalted. ESI mass spectrometry of representative 
oligonucleotides SDFP and STPP (with the sequence 5’-GGCTXGATCACCAG-3’ where X is 
DFP and TPP for SDFP and STPP, respectively) revealed they had molecular weights of 4276.3 
and 4290.8 Da (expected 4276.8 and 4289.9 Da), consistent with the expected values (see 
Figures S2.2 and S2.3 for the mass spectra). For longer deprotection time under the same 
conditions, ESI-MS revealed the formation of a product with a mass 32 Da higher than expected. 
This was most-likely due to the attack of the methoxide nucleophile on the bicyclic pyrimidine 
moieties during the deprotection step. The composition of SDFP and STPP was further confirmed 
by enzymatic digestion to their constituent nucleosides with a mixture of snake venom 
phosphodiesterase and calf intestinal phosphatase followed by C18 RP-HPLC analysis (see 
Figures S2.4 and S2.5 for the chromatographs). The presence of the DFP or TPP nucleosides 
was established by the appearance of one additional peak to the four standard nucleosides, which 
eluted from the HPLC column with a retention time of 7.7 min for the DFP nucleoside and 9.1 
min for TPP nucleoside. The later elution of the TPP relative to the DFP nucleoside can be 
attributed to the presence of additional methylene linkage in the former which increases its 
hydrophobicity. UV scans of DFP and TPP revealed that they had a reduced absorbance at 260 
nm (the wavelength at which absorbance is monitored by the HPLC detector to detect the elution 
of nucleosides from the C18 column) relative to the four other nucleosides. Thus the C18 RP-
HPLC experiments were simultaneously monitored at both 260 and 300 nm for the modified and 
standard nucleosides. 
2.6.1.3 UV thermal denaturation of DNA duplexes and mismatch studies.   
 The influence of the DFP and TPP modifications on duplex stability was assessed by UV 
thermal denaturation experiments involving oligonucleotides SDFP and STPP hybridized to 
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complementary DNA (see Figure S2.6). The melting curves of the duplexes containing DFP or 
TPP were sigmoidal with a comparable hyperchromicity between them that was slightly higher 
relative to the control duplex.  The melting temperatures observed for duplexes containing DFP 
or TPP with adenine as the base pairing partner on the complementary strand were 48 and 49 
o
C, 
respectively, a significant reduction relative to the control duplex (62
o





EtdT were found to have melting temperatures of 51 and 52 
o
C, respectively, 
comparable to the destabilizing influence of O
4
-alkylated dT in DNA duplexes that has been 
reported previously.
250,251





-EtdT suggest that the rigidity of the bicyclic pyrimidine system bears little impact 





been shown, through NMR
25
 and computational studies,
252
 to adopt a wobble base pairing motif 
when paired with a dA residue.  Given the similar trends observed in the Tm values, it is 
reasonable to expect that DFP and TPP can engage in similar hydrogen bond interactions when 
paired with adenine.     
 The influence of other base pairings involving the DFP and TPP modifications were also 
studied by UV thermal denaturation experiments. The Tm values of duplexes containing these 




-EtdT when mispaired against cytosine or 
thymine. An increase in Tm was observed for all the O
4
-alkylated thymidine analogs with 
guanine as the base pairing partner relative to the other pairings. These findings for duplexes 










-EtdT modifications reported biphasic thermal profiles with purine mispairs.
250,253
 
However, this behavior was not observed in this study, perhaps due to differences with the 
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sequence investigated. Cruzeiro-Hansson and Goodfellow’s computational analysis showed that 




 In this 
orientation, there are three hydrogen bonds between guanine and methylated thymine, namely 






 (weak), and N1H-N3 (weak), respectively. The bicyclic 
constructs of DFP and TPP inherently lock the methylene group in the anti conformation, 
however, hydrogen bonding interactions between the same atoms as the O
4
-MedT·dG pair is 
possible. 
2.6.1.4 Circular dichroism spectroscopy and molecular modeling of DNA 
duplexes.   
 CD spectra of duplexes composed of DFP and TPP paired against adenine on the 
complementary strand were acquired at 15 
o
C. The spectra (see Figure S2.7) displayed typical 
B-form DNA signatures with a wavelength maximum of 280 nm, an intercept at approximately 
260 nm, and a minimum around 250 nm, similar to the DNA duplex control (containing a dT·dA 
base pair). This suggests that the presence of the bicyclic pyrimidine moiety had a minimal 
influence on the global DNA structure, similar to what has been observed previously in NMR 









-EtdT·dA, DFP·dA or 
TPP·dA pair were constructed using Hyperchem® 7.5 software package starting from the 
canonical B-form duplexes. These were subject to geometry optimization using AMBER force 
field (see Figures S2.8 and S2.9 for structures of the duplexes with the water molecules omitted 
for clarity and views of the modified and flanking base pairs from the top). Both optimized 




-EtdT·dA base pairs had very similar features with 
the alpha carbon adopting a syn conformation with respect to the N3-atom, in agreement with 
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published structural data by NMR and results from computational studies.
25,252 
The DFP and 




-EtdT. The duplexes exhibited 
minor global structural perturbations from the control duplex, namely retaining key features of 
B-form DNA. On a local level, the DFP and TPP modifications engaged with only one 
hydrogen bond contact between the N6H of adenine and O
4
 of the modified pyrimidine at the 
Watson-Crick face. The modified pyrimidine bases were slightly shifted towards the major 
groove of the duplex to accommodate the bulk of the bicyclic construct. These slight distortions 
could explain the decrease in Tm values and increase in hyperchromicity changes observed. In 
general, the molecular model of DFP and TPP modifications do not seem to induce any gross 
geometrical distortions on the global structure, as corroborated by the circular dichroism 
experiments.  
2.6.2 Supporting Methods 
2.6.2.1 General  
 1-(α)-Chloro-3,5-di-O-(p-toluoyl)-2-deoxy-D-ribose was purchased from Berry & 
Associates, Inc. (Dexter, MI).  N,N-Diisopropylaminocyanoethylphosphonamidic chloride was 
purchased from ChemGenes Corporation (Wilmington, MA). 5-O-Dimethoxytrityl-2’-
deoxyribonucleoside-3-O-(β-cyanoethyl-N,N-diisopropyl)phosphoramidites and protected 2´-
deoxyribonucleoside-CPG supports were purchased from Glen Research (Sterling, Virginia). All 
other chemicals and solvents were purchased from the Aldrich Chemical Company (Milwaukee, 
WI) or EMD Chemicals (Gibbstown, NJ). Flash column chromatography was performed using 
silica gel 60 (230-400 mesh) obtained from Silicycle (Quebec City, QC). Thin layer 
chromatography (TLC) was carried out using precoated TLC plates (Merck, Kieselgel 60 F254, 
0.25 mm) purchased from EMD Chemicals Inc. (Gibbstown, NJ). NMR spectra were recorded 
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on a Varian 500 MHz NMR spectrometer at room temperature. 
1
H NMR spectra were recorded at 
a frequency of 500.0 MHz and chemical shifts were reported in parts per million (ppm) 
downfield from tetramethylsilane. 
13
C NMR spectra (
1
H decoupled) were recorded at a 
frequency of 125.7 MHz and chemical shifts were reported in ppm with tetramethylsilane as a 
reference. 
31
P NMR spectra (
1
H decoupled) were recorded at a frequency of 202.3 MHz and 
chemical shifts were reported in ppm with H3PO4 used as an external standard. High resolution 
mass spectrometry of modified nucleosides were carried out using an LTQ Orbitrap Velos - ETD 
mass spectrometer (Thermo Scientific) at the Concordia University Centre for Biological 
Applications of Mass Spectrometry (CBAMS) or using a 7T-LTQ FT ICR mass spectrometer 
(Thermo Scientific) at the Concordia University Centre for Structural and Functional Genomics. 
The mass spectrometer was operated in full scan, positive ion detection mode. ESI mass spectra 
for oligonucleotides were obtained at CBAMS using a Micromass Qtof2 mass spectrometer 
(Waters) equipped with a nanospray ion source. The mass spectrometer was operated in full scan, 
negative ion detection mode.  
2.6.2.2 Chemical synthesis of nucleosides.   




 To a solution of NaOEt (1.23 g, 18.1 mmol) in EtOH (90 mL) was added compound 2.1a 
(7.55 g, 48.4 mmol). After 16h, the solvent was removed in vacuo and the crude was taken up in 
a minimal amount of boiling water. The solution was acidified (to a pH ~ 2-3) on an ice bath and 
the precipitate was isolated by vacuum filtration and washed with cold EtOH (3  40 mL). To 
maximize the yield, the filtrate was evaporated and the solid was resuspended in EtOH (50 mL). 
The solid was isolated and washed once more according to the procedure described above to give 
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2.2a in an overall yield of 7.16 g (94.8%) as a colorless powder. λmax(MeCN) 262 nm.  
1
H NMR 
(500MHz, d6-DMSO, ppm): 10.99 (broad s, 1H, NH), 10.64 (broad s, 1H, NH), 7.19 (s, 1H, H6), 
4.52 (t, 1H, OH, J = 5.5 Hz), 3.44 (m, 2H, CH2OH), 2.30 (t, 2H, CH2Ar, J = 6.5 Hz). 
13
C NMR 
(125.7 MHz, d6-DMSO, ppm): 164.6, 151.4, 138.8, 109.1, 59.44, 29.7. IR (thin film); νmax (cm
−1
) 
3680, 2922, 2849, 2382, 2349, 1755, 1674, 1451, 1244, 1032. HRMS (ESI-MS) m/z calculated 
for C6H8N2O3Na
+




 To a solution of NaOEt (1.52 g, 22.4 mmol) in EtOH (225 mL) was added compound 
2.1b (4.76 g, 28.0 mmol). After 16h, the solvent was removed in vacuo and the crude was taken 
up in a minimal amount of boiling water. The solution was acidified (to a pH ~ 2-3) and cooled, 
and the precipitate was isolated by vacuum filtration and washed with cold EtOH (3  50 mL). 
To maximize the yield, the filtrate was evaporated and the solid was resuspended in EtOH (50 
mL). The solid was isolated and washed once more according to the procedure described above 
to give 2.2b in an overall yield of 4.75 g (>99%) as a colorless powder. λmax(MeCN)  261 nm. 
1
H 
NMR (500 MHz, d6-DMSO, ppm): 10.92 (broad s, 1H, NH), 10.54 (broad s, 1H, NH), 7.14 (s, 
1H, H6), 4.63 (t, 1H, OH, J = 5.0 Hz), 3.35 (m, 2H, CH2OH), 2.17 (t, 2H, CH2Ar, J = 8 Hz), 
1.54 (m, 2H, CH2CH2CH2).
 13
C NMR (125.7 MHz, d6-DMSO, ppm): 164.9, 151.7, 138.1, 111.9, 
61.7, 31.3, 23.1. IR (thin film); νmax (cm
−1
) 3680, 2922, 2849, 2381, 2349, 1755, 1674, 1451, 
1244, 1032. HRMS (ESI-MS) m/z calculated for C7H10N2O3Na
+





 To a solution of compound 2.2a (2.4 g, 15.4 mmol) in HMDS (60 mL, 164 mmol) was 
added TMS-Cl (0.4 mL, 3.14 mmol) which was then stirred vigorously at 140 
o
C. After 5 h the 
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excess HMDS was removed in vacuo and the resulting gum was left on the high vacuum for 2 h. 
The gum was then dissolved in 1,2-dichloroethane (60 mL) and to this was added a solution of 1-
(α)-chloro-3,5-di-O-(p-toluoyl)-2-deoxy-D-ribose (2.0 g, 5.1 mmol) in 1,2-dichloroethane (80 
mL) while stirring at room temperature. After 16 h the solvent was removed in vacuo and the 
residue was taken up in CH2Cl2 (60 mL) then washed with 3% (aq) NaHCO3 (w/v, 2  50 mL). 
The organic layer was dried over anhydrous Na2SO4, decanted and the solvent evaporated. Then, 
1 M TBAF (in THF, 5 mL, 5 mmol) was added and the reaction stirred for 15 min. The solvent 
was removed and the mixture of anomers was purified via flash column chromatography using a 
CH3OH:CH2Cl2 solvent system (2% → 5%, v/v). The β-anomer was isolated by precipitation 
from EtOAc: hexanes (1:1, v/v) at a concentration of 31 mM with stirring at room temperature 
for 10 min. The resulting suspension was filtered under vacuo to afford 1.15 g (44%) of 2.3a as a 
colorless foam. Rf (SiO2 TLC): 0.33 CH3OH:CH2Cl2 (5%, v/v). λmax(MeCN)  241 nm. 
1
H NMR 
(500MHz, d6-DMSO, ppm): 11.37 (s, 1H, NH), 7.92-7.87(m, 4H, Ar), 7.48 (s, 1H, H6), 7.36-
7.30 (m, 4H, Ar), 6.28 (t, 1H, H1’, J = 8 Hz), 4.61 (m, 1H, H3’), 4.55 (m, 1H, H5’), 4.51 (m, 1H, 
H5’’), 4.46 (m, 1H, H4’), 3.37 (m, 2H, CH2OH), 2.95 (m, 1H, H2’), 2.53 (m, 1H, H2’’), 2.39 (s, 
3H, CH3Ph), 2.38 (s, 3H, CH3Ph), 2.24 (t, 2H, CH2Ar, J = 7.0 Hz). 
13
C NMR (125.7 MHz, 
CDCl3, ppm): 166.6, 166.5, 163.6, 150.8, 145.1, 145.0, 136.8, 130.4, 130.1, 130.0, 129.8, 127.1, 
126.8, 112.9, 85.5, 83.2, 75.3, 64.7, 60.8, 38.5, 30.6, 22.3, 22.2. IR (thin film); νmax (cm
−1
) 3204, 
3064, 2955, 2925, 1719, 1685, 1612, 1510, 1464, 1269, 1178, 1100, 1020. HRMS (ESI-MS) m/z 
calculated for C27H29N2O8
+
 509.1918: found 509.1935 [M+H]
+
. 
Alternative method for resolution of the anomers: To a solution of the purified mixture of 
anomers (3.7 g, 7.3 mmol) and imidazole (1.6 g, 23 mmol) in CH2Cl2 (80 mL) was added TBS-
Cl (1.8 g, 12 mmol) under stirring. After 4h the solvent was removed in vacuo and the content 
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was taken up in DCM (50 mL), washed with 3% (aq.) NaHCO3 (2  50 mL), dried over 
anhydrous Na2SO4, decanted and the solvent evaporated. Purification was performed by flash 
column chromatography using an EtOAc: Hex solvent system (1:4, then 1:3, v/v) to afford 3.1 g 
(65%) of the β-anomer and 0.82 g (17 %) of the α-anomer, both as colorless foams. To a solution 
of the β-anomer 2.3a (2.6 g, 4.1 mmol) in THF (40 mL) was added 1 M TBAF (in THF, 4.9 mL, 
4.9 mmol) which was heated to 45
o
C under stirring. After 1 h the solvent was removed in vacuo 
and the residue was taken up in DCM (50 mL) then washed with 3% (aq., w/v) NaHCO3 (2  50 
mL). The organic layer was dried over anhydrous Na2SO4, decanted and the solvent was 
evaporated. Purification was achieved by flash column chromatography using a CH3OH:CH2Cl2 
solvent system (1%  3%, v/v) to afford 2.0 g (96 %) of 3a as a colorless foam.  
3´,5´-O-bis-Toluoyl-5-hydroxypropyl-2´-deoxyuridine (2.3b) 
 To a solution of compound 2b (4.5 g, 26.4 mmol) in HMDS (95 mL) was added TMS-Cl 
(0.73 mL, 5.74 mmol) while stirred at 135
o
C. After 5h, the excess HMDS was removed in vacuo 
and the resulting gum was placed on the high vacuum for 1 h. To a solution of the gum in 1,2-
dichloroethane (225 mL) was added 1-(α)-chloro-3,5-di-O-(p-toluoyl)-2-deoxy-D-ribose (3.5 g, 
9.0 mmol) and the atmosphere was exchanged with Ar while stirring at room temperature. After 
16h the solvent was removed in vacuo and the crude was taken up in CH2Cl2 (125 mL), washed 
with cold brine (50 mL) followed by cold 3% (aq., w/v) NaHCO3 (2  50mL). The organic layer 
was dried over anhydrous Na2SO4, decanted and the solvent was evaporated. The product was 
purified via flash column chromatography (short column) using an isocratic CH3OH:CH2Cl2 
solvent system (4%, v/v). A mixture of silylated and desilylated products were isolated to which 
1 M TBAF (in THF, 5 mL, 5 mmol) was added under stirring. After 15 min, the solvent was 
removed in vacuo and the mixture of desilylated anomers were purified by flash column 
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chromatography using a CH2Cl2:CH3OH solvent system (2 % → 4 % by increments of 0.5 %, 
v/v). The β-anomer was isolated by precipitation from EtOAc at a concentration of 31 mM with 
stirring at room temperature for 10 min. The resulting suspension was filtered under vacuo to 
afford 2.05 g (44 %) of 2.3b as a colorless foam. Rf (SiO2 TLC): 0.41 CH3OH:CH2Cl2 (1:19, 
v/v). λmax(MeCN) 242 nm. 
1
H NMR (500MHz, CDCl3, ppm): 7.92-7.89 (m, 4H, Ar), 7.28 (s, 1H, 
H6), 7.25-7.23 (m, 4H, Ar), 6.41 (dd, 1H, H1´, J = 8.5, 8.75 Hz), 5.61 (m, 1H, H3´), 4.78 (dd, 
1H, H5´, J = 3.5, 12.5 Hz), 4.63 (dd, 1H, H5´, J = 3.5, 12 Hz), 4.52 (m, 1H, H4´), 3.44 (m, 2H, 
CH2OH), 2.43 (s, 3H, CH3Ph), 2.42 (s, 3H, CH3Ph), 2.29 (m, 1H, H2´), 2.21 (m, 2H, CH2Ar), 
2.13 (m, 1H, H2’’), 1.52 (m, 2H, CH2CH2CH2).
 13
C NMR (125.7 MHz, CDCl3, ppm): 166.14, 
166.12, 164.1, 150.4, 144.61, 135.4, 129.8, 129.7, 129.6, 129.5 , 129.4, 129.3, 126.5, 126.3, 
115.1, 85.0, 82.3, 74.9, 64.2, 60.8, 60.4, 38.0, 32.0, 31.8, 22.7, 21.73, 21.67, 21.0, 14.2. IR (thin 
film); νmax (cm
−1
) 3495, 3191, 300, 2926, 1718, 1611, 1466, 1377, 1270, 1178, 1103, 1020. 
HRMS (ESI-MS) m/z calculated for C28H31N2O8
+
 523.2075: found 523.2099 [M+H]
+
. 
Alternative method for the resolution of anomers: To a solution of a purified mixture of anomers 
(2.0 g, 3.8 mmol) and imidazole (1.2 g, 17 mmol) in CH2Cl2 (38 mL) was added TBS-Cl (1.3 g, 
8.4 mmol) while stirring. After 4h the solvent was removed in vacuo and the content was taken 
up in CH2Cl2 (50 mL) and washed with 3% (aq., w/v) NaHCO3 (2  50 mL). The organic layer 
was dried over anhydrous Na2SO4, decanted and the solvent removed in vacuo. Purification was 
achieved by flash column chromatography using an EtOAc:hexanes solvent system (35:65, v/v) 
to afford 1.2 g (49 %) of the β-anomer and 0.68 g (28 %) of the α-anomer, both as colorless 
foams. To a solution of the β-anomer of 2.3b (0.50 g, 0.79 mmol) in THF (4 mL) was added 1 M 
TBAF (in THF, 1.2 mL, 1.2 mmol) which was heated to 45 
o
C with stirring. After 4 h the solvent 
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was removed in vacuo and the content purified by flash column chromatography using a solvent 
system (1%  3%, v/v) to afford 0.33 g (81 %) of 2.3b a colorless foam.  
3-(2´-Deoxy-3´-5´-O-bis(toluoyl)-β-D-ribofuranosyl)-5,6-dihydrofuro[2,3-d]pyrimidin-2(3H)-
one  (2.4a) 
 To a solution of compound 2.3a (1.2 g, 2.3 mmol) in pyridine (25 mL) was added MsCl 
(240 μL, 3.1 mmol) dropwise at 0oC while stirring. After 5 h, the reaction was diluted with THF 
(300 mL) and DBU (1.2 mL, 8.0 mmol) was added and heated to a gentle reflux. After 16 h the 
solvent was removed in vacuo and the content was taken up in CH2Cl2 (100 mL), washed with 
brine (2 50 mL) and 3% (aq.) NaHCO3 (2 x 50 mL). The organic layer was dried over anhydrous 
Na2SO4, decanted and the solvent was removed in vacuo to produce a yellow gum. The product 
was purified via flash column chromatography using a gradient of CH2Cl2:CH3OH (1 % → 4 % 
increased by increments of 0.5 %, v/v) to afford 1.0 g (91%) of 2.4a as a colorless foam. Rf (SiO2 
TLC):  0.45 CH3OH:CH2Cl2 (5% , v/v).  λmax(MeCN) = 241 nm. 
1
H NMR (500 MHz, CDCl3, ppm): 
7.95 (d, 2H, Ar, J = 8.5 Hz), 7.87 (d, 2H, Ar, J = 8.5 Hz), 7.72 (s, 1H, H6), 7.31 - 7.23, (m, 4H, 
Ar), 6.41 (dd, 1H, H1´, J = 6.0, 14 Hz), 5.61 (m, 1H, H3´), 4.83 (m, 1H, H5´), 4.66 - 4.60 (m, 
3H, H4´ and  CH2O), 4.55 (m, 1H, H5´´), 3.06 (m, 1H, H2´), 2.91 (m, 1H, CH2Ar), 2.69 (m, 1H, 
CH2Ar), 2.44 (s, 3H, CH3Ph), 2.43 (s, 3H, CH3Ph), 2.22 (m, 1H, H2´´). 
13
C NMR (125.7 MHz, 
CDCl3, ppm): 166.1, 166.0, 162.8, 150.2, 144.61, 144.60, 136.9, 129.9, 129.7, 129.6, 129.5, 
129.39, 129.37, 129.3, 126.6, 126.3, 111.4, 85.0, 82.9, 74.9, 64.1, 42.6, 38.1, 30.4, 21.75, 21.73. 
IR (thin film); νmax (cm
−1
) 3196, 3061, 2923, 2851, 1718, 1611, 1577, 1465, 1377, 1270, 11178, 
1101, 1020. HRMS (ESI-MS) m/z calculated for C27H27N2O7
+










 To a solution of compound 2.3b (1.5 g, 2.9 mmol) in CH2Cl2 (30 mL) was added NEt3 
(0.80 mL, 5.74 mmol) which was allowed to stir at 0 
o
C for 15 min. MsCl (0.30 mL, 3.9 mmol) 
was added dropwise over 10 min and cooled to -20 
o
C for 1 h without stirring. The reaction was 
diluted with CH2Cl2 (100 mL) and washed with ice/water (50 mL), ice/brine (50 mL) and ice/3% 
aq. (w/v) NaHCO3 (50 mL). The organic layer was then dried over anhydrous Na2SO4, decanted 
and the solvent was removed in vacuo to produce a yellow gum.  The gum was dissolved in THF 
(400 mL), DBU (0.40 mL, 2.7 mmol) was added and the reaction was gently refluxed under 
stirring. After 3 h the solvent was removed in vacuo and the crude was taken up in CH2Cl2 (150 
mL), washed with ice/brine (50 mL) and 3% aq. NaHCO3 (w/v, 2  50mL). The organic layer 
was dried over anhydrous Na2SO4, decanted and the solvent was removed in vacuo to produce a 
yellow gum. Purification was achieved by flash column chromatography using a CH3OH:CH2Cl2 
solvent system (3 → 4 %, v/v) to afford 1.27 g (88%) of 2.4a as a colorless foam. Rf (SiO2 TLC): 
0.33 CH3OH:CH2Cl2 (6 %). λmax(MeCN)  239 nm. 
1
H NMR (500 MHz, CDCl3, ppm): 7.96 - 7.94 
(d, 2H, Ar, J = 8.5 Hz), 7.87 - 7.85 (d, 2H, Ar, J = 8.5 Hz), 7.67 (s, 1H, H6), 7.28 - 7.24 (m, 4H, 
Ar), 6.41 (dd, 1H, H1´, J = 5.5, 8.0 Hz), 5.61 (m, 1H, H3´), 4.84 (dd, 1H, H5´, J = 4, 13 Hz), 
4.64 - 4.60 (m, 2H, H4´ and H5´´), 4.33 (m, 1H, CH2O), 4.26 (m, 1H, CH2O), 3.10 (dd, 1H, H2´, 
J = 5, 14.5 Hz), 2.44 (s, 3H, CH3Ph), 2.42- 2.38 (m, 4H, 1H from CH2Ar and CH3Ph), 2.23 (m, 
1H, H2´´), 2.15 (m, 1H, CH2Ar), 1.87 (m, 1H, CH2CH2CH2), 1.79 (m, 1H, CH2CH2CH2).
 13
C 
NMR (125.7 MHz, CDCl3, ppm): 170.0, 166.2, 166.0, 155.3, 144.55, 144.52, 140.4, 129.8, 
129.5, 129.41, 129.37, 129.3, 129.2, 126.5, 126.3, 101.4, 87.5, 83.7, 75.3, 68.5, 64.3, 39.6, 21.72, 
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21.69. 21.6, 21.5. IR (thin film); νmax (cm
−1
)  3357, 2923, 2851, 2362, 2336, 1719, 1667, 1611, 








 Compound 2.4a (0.59 g, 1.2 mmol) was allowed to stir at 0 
o
C in a solution of saturated 
methanolic ammonia (250 mL) and gradually allowed to warm up to room temperature. After 5 h 
the solvent was removed in vacuo and the resulting residue was washed with Et2O (2  25mL). 
The deprotected nucleoside was partially purified by flash column chromatography (using a short 
column) with a gradient of CH3OH:CH2Cl2 (4 % →15 %, v/v) to elute the product as a colorless 
powder. This powder was taken up in pyridine (15 mL) and stirred at 0 
o
C for 15 min. To this 
solution was added DMAP (cat) and DMT-Cl (0.38 g, 1.1 mmol) in small portions over 20 min 
under stirring. After 16 h, the solvent was removed in vacuo and the content was taken up in 
CH2Cl2 (100 mL), washed with 3 % (w/v) aqueous solution of NaHCO3 (2  100 mL) and brine 
(100 mL). The organic layer was dried over anhydrous Na2SO4, decanted and the solvent was 
removed in vacuo to produce a yellow gum. The product was purified via flash column 
chromatography using a gradient of CH3OH:CH2Cl2 (2% → 4%, v/v) to afford 0.32 g (48%) of 
2.5a as a colorless foam. Rf (SiO2 TLC):0.18 CH3OH:CH2Cl2 (5%, v/v). λmax(MeCN) 283 nm. 
1
H 
NMR (500 MHz, CDCl3, ppm): 8.08 (s, 1H, H6), 7.35 (d, 2H, Ar, J = 7.5 Hz), 7.28 - 7.19 (m, 
7H, Ar), 6.81 (d, 4H, Ar, J = 9 Hz), 6.28 (t, 1H, H1´, J = 6.0 Hz), 4.61 - 4.50 (m, 3H, H3´ and 
CH2O), 4.07 (m, 1H, H4´), 3.78 (s, 6H, OCH3),  3.48 (dd, 1H, H5´, J = 3, 11 Hz), 3.42 (dd, 1H, 
H5’, J = 3, 10.5 Hz), 2.69 - 2.62 (m, 2H, H2´ and 1H from CH2Ar), 2.49 - 2.41 (m, 1H, CH2Ar), 
2.32 (m, 1H, H2’´´), 2.08 (d, 1H, OH, J = 4 Hz). 13C NMR (125.7 MHz, CDCl3, ppm): 177.9, 
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158.68, 158.67, 156.6, 144.5, 137.4, 135.3, 130.09, 130.06, 128.1, 128.0, 127.0, 113.29, 113.27, 
103.9, 87.2, 86.9, 86.3, 71.7, 71.2, 63.0, 55.3, 42.3, 24.0. IR (thin film); νmax (cm
−1
) 3361, 2922, 
2650, 1673, 1608, 1570, 1509, 1481, 1437, 1322, 1251, 1178, 1154, 1034. HRMS (ESI-MS) m/z 
calculated for C32H32N2O7Na
+





 Compound 2.4b (0.95 g, 1.9 mmol) was allowed to stir in a solution of saturated 
methanolic ammonia (500 mL) at 0
o
C and gradually allowed to warm to room temperature. After 
5 h, the solvent was removed in vacuo and the resulting residue was washed with Et2O (3  5 
mL). The resulting gum was diluted with pyridine (18 mL) and stirred at 0 
o
C for 15 min. To this 
solution was added DMAP (cat) and DMT-Cl (0.38 g, 1.1 mmol) in pyridine (10 mL) dropwise 
over 25 min under stirring. The reaction was allowed to gradually warm up to room temperature. 
After 16h the solvent was removed in vacuo and the content was taken up in CH2Cl2 (50 mL) 
then washed with ice/brine (50 mL) followed by ice/3% (aq.) NaHCO3 (w/v, 2  50 mL). The 
organic layer was then dried over anhydrous Na2SO4, decanted and the solvent was removed in 
vacuo to produce a yellow-orange gum. The product was purified via flash column 
chromatography using a gradient of CH3OH:CH2Cl2 (3% → 5%, v/v) to afford 0.39 g (36%) of 
2.5b as a colorless foam. Rf (SiO2 TLC): 0.18 CH3OH:CH2Cl2 (5%, v/v). λmax(MeCN) 282 nm. 
1
H 
NMR (500 MHz, CDCl3, ppm): 8.05 (s, 1H, H6), 7.38 (d, 2H, Ar, J = 7.5 Hz), 7.31 - 7.21 (m, 
7H, Ar), 6.83 (d, 4H, Ar, J = 9 Hz), 6.32 (t, 1H, H1´, J = 6.0 Hz), 4.49 (m, 1H, H3´), 4.30 (m, 
2H, CH2O), 4.11 (m, 1H, H4´), 3.80 (s, 6H, OCH3),  3.50 (dd, 1H, H5´, J = 3, 10.5 Hz), 3.38 (dd, 
1H, H5´´, J = 3, 10.5 Hz), 2.70 (m, 2H, H2´), 2.35 (m, 1H, H2´´), 2.21 (d, 1H, OH, J = 3.5 Hz), 
2.15 (m, 1H, CH2Ar), 1.87 (m, 1H, CH2Ar), 1.81 (m, 2H, CH2CH2CH2). 
13
C NMR (125.7 MHz, 
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d6-DMSO, ppm): 170.0, 158.7, 155.0, 144.1, 142.1, 135.9, 135.7, 130.22, 130.16, 128.4, 128.1, 
127.3, 113.8, 101.7, 86.4, 86.3, 86.2, 70.5, 68.7, 63.8, 55.54, 55.46,  41.5, 21.5, 21.2. IR (thin 
film); νmax (cm
−1
) 3360, 2921, 2850, 1661, 1632, 1522, 1509, 1454, 1336, 1250, 1177, 1117, 
1033. HRMS (ESI-MS) m/z calculated for C33H35N2O7
+





 To a stirred solution of compound 2.5a (0.25 g, 0.45 mmol) and DIPEA (0.147 mL, 0.844 
mmol) in THF (4.5 mL) was added dropwise Cl-POCENiPr2 (0.149 mL, 0.674 mmol). After 30 
min, the solvent was evaporated in vacuo and the content was diluted with EtOAc (50 mL) then 
washed with 3% (aq., w/v) NaHCO3 (2 × 50 mL) and brine (50 mL). The organic layer was dried 
over anhydrous Na2SO4, decanted and the solvent was removed in vacuo to produce a yellow 
gum. Purification was achieved via short flash column chromatography using EtOAc:hexanes 
(4:1, v/v) (with 0.1% NEt3, v/v) as eluent to afford 0.25 g (74 %) of 2.6a as a colorless foam. Rf 
(SiO2 TLC): 0.40, 0.31 EtOAc/hexanes (4:1, v/v). λmax(MeCN)  283 nm. 
1
H NMR (500 MHz, d6-
acetone, ppm): 8.14-8.09 (m, 1H, H6), 7.53-7.50 (m, 2H, Ar), 7.40 - 7.25 (m, 7H, Ar), 6.95-6.92 
(m, 4H, Ar), 6.33-6.26 (m, 1H, H1´), 4.83-4.77 (m, 1H, H3´), 4.64-4.56 (m, 2H, CH2O), 4.26-
4.20 (m, 1H, H4´), 3.94-3.47 (m, 12H, CH2OP, NCH, H5´, H5´´ and OCH3),  2.92-2.58 (m, 5H, 
CH2CN, CH2Ar &  H2´), 2.43-2.36 (m, 1H, H2´´), 1.33-1.14 (m, 12H, 4  CH3). 
13
C NMR 
(125.7 MHz, d6-acetone, ppm): 177.89, 177.88, 158.9, 155.7, 144.95, 144.93, 136.9, 136.8, 
135.7, 136.6, 135.5, 135.4, 130.2, 130.1, 128.2, 128.1, 127.90, 127.89, 126.91, 126.88, 118.1, 
118.0, 113.2, 103.9, 103.8, 86.74, 86.71, 86.5, 86.4, 85.5, 85.2, 73.2, 71.5, 62.9, 62.7, 58.72, 
58,65, 58.6, 58.5, 58.2, 54.7, 45.0, 44.9, 43.1, 43.0, 40.7, 40.5, 24.1, 24.02, 24.00, 23.92, 23.89, 
22.29, 22.29, 22.2, 19.91, 19.85, 19.8, 19.5, 19.4. 
31
P NMR (202.3 MHz, d6-acetone, ppm): 
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148.27, 148.11. IR (thin film); νmax (cm
−1
) 2967, 2929, 2362, 2337, 1678, 1570, 1509, 1322, 
1250, 1179, 1034. HRMS (ESI-MS) m/z calculated for C41H50N4O8P
+






 To a stirred solution of compound 2.5b (0.25 g, 0.44 mmol) and DIPEA (0.143 mL, 0.816 
mmol) in THF (4.3 mL) was added dropwise Cl-POCENiPr2 (0.146 mL, 0.656 mmol). After 30 
min the solvent was evaporated in vacuo and the content was diluted in EtOAc (50 mL) then 
washed with 3 % (w/v) aqueous solution of NaHCO3 (2  50 mL) and brine (50 mL). The 
organic layer was dried over anhydrous Na2SO4, decanted and the solvent was removed in vacuo 
to produce a yellow gum. Purification was achieved via short flash column chromatography 
using EtOAc (with 0.1 % NEt3, v/v) as eluent to afford 0.25 g (74%) of 2.6b as a colorless foam. 
Rf (SiO2 TLC): 0.20, 0.14 EtOAc. λmax(MeCN) 283 nm. 
1
H NMR (500 MHz, d6-acetone, ppm): 
8.04-8.00 (m, 1H, H6), 7.54-7.48 (m, 2H, Ar), 7.41 - 7.25 (m, 7H, Ar), 6.96-6.89 (m, 4H, Ar), 
6.33-6.27 (m, 1H, H1´), 4.80-4.73 (m, 1H, H3´), 4.40-4.11 (m, 4H, CH2O, H4´, 1H from 
CH2OP), 3.94-3.47 (m, 11H, 1 H from CH2OP, NCH, H5´, H5´´and OCH3),  2.96-2.38 (m, 4H, 
CH2CN, H2’, H2’’), 2.29-2.24 (m, 1H, CH2Ar), 2.09-1.97 (m, 1H, CH2Ar), 1.87-1.79 (m, 2H, 
CH2CH2CH2), 1.34-1.11 (m, 12H, 4  CH3). 
13
C NMR (125.7 MHz, d6-acetone, ppm): 169.9, 
169.82, 169.80, 158.93, 158.92, 154.81, 154.79, 144.9, 144.77, 144.76, 141.5, 141.4, 141.3, 
135.69, 135.66, 135.6, 135.5, 135.4, 130.20, 130.18, 103,16, 130.1, 128.22, 128.18, 128.0, 
127.91, 127.90,  127.0, 126.9, 113.23, 113.18, 101.4, 101.2, 101.1, 87.0, 86.72, 86.69, 86.3, 86.1, 
85.6, 68.3, 68.2, 62, 9, 54.7, 43.1, 43.0, 24.1, 24.0,23.9, 22.31, 22.29, 21.50, 21.48, 21.3, 19.9, 
19.4, 19.30, 19.27. 
31





) 2968, 2927, 2849, 1736, 1669, 1510, 1455, 1337, 1250, 1179, 1118, 1035. HRMS (ESI-
MS) m/z calculated for C42H52N4O8P
+
 771.3517: found 771.3542 [M+H]
+
. 
2.6.2.3 Solid phase synthesis and purification of oligonucleotides.   
 All DNA sequences were synthesized using an Applied Biosystems Model 3400 
synthesizer on a 1.5 μmol scale employing standard β-cyanoethyl phosphoramidite cycles 
supplied by the manufacturer with modifications to certain coupling times described below. 
Commercially available 3´-O-2´-deoxynucleoside phosphoramidites, containing “fast” 
deprotecting groups, were dissolved in anhydrous acetonitrile at a concentration of 0.1 M. The 
modified 3´-O-2´-deoxynucleoside phosphoramidites (2.6a and 2.6b) were dissolved at a 
concentration of 0.12 M. Assembly of sequences began with detritylation (3% trichloroacetic 
acid (TCA) in CH2Cl2, v/v), followed by phosphoramidite coupling: Commercially available 3´-
O-2´-deoxyphosphoramidites for 120 s and modified phosphoramidites (2.6a and 2.6b) for 600 s. 
Capping with phenoxyacetic anhydride-pyridine-tetrahydrofuran (1:1:8; solution A) and 1-
methyl-1H-imidazole-tetrahydrofuran (16:84 w/v; solution B) then oxidation (0.02 M iodine in 
tetrahydrofuran-water-pyridine,  2.5:2:1, v/v/v) followed every coupling. Removal of the 5´-
terminal trityl group on the oligonucleotide was carried out on the synthesizer. 
 The oligomer-bound CPG support was removed from the column and transferred into 
screw cap microfuge tubes fitted with Teflon lined caps. The oligonucleotides containing the 
modifications  3-(2´-deoxypentofuranosyl)-5,6-dihydrofuro[2,3-d]pyrimidin-2(3H)-one (DFP) 
and 3-(2´-deoxypentofuranosyl)-3,5,6,7-tetrahydro-2H-pyrano[2,3-d]pyrimidin-2-one (TPP) 
were deprotected and cleaved from the solid support with mild deprotection conditions using 
freshly prepared anhydrous K2CO3 in CH3OH (0.05 M) for 3.5 h at room temperature in the 
dark. The K2CO3 was neutralized with an equimolar amount of acetic acid prior to being 
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transferred into clean vials to separate the solution from the CPG. The CPG was rinsed twice 
with 250 μL aqueous CH3CN (50%, v/v). The crude DNA was dried down in a centrifugal 
lypophilizer (“Speed vac”) and then desalted using C-18 SEP PAK cartridges (Waters) prior to 
purification. 
 All oligonucleotide sequences were purified from pre-terminated products by strong 
anion exchange (SAX) HPLC using a Dionex DNAPAC PA-100 column (0.4 cm  25 cm) 
purchased from Dionex (Sunnyvale, CA) with a linear gradient of 0-52% buffer B, v/v, over 24 
min (buffer A: 100 mM Tris HCl, pH 7.5, 10% acetonitrile and buffer B: 100 mM Tris HCl, pH 
7.5, 10% CH3CN, 1 M NaCl) at 55 
o
C. The columns were monitored at 260 nm for analytical 
runs and/or 280 nm for preparative runs. The purified oligomers were desalted using C-18 SEP 
PAK cartridges (Waters).  
2.6.2.4 Oligonucleotide characterization by ESI-MS and nuclease digestion.   
 Mass spectra for the oligonucleotides were acquired at the Concordia University Centre 
for Biological Applications of Mass Spectrometry (CBAMS) using a Micromass Qtof2 mass 
spectrometer (Waters) equipped with a nanospray ion source. The mass spectrometer was 
operated in full scan, negative ion detection mode and the raw data were deconvoluted.  
 The oligomers (0.05 A260 units / 0.38 nmol) were characterized by enzymatic digestion 
(snake venom phosphodiesterase: 0.28 units and calf intestinal phosphatase: 5 units) in buffer 
consisting of 10 mM Tris HCl, pH 8.1, and 2 mM MgCl2 for 48 h at 37 
o
C. The resulting mixture 
of nucleosides was analyzed by reversed phase HPLC using a Symmetry® C-18 5 µm column 
(4.6 mm  150 mm, Waters). A linear gradient of 0-70% buffer B (v/v) over 30 min was used to 
elute the analytes (buffer A: 50 mM sodium phosphate, pH 5.8, 2% CH3CN (v/v) and buffer B: 
50 mM sodium phosphate, pH 5.8, 50% CH3CN (v/v)). The identity of the nucleosides was 
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verified by co-injection with the corresponding standards and eluted at the following times: dC 
(4.3 min), dG (6.7 min), dT (7.4 min), dA(8.5 min), modified bicyclic pyrimidyl nucleosides (7.7 
min for the DFP, and 9.1 min for the TPP nucleosides), and the ratio of unmodified nucleosides 
was determined. The bicyclic pyrimidyl nucleosides showed poor absorbance at 260nm and 
improved absorbance at 300 nm. As a result, absorption of the modified nucleosides was 
monitored at 300 nm and their presence confirmed by an independent injection of the 
deprotected analogues of 2.4a and 2.4b, respectively. The molecular weights of the modified 
oligomers were determined by ESI-QToF MS and these were in agreement with the calculated 
values. 
2.6.2.5 UV thermal denaturation studies of DNA duplexes.   





) of the mononucleotides and dinucleotides. The 
molar extinction coefficients for thymidine were used for the modified nucleotides. All duplexes 
were prepared by mixing equimolar amounts of the interacting strands (0.5 A260 unit of the strand 
containing the modification / 3.8 nmol) and lyophilizing the mixture to dryness in a centrifugal  
concentrator under vaccum. The resulting pellet was dissolved in 90 mM NaCl, 10 mM sodium 
phosphate, and 1 mM EDTA buffer (pH 7.0) to give a final concentration of 3.8 μM duplex. 
Before the thermal run, samples were degassed in a centrifugal concentrator for 1 min. Samples 
were held at 90 
o
C for 5 min to ensure duplex melting. Annealing profiles were acquired at 260 




, from 90 to 15 
o
C, using a Varian CARY Model 3E 
spectrophotometer equipped with a 6-sample thermostated cell block and a temperature 
controller. Samples were held at 15 
o









reversibility (data not shown). The data were analyzed according to the published procedure 
from Puglisi and Tinoco
254
 and transferred to Microsoft Excel
TM
 software. 
2.6.2.6 Circular dichroism (CD) spectroscopy of DNA duplexes.    
 Circular dichroism spectra were acquired on a Jasco J-815 spectropolarimeter equipped 
with a Julaba F25 circulating bath as previously reported.
150 
The spectra are an average of 5 
scans acquired at a rate of 20 nm min
−1
, with a bandwidth of 1 nm and a sampling wavelength of 
0.2 nm in fused quartz cells (Starna 29-Q-10). Scans were performed between 350 and 220 nm at 
15 °C. The molar ellipticity [θ] was calculated from the equation, θ = ε/Cl, where ε is the relative 
ellipticity (mdeg), C is the concentration of the DNA duplex (M), and l is the path length (cm).  
2.6.2.7 Molecular modeling of DNA duplexes. 
 Molecular modeling was performed with the Hyperchem 7.5 software package from 





-EtdT·dA, DFP·dA, and TPP·dA base pair were constructed from the nucleic 
acid template option using a B-form duplex. Duplexes were solvated with water using a periodic 
box occupying about 3 times the volume of the duplex alone. Standard Amber99 parameters 
were used with the dielectric set to constant. “One to four scale factors” non-bonded interactions 
were set to 0.5 (both electrostatic and van der Waals). Cutoffs were applied to “switched” to an 
outer and inner radius of 13.5 and 9.5 Å, respectively. All structures were geometry optimized 
using Polak-Ribiere conjugate gradient until the RMS gradient was less than 0.1 kcal/(Å mol) 
using the periodic boundary condition option. 
2.6.2.8 Steady-state kinetics with hPol η.   
 The 5´-FAM-labeled primer (5´-TCGTAAGCGTCAT-3´) and template DNA (3´-
AGCATTCGCAGTAXTACT-5´, where X denotes the modified nucleotide) were mixed in a 1:1 
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molar ratio and annealed by heating to 90 
o
C, followed by slow cooling. Steady-state 
experiments were conducted with typical hPol η concentrations of 1.9-7 nM and 5 µM template-
primer duplex substrates in 40 mM Tris HCl buffer (pH 7.5) containing 100 mM KCl, 5mM 
MgCl2, 10 mM DTT, 5% glycerol (w/v), and 100 µg/ml bovine serum albumin (BSA), to which 
was added varying concentrations of a single dNTP (added last to initiate the reaction). 
Experiments were carried out at 37 
o
C and reactions were typically run for 5 to 15 min in order 
to keep product formation below 20% of the oligonucleotide substrate concentration. 
 Reactions were terminated with a quench solution containing formamide, EDTA, 
bromophenol blue and xylene cyanol, and aliquots were applied to an 18% (w/v) acrylamide/7.5 
M urea gel and separated by electrophoresis.
255
 Fluorescence in the substrate and product primer 
bands was monitored and quantified using a Typhoon system (GE Healthcare Life Sciences, 
Pittsburgh, PA) and the data were fit to hyperbolic plots (Michaelis-Menten equation) using the 
program GraphPad Prism (GraphPad, La Jolla, CA). 
2.6.2.9 LC-MS/MS Analysis of Full-length Extension Products.   
 The 5´-FAM-labeled primer (5´-TCGTAAGCGUCAT-3´) and template (3´-
AGCATTCGCAGTAXTACT-5´ where X denotes the modified nucleotide) were annealed as 
described above. 2´-Deoxyuridine (U) was included in the primer for facile cleavage of the 
product to a shorter oligonucleotide (by treatment with uracil DNA glycosylase followed by hot 
piperidine) that could be analyzed with an ion-trap mass spectrometer, as previously 
described.
229,236,256–258
 DNA primer extension was accomplished by mixing hPol η (76 pmol, 0.95 
μM) with template-primer duplex (2 nmol, 10 μM) and a mixture of 1 mM each of dATP, dCTP, 
dGTP, and dTTP at 37 °C for 1-1.5 h in 50 mM Tris-HCl buffer (pH 7.5), 50 mM NaCl, 5 mM 
DTT, 5 mM MgCl2 and 50 µg/mL bovine serum albumin (BSA). The reactions were terminated 
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by spin column separations to extract the dNTPs and Mg
2+
. The extent of the reaction was 
determined by electrophoresis/fluorography prior to LC-MS analysis. The resulting product was 
then treated with 25 units of uracil DNA glycosylase and 0.25 M piperidine.
229,236,256–258
 To 
identify the products, the resulting reactions were analyzed by LC-MS/MS using an Acquity 
UPLC system (Waters) interfaced to a Thermo-Finnigan LTQ mass spectrometer (Thermo 
Scientific, San Jose, CA) equipped with a negative ion electrospray source. Chromatographic 
separation was achieved with an Acquity UPLC BEH octadecylsilane (C18) column (2.1 mm   
100 mm, 1.7 μm). The LC solvent system was as follows: Mobile phase A, 10 mM CH3CO2NH4 
in 98% H2O; mobile phase B, 10 mM CH3CO2NH4 in 90% CH3CN (v/v). The following gradient 
(v/v) was used with a flow rate of 300 μL min-1 at a temperature of 50 oC: Linear gradient from 
0-3% B (v/v) in 3 min, followed by a linear increase to 20% B (v/v) from 3-5 min, then 20-100% 
B (v/v) from 5-6 min which is held for 2 min. The column was re-equilibrated for 3 min with 
100% A (v/v). MS conditions were as follows: Source voltage, 4 kV; source current 100 μA; 
capillary voltage,- 49 V; capillary temperature, 350 °C; tube lens voltage, -90 V. Product ion 
spectra were recorded over the range m/z 300-2000 and the most abundant species (-2 charge) 
was used for collision-induced dissociation (CID) analysis. The calculation for the 
oligonucleotide sequence CID fragmentation was carried out using the Mongo Oligo Mass 
Calculator v2.06 from The RNA Institute (College of Arts and Science, University at Albany 
State University of New York). The relative yields of various products were calculated based on 
the peak areas of extracted ion chromatograms from LC-MS analyses. The sum of the peak areas 






 Crystals were obtained by the hanging drop vapor diffusion technique at 18 °C. O
4
-
Alkylthymidine modified DNA solutions were prepared by mixing template and primer strands 
in a 1:1 molar ratio and annealing the mixture in the presence of 10 mM sodium HEPES buffer 
(pH 8.0), 0.1 mM EDTA, and 50 mM NaCl at 85 °C for 5-10 min, followed by slow cooling to 
room temperature. hPol η protein was mixed with the DNA duplex in a 1:1.2 molar ratio in the 
presence of 50 mM Tris-HCl, pH 7.5, containing 450 mM KCl, and 3 mM DTT, followed by 
addition of either 5 µL of 100 mM MgCl2 or 5 µL of 100 mM CaCl2. Using a spin concentrator 
with Amicon cutoff filter (Millipore, Billerica, MA), the complex was concentrated to a final 
concentration of ~2 mg/mL. Either dTTP or one of the non-hydrolyzable nucleoside triphosphate 




. The ternary complex 
solution was mixed with equal volume of reservoir solution containing 0.1 M MES (pH 5.5), 5 
mM MgCl2, and 16-22% (w/v) PEG 2000 monomethyl ether (MME) and equilibrated against 
500 µL reservoir solutions. Crystals typically appeared after overnight incubation and were 
allowed to grow for one to a few weeks. They were transferred to cryoprotectant solution 
containing reservoir solution along with 25% glycerol (v/v), and then frozen in liquid nitrogen 
for data collection.  
2.6.2.11 X-ray Diffraction Data Collection, Structure Determination and 
Refinement  
 The atomic coordinates and structure factors (codes 5DLF, 5DLG, 5DQG, 5DQH and 
5DQI) have been deposited in the Protein Data Bank (http://wwpdb.org/). X-ray diffraction data 
were collected at 100 K either on the 21-ID-F or the 21-ID-G beamline of the Life Sciences 
Collaborative Access Team (LS-CAT) at the Advanced Photon Source (APS), Argonne National 
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Laboratory (Argonne, IL). All data were processed with the program HKL2000.
259
 Data 
collection statistics are summarized in Table S2.3. All structures were determined by Molecular 
Replacement in PHASER,
260,261
 using the coordinates of the complex between hPol η and native 
DNA (PDB ID code 4O3N)
229





 and model building was carried out in COOT.
264
 Model statistics 




2.6.3 Supporting Schemes, Figures, and Tables 
 
 
Scheme S2.1: Reagents and conditions for a-series:  i) NaOEt, EtOH, reflux. ii) 1. HMDS, 
TMS-Cl. 2. 1-(α)-chloro-3,5-di-O-(p-toluoyl)-2-deoxy-D-ribose, 1,2-dichloroethane. 3. TBAF (1 
M in THF). iii) 1. Ms-Cl, Py 2. DBU, THF, reflux. iv) NH3/CH3OH (sat. solution). 2. DMTr-Cl, 
DMAP, pyridine. v) Cl-P(OCEt)N(iPr)2, DIPEA, THF. Reagents and conditions for b-series: 





Figure S2.1: SAX-HPLC profile of purified (a) SDFP and (b) STPP. The column was eluted 
using a linear gradient of 0-52% buffer B over 24 min (buffer A: 100 mM Tris HCl, pH 7.5, 






















Figure S2.4: C-18 HPLC profile of digested oligomer SDFP at (a) 260 nm and (b) 300 nm. 
The column was eluted with a linear gradient of 0-70% buffer B over 30 min was used to 
elute desired analytes (buffer A: 50 mM sodium phosphate, pH 5.8, 2% acetonitrile and 







Figure S2.5: C-18 HPLC profile of digested oligomer STPP at (a) 260 nm and (b) 300 nm. 
The column was eluted with a linear gradient of 0-70% buffer B over 30 min was used to 
elute desired analytes (buffer A: 50 mM sodium phosphate, pH 5.8, 2% acetonitrile and 








Figure S2.6: Tm values (
o




-EtdT, DFP or TPP 
across different base pairing partners. The sequence of the DNA duplex was 





EtdT, DFP or TPP and Y is dA, dG, dC or dT. The solutions contain a total strand 
concentration of 3.8 μM for the duplexes in a buffer consisting of 90 mM sodium chloride, 
pH 7.0, 10 mM sodium phosphate, and 1 mM EDTA buffer.  Data was acquired at 0.5 
°C/min from 90 
o
C to 15 
o
C monitoring UV absorption at 260 nm. Samples were held at 15 
o
C for 2 min and re-heated at 0.5 
o
C/min to 90 
o




Figure S2.7: Far-UV circular dichroism spectra of DNA sequences containing the modified 
adducts in duplexes 5´ GGCTXGATCACCAG 3´ / 5´ CTGGTGATCAAGCC 3´ where X is 
dT (—), DFP (– – –) or TPP (– • –). Solutions containing a total strand concentration of 3.8 
μM for the duplexes were prepared in buffer containing 90 mM sodium chloride, pH = 7.0, 





Figure S2.8: Side view of geometry optimized models of DNA duplexes 5’ 
GGCTXGATCACCAG 3’ / 5’ CTGGTGATCAAGCC 3’ where X is (a) dT, (b) O4-MedT, 
(c) DFP, (d) O
4





Figure S2.9:  Top view of geometry optimized models of the DNA duplexes 5’ 
GGCTXGATCACCAG 3’ / 5’ CTGGTGATCAAGCC 3’ where X is (a) dT, (b) O4-MedT, 
(c) DFP, (d) O
4
-EtdT, and (e) TPP.  All X · A base pairs are colored in green and flanking 
base pairs are red and purple. The modified thymidinyl nucleotides were found to adopt a 

















and TPP by hPol η with individual dNTPs. Values are reported in Table S2.1. Panels (a-d) 
are different representations of steady-state kinetic data. Note that Panel (a) is re-depicted 




Figure S2.11: LC-MS analysis of the most abundant full-length extension products opposite 
unmodified dT in the DNA template by hPol η in the presence of all four dNTPs. (a) Sample 
reconstructed extracted ion chromatogram for m/z 1247.8 for product with sequence 5’-pCAT 
AATGA and (b) mass spectrum of peak at retention time 3.24 min. See Table S2.2 in the 





Figure S2.12: LC-MS analysis of the most abundant full-length extension products opposite 
O
4
-MedT in the DNA template by hPol η in the presence of all four dNTPs. (a) Sample 
reconstructed extracted ion chromatogram for m/z 1247.8 for product with sequence 5’-pCAT 
AATGA and (b) mass spectrum of peak at retention time 3.25 min. (c) Sample reconstructed 
extracted ion chromatogram for m/z 1255.8 for product with sequence 5’-pCAT GATGA and 
(d) mass spectrum of peak at retention time 3.12 min. (e) Sample reconstructed extracted ion 
chromatogram for m/z 1091.2 for product with sequence 5’-pCAT _ATGA and (f) mass 
spectrum of peak at retention time 3.20 min. See Table S2.2 in the manuscript for the full list 





Figure S2.13: LC-MS analysis of the most abundant full-length extension products opposite 
O
4
-EtdT in the DNA template by hPol η in the presence of all four dNTPs. (a) Sample 
reconstructed extracted ion chromatogram for m/z 1247.8 for product with sequence 5’-pCAT 
AATGA and (b) mass spectrum of peak at retention time 3.26 min. (c) Sample reconstructed 
extracted ion chromatogram for m/z 1255.8 for product with sequence 5’-pCAT GATGA and 
(d) mass spectrum of peak at retention time 3.14 min. See Table S2.2 in the manuscript for 





Figure S2.14: LC-MS analysis of the most abundant full-length extension products opposite 
DFP in the DNA template by hPol η in the presence of all four dNTPs. (a) Sample 
reconstructed extracted ion chromatogram for m/z 1247.8 for product with sequence 5’-pCAT 
AATGA and (b) mass spectrum of peak at retention time 3.27 min. (c) Sample reconstructed 
extracted ion chromatogram for m/z 1255.8 for product with sequence 5’-pCAT GATGA and 
(d) mass spectrum of peak at retention time 3.13 min. See Table S2.2 in the manuscript for 






Figure S2.15: LC-MS analysis of the most abundant full-length extension products opposite 
TPP in the DNA template by hPol η in the presence of all four dNTPs. (a) Sample 
reconstructed extracted ion chromatogram for m/z 1247.8 for product with sequence 5’-pCAT 
AATGA and (b) mass spectrum of peak at retention time 3.65 min. (c) Sample reconstructed 
extracted ion chromatogram for m/z 1255.8 for product with sequence 5’-pCAT GATGA and 
(d) mass spectrum of peak at retention time 3.56 min. See Table S2.2 in the manuscript for 





Figure S2.16: Space filling model of the hPol  active site with O4-MedT (magenta carbon 
atoms) wedged between Trp-64 and Ser-62 (protein residues are green), allowing for 
extensive hydrophobic interactions between the O
4
-MedT methyl group and surrounding 
residues from the polymerase finger domain. Carbon atoms of the incoming dATP are 
colored in light blue and template dT 3 to the lesion and the 5-adjacent T:A base pair are 












Figure S2.17: Quality of the final models of ternary hPol η complexes with O4-MedT/O4-
EtdT-adducted DNA template strands. Fourier (2Fo-Fc) sum electron density drawn at the 
1threshold (green meshwork) around the active site region. A, O4-MedT and dATP, 
insertion stage. B, O
4
-MedT and dGMPNPP, insertion stage. C, O
4
-EtdT and dAMPNPP, 
insertion stage. D, O
4
-EtdT and dGMPNPP, insertion stage. E, O
4
-EtdT opposite primer dA, 
followed by dCTP opposite template dG; extension stage. F, Omit (Fo-Fc) electron density 
drawn at the 3σ threshold (purple meshwork) around the 3´-terminal primer dC that was 




-EtdT, the incoming 
nucleotide triphosphate, and selected hPol η amino acid side chains are colored in maroon, 
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 ions are cyan and pink spheres, 
respectively. Carbon atoms of the template dA paired to O
4
-EtdT and those of the 3-terminal 







Figure S2.18: Model of the active site configuration in the ternary hPol η insertion-step 
complex with dGMPNPP opposite TPP (black carbon atoms). The TPP moiety was modeled 
in place of the ethyl adduct (O
4
-EtdT) seen in the crystal structure of the complex. The 
bicyclic ring protrudes into the major groove of the template-primer duplex, and can be 
accommodated without clashing with incoming nucleotide triphosphate or amino acid side 










-EtdT, DFP, and TPP by hPol η. 
Template base dNTP kcat (s
-1








dATP 1.60 ± 0.03 1.4 ± 0.1 1.2 ± 0.1  
dGTP 0.71 ± 0.03 4.6 ± 0.7 0.15 ± 0.02 0.13 
dCTP 0.16 ± 0.01 29 ± 7 0.006 ± 0.001 0.005 




dATP 0.69 ± 0.03 3.9  ± 0.6 0.18  ± 0.03 0.94 
dGTP 1.18 ± 0.02 6.2  ± 0.4 0.19  ± 0.01  
dCTP 0.11 ± 0.01 15 ± 3 0.007  ± 0.002 0.04 




dATP 0.83 ± 0.03 9  ± 1 0.10 ± 0.01  
dGTP 0.61 ± 0.02 10 ± 1 0.06 ± 0.01 0.63 
dCTP 0.12 ± 0.01 43 ± 10 0.003 ± 0.001 0.03 
dTTP 0.19 ± 0.02 27 ± 7 0.007 ± 0.002 0.07 
DFP 
dATP 1.18 ± 0.05 4.4 ± 0.7 0.27 ± 0.04  
dGTP 1.15 ± 0.02 5.7 ± 0.4 0.20 ± 0.02 0.76 
dCTP 0.12 ± 0.01 55 ± 14 0.002 ± 0.001 0.01 
dTTP 0.20 ± 0.02 84 ± 21 0.002 ± 0.001 0.01 
TPP 
dATP 1.33 ± 0.04 5.4 ± 0.6 0.24 ± 0.03  
dGTP 1.18 ± 0.03 6.2 ± 0.6 0.19 ± 0.02 0.78 
dCTP 0.12 ± 0.01 54 ± 12 0.002 ± 0.001 0.01 
dTTP 0.21 ± 0.01 51 ± 11 0.004 ± 0.001 0.02 
1










-EtdT, DFP and TPP by hPol η (values are reported in %). 




-EtdT DFP TPP 
7Del 5’-pCAT _ATGA  6 2 < 1 < 1 
8A 5’-pCAT AATGA 89 27 22 21 16 
8_A 5’-pCAT _ATGAA < 1 1 < 1 < 1 < 1 
8G 5’-pCAT GATGA 3 45 50 69 72 
8_G 5’-pCAT _ATGAG 3 3 1  < 1 
8C 5’-pCAT CATGA < 1  < 1  < 1 
8T 5’-pCAT TATGA  1 2   
9AA 5’-pCAT AATGAA 3 1 1 < 1  
9AG 5’-pCAT AATGAG 2 1 1 < 1 < 1 
9GA 5’-pCAT GATGAA < 1 8 10 4 4 





























     
Wavelength [Å] 0.97856 0.97856 0.97856 0.97872 0.97872 
Space group P61 P61 P61 P61 P61 
Resolution [Å] 




50 - 2.35  
(2.39 - 2.35) 
50 - 2.29  
(2.35 - 2.29) 
50 - 1.99 
(2.02 - 1.99) 
50 - 2.30 
(2.34 - 2.30) 
Unit cell  
a=b, c [Å] 















100 (100) 97.9 (96.5) 100 (100) 98.9 (98.5) 99.4 (94.5) 





16.0 30.9  26.1 22.8 43.9 
R-merge 0.165 (0.834) 0.127 (0.941) 0.140 (0.539) 0.139 (0.997) 0.093 (0.897)  
Redundancy 5.7 (5.7) 4.2 (3.5) 5.6 (5.6) 11.4 (10.0) 7.2 (5.6) 
Refinement      
R-work 0.165 (0.213) 0.171 (0.238) 0.176 (0.156) 0.161 (0.198) 0.204 (0.289)  











) 31/2 30/2 31/2 28/2 (Ca
2+
) 
Water/Solute 494/1 222/1 212/1 362/1 103/0 
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Protein residues 439 430 430 438 424 
B-factor [Å
2
]      
Average 24.0 34.0 31.0 28.0 55.5 





20.5/12.8 28.3/28.6 19.3/17.8 23.6/18.9 39.3/41.6 
Water/ glycerol 30.4/13.4 35.2/27.1 30.1/20.9 32.5/ 19.5 47.9/- 
R.m.s. 
deviations 
     
bonds [Å] 0.016 0.009 0.012 0.008 0.011 
angles [deg.] 1.6 1.1 1.4 1.1 1.5 
Ramachandran      
Favored (%) 98 97 97 98 96 
Allowed (%) 1.5 2.3 2.8 1.8 3.0 
Outliers (%) 0.5 0.7 0.2 0.2 1.0 
PDB ID Code 5DLF 5DLG 5DQG 5DQH 5DQI 
a
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 Oligonucleotides tethered by an alkylene linkage between the O
6
-atoms of two 
consecutive 2’-deoxyguanosines, which lack a phosphodiester linkage between these 
residues, have been synthesized as a model system of intrastrand cross-linked (IaCL) DNA. 
UV thermal denaturation studies of duplexes formed between these butylene and heptylene 
linked oligonucleotides with their complementary DNA sequences revealed ca. 20
o
C 
reduction in stability relative to the unmodified duplex. Circular dichroism spectra of the 
model IaCL duplexes displayed a signature characteristic of B-form DNA suggesting 
minimal global perturbations are induced by the lesion. The model IaCL containing duplexes 
were investigated as substrates of O
6
-alkylguanine DNA alkyltransferase (AGT) proteins 
from human and E. coli (Ada-C and OGT). Human AGT was found to repair both model 
IaCL duplexes with greater efficiency towards the heptylene versus butylene analog adding to 





DNA is susceptible to modification by various endogenous metabolites and 
environmental agents.
31,266
 Any chemical or structural change to this important biomolecule 
may have a profound effect on an organism since genetic instructions may be compromised. 
Lesions that can form in DNA include interstrand cross-links (ICL), intrastrand cross-links 
(IaCL), DNA-protein cross-links (DPCs) and various mono-alkylated adducts. The presence 
of ICL affects both strands of DNA and can block vital cellular processes that require 
unwinding such as replication and transcription.
54,57,267
 The introduction of IaCL in DNA 
modifies only one of the strands but can lead to a distortion of DNA structure which can 
result in the interference of critical cellular processes.
69,95,268,269
 These modifications can have 
an impact on DNA structural features such as helical bending that can affect the affinity of 




DNA IaCL can arise from numerous sources. For example, γ-radiation can induce a 
 G[8,5-Me]T IaCL lesion inducing  structural perturbations in the DNA that has been shown 
to lead to blockage of Pol IV (dinB) of E. coli and Taq polymerase in vitro. 
273
 UV radiation 
is the main cause of photocarcinogenesis inducing high levels of p53 mutations at 
bipyrimidine sites in skin tumors.
75,274–277
 Cyclobutane-pyrimidine dimers (CPDs) and 
pyrimidine (6-4) pyrimidone photoproducts (in addition to their Dewar isomers) are two 
major classes of IaCL DNA lesions introduced by UV radiation.
75,278,279
 Structural 
investigation of oligomers containing different UV induced IaCL lesions revealed variation in 
global and local structures, all of which impair the proper functioning of DNA polymerases. 
280
  
Some chemical agents can introduce both DNA ICL and IaCL lesions and have 
applications in various chemotherapeutic regimens. One of the most-widely studied and 
118 
 
administered chemotherapeutic cancer drug, cisplatin, has an estimated lesion distribution of 
90-95% IaCL and the remaining 5-10% is attributed to ICL, mono-adducts and DPCs 
107,268,281–283







 have all been shown to introduce IaCL lesions in DNA. A common 
cross-linking site on DNA occurs between the N7-atoms of adjacent purines.
69,286
 For 
example, busulfan's main IaCL lesion occurs at 5'-d(GA) sites linking the N7-atoms.
69
 
A major mechanism of chemotherapeutic resistance involves DNA damage 
recognition and repair. IaCL DNA is thought to be repaired primarily by nucleotide excision 
repair (NER)
66,287
  and translesion synthesis (TLS).
71,288
 Studies with an oxidatively generated 
IaCL between guanine and pyrimidine bases have revealed recognition and, in some cases, 
incision by the NER machinery in E coli.
81,289
 Interestingly, proteins containing a high 
mobility group (HMG) domain DNA-binding motif showed inhibition of mammalian NER 
factors from acting on IaCL DNA.
83
 Certain platinum IaCL in DNA, 1,2 d(GG) and 1,3 
d(GNG) in particular, are readily recognized and excised by the NER pathway.
290,291
 Y-
family DNA polymerases, such as Pol η, are efficient and accurate in bypassing the platinum-
based IaCL between guanine residues.
224–226
 Cell lines with mutations in the POLH gene, 
responsible for encoding Pol η, are hypersensitive to both UV-radiation292 and platinum-
based drugs
230,293
 despite proper functioning of NER.  
The preparation of site-specific chemical modifications within DNA has been an 
important tool for investigating structural and biochemical relationships related to DNA 
synthesis and repair.
54,287,294
 Kowalczyk and coworkers introduced an IaCL of various 
alkylene chain lengths between the exocyclic N
2
 atoms using a post-synthetic 
methodology.
269
 This elegant approach to introduce site-specific IaCL requires access to the 
appropriate convertible nucleosides that are stable during the reactions encountered during 
the solid-phase oligonucleotide synthesis. 
119 
 
Using a combination of solution and solid phase synthesis, we and others have 
developed methods to introduce site specific ICL and IaCL in DNA.
295–299
 However, it can be 
challenging to generate adducts at certain positions in the DNA scaffold. For example, N7-
methylated 2’-deoxyguanosine (dG) can undergo depurination300 or ring opening to form the 
formamidopyrimidine (Fapy) derivative.
301
 Albeit to a lesser extent relative to the N7 
position, the O
6
-atom of dG can undergo alkylation from exposure to different electrophiles 
such as the chemotherapeutic drugs temozolomide
157
 and the chloroethylating and cross-
linking agent carmustine.
302
 Alkylation at the O
6
-site of dG is mutagenic since the disruption 
of proper Watson-Crick base pairing leads to misinsertions of thymine across the modified 
residue.
19





 and tumor production, 
303–305
 making the study of this 
alkylation site invaluable. 
Previously, DNA duplexes containing ICL attaching the O
6
-atoms of dG by alkylene 
linkers in various sequence motifs have been prepared and it has been shown that such cross-





 AGT proteins are found in various organisms 





 The mechanism of AGT repair involves flipping of the alkylated nucleotide 
out of the duplex and into the protein’s active site, allowing the activated C145 residue to 
attack the carbon adjacent to the O
6
-atom of dG. A tyrosyl residue (Tyr114 in hAGT) 
promotes the flipping of the alkylated dG residue into the active site via steric and / or 
electronic interactions. It is, however, uncertain how Tyr114 interacts with the 3’-
phosphodiester linkage to aid in repair of the alkylated nucleobase.
137,168
 The irreversibly 
alkylated protein is then rapidly degraded by the ubiquitin pathway.  hAGT has demonstrated 




 The substrate 
120 
 
specificity of hAGT has been explored for protein tagging
178
 and an approach to analyze 
hAGT activity monitoring conformational changes on DNA origami has been reported. 
307
 
Recently, it has been shown that hAGT can also repair O
6
-methyl-dG adducts in G-











-dG, Figure 3.1) has been developed. This IaCL 
DNA lacks a phosphodiester linkage between the connected residues which confers added 
flexibility of the modified position and a simplified synthetic strategy to prepare the 
substrates, relative to one containing a phosphodiester linkage at this modified position in the 
chemically synthesized oligonucleotide. The influence of this IaCL modification was 
assessed by UV thermal denaturation and circular dichoism experiments.  Finally, repair of 
these novel IaCL by various AGTs (from human and E. coli) was evaluated to address 
whether these enzymes can act upon this specific O
6
-alkylated substrate. Repair of DNA 
containing ICL with similar alkylene tethers (butylene and heptylene) by AGTs have been 
observed previously. Moreover, the IaCL DNA probes aid in understanding the importance of 
the phosphodiester linkage at the 3’ and 5’ of O6-alkylated-dG for AGT-mediated repair. For 
this study, IaCL containing butylene and heptylene linkers were selected on the basis that 
butylene linked IaCL can be introduced into DNA by the action of the drug busulfan which 
has been demonstrated to link the N7-positions of 5'-d(GA) and 5'-d(GG) sequences.
69
  It 
should be noted, however, that a specific IaCL between the O
6
-positions of 5'-d(GG) 
sequences has not been identified. Hepsulfam, an alkyl sulfamate, has been shown to be 
proficient at producing heptylene linked ICL at the N7-positions of guanine at 5’-d(GNC) 





Figure 3.1: Structure of the O
6
-2′-deoxyguanosine-alkylene-O6-2′-deoxyguanosine IaCL 
mimic lacking a phosphodiester linkage between these two residues. The position of this 
IaCL mimic is shown by GG (where GG4 has a butylene linker and GG7 a heptylene linker). 
3.2 Results and Discussion 
3.2.1 Synthesis and characterization of GG IaCL DNA 





required the synthesis of oligonucleotides containing this modification in a defined position. 










-dG IaCL (GG4 and GG7) is shown in Figure 
3.1. The synthesis of the cross-linked amidites 3.9a and 3.9b, required for the synthesis of 
GG4 and GG7, is shown in Scheme 3.1. Starting with commercially available 5'-O-
dimethoxytrityl-N
2
-phenoxyacetyl-2'-deoxyguanosine 3.1, the 3’-OH position was protected 
with a phenoxyacetyl group to furnish 3.2 in decent yield. The phenoxyacetyl, rather than an 
acetyl group, was selected for protection at the 3’-OH position due to possible transamidation 
observed at the exocyclic N
2
 during oligonucleotide assembly and for its facile removal under 




 Coupling of 
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compound 3.2 at the O
6
-position with the appropriate tert-butyldiphenylsiloxy mono-
protected diol (1,4-butanediol or 1,7-heptanediol) was accomplished by the Mitsunobu 
reaction. This reaction is known for its selectivity at introducing alkyl groups at the O
6
-
position of protected dG and has been utilized previously to generate O
6
-alkylene-linked 
dimers containing dG for the preparation of ICL duplexes.
65,151,311,312
 Slightly diminished 
yields were observed for this reaction relative to those previously reported,
65,151,311,312
 which 
may be attributed to some loss of the Pac group under the mild basic conditions used to 
prepare compounds 3.3a and 3.3b. Desilylation to unmask the terminal hydroxyl of the linker 
produced nucleosides 3.4a and 3.4b for the dimerization step. In parallel, a second monomer 
was prepared from 3.1 starting with the introduction of a tert-butyldimethylsilyl (TBS) group 
at the 3'-OH and removal of the 5’-O-dimethoxytrityl group, respectively, followed by 
phenoxyacetylation to yield compound 3.6, required to form the dimer. A second Mitsunobu 
reaction was performed to couple the protected monomers 3.4a or 3.4b with 3.6 to produce 
butylene or heptylene linked dimers 3.7a or 3.7b. Removal of the tert-butyldimethylsilyl 
group resulted in compounds 3.8a and 3.8b which were then phosphitylated to yield the 
phosphoramidites 3.9a and 3.9b, respectively. The masses observed by HRMS analysis of 
phosphoramidites 3.9a and 3.9b were in agreement with the expected values. 
31
P NMR 
analysis revealed two sharp signals for compounds 3.9a (148.62 ppm and 148.57 ppm) and 




Scheme 3.1: Reagents and conditions for a-series: (i) Pac-Cl (1.5 eq), NEt3 (2 eq), Py, 21
o
C, 
30 min. (ii)  4-(tert-butyldiphenylsilyloxy)butan-1-ol (1.1 eq), Ph3P (2.1 eq), DIAD (2.1 eq), 
dioxane, 21
o
C, 16h. (iii) TBAF (1.6 eq), THF, 21
o
C, 30min. (iv) 1. TBS-Cl (2.2 eq), Im (4.4 
eq), DMF, 21
o
C, 30 min, 2. p-TsOH•H2O (1.2 eq), MeOH/DCM (1:4), 21
o
C, 30 min. (v) Pac-
Cl (1.5 eq), NEt3 (1.8 eq), THF, 21
o
C, 30 min. (vi) 3.6 (0.91 eq), Ph3P (2 eq), DIAD (2 eq), 
dioxane, 21
o
C,  16h. (vii) TBAF (1M in THF) (1.2 eq), THF, 21
o
C, 30 min. (viii) Cl-
P(OCEt)N(iPr)2 (1.2 eq), DIPEA (1.5 eq), THF, 21
o
C, 30 min. 
Reagents and conditions for b-series: Identical to a-series except step (ii) 7-(tert 




IaCL DNA assembly employed either dimer phosphoramidite 3.9a or 3.9b, which 
differed only in their respective linker length. The presence of one DMTr group and 
phosphoramidite moiety on the dimer scaffolds of 3.9a and 3.9b rendered the linear 
construction of the IaCL oligomers GG4 and GG7 straightforward requiring only minor 
modifications to the standard solid phase synthesis methodology for unmodified DNA.
312
 
Wait times were extended for amidites 3.9a and 3.9b in order to ensure complete coupling of 
the dimer.  GG4 and GG7 were deprotected and cleaved from the solid support with aqueous 
NH4OH : EtOH (3 : 1 v/v) for 4h at 55
o
C with no detectable degradation of the cross-link 
observed by SAX-HPLC (see Figure S1.1). Analysis of the GG4 and GG7 oligomers 
revealed a deconvoluted mass in agreement with the expected mass (values shown in Table 
124 
 
3.1). Further characterization by enzymatic digest to the constituent nucleosides followed by 
RP-HPLC demonstrated the appearance of a new peak (in addition to the other four 
nucleosides) with retentions of 16.4 min and 24.8 min for the butylene and heptylene 
containing dG dimers, respectively.  
Table 3.1: Amounts, retention times, nucleoside ratios and MS data for cross-linked 
oligonucleotides 
 




Nucleoside  Nucleoside Ratio Mass 
Exp Obs Exp Obs 
GG4 60 (31) 
dC 2 2.1 
4610.1 4611.1 
dG 2 2.2 
dT 1 1.0 
dA 1.5 1.5 
dG-4C-dG 0.5 0.5 
GG7 55 (25) 
dC 2 1.9 
4652.1 4653.1 
dG 2 2.1 
dT 1 1.0 
dA 1.5 1.4 
dG-7C-dG 0.5 0.4 
[a]
 A260 of purified oligonucleotide is shown in brackets. 
 
 
3.2.2 UV thermal denaturation and circular dichroism studies of IaCL 
DNA 
Impact of this IaCL mimic on duplex stability with the complementary DNA 
sequence, relative to the native duplex, was assessed by UV thermal denaturation 
experiments. The thermal denaturation profiles of the IaCL containing DNA duplexes were 






C for GG4, GG7 and the unmodified 
duplex, respectively (Figure 3.2). Duplexes containing a single O
6
-methyl-dG insert leads to 
a reduction in Tm by approximately 18
o





relative to unmodified sequences.
313–315





-dG IaCL (GG4 and GG7) were found to decrease the 
Tm by 19-21
o
C relative to the control, which was lower than expected. The decreased stability 
is most-likely attributed to the disruption of H-bonding between the alkylated 2`-
deoxyguanosines and base paired 2`-deoxycytidines particularly with the bulky alkylene 
linkers which could induce local and global structural perturbations. However, flexibility at 
this site due to the lack of the phosphodiester linkage may reduce this effect. 
 
Figure 3.2: Fraction change of maximum absorbance at 260 nm (A260) versus temperature 
(
o
C) profiles of duplexes containing GG4 (- • -), GG7 (- - -) and unmodified DNA (—). 
Circular dichroism spectroscopy was performed to determine the global structural 
influence of the IaCL mimics on the duplexes. CD profiles of duplexes containing GG4 and 
GG7 displayed signatures consistent with the B-DNA family with maxima near 280 nm, 
cross-overs at about 260 nm and minima around 240 nm (shown in Figure 3.3). These results 
indicate minor global structural distortions were induced by the presence of the IaCL. Similar 
findings were observed for mono-adducts at the O
6
-atom of dG (data not shown). Structures 
of unmodified, GG4 and GG7 were geometry optimized using the AMBER force field. In 
both cases, the alkylene linker protruded into the major groove, with a slight widening 
126 
 
observed. The effect was more pronounced for GG4 than GG7, relative to the control. The 
molecular models suggest that the presence of the cross-link does not greatly distort the 
global structure of the duplex (see Figure S3.5 for models).   
 
Figure 3.3: Circular dichroism spectra of IaCL duplexes GG4 (- • -), GG7 (- - -) and 
unmodified DNA (—). 
3.2.3 AGT repair of IaCL DNA substrates 
Four AGT proteins (hAGT, OGT, a S134P OGT variant, and Ada-C) were evaluated 
for their ability to repair duplexes GG4 and GG7. The damaged strand was radio-labeled 
using γ-[32P]-ATP, annealed with an equimolar amount of the complement followed by 
incubation overnight at 37
o
C with the AGT (2 pmol DNA and 10 pmol protein). The repair 
reactions were quenched in stop reaction buffer to prevent complexation before loading onto 
the denaturing gel.  Repair assays conducted on GG4 and GG7 revealed that only hAGT was 
capable of repair (lanes 2 and 7 in Figure 4). The lack of OGT and Ada-C repair was not 
surprising given their low proficiency in repairing lesions larger than a methyl group at the 
O
6





 OGT was incapable of processing the IaCL even at higher AGT concentration 
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ratios and for elongated reaction times (data not shown). The OGT S134P variant,
149
 
presumably containing a larger active site, was also tested against the GG4 and GG7 




Figure 3.4: Repair of GG4 and GG7 by hAGT, OGT, Ada-C, and OGT S134P. Denaturing 
PAGE of repair reactions as described in the experimental section: Lane 1, 2 pmol GG4; lane 
2, 2 pmol GG4 + 10 pmol hAGT; lane 3, 2 pmol GG4 + 10 pmol OGT; lane 4, 2 pmol GG4 
+ 10 pmol Ada-C; lane 5, 2 pmol GG4 + 10 pmol  OGT S134P; lane 6, 2 pmol GG7; lane 7, 
2 pmol GG7 + 10 pmol hAGT; lane 8, 2 pmol GG7 + 10 pmol OGT; lane 9, 2 pmol GG7 + 
10 pmol Ada-C; lane 10, 2 pmol GG7 + 10 pmol  OGT S134P; lane 11, 2 pmol control 
unmodified DNA + 10pmol hAGT. 
The repair of GG4 and GG7 by hAGT is proposed to proceed by a first reaction to 
generate a DNA-protein cross-link, which can then undergo a second repair event by another 
AGT molecule ultimately forming a protein-protein cross-link (Figure 3.5). Given the lack of 
the phosphodiester linkage at the cross-link site, repair of the IaCL DNA would produce two 
smaller DNA fragments, which are resolvable on PAGE and detected by autoradiography.  
Trials were initially carried out overnight at 37
o





-dG IaCL.  
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Lanes 1 and 6 contain the GG4 and GG7 ssDNA, respectively. Lane 11 contains the 
unmodified ssDNA strand (with a phosphodiester linkage at the corresponding site relative to 
the IaCL ssDNA) of identical nucleotide sequence as GG4 and GG7. As shown in Figure 
3.4, the presence of the alkylene appendage and having one less phosphodiester linkage 
reduces the DNA migration on the denaturing gel with the unmodified ssDNA migrating 
fastest and GG7 the slowest.  Lanes 2 and 7 display the repair reaction of GG4 and GG7 (2 
pmol), respectively, with 10 pmol of hAGT. In both cases the band corresponding to the 
intact IaCL DNA disappears and two new bands appear, one which migrates much slower 
compared to the substrate and another that migrates faster. The slow migrating band most-
likely corresponds to the hAGT covalently attached to the DNA species, as observed 






 The faster migrating 
species is likely the smaller [
32
P]-labeled repair product. 
 
Figure 3.5: Proposed repair pathway of IaCL species by wild-type hAGT (MP - median 
product; RP- repair product).  
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The repair assays revealed that hAGT was more proficient in repairing GG7 
compared to GG4; leaving approximately 2 % and 15 % of unrepaired GG7 and GG4 
substrates, respectively. Median products (MP) consisted of 6 % and about 9 % of the total 
counts for GG7 and GG4 experiments. Finally, repair products (RP) were generated at levels 
of 91 % and 76 % for GG7 and GG4, respectively. Interestingly, these results follow a 
similar trend as repair of ICL DNA containing identical-length alkylene linkers. That is, the 
size of the linker affected hAGT repair with higher efficiency observed for heptylene linkers 
compared to butylene linkers.
65
 Repair of the GG7 and GG4 by hAGT was greater compared 





-dG IaCL DNA are more-readily repaired by hAGT compared to 
ICL DNA.  
Time course assays were performed using 10 pmol hAGT and 2 pmol of either GG4 
or GG7 substrates by quantifying the amounts of unrepaired, MP and RP products (see 
Figure S3.7 for denaturing PAGE). GG7 was repaired faster with respect to GG4 (Figure 
3.6). The formation of the RP reached the plateau faster in the case of GG7 compared to 
GG4. After repair reaction times of 15 min and 8h, 80% and 18 % of GG4 remained, 
respectively, whereas only 21% and 2 % of GG7 remained, respectively. The greater 







 The current understanding of the AGT-mediated repair 
mechanism involves flipping the O
6
-modified nucleotide into the active site followed by alkyl 
transfer to the activated thiol of C145.
137





-dG IaCL relative to ICL DNA  may be attributed to additional strain involved in 
flipping the O
6
-alkylated nucleotide tethered to the complementary strand of the ICL, relative 
to the IaCL lesion which resides on one strand only. Protein binding on the complementary 
alkylated strand of the ICL DNA may also be a contributing factor to reduced repair relative 
130 
 
to the IaCL. The faster repair of GG7 compared to GG4 is most-likely because the greater 
flexibility of the larger linker, which facilitates rotation of the nucleotide out of the duplex. 




 distance for adjacent dG nucleotides 
of 3.1 Å, 3.3 Å and 4.0 Å for GG4, GG7 and unmodified duplex. Increased tilting of the 
cross-linked guanine bases was seen in the case of GG4 relative to GG7, which suggests that 
more strain is observed with the shorter alkylene linker. As a result, the guanine bases in 
GG7 are presumably more easily rotated into the active site of the protein for repair. 
Additional strain observed in GG4 could explain why this substrate is not fully repaired with 
extended repair assay times, and the GG7 substrates are almost fully consumed.  
Formation of RP and MP occurs at different rates with RP forming faster compared 
to MP. This would suggest, as in the case of ICL DNA repair, that hAGT preferentially 
repairs the MP over the initial substrate since no accumulation of MP is observed at any 
time. GG7 repair shows a crossover between the substrate consumption curve and MP 
formation curve. This was not observed in the case of GG4 nor any ICL DNA previously 
tested.
64,65
 Moreover, GG7 was virtually completely consumed by a fivefold excess of hAGT 
protein after extended reaction times (8h), which was not observed in the case of the 
interstrand cross-linked probes. As for ICL DNA, GG4 repair was not observed to proceed to 
completion over time which presumably was due to reacted hAGT binding to another DNA 
containing lesion.
169
 Another possible explanation is that the alkylene linker adopts a less 





 Using in vitro assays, these results demonstrate that IaCL DNA containing four and 
seven carbon atoms linking two adjacent O
6
-dG residues, lacking the phosphate group, are 
efficiently repaired by hAGT adding to our knowledge of the range of substrates that this 
repair protein can act upon. Intrastrand cross-links can be formed in DNA by the bifunctional 
alkylating drug busulfan and other chemotherapeutic drugs, although to our knowledge no 
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IaCL linking the O
6
-atoms of dG has been identified. In a previous study, it was shown that 
AGT-deficient CHO cells were sensitive to killing by hepsulfam.
65
 These results suggest that 
expression of AGT protects, to a certain extent, CHO cells from exposure to hepsulfam but 
not busulfan. These preliminary results are also consistent with the more efficient repair 
observed for the heptylene versus butylene IaCL adducts by hAGT.  
 
Figure 3.6: Time course repair assay of GG4 (A) and GG7 (B) by hAGT displaying 
significant faster repair of GG7 by about a 14-fold factor. Graphical illustrations display 
abundances (%) of MP (- • -), RP (- - -) and substrate (—) over time (min). 




-dG IaCL is the lack of a 5', 3'-phosphodiester 
linkage between the nucleotides at the modified site. Previous crystallographic studies have 
suggested that Tyr114 is necessary for flipping of the damaged nucleotide mediated by steric 
repulsion between this residue of AGT with the 3'-phosphate group of the target 
nucleotide.
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ethanoxanthine-containing DNA complexes have illustrated the role of this steric interaction 
between Tyr114 and the 3’-phosphate group.137 This was further supported by studies using 
Y114F and Y114A mutants, which showed significant reduction in activity towards O
6
-
alkylated-dG DNA adducts. A computational approach to elucidate the AGT repair 
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mechanism pathway deciphered a different role for the Tyr114, whereby interactions would 
be mediated solely via electronics, rather than sterics.
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-dG IaCL which lacks a 3'-phosphate 
group between the two O
6
-modified-dG residues is observed to undergo repair by hAGT. 




-dG IaCL with the 
corresponding lesion containing a phosphodiester linkage at this site may contribute to 
probing the steric versus electronic role that the Tyr114 residue plays in AGT-mediated 
repair. Investigation of the synthetic probes herein sheds light on AGT repair of O
6
-alkylated-
dG lacking the 3’-phosphate group further contributing to our understanding of AGTs. 
Further work on IaCL DNA and AGT mutants will provide insights on the effect of the 3’-
phosphate group on repair by AGTs as well.  
3.3 Conclusions 





IaCL were prepared using a nucleoside dimer phosphoramidite, followed by solid-phase 
synthesis assembly. IaCL DNA were deprotected and cleaved off solid support using 
standard protocols and purification was achieved by SAX-HPLC to obtain the probes in high 
yields and purity. Thermal denaturation analysis of duplexes containing IaCL of butylene and 
heptylene linkages were found to have similar Tm values; both of which led to a reduction in 
stability by 20
o
C relative to the unmodified duplex. Circular dichroism and molecular 
modeling suggested minimal global perturbation in the structure. Both GG4 and GG7 were 
repaired by hAGT, with a much higher efficiency for IaCL containing a heptylene versus 
butylene linker, despite lacking the phosphate group at the cross-link site. These results serve 




3.4 Experimental Section 
3.4.1 Purification and characterization of oligomer containing the 
phosphateless IaCL  
The cross-linked duplexes, whose sequences are shown in Figure 3.1, were 
assembled on an Applied Biosystems Model 3400 synthesizer on a 1.5 μmol scale using 
standard β-cyanoethylphosphoramidite chemistry supplied by the manufacturer with slight 
modifications to coupling times. The nucleoside phosphoramidites containing standard 
protecting groups were prepared in anhydrous MeCN at a concentration of 0.1 M for the 3’-
O-deoxyphosphoramidites, and 0.15 M for the cross-linked 3’-O-deoxyphosphoramidite. 
Oligomer sequence assembly was carried out as follows: (1) detritylation, 3% trichloroacetic 
acid in dichloromethane; (2) nucleoside phosphoramidite coupling time of 2 min for 
commercial 3’-O-deoxyphosphoramidites, and 10 min for the cross-linked phosphoramidites 
3.9a or 3.9b; (3) capping, phenoxyacetic anhydride/pyridine/ tetrahydrofuran 1:1:8 (v/v/v; 
solution A) and 1-methyl-imidazole/ tetrahydrofuran 16:84 (w/v; solution B); (4) oxidation, 
0.02 M iodine in tetrahydrofuran/water/pyridine 2.5:2:1.  
Protecting groups and cleavage from the solid support was carried out by treatment 
with aqueous (28% v/v) ammonium hydroxide in EtOH (1 mL of a 3 : 1 v/v solution) for 4h 
at 55 
o
C in 2 mL screw cap microfuge tubes fitted with Teflon lined caps. Crude oligomers 
were transferred and evaporated in a speedvac concentrator followed by purification by 
strong-anion exchange HPLC using a Dionex DNAPAC PA-100 column (0.4 cm × 25 cm) 
purchased from Dionex Corp, Sunnyvale, CA using a linear gradient of 0-52% buffer B over 
24 min (buffer A: 100 mM Tris HCl, pH 7.5, 10% acetonitrile and buffer B: 100mM Tris 
HCl, pH 7.5, 10% acetonitrile, 1 M NaCl) at 55
o
C. The columns were monitored at 260 nm 
for analytical runs or 280 nm for preparative runs. The purified oligomers were desalted 
using C-18 SEP PAK cartridges (Waters Inc.) as previously described.
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 The amounts of 
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purified oligomers obtained are shown in Table 3.1 (crude A260 of 60 and 55 and pure A260 of 
31 and 25 for GG4 and GG7, respectively). 
Modified oligomers (0.05 A260 units) were characterized by digestion with snake 
venom phosphodiesterase (0.28 units) and calf intestinal phosphatase (5 units) in a buffer 
containing 10 mM Tris (pH 8.1) and 2 mM magnesium chloride for 2 days at 37 °C as 
previously described.
298
 The resulting mixture of nucleosides was analyzed by reversed phase 
HPLC using a Symmetry C-18 5 μm column (0.46 × 15 cm) purchased from Waters Inc., 
Milford, MA. A linear gradient of 0–30% buffer B over 30 min (buffer A, 50 mM sodium 
phosphate, pH 5.8 and buffer B, 50 mM sodium phosphate, pH 5.8, 50% acetonitrile) was 
used to elute the analytes. The peaks in the elution profile were identified by coinjection with 
the corresponding standards with the following elution times: dC (4.5 min), dG (7.4 min), dT 
(8.0 min), dA (9.0 min), and cross-linked dimers (16.4 min and 24.8 min for the butylene and 
heptylene dimers, respectively), and the ratio of nucleosides was determined. The results are 
given in Table 3.1. The molecular mass of the modified oligomers were identifed by ESI-MS 
and the measured values were in agreement with the expected masses (see Figure S3.3 and 
Figure S3.4 for MS spectra). 
3.4.2 Protein expression and purification 
All AGT homologues were expressed under the promoter of the pQE30 vector in XL-
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3.6 Supporting information 
3.6.1 Supporting Methods 
3.6.1.1 General 
 5’-O-(4,4’-Dimethoxytrityl)-N2-phenoxyacetyl-2’-deoxyguanosine and  N,N-
diisopropylaminocyanoethylphosphonamidic chloride were purchased from ChemGenes, Inc. 
(Wilmington, MA). 5’-O-(4,4’-Dimethoxytrityl-2’-deoxyribonucleoside-3’-O-(β-cyanoethyl-
N,N-diisopropyl)phosphoramidites and protected 2’-deoxyribonucleoside–CPG supports 
were purchased from Glen Research (Sterling, Virginia). All other chemicals and solvents 
were purchased from the Aldrich Chemical Company (Milwaukee, WI) or EMD Chemicals 
Inc. (Gibbstown, NJ). Flash column chromatography was performed using silica gel 60 (230–
400 mesh) purchased from Silicycle (Quebec City, QC). Thin layer chromatography (TLC) 
was carried out with precoated TLC plates (Merck, Kieselgel 60 F254, 0.25 mm) purchased 
from EMD Chemicals Inc. (Gibbstown, NJ). NMR spectra were recorded on a Varian 500 
MHz NMR spectrometer at room temperature. 
1
H NMR spectra were recorded at a frequency 
of 500.0 MHz and chemical shifts were reported in parts per million (ppm) downfield from 
tetramethylsilane. 
13
C NMR spectra (
1
H decoupled) were recorded at a frequency of 125.7 





H decoupled) were recorded at a frequency of 202.3 MHz and chemical shifts 
were reported in ppm with H3PO4 used as an external standard. High resolution mass 
spectrometry of modified nucleosides were obtained using an LTQ OrbitrapVelos – ETD 
(Thermo Scientific) at the Concordia University Centre for Biological Applications of Mass 
Spectrometry (CBAMS). The mass spectrometer was operated in full scan, positive ion 
detection mode. ESI mass spectra for oligonucleotides were obtained at CBAMS using a 
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Micromass Qtof2 mass spectrometer (Waters) equipped with a nanospray ion source. The 
mass spectrometer was operated in full scan, negative ion detection mode. Ampicillin, 
isopropyl β-D-thiogalactopyranoside (IPTG), and most other biochemical reagents as well as 
polyacrylamide gel materials were purchased from Bioshop Canada Inc (Burlington, ON). 
Ni-NTA Superflow Resin was purchased from Qiagen (Mississauga, ON). Complete, Mini, 
EDTA-free Protease Inhibitor Cocktail Tablets were obtained from Roche (Laval, QC) Nitro- 
cellulose filters (0.20 μm) were obtained from Millipore. XL-10 Gold and Bl21(DE3) E. coli 
cells were obtained from Stratagene (Cedar Creek, TX). T4 polynucleotide kinase (PNK) was 
obtained from Fermentas (Burlington, ON). γ-[32P]-ATP was purchased from Amersham 
Canada Ltd (Oakville, ON). Phusion Polymerase was obtained from New England Biolabs 
(Ipswich, MA). DNA primers for site directed mutagenesis and cloning were purchased from 
Biocorp (Montreal, QC). 
3.6.1.2 Chemical Synthesis of nucleosides 
The synthesis of phosphoramidites 3.9a and 3.9b are shown in Scheme 3.1 
 3’-O-N2-bis(phenoxyacetyl)-5’-O-(4,4’-dimethoxytrityl)- 2’-deoxyguanosine (3.2): 
 To a solution of 5’-O-(4,4’-dimethoxytrityl)- N2-phenoxyacetyl-2’-deoxyguanosine 
(2.5  g, 3.6 mmol) and TEA (1.8 mL, 12.9 mmol) in THF (25 mL) was added phenoxyacetyl 
chloride (1.1 mL, 8.2 mmol) dropwise while stirring at 0
o
C. After 30 min, the solvent was 
removed in vacuo and the content taken up in DCM (50 mL), washed with NaHCO3 (aq, 3%) 
(2 x 50mL), dried over anhydrous Na2SO4, decanted and the solvent removed to produce a 
yellow gum. The product was purified via flash column chromatography using MeOH : DCM 
(1 % → 3 % by increments of 0.5 %) to afford 2.4 g (79 %) of a yellow foam. Rf (SiO2 
TLC):0.23 MeOH : DCM (5 %). λmax (ACN) = 276 nm. 
1
H NMR (500MHz, CDCl3, ppm): 
11.77 (s, 1H, NH), 9.05 (s, 1H, NH), 7.78 (s, 1H, H8),  7.40-7.17(m, 14H, Ar), 7.09-7.07 (m, 
1H, Ar), 7.04-6.97 (m, 2H, Ar), 6.93-6.90 (m, 2H, Ar), 6.79-6.76 (m, 4H, Ar), 6.17 (dd, 1H, 
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H1’, J = 7 Hz), 5.69 (m, 1H, H3’), 4.67 (s, 2H, PhOCH2CO), 4.64  (s, 2H, PhOCH2CO), 
4.24, (m, 1H, H4’), 3.76 (s, 6H, 2 x OCH3), 3.41 (m, 1H, H5’), 3.34 (m, 1H, H5''), 2.91 (m, 
1H, H2’), 2.57 (m, 1H, H2''). 13C NMR (125.7 MHz, CDCl3, ppm): 169.5, 168.4, 158.63, 
158.62, 156.4, 147.6, 146.2, 144.2, 137.3, 135.35, 135.31, 130.03, 130.01, 129.7, 128.0, 
127.9, 127.0, 123.0, 122.2, 122.0, 114.9, 114.6, 113.2, 86.8, 83.9, 83.7, 75.7, 66.9, 65.3, 63.3, 
55.2, 37.7. IR (thin film); νmax (cm
−1
) =3217, 3059, 2931, 2836, 1762, 1698, 1609, 1557, 
1508, 1495, 1250, 1175, 1086, 1032. HRMS (ESI-MS) m/z calculated for C47H44N5O10
+
 
838.3083: found 838.3122 [M+H]
+
.   
3’-O-N2-bis(phenoxyacetyl)-5’-O-(4,4’-dimethoxytrityl)-O6-(4-(tert-
butyldiphenylsilyloxy)butyl)-2’-deoxyguanosine (3.3a): 
 To a solution of 3.2 (2.2 g, 2.7 mmol), 4-(tert-butyldiphenylsilyloxy)butan-1-ol (1.0 g, 
3.2 mmol), and  Ph3P (1.7 g, 6.4 mmol) in dioxane (11 mL) was added DIAD (1.1 mL, 6.4 
mmol) dropwise while stirring. After 16 h, the solvent was removed in vacuo and the content 
taken up in DCM (50 mL), washed with NaHCO3 (aq, 3%) (2 x 75 mL), dried over anhydrous 
Na2SO4, decanted and the solvent removed to produce a yellow gum. The product was 
purified via flash column chromatography using EtOAc : hexanes (3 : 7, 2 : 3) to afford 1.0 g 
(66 %) of a colorless foam. Rf (SiO2 TLC):0.53 EtOAc : Hex (1 : 1). λmax (MeCN) = 270 nm. 
1
H 
NMR (500MHz, CDCl3, ppm): 8.64 (s, 1H, NH), 7.98 (s, 1H, H8),  7.67-7.65 (m, 4H, Ar), 
7.41-7.16 (m, 19H, Ar), 7.06-7.00 (m, 4H, Ar), 6.93-6.91 (m, 2H, Ar), 6.80-6.75 (m, 4H, Ar), 
6.39 (dd, 1H, H1’, J = 7 Hz), 5.68 (m, 1H, H3’), 4.74 (s, 2H, PhOCH2CO), 4.69  (s, 2H, 
PhOCH2CO), 4.60 (t, 2H, ArOCH2,  J = 7 Hz),  4.26 (m, 1H, H4’), 3.75-3.70 (m, 8H, 2 x 
OCH3 & CH2OSi), 3.51 (m, 1H, H5’), 3.39 (m, 1H, H5'’), 3.00 (m, 1H, H2’), 2.63 (m, 1H, 
H2'’), 2.02 (m, 2H, CH2CH2), 1.77 (m, 2H, CH2CH2), 1.05 (s, 9H, (CH3)3CSi).
 13
C NMR 
(125.7 MHz, CDCl3, ppm): 168.4, 161.3, 158.59, 158.58, 157.6, 152.5, 151.2, 144.4, 139.8, 
135.6, 135.48, 135.45, 133.9, 130.04, 130.02, 129.8, 129.7, 129.6, 127.0, 122.4, 122.0, 118.9, 
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115.0, 114.7, 113.2, 86.8, 84.3, 84.0, 76.2, 68.0, 67.9, 65.3, 63.7, 63.4, 55.2, 38.0, 29.0, 26.9, 
25.5, 19.2. IR (thin film); νmax (cm
−1
) = 3409, 3069, 2931, 2856, 1764, 1724, 1696, 1605, 
1510, 1496, 1427, 1248, 1176, 1110, 1087, 1034. HRMS (ESI-MS) m/z calculated for 
C67H70N5O11Si
+
 1148.4836: found 1148.4893 [M+H]
+
.   
 3’-O-N2-bis(phenoxyacetyl)-5’-O-(4,4’-dimethoxytrityl)-O6-(7-(tert-
butyldiphenylsilyloxy)heptyl)-2’-deoxyguanosine (3.3b): 
 To a solution of 3.2 (2.1 g, 2.4 mmol), 7-(tert-butyldiphenylsilyloxy)heptan-1-ol (1.1 
g, 2.9 mmol), and  Ph3P (1.3 g, 4.9 mmol) in dioxane (8.2 mL) was added DIAD (1.0 mL, 4.9 
mmol) dropwise while stirring. After 16 h, the solvent was removed in vacuo and the content 
taken up in EtOAc (50 mL), washed with NaHCO3 (aq, 3%) (2 x 75 mL) and brine (75 mL), 
dried over anhydrous Na2SO4, decanted and the solvent removed to produce a yellow gum. 
The product was purified via flash column chromatography using EtOAc : hexanes (3 : 7, 2 : 
3) to afford 2.0 g (67 %) of a colorless foam. Rf (SiO2 TLC):0.56 EtOAc : Hex (1 : 1). λmax 
(ACN) = 269 nm. 
1
H NMR (500MHz, CDCl3, ppm): 8.69 (s, 1H, NH), 7.98 (s, 1H, H8),  
7.67-7.66 (m, 4H, Ar), 7.42-7.16 (m, 19H, Ar), 7.07-6.99 (m, 4H, Ar), 6.93-6.91 (m, 2H, Ar), 
6.77-6.76 (m, 4H, Ar), 6.38 (dd, 1H, H1’, J = 6 Hz), 5.68 (m, 1H, H3’), 4.74 (s, 2H, 
PhOCH2CO), 4.69  (s, 2H, PhOCH2CO), 4.57 (t, 2H, ArOCH2,  J = 6.75 Hz),  4.26 (m, 1H, 
H4’), 3.75 (s, 6H, 2 x OCH3), 3.65 (t, 2H, CH2OSi, J = 6.5 Hz), 3.51 (m, 1H, H5’), 3.37 (m, 
1H, H5''), 3.01 (m, 1H, H2’), 2.63 (m, 1H, H2'’), 1.87 (m, 2H, CH2), 1.57 (m, 2H, CH2), 1.47 
(m, 2H, CH2), 1.36 (m, 4H, CH2CH2), 1.04 (s, 9H, (CH3)3CSi).
 13
C NMR (125.7 MHz, 
CDCl3, ppm): 168.4, 161.4, 158.6, 157.6, 152.5, 151.2, 144.4, 139.8, 135.6, 135.48, 135.45, 
134.2, 130.04, 130.02, 129.8, 129.7, 129.5, 128.1, 127.9, 127.6, 127.0, 122.4, 122.0, 115.0, 
114.7, 113.2, 86.8, 84.3, 84.0, 76.2, 68.0, 65.3, 63.9, 63.7, 55.2, 38.0, 32.5, 29.7, 29.2, 28.8, 
26.9, 25.8, 19.2. IR (thin film); νmax (cm
−1
) = 3407, 3054, 2931, 2856, 2361, 1764, 1723, 
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1606, 1509, 1496, 1111, 1086, 1035. HRMS (ESI-MS) m/z calculated for C70H76N5O11Si
+
 
1190.5305: found 1190.5358 [M+H]
+
.   
3’-O-N2-bis(phenoxyacetyl)-5’-O-(4,4’-dimethoxytrityl)-O6-(hydroxybutyl)-2’-
deoxyguanosine (3.4a): 
 To a solution of 3.3a (1.0 g, 0.87 mmol) in THF (5 mL) was added TBAF (1.4 mL of 
a 1M solution in THF) dropwise over 30 seconds. After 30 min, the solvent was removed in 
vacuo and purified via flash column chromatography using MeOH : DCM (2 %, 3 %) to 
afford 0.50 g (63 %) of a colorless foam. Rf (SiO2 TLC):0.27 MeOH : DCM (4 %). λmax (MeCN) 
= 269 nm. 
1
H NMR (500MHz, CDCl3, ppm): 8.76 (s, 1H, NH), 7.97 (s, 1H, H8),  7.37-7.16 
(m, 13H, Ar), 7.07-6.99 (m, 4H, Ar), 6.93-6.91 (m, 2H, Ar), 6.80-6.75 (m, 4H, Ar), 6.37 (dd, 
1H, H1’, J = 6 & 8 Hz), 5.68 (m, 1H, H3’), 4.72 (s, 2H, PhOCH2CO), 4.68  (s, 2H, 
PhOCH2CO), 4.64 (t, 2H, ArOCH2,  J = 3 Hz),  4.26 (m, 1H, H4’), 3.75-3.71 (m, 9H, 2 x 
OCH3 & CH2OH), 3.50 (m, 1H, H5’), 3.38 (m, 1H, H5'’), 3.01 (m, 1H, H2’), 2.63 (m, 1H, 
H2’'), 2.01 (m, 2H, CH2CH2), 1.77 (m, 2H, CH2CH2). 
13
C NMR (125.7 MHz, CDCl3, ppm): 
168.4, 161.2, 158.58, 158.57, 157.6, 157.1, 152.5, 151.2, 144.4, 139.9, 135.5, 135.4, 130.03, 
130.01, 129.9, 129.7, 129.6, 128.1, 127.9, 127.0, 122.4, 122.0, 118.9, 115.0, 114.7, 113.2, 
86.8, 84.3, 84.0, 76.1, 68.0, 67.6, 65.3, 63.7, 62.2, 55.2, 38.0, 29.0, 25.2.
 
IR (thin film); νmax 
(cm
−1
) = 3359, 3192, 3057, 2955, 2922, 2851, 2298, 1766, 1723, 1606, 1510, 1496, 1421, 
1249, 1175, 1084, 1033. HRMS (ESI-MS) m/z calculated for C51H52N5O11
+
 910.3658: found 
910.3699 [M+H]
+
.   
3’-O-N2-bis(phenoxyacetyl)-5’-O-(4,4’-dimethoxytrityl)-O6-(hydroxyheptyl)-2’-
deoxyguanosine (3.4b):  
 To a solution of 3.3b (1.0 g, 0.84 mmol) in THF (5 mL) was added TBAF (1.5 mL of 
a 1M solution in THF) dropwise over 30 seconds. After 30 min, the solvent was removed in 
vacuo and purified via flash column chromatography using MeOH : DCM (2 %, 3.5 %) to 
140 
 
afford 0.54 g (68 %) of a colorless foam. Rf (SiO2 TLC):0.18 MeOH : DCM (2 %). λmax (MeCN) 
= 269 nm. 
1
H NMR (500MHz, CDCl3, ppm): 8.72 (s, 1H, NH), 7.98 (s, 1H, H8),  7.37-7.16 
(m, 13H, Ar), 7.07-6.99 (m, 4H, Ar), 6.93-6.91 (m, 2H, Ar), 6.79-6.77 (m, 4H, Ar), 6.37 (dd, 
1H, H1’, J = 5.5 & 8 Hz), 5.67 (m, 1H, H3’), 4.75 (s, 2H, PhOCH2CO), 4.69  (s, 2H, 
PhOCH2CO), 4.60 (t, 2H, ArOCH2,  J = 7.25 Hz),  4.25 (m, 1H, H4’), 3.76 (s, 6H, 2 x 
OCH3), 3.64 (t, 2H, CH2OH, J = 6.5 Hz),  3.50 (m, 1H, H5’), 3.38 (m, 1H, H5’'), 3.00 (m, 
1H, H2’), 2.63 (m, 1H, H2’'), 1.90 (m, 2H, CH2CH2), 1.58 (m, 2H, CH2CH2), 1.53 (m, 2H, 
CH2CH2), 1.41 (m, 4H, CH2CH2).
 13
C NMR (125.7 MHz, CDCl3, ppm): 168.4, 161.3, 158.6, 
157.6, 157.2, 152.4, 151.2, 144.4, 139.8, 135.5, 135.4, 130.03, 130.02, 129.8, 129.7, 128.1, 
127.9, 127.0, 122.4, 122.0, 118.9, 114.9, 114.7, 113.2, 86.8, 84.3, 84.0, 77.3, 76.2, 67.99, 
67.95, 65.3, 63.7, 62.9, 55.2, 38.0, 32.7, 29.0, 28.6, 25.9, 25.5. IR (thin film); νmax (cm
−1
) = 
3408, 3058, 2931, 2855, 1765, 1700, 1607, 1510, 1496, 1175, 1085. HRMS (ESI-MS) m/z 
calculated for C54H58N5O11
+
 952.4127: found 952.4176 [M+H]
+
.   
3’-O-(tert-butyldimethylsilyl)-N2-phenoxyacetyl-2’-deoxyguanosine  (3.5): 
 To a solution of 3.1 (1.3 g, 1.8 mmol), imidazole (0.53 g, 7.8 mmol) and DMAP (cat.) 
in DCM (18 mL) was added TBS-Cl (0.59 g, 3.9 mmol) while stirring. After 4h, the reaction 
was diluted with DCM (100 mL total volume), washed with NaHCO3 (aq, 3%) (2 x 50 mL) 
and brine (50 mL), dried over anhydrous Na2SO4, decanted and the solvent was evaporated to 
produce a colorless gum. To a solution of the resulting content in DCM : MeOH (30 mL : 10 
mL) was added p-TsOH•H2O (0.37 g, 1.94 mmol) while stirring. After 10 min, the solvent 
was removed in vacuo and the content was taken up in EtOAc (75 mL), washed with 
NaHCO3 (aq, 3%)  (2 x 75 mL) and brine (75 mL), dried over anhydrous Na2SO4), decanted 
and the solvent was once more removed to produce a yellow gum. The product was purified 
via flash column chromatography using MeOH : DCM (4 %, 5 %) to afford 0.73 g (81 %) of 





(500MHz, CDCl3, ppm): 11.78 (br. s, 1H, NH), 9.38 (br. s, 1H, NH), 7.88 (s, 1H, H8),  7.38-
7.34 (m, 2H, Ar), 7.10-7.07 (m, 1H, Ar),7.04-7.01 (m, 2H, Ar), 6.24 (dd, 1H, H1’, J = 8.5, 
5.5 Hz), 4.94 ( br. s, 1H, OH), 4.71 (s, 2H, PhOCH2CO),  4.68 (m, 1H, H3’), 4.11 (m, 1H, 
H4’), 3.97 (m, 1H, H5’), 3.78 (m, 1H, H5’'), 2.76 (m, 1H, H2’), 2.29 (m, 1H, H2'’), 0.94 (s, 
9H, (CH3)3CSi), 0.13 (s, 6H, (CH3)2Si).
 13
C NMR (125.7 MHz, CDCl3, ppm): 169.6, 156.3, 
155.0, 146.8, 146.1, 138.6, 129.9, 122.8, 114.8, 89.5, 86.4, 73.2, 66.7, 62.6, 41.7, 25.7, 18.0, -
4.72, -4.79. IR (thin film); νmax (cm
−1
) = 3371, 3238, 3055, 2956, 2930, 2856, 1704, 1613, 
1600, 1560, 1497, 1443, 1265, 1212, 1141, 1038, 947. HRMS (ESI-MS) m/z calculated for 
C24H34N5O6Si
+
 516.2273: found 516.2295 [M+H]
+
.   
3’-O-(tert-butyldimethylsilyl)-5’-O-N2-bis(phenoxyacetyl)- 2’-deoxyguanosine (3.6):  
 To a solution of 3.5 (0.80 g, 1.6 mmol) and TEA (0.37 mL, 2.7 mmol) in THF (15 
mL) was added Pac-Cl (0.31 mL, 2.2 mmol) dropwise while stirring at 0
o
C. After 30 min, the 
solvent was removed in vacuo and the content taken up in DCM (50 mL), washed with 
NaHCO3 (aq, 3%) (2 x 50mL), dried over anhydrous Na2SO4, decanted and the solvent was 
evaporated to produce a yellow gum. The product was purified via flash column 
chromatography using MeOH : DCM (1 % → 4 % by increments of 1 %) to afford 0.87 g (86 
%) of a yellow foam. Rf (SiO2 TLC):0.36 MeOH : DCM (2 %). λmax (MeCN) = 260 nm. 
1
H 
NMR (500MHz, CDCl3, ppm): 11.79 (br. s, 1H, NH), 9.17 (br. s, 1H, NH), 7.88 (s, 1H, H8),  
7.37-7.33 (m, 2H, Ar), 7.26-7.22 (m, 2H, Ar), 7.10-7.07 (m, 1H, Ar), 7.00-6.97 (m, 3H, Ar), 
6.87-6.84 (m, 2H, Ar), 6.26 (dd, 1H, H1’, J = 6.75 Hz), 4.64 (m, 4H, 2 x PhOCH2CO),  4.46 
(m, 1H, H5’), 4.40-4.36 (m, 2H, H3’ & H5’'), 4.20 (m, 1H, H4’), 2.61 (m, 1H, H2’), 2.28 (m, 
1H, H2’'), 0.91 (s, 9H, (CH3)3CSi), 0.08 (s, 6H, (CH3)2Si).
 13
C NMR (125.7 MHz, CDCl3, 
ppm): 169.6, 169.0, 157.4, 156.5, 155.2, 147.5, 146.1, 137.6, 129.9, 129.6, 122.9, 122.5, 
122.0, 114.9, 114.3, 84.9, 84.4, 72.5, 67.0, 65.0, 64.3, 40.2, 25.7, 17.9, -4.77, -4.92. IR (thin 
film); νmax (cm
−1
) = 3414, 3061, 2953, 2930, 2857, 2362, 1689, 1608, 1556, 1509, 1463, 
142 
 
1431, 1329, 1252, 1178, 1109, 1035. HRMS (ESI-MS) m/z calculated for C32H40N5O8Si
+
 
650.2641: found 650.2671 [M+H]
+








 To a solution of 3.4a (0.47 g, 0.52 mmol), 3.6 (0.31 g, 0.47 mmol) and Ph3P (0.25 g, 
0.94 mmol) in dioxane (1.4 mL) was added DIAD (0.185 mL, 0.94 mmol) dropwise while 
stirring. After 3 days, the solvent was removed in vacuo and the content taken up in DCM (50 
mL), washed with NaHCO3 (aq, 3%) (2 x 75 mL), dried over anhydrous Na2SO4, decanted 
and the solvent removed to produce a yellow gum. The product was purified via flash column 
chromatography using EtOAc : hexanes (4 : 1, 9 : 1) to afford 0.51 g (70 %) of a colorless 
foam. Rf (SiO2 TLC):0.47 MeOH : DCM (6 %). λmax (MeCN) = 269 nm. 
1
H NMR (500MHz, 
CDCl3, ppm): 8.86-8.85 (m, 2H, NH), 8.03 (s, 1H, H8), 7.98 (s, 1H, H8),  7.37-7.16 (m, 18H, 
Ar), 7.04-6.86 (m, 11H, Ar), 6.77-6.75 (m, 4H, Ar), 6.40-6.33 (m, 2H, H1’a & H1’b), 5.67 
(m, 1H, H3'a), 4.77-4.63 (m, 13H, 4 x PhOCH2CO, H3’b & ArOCH2(CH2)2CH2OAr), 4.56 
(m, 1H, H5’b), 4.45 (m, 1H, H5’’b),  4.25 (m, 1H, H4’a), 4.17 (m, 1H, H4’b), 3.75 (s, 6H, 2 x 
OCH3), 3.51 (m, 1H, H5’a), 3.38 (m, 1H, H5’'a), 3.00 (m, 1H, H2’a), 2.93 (m, 1H, H2’b), 
2.63 (m, 1H, H2’'a), 2.35 (m, 1H, H2’’b), 2.12 (m, 4H, CH2CH2), 0.90 (s, 9H, (CH3)3CSi), 
0.09 (s, 6H, (CH3)2Si).
 13
C NMR (125.7 MHz, CDCl3, ppm): 168.7, 168.4, 161.2, 158.6, 
157.7, 157.6, 152.5, 152.3, 151.0, 144.4, 139.9, 135.47, 135.45, 130.04, 130.02, 129.8, 129.7, 
129.6, 128.1, 127.9, 127.0, 122.3, 122.0, 121.8, 115.0, 114.9, 114.7, 114.5, 113.2, 86.8, 85.1, 
85.0, 84.3, 84.0, 76.2, 72.6, 68.0, 67.2, 65.3, 65.2, 64.7, 63.7, 55.2, 39.8, 38.0, 30.9, 25.7, 
25.5, 18.0, -4.74, -4.88. IR (thin film); νmax (cm
−1
) = 3406, 3055, 2955, 2928, 2854, 1766, 
1722, 1606, 1510, 1496, 1442, 1420, 1383, 1265, 1250, 1175, 1085, 1034. HRMS (ESI-MS) 
m/z calculated for C83H89N10O18Si
+
 1541.6120: found 1541.6211 [M+H]
+









heptane (3.7b) : 
 To a solution of 3.4b (0.54 g, 0.57 mmol), 3.6 (0.34 g, 0.52 mmol) and Ph3P (0.27 g, 
1.0 mmol) in dioxane (1.5 mL) was added DIAD (0.205 mL, 1.0 mmol) dropwise while 
stirring. After 3 days, the solvent was removed in vacuo and the content taken up in DCM (50 
mL), washed with NaHCO3 (aq, 3%) (2 x 75 mL), dried over anhydrous Na2SO4, decanted 
and the solvent was evaporated to produce a yellow gum. The product was purified via flash 
column chromatography using MeOH : DCM (0.75 % → 3% by increments of about 0.5 %) 
to afford 0.62 g (76 %) of a colorless foam. Rf (SiO2 TLC):0.54 MeOH : DCM (5 %). λmax 
(MeCN) = 269 nm. 
1
H NMR (500MHz, CDCl3, ppm): 8.79-8.71 (m, 2H, NH), 7.89 (s, 1H, H8), 
7.88 (s, 1H, H8),  7.41-7.17 (m, 18H, Ar), 7.09-6.88 (m, 11H, Ar), 6.77-6.74 (m, 4H, Ar), 
6.40-6.32 (m, 2H, H1’a & H1’b), 5.68 (m, 1H, H3’a), 4.74-4.63 (m, 8H, 4 x PhOCH2CO & 
H3’b), 4.60-4.51 (m, 5H, H5’b & ArOCH2(CH2)2CH2OAr),  4.47 (m, 1H, H5’’b),  4.26 (m, 
1H, H4’a), 4.17 (m, 1H, H4’b), 3.75 (s, 6H, 2 x OCH3), 3.51 (m, 1H, H5’a), 3.37 (m, 1H, 
H5’'a), 3.02 (m, 1H, H2’a), 2.95 (m, 1H, H2’b), 2.63 (m, 1H, H2’'a), 2.32 (m, 1H, H2’’b), 
1.90 (m, 4H, CH2CH2), 1.57-1.43 (m, 6H, CH2CH2CH2 ), 0.91 (s, 9H, (CH3)3CSi), 0.10 (s, 
3H, (CH3)Si), 0.09 (s, 3H, (CH3)Si).
 13
C NMR (125.7 MHz, CDCl3, ppm): 168.6, 168.3, 
161.3, 161.2, 158.4, 157.5, 157.1, 152.3, 152.1, 151.1, 150.9, 144.3, 140.7, 139.7, 135.35, 
135.33, 129.90, 129.88, 129.69, 129.68, 129.6, 129.54, 129.48, 129.3, 129.2, 127.9, 127.85, 
127.76, 126.8, 122.2, 121.8, 121.7, 119.3, 118.8, 114.82, 114.80, 114.54, 114.47, 114.37, 
114.25, 113.15, 113.06, 86.2, 85.0, 84.9, 84.2, 83.9, 76.1, 72.4, 67.88, 67.86, 67.8, 67.7, 65.1, 
65.0, 64.6, 63.6, 55.1, 39.6, 37.8, 29.02, 28.96, 28.6, 25.7, 25.6, 25.5, 22.0, 21.9, 17.8, -4.86, 
-5.00. IR (thin film); νmax (cm
−1
) = 3411, 3061, 2929, 2855, 1765, 1723, 1602, 1501, 1496, 
144 
 











-[5’-O-N2-bis(phenoxyacetyl)- 2’-deoxyguanidinyl]}-butane (3.8a): 
 To a solution of 3.7a (0.58 g, 0.37 mmol) in THF (2 mL) was added TBAF (0.44 mL 
of a 1M solution in THF) dropwise over 30 seconds. After 30 min, the solvent was removed 
in vacuo and the crude compound purified via flash column chromatography using MeOH : 
DCM (2 %, 2.5 %) to afford 0.29 g (54 %) of a colorless foam. Rf (SiO2 TLC):0.30 MeOH : 
DCM (6 %). λmax (MeCN) = 269 nm. 
1
H NMR (500MHz, d6-acetone, ppm): 9.47 (s, 1H, NH), 
9.37 (s, 1H, NH), 8.26 (s, 1H, H8), 8.02 (s, 1H, H8),  7.40-7.39 (m, 2H, Ar), 7.33-7.13 (m, 
16H, Ar), 7.02-6.89 (m, 11H, Ar), 6.80-6.69 (m, 4H, Ar), 6.49-6.44 (m, 2H, H1’ & H1’b), 
5.72 (m, 1H, H3’a), 5.05-5.04 (m, 4H, 2 x PhOCH2CO), 4.82-4.80 (m, 3H, PhOCH2CO & 
H3’b), 4.75-4.67 (m, 6H, PhOCH2CO & ArOCH2(CH2)2CH2OAr), 4.51-4.47 (m, 2H, H5’b & 
H5’'b),  4.35 (m, 1H, H4’a), 4.22 (m, 1H, H4’b), 3.74 (s, 6H, 2 x OCH3), 3.65 (m, 1H, H5’a), 
3.43 (m, 1H, H2’a), 3.34 (m, 1H, H5’'a), 2.98 (m, 1H, H2’b), 2.84 (s, 1H, OH), 2.66 (m, 1H, 
H2’), 2.50 (m, 1H, H2’’b), 2.10 (m, 4H, CH2CH2). 
13
C NMR (125.7 MHz, d6-acetone, ppm): 
168.5, 168.3, 160.9, 158.64, 158.56, 158.2, 158.14, 158.05, 152.7, 152.6, 151.7, 151.5, 145.2, 
141.4, 141.1, 135.9, 135.7, 130.1, 30.0, 129.9, 129.48, 129.45, 129.4, 128.0, 127.5, 126.6, 
121.4, 121.3, 121.23, 121.20, 118.7, 118.5, 114.8, 114.7, 114.6, 114.6, 112.9, 112.8, 86.1, 
84.9, 84.8, 84.6, 84.5, 76.0, 71.5, 68.0, 67.9, 66.9, 66.8, 64.9, 64.73, 64.70, 64.6, 54.59, 
54.58, 39.3, 36.1, 25.3. IR (thin film); νmax (cm
−1
) = 3409, 3059, 2926, 2852, 2362, 1761, 
1722, 1606, 1510, 1496, 1442, 1420, 1383, 1248, 1175, 1086, 1034. HRMS (ESI-MS) m/z 
calculated for C77H75N10O18
+
 1427.5255: found 1427.5338 [M+H]
+






-[5’-O-N2-bis(phenoxyacetyl)- 2’-deoxyguanidinyl]}-heptane (3.8b): 
145 
 
 To a solution of 3.7b (0.51 g, 0.33 mmol) in THF (2 mL) was added TBAF (0.36 mL 
of a 1M solution in THF) dropwise over 30 seconds. After 30 min, the solvent was removed 
in vacuo and the crude compound purified via flash column chromatography using MeOH : 
DCM (2 %, 4 %) to afford 0.13 g (27 %) of a colorless foam. Rf (SiO2 TLC):0.26 MeOH : 
DCM (5 %). λmax (MeCN) = 269 nm. 
1
H NMR (500MHz, d6-acetone, ppm): 9.44 (s, 1H, NH), 
9.33 (s, 1H, NH), 8.24 (s, 1H, H8), 8.18 (s, 1H, H8),  7.34-7.14 (m, 18H, Ar), 7.01-6.87 (m, 
11H, Ar), 6.77-6.68 (m, 4H, Ar), 6.48-6.43 (m, 2H, H1’a & H1’b), 5.71 (m, 1H, H3’a), 5.02-
4.99 (m, 4H, 2 x PhOCH2CO), 4.80-4.79 (m, 3H, PhOCH2CO & H3’b),4.71-4.68 (m, 3H, 
PhOCH2CO & H5’b) 4.61-4.53 (m, 4H, ArOCH2(CH2)2CH2OAr),  4.47 (m, 1H, H5’’b),  4.33 
(m, 1H, H4’a), 4.21 (m, 1H, H4’b), 3.73 (s, 6H, 2 x OCH3), 3.64 (m, 1H, H5’a), 3.42 (m, 1H, 
H2’a), 3.33 (m, 1H, H5’'a), 2.98 (m, 1H, H2’b), 2.83 (s, 1H, OH), 2.64 (m, 1H, H2’'a), 2.48 
(m, 1H, H2’’b), 1.86 (m, 4H, CH2CH2), 1.48 (m, 6H, CH2CH2CH2 ).
 13
C NMR (125.7 MHz, 
d6-acetone, ppm): 168.5, 168.3, 166.8, 161.03, 161.01, 158.64, 158.56, 158.2, 158.14, 158.06, 
152.7, 152.6, 151.7, 151.6, 151.55, 151.47, 145.3, 141.3, 141.0, 135.9, 135.8, 130.1, 129.9, 
129.5, 129.4, 128.0, 127.5, 126.6, 121.4, 121.3, 121.2, 118.8, 118.6, 114.8, 114.7, 114.6, 
114.5, 112.9, 112.8, 86.1, 84.9, 84.81, 84.77, 84.6, 84.5, 76.0, 71.5, 71.4, 67.93, 67.90, 67.3, 
67.2, 64.9, 64.74, 64.72, 64.6, 54.59, 54.58, 54.1, 39.21, 39. 16, 36.1, 30.5, 25.70, 25.67. IR 
(thin film); νmax (cm
−1
) = 3409, 3264, 3061, 2934, 2856, 2362, 2335, 2057, 1933, 1762, 1724, 
1606, 1510, 1496, 1383, 1174, 1086. HRMS (ESI-MS) m/z calculated for C80H81N10O18
+
 
1469.5725: found 1469.5822 [M+H]
+







deoxyguanidinyl]}-butane (3.9a) : 
 To a solution of compound 3.8a (0.14 g, 0.098 mmol) and DIPEA (28 μL, 0.16 
mmol) in THF (1.5 mL) was added Cl-POCENiPr2 (28 μL, 0.13 mmol) dropwise while 
146 
 
stirring. After 30 min, the solvent was evaporated in vacuo and the content was diluted with 
EtOAc (50 mL), washed with NaHCO3 (aq, 3%) (2 x 35 mL) and brine (35 mL), dried over 
anhydrous Na2SO4, decanted and the solvent was evaporated to produce a yellow gum. 
Purification was achieved via short flash column chromatography using EtOAc as eluent 
(with 0.1 % NEt3) to afford 0.13 g (80 %) of a colorless foam. Rf (SiO2 TLC):0.36, 0.28 
EtOAc. λmax (MeCN) = 269 nm. 
1
H NMR (500MHz, d6-acetone, ppm): 9.31 (s, 1H, NH), 9.22 
(s, 1H, NH), 8.11 (s, 1H, H8), 8.04 (s, 1H, H8),  7.24-7.22 (m, 2H, Ar), 7.16-6.97 (m, 16H, 
Ar), 6.86-6.73 (m, 11H, Ar), 6.64-6.53 (m, 4H, Ar), 6.35-6.27 (m, 2H, H1’a & H1’b), 5.56 
(m, 1H, H3’a), 4.87-4.80 (m, 5H, H3’b & 2 x PhOCH2CO), 4.65 (s, 2H, PhOCH2CO), 4.57-
4.50 (m, 6H, PhOCH2CO & ArOCH2(CH2)2CH2OAr), 4.45-4.33 (m, 2H, H5’b & H5''b),  
4.26 (m, 1H, H4’b), 4.19 (m, 1H, H4’a), 3.82-3.66 (m, 2H, CH2OP), 3.60-3.42 (m, 9H, 2 x 
CHN, H5’a & 2 x OCH3), 3.25 (m, 1H, H2’a), 3.18 (m, 1H, H5’'a), 2.98 (m, 1H, H2’b) 2.66-
2.42 (m, 4H, CH2CN, H2’'a & H2’’b), 1.95-1.89 (m, 4H, CH2CH2), 1.09-1.03 (m, 12H, 4 x 
CH3). 
13
C NMR (125.7 MHz, d6-acetone, ppm):
 
170.01, 168.49, 168.42, 168.24, 160.92, 
160.88, 158.62, 158.54, 158.17, 158.12, 158.03, 152.62, 151.69, 151.52, 145.23, 141.39, 
141.17, 135.85, 135.74, 130.11, 129.91, 129.48, 129.46, 129.45, 129.42, 128.03, 127.54, 
126.57, 121.36, 121.29, 121.23, 118.72, 118.63, 118.23, 114.76, 114.74, 114.61, 114.49, 
112.86, 112.80, 86.11, 84.92, 84.65, 84.58, 84.05, 75.99, 73.74, 67.92, 66.89, 66.84, 65.23, 
64.91, 64.77, 64.75, 64.57, 64.44, 64.33, 59.66, 58.74, 58.58, 54.61, 54.60, 43.22, 43.17, 
43.12, 43.07, 38.31, 36.09, 25.30, 24.04, 24.01, 23.98, 21.93, 19.97, 19.92, 19.89, 19.87, 
19.84, 14.75, 13.64. 
31
P NMR (202.3 MHz, d6-acetone, ppm): 148.62, 148.57. IR (thin film); 
νmax (cm
−1
) =. HRMS (ESI-MS) m/z calculated for C86H92N12O19P
+













 To a solution of compound 3.8b (0.20 g, 0.14 mmol) and DIPEA (38 μL, 0.22 mmol) 
in THF (1.5 mL) was added Cl-POCENiPr2 (39 μL, 0.18 mmol) dropwise while stirring. 
After 30 min, the solvent was evaporated in vacuo and the content was diluted with EtOAc 
(50 mL), washed with NaHCO3 (aq, 3%) (2 x 35 mL) and brine (35 mL), dried over 
anhydrous Na2SO4, decanted and the solvent evaporated to produce a yellow gum. 
Purification was achieved via short flash column chromatography using an EtOAc : hexanes 
(9 : 1) solvent system (with 0.1 % NEt3) to afford 0.16 g (73 %) of a colorless foam. Rf (SiO2 
TLC):0.69, 0.64 EtOAc. λmax (MeCN) = 269 nm. 
1
H NMR (500MHz, d6-acetone, ppm) ): 9.26 
(s, 1H, NH), 9.17 (s, 1H, NH), 8.10 (s, 1H, H8), 8.04 (s, 1H, H8),  7.25-7.24 (m, 2H, Ar), 
7.18-6.98 (m, 16H, Ar), 6.88-6.74 (m, 11H, Ar), 6.63-6.54 (m, 4H, Ar), 6.36-6.29 (m, 2H, 
H1’a & H1’b), 5.58 (m, 1H, H3’a), 4.87 (m, 5H, H3’b & 2 x PhOCH2CO), 4.66 (s, 2H, 
PhOCH2CO), 4.59-4.58 (m, 2H, PhOCH2CO), 4.47-4.33 (m, 6H, 2 x H5’a & 
ArOCH2(CH2)5CH2OAr),  4.26 (m, 1H, H4’b), 4.19 (m, 1H, H4’a), 3.82-3.68 (m, 2H, 
CH2OP), 3.62-3.49 (m, 9H, 2x CHN, H5’b & 2 x OCH3), 3.29 (m, 1H, H2’a), 3.19 (m, 1H, 
H5’’b), 3.01 (m, 1H, H2’b), 2.67-2.46 (m, 4H, CH2CN, H2’'a & H2’’b), 1.76-1.68 (m, 4H, 
CH2(CH2)3CH2), 1.40-1.32 (m, 6H, (CH2)3), 1.10-1.03 (m, 12H, 4 x CH3). 
13
C NMR (125.7 
MHz, d6-acetone, ppm):
 δ 169.99, 168.46, 168.39, 168.22, 161.06, 161.01, 158.62, 158.54, 
158.13, 158.05, 152.63, 151.53, 145.25, 141.33, 141.13, 135.87, 135.75, 130.11, 129.90, 
129.46, 129.46, 129.41, 128.03, 127.52, 126.54, 121.34, 121.27, 118.79, 118.21, 114.76, 
114.74, 114.60, 114.49, 112.84, 112.78, 86.08, 84.93, 84.68, 84.60, 84.01, 76.01, 73.76, 
67.88, 67.24, 67.16, 64.90, 64.76, 64.74, 64.59, 64.42, 64.33, 59.64, 58.73, 58.58, 54.58, 





P NMR (202.3 MHz, d6-acetone, ppm): 148.60, 148.55. IR (thin film); νmax 
(cm
−1
) =. HRMS (ESI-MS) m/z calculated for C89H98N12O19P
+




3.6.2 Supporting Figures  
 
 
Figure S3.1: IEX-HPLC profile of GG4 (A) and GG7 (B). The column was eluted using a 
linear gradient of 0-52% buffer B over 24 min (buffer A: 100 mM Tris HCl, pH 7.5, 10% 
acetonitrile and buffer B: 100mMTris HCl, pH 7.5, 10% acetonitrile, 1 M NaCl) at 55
o
C and 





Figure S3.2: C-18 HPLC profile of nuclease digested GG4 (A) and GG7 (B). The column 
was eluted with a linear gradient of 0-60% buffer B over 30 min (buffer A: 50 mM sodium 
phosphate, pH 5.8 and buffer B: 50 mM sodium phosphate, pH 5.8, 50% acetonitrile) at a 
































Figure S3.5: Molecular models of unmodified control duplex and duplexes containing GG4 





Figure S3.6: Graphical representation of the % IaCL of GG4 and GG7 remaining in the 




Figure S3.7: Time course repair gel of GG4 (left) and GG7 (right) by hAGT. (A) 
Denaturing gel of the repair of 2 pmol of GG4 by 10 pmol hAGT as a function of time: lane 
1, 2 pmol Control; lanes 2-15, 2 pmol GG4 + 10 pmol hAGT incubated for 1, 2.5, 5, 10, 15, 
25, 35, 45, 60, 90, 120, 180, 240 and 480 min, respectively (B) Denaturing gel of the repair of 
2 pmol of GG7 by 10 pmol hAGT as a function of time: lane 1, 2 pmol Control; lanes 2-15, 2 
pmol GG7 + 10 pmol hAGT incubated for 1, 2.5, 5, 10, 15, 25, 35, 45, 60, 90, 120, 180, 240 





Figure S3.8: Time course repair assay of GG4 (top) and GG7 (bottom) by hAGT showing 
the full length assay (480 min). Graphical illustrations display abundances (%) of MP (—•—
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Oligonucleotides containing an alkylene intrastrand cross-link (IaCL) between the O
6
-atoms of 
two consecutive 2'-deoxyguanosines (dG) were prepared by solid-phase synthesis. UV thermal 
denaturation studies of duplexes containing butylene and heptylene IaCL revealed a 20 
o
C 
reduction in stability compared to the unmodified control duplexes. Circular dichroism profiles 
of these IaCL DNA duplexes exhibited signatures consistent with B-form DNA, suggesting low 
global perturbations induced by these IaCL. Repair of DNA duplexes containing the IaCL 
modifications by O
6
-alkylguanine DNA alkyltransferase (AGT) proteins from human and E. coli 
(OGT and Ada-C) was evaluated. Human AGT was capable of repairing both IaCL duplexes 
with slightly greater efficiency towards the heptylene analogue. Interestingly, repair efficiencies 
of hAGT towards these IaCL were lower compared to O
6
-alkylene linked IaCL lacking the 5'-3'-
phosphodiester linkage between the connected 2’-deoxyguanosine residues. These results 
demonstrate that the proficiency of hAGT activity towards IaCL at the O
6
-atom of dG is 





 DNA insults may be incurred by environmental agents, endogenous metabolic processes 
and chemotherapeutic drugs.
31,266
 Some chemotherapy regimens exploit the use of bi-functional 
electrophilic agents, which act on DNA to produce lesions and interfere with vital processes such 
as DNA replication.
54
 Stalling these processes or modification of the information encoded in 
DNA can have severe effects on the cell. Bi-functional electrophilic agents can form adducts in 
DNA which link the atoms of two nucleotides on the same (intra) or opposing (inter) strands. 
Interstrand cross-links (ICL) in DNA are particularly cytotoxic given that the unwinding of the 
individual strands is prevented, which impedes cellular proliferation.
54,57,267
 Although damage 
occurs on one strand for intrastrand cross-linked (IaCL) DNA, information content and structure 
can be affected. Cisplatin, a platinum-based drug used for the treatment of some forms of cancer, 




 and mitomycin 
C,
70,284
 are examples of bis-electrophilic agents which can introduce IaCL lesions in DNA, and 





-Alkyl-2’-deoxyguanosine adducts can be formed by exposure to carcinogenic agents 
such as nitrosamines and chemotherapeutic alkylating agents such as temozolomide.
139
 This class 
of lesions can induce transitional mutations via proficient base pairing with thymidine during 
DNA replication
19
 and the activation of mismatch repair can result in futile excision-resynthesis 
ultimately leading to apoptosis.
53,320
 Our group has shown that human O
6
-alkylguanine DNA 
alkyltransferase (hAGT) is capable of repairing certain ICL.
64,65,150,151,321
 The primary role of 
AGTs is to remove alkyl lesions found at the O
6





 In the active site of the protein, the alkyl lesion becomes transferred to an 
158 
 
activated cysteine, rendering the AGT protein irreversibly inactivated and ultimately degraded in 
vivo by the ubiquitin pathway.
135,322
 
 The human AGT (hAGT) variant is capable of repairing butylene and heptylene ICL 
linking the O
6
-positions of dG residues in a directly opposed fashion, as well as in a 5'-GNC 
motif.
64,65
 Recently, we demonstrated that hAGT could also act on a DNA duplex containing an 
IaCL on one of the strands consisting of an alkylene functionality attaching the O
6
-atoms of two 
dG residues that lack a phosphodiester linkage in the backbone between them (Figure 4.1A).
323
 
hAGT was proficient towards removing the lesion, with almost complete consumption observed 
for a heptylene-linked substrate within 60 min. These results prompted us to explore AGT 
activity towards the IaCL containing a phosphodiester linkage at this site (Figure 4.1B).  





-2’-deoxyguanosine IaCL (O6-dG-alkylene-O6-dG, Figure 4.1B) was developed. The 
influence of this IaCL modification in a DNA duplex was assessed by UV thermal denaturation 
and circular dichroism. Repair of this IaCL DNA by a variety of AGTs (human and E. coli) was 
evaluated. Given the efficient action of hAGT on the IaCL DNA probes lacking the 
phosphodiester linkage between the 3'- and 5'-O groups of the O
6
-alkylene linked dG residues, 
these new IaCL probes may aid in the understanding of backbone flexibility versus rigidity 
imposed by the phosphodiester linkage. Butylene and heptylene IaCL linkages were chosen on 
the basis that busulfan can react with DNA to produce butylene linked IaCL at the N7-positions 
of 5’-d(GA) and 5’-d(GG) sequences.69 To be noted is that specific IaCL between the O6-
positions of 5’-d(GG) sequences have not been identified. The heptylene linkage was also 
prepared as the sulfamate hepsulfam has been demonstrated to introduce an ICL at the N7-
159 
 
positions of 2’-deoxyguanosine in a 5’-d(GNC) motif.324 The processing of this IaCL by hAGT 
will contribute to our understanding of the substrate range that can undergo repair by this protein. 
 





cross-link (A) lacking or (B) containing the phosphodiester linkage and (C) the oligonucleotide 
sequence indicating the position of the IaCLs (shown by GG). 
 
4.2 Results and Discussion 
4.2.1 Synthesis and characterization of GpG IaCL DNA 




-dG cross-links containing a phosphodiester 
linkage between the 5’- and 3’-O atoms (GpG4 and GpG7) and their position in an 
oligonucleotide is shown in Figure 4.1. The synthesis approach for cross-linked amidites 4.6a 
and 4.6b is shown in Scheme 4.1 and began with commercially available N
2
-phenoxyacetyl-2'-
deoxyguanosine. This material was azeotropically dried with anhydrous pyridine, followed by 
bis-silylation at the 3' and 5' hydroxyl functionalities. Compounds 4.2a and 4.2b were prepared 
according to procedures described previously by our group.
65
 Dimers 4.3a and 4.3b were 
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produced using the Mitsunobu reaction of mono-adducts 4.2a and 4.2b, respectively, with 
compound 4.1 followed by the Pd
(0)
 catalyzed removal of the allyloxycarbonyl group. Fully-
protected versions of 4.3a and 4.3b were particularly difficult to isolate in high purity due to co-
elution with mixtures of triphenylphosphine / triphenylphosphineoxide. The subsequent removal 
of the allyloxycarbonyl group, deprotecting the 3'-hydroxyl functionality, facilitated the 
chromatographic purification of the desired dimers (4.3a and 4.3b). Phosphorylation of 4.3a and 
4.3b was accomplished by adapting reported approaches which produced dimers 4.4a and 4.4b, 
respectively.
297,325,326
 Solubility proved to be an issue during the washing (work-up) stages of the 
latter intermediates, particularly for 4.4a. The introduction of NEt3 in the work-up solvent 
alleviated this issue as the corresponding triethylammonium phosphate salts are generally more 
soluble in organic solvents. The ring-closing reaction to access 4.5a and 4.5b was accomplished 
according to a procedure described previously.
325
 The use of MSNT (1-(2-Mesitylenesulfonyl)-
3-nitro-1H-1,2,4-triazole) as the condensing reagent favors attack by the 5'-OH, as opposed to 
the 3'-OH, of the desilylated residue.
297,325,326
 We hypothesized that these transformations would 
occur more quickly for our system, which we tested on starting material 4.4a. First, the 
desilylation reaction was reduced to 1 h (as opposed to 6 h) and the cyclization reaction time was 
reduced to 4 h compared to 16 h with no significant yield differences observed (51 % and 52 % 
for shorter and longer reaction times, respectively). For the heptylene analogue 4.4b, a 
cyclization reaction time of 16 h was used. Phosphoramidites 4.6a and 4.6b were synthesized 
according to previously described procedures.
323
 In our hands, phosphoramidite products of 
greater purity are generally attained using column chromatography, relative to hexanes 
precipitation. However, we initially resorted to hexanes precipitation for isolating 





NMR analysis revealed sharp signals in the region of 148-150 ppm characteristic of 
phosphoramidites. Compounds 4.6a and 4.6b were further characterized by HRMS and the 
masses observed were in agreement with the expected values. 
 
Scheme 4.1: Reagents and conditions: (i) TBS-Cl (2.5 eq), Im (5.0 eq), DMAP (cat), DCM, 
21
o
C, 16 h. (ii) 1. 4.1 (1.0 eq), 4.2a or 4.2b (1.1 eq), Ph3P (1.2 eq), DIAD (1.2 eq), dioxane, 21 
o
C, 16 h. 2. Pd(Ph3P)4 (0.2 eq), Ph3P (0.4 eq), n-BuNH2 (7 eq), HCOOH (7 eq), THF, 21 
o
C, 30 
min. (iii) 2-chlorophenyl dichlorophosphate (5 eq), 1,2,4-triazole (10 eq), NEt3 (10 eq), THF, Py, 
21 
o
C, 2 h. (iv) 1. TBAF (10 eq), THF, 21
o
C, 6h. 2. MSNT (5 eq), Py, 21 
o
C, 16 h. (v) Cl-
P(OCEt)N(iPr)2 (1.2 eq), DIPEA (1.5 eq), THF, 21 
o
C, 30 min. 
 The IaCL DNA synthesis employed either cyclized dimer phosphoramidite 4.6a or 4.6b, 
which differed only in their respective alkylene linker length. The presence of a single DMTr 
group and single phosphoramidite moiety on the dimer scaffolds rendered a straightforward 
construction of the IaCL DNA. Assembly of oligonucleotides GpG4 and GpG7 by automated 
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solid-phase synthesis was carried out according to previous published procedures used to prepare 
ICL and IaCL DNA containing similar modifications.
65,323
 Coupling wait times for 
phosphoramidites 4.6a and 4.6b were extended to 10 min, relative to 2 min for standard 3'-O-
phosphoramidites, in order to ensure efficient coupling of the dimers to the nascent oligomer.  
GpG4 and GpG7 were deprotected and cleaved from the solid support using a protocol 
described by Glen Research (aqueous NH4OH (28 %) for 17 h at room temperature with gentle 
rocking and an additional 4 h at 55
o
C) with no detectable degradation of the cross-link observed 
by SAX-HPLC (Figure S4.1). Failure sequences due to incomplete couplings of 4.6a or 4.6b 
were well-resolved from desired products by SAX-HPLC. This was also observed for shorter 
sequences that were prepared (12-mer, data not shown). MS analysis of the GpG4 and GpG7 
revealed deconvoluted masses in agreement with the expected masses (values shown in Table 
4.1 and spectra illustrated in Figures S4.3 and S4.4). Further characterization by enzymatic 
digest followed by RP-HPLC showed the appearance of a new peak with retentions of 9.2 min 
and 14.7 min for the butylene and heptylene 2'-deoxyguanosine adducts, respectively (Figure 
S4.2). The retention of these dimers were significantly lower compared with those observed for 
the enzymatic digestion of GG4 and GG7 (16.4 min and 24.8 min),
323
 respectively, suggesting 
incomplete digestion near the cross-linked site, as previously observed for other DNA 
modifications.
327,328
   
Table 4.1. Retention time and mass spectrometry 







GpG4 21.1 4672.1 4673.0 




4.2.2 UV thermal denaturation and circular dichroism studies of IaCL DNA 
 
 The influence of the GpG4 and GpG7 IaCL on duplex stability with the complementary 
DNA sequence, relative to the native duplex and the more “flexible” IaCL GG4 and GG7 
(reported previously), was assessed by UV thermal denaturation experiments. The thermal 
denaturation profiles of the IaCL containing DNA duplexes were monophasic with Tm values of 
45, 48 and 68 
o
C for GpG4, GpG7 and the unmodified duplex, respectively (Figure 4.2). 
Presence of a single O
6
-methyl-dG insert in a DNA duplex resulted in a Tm reduction of 
approximately 18 
o
C and two inserts dropped the value by 40 
o
C, compared to unmodified 
sequences.
313,315
 The influence of two O
6
-alkylated dG residues for the butylene- and heptylene 
linked IaCL (GpG4 and GpG7) resulted in an overall reduction in Tm by 20 - 23 
o
C relative to 
the control, which was lower than expected. The reduction in stability is most likely attributed to 
the disruption of hydrogen bonding between the alkylated 2’-deoxyguanosines, containing the 
flexible alkylene linkers, with their paired 2’-deoxycytidines that may result in local and global 
structural perturbations. Interestingly, these values were comparable to the IaCL analogs which 
lack the phosphodiester linkage (46 
o
C and 48 
o
C for GG4 and GG7, respectively). We had 
originally hypothesized that the added flexibility and lack of the anionic phosphodiester linkage 
at the cross-linked site for the GG4- and GG7-containing duplexes may have reduced repulsion 
effects relative to GpG4 and GpG7, resulting in higher Tm values, which was not the case. This 
would suggest that the electrostatic repulsion involved in duplexes containing GpG4 and GpG7 
is compensated for by other contributing factors. Towards this end, we performed Van’t Hoff 
experiments to determine the thermodynamic parameters in order to evaluate if the decrease in 
Tm with respect to the unmodified control could be attributed to an enthalpic or entropic cost (see 
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Figure S4.7 for Tm profiles and Table S4.1 for Tm values). The data suggest that the reduction in 
stability due to the presence of the flexible IaCL and phosphodiester linkage was generally 
attributed to an enthalpic cost. There seemed to be an entropic cost for GG7- and GpG4-
containing duplexes, whereas GG4- and GpG7-containing duplexes revealed an entropic gain 
relative to the unmodified control. 
 
Figure 4.2 Fraction change of maximum absorbance at 260 nm (A260) versus temperature [
o
C] 
profiles of duplexes containing GG4 (•••),323 GG7 (- - -),323 GpG4 (―••), GpG7 (–•–) and 
unmodified DNA (―). 
 Circular dichroism (CD) spectroscopy was performed to determine the global structural 
influence of the GpG4 and GpG7 IaCL in the DNA duplex. CD profiles of these modified 
duplexes displayed signatures consistent with the B-DNA form with maxima near 280 nm, cross-
overs near 250-260 nm and minima around 240 nm (shown in Figure 4.3). However, the profile 
for duplexes containing the GpG4 IaCL displayed a slight blue shift of the characteristic profile 
relative to the unmodified control. Nonetheless, these results indicate minor global structural 
distortions were induced by the presence of the alkylene IaCL in DNA duplexes. Similar 
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findings were observed for the “flexible” IaCL DNA (GG4 and GG7) and duplexes containing 
monoadducts at the O
6
-atom of dG (data shown only for GG4 and GG7 in Figure 4.3). 
Duplexes containing the GpG4 and GpG7 IaCL (and unmodified control) were geometry 
optimized using the AMBER force field (Figure S4.8). In both cases, the alkylene linker 
protruded into the major groove, with a slight widening observed in addition to buckling of the 
5’-end O6-alkylated dG nucleobase. The buckling effect was more pronounced for GpG4 
compared to GpG7, relative to the “flexible” GG4, GG7 and control. The molecular models 
suggest that the presence of the cross-link does not greatly distort the global structure of the 
duplex consistent with the small variation in the CD profiles observed for GpG4 and GpG7. 
High resolution structures of duplexes containing GpG4 or GpG7 are currently being 
investigated via by a combination of molecular dynamics and high-field NMR experiments. 
 
Figure 4.3. Circular dichroism spectra of IaCL duplexes,  GG4 (- - -),
323
 GG7 (•••),323 GpG4 (–




4.2.3 AGT-mediated repair of IaCL DNA 
 Four AGT proteins (hAGT, OGT, an S134P OGT variant, and Ada-C) were interrogated 
against the single strands GG4 and GG7, as well as duplexes containing GpG4 and GpG7. The 
repair of duplexes containing GG4 and GG7 has been described previously.
323
 The modified 
strand was radiolabeled using γ-[32P]ATP and either used as is or annealed with a 10% molar 
excess of the complement followed by incubation for 16 h, at 37 
o
C with the AGT protein of 
interest (2 pmol DNA and either 10 pmol or 60 pmol protein). Repair reactions were quenched 
and boiled to prevent complexation before loading onto the denaturing gel. Analysis of the AGT 
activity upon single stranded GG4 and GG7 revealed that only the human variant was capable of 
removing the lesion at 5-fold protein equivalence (Figure S4.9-S4.11). Interestingly, repair 
efficiencies of the GG4 and GG7 single strands by hAGT were in agreement with repair of 
duplexes containing the IaCL DNA, respectively.
323
 No repair was observed, however, for other 
AGTs tested at 5-fold protein equivalence, whereas minimal repair (< 15 %) was observed by 
OGT, Ada-C and OGT S134P at 30-fold protein equivalence (see Figure S4.9-S4.11). Repair 
studies conducted on double stranded GpG4 and GpG7 revealed that only hAGT reacted with 
these IaCL, with slightly higher efficiency towards the GpG7 (lane 4 and 10 in Figure 4.4). 
Surprisingly, the levels of repair were much lower for the IaCL DNA containing the 
phosphodiester linkage compared to both the single strands and duplexes containing the flexible 
GG4 and GG7 IaCL.
323
 The GG4 and GG7 duplex substrates were virtually entirely consumed 
(4 and 5 % IaCL substrate remaining, respectively) compared to 74 % and 64 % substrate 
remaining for GpG4 and GpG7 duplexes, respectively, at thirty fold excess protein. OGT and 
Ada-C were incapable of repairing the IaCL DNA studied (10 pmol protein and 2 pmol DNA), 





-atom of dG. Although OGT is capable of repairing larger O
4
-alkylated thymidine mono-
adducts (but not ICL DNA),
150
 OGT demonstrated no repair activity against GpG4 and GpG7, 
even at higher AGT concentration ratios (data not shown). The OGT S134P variant
321
 
demonstrated no activity towards these IaCL DNA duplexes as well.  
 Complete repair of these IaCL DNA (GpG4 and GpG7) by hAGT would begin with a 
reaction to generate a median product (MP in Figure 4.4) consisting of a hAGT-DNA cross-
linked species. Repair of this hAGT-DNA MP by a second AGT protein would generate the 
completely repaired product (RP in Figure 4.4). Repair assays of various AGTs with GpG4 and 
GpG7 were performed and the products analyzed by denaturing gel electrophoresis (Figure 4.4). 
Lanes 2 and 8 contain the GpG4 and GpG7 ssDNA, respectively. Lane 1 contains the 
unmodified control DNA strand of identical sequence as GpG4 and GpG7. The control DNA 
strand migrated slightly faster compared to the IaCL DNA, which indicated that resolution of the 
IaCL DNA and repaired DNA by electrophoresis was feasible. Lanes 3 and 9 display the product 
of the repair reaction for GpG4 and GpG7 (2 pmol) with hAGT (10 pmol), respectively. Lanes 4 
and 10 display similar reactions with higher hAGT concentrations (60 pmol), for GpG4 and 
GpG7 respectively. Two new bands are observed for the reaction of GpG4 and GpG7 with 
hAGT; one which migrates much slower and another that migrates slightly faster. The slowly 
migrating band can be attributed to the formation of hAGT covalently bound to the damaged 




-dG IaCL and ICL 
DNA.
64,150,151,323




Figure 4.4. Repair of GpG4 and GpG7 by hAGT, OGT, Ada-C, and OGT S134P. Denaturing 
PAGE of repair reactions as described in the Experimental Section. Lane 1, 2 pmol control 
unmodified DNA + 10 pmol hAGT; lane 2, 2 pmol GpG4; lane 3, 2 pmol GpG4 +10 pmol 
hAGT; lane 4, 2 pmol GpG4 +60 pmol hAGT; lane 5, 2 pmol GpG4 +10 pmol OGT; lane 6, 2 
pmol GpG4 +10 pmol Ada-C; lane 7, 2 pmol GpG4 +10 pmol OGT S134P; lane 8, 2 pmol 
GpG7; lane 9, 2 pmol GpG7 +10 pmol hAGT; lane 10, 2 pmol GpG7 +60 pmol hAGT; lane 11, 
2 pmol GpG7 +10 pmol OGT; lane 12, 2 pmol GpG7 +10 pmol Ada-C; lane 13, 2 pmol GpG7 
+10 pmol OGT S134P. 





-dG ICL (XL4, with approximately 65-70% of ICL DNA left 
unrepaired), whereas repair of the duplex containing a heptylene ICL (XL7) surpassed that of the 
GpG7 (approximately 43% and 65% remaining of unrepaired XL7 and GpG7, respectively). 
Previously, Abdu and coworkers described poor hAGT-mediated repair of DNA containing a 




 Our group has 
also observed that various AGTs were incapable of repairing DNA containing conformationally 
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locked analogues of O
4
-alkyl-thymidine (Figure S4.17) where a methylene group at the O
4
-
position is anti relative to the N3-atom. Together, the latter two examples suggest that repair by 
AGTs may be dependent on lesion conformation, whereby attack by the active site Cys thiolate 
anion only proceeds if the α-carbon of the lesion is positioned correctly. The orientation of the 
alpha carbons of the O
6
-alkylene linkers in GpG4 and GpG7 may not have the conformational 
freedom to adopt an optimal orientation for successful repair, which may explain the large 
discrepancies observed in the repair of the IaCL DNA containing the phosphodiester linkage. 
The alkylene linkers in these IaCL, lacking the phosphodiester linkage, may be more flexible and 
are thus capable of adopting multiple different conformations relative to the IaCL DNA 
investigated in this study. Fang and coworkers generated a molecular model of hAGT in 




-dG ICL DNA, which suggested that the preferential repair 
of longer ICL DNA by hAGT is due to the shape of the hAGT active site once the DNA is bound 
(similar to a “tunnel”).64 The longer heptylene linker in GpG7 may be accommodated more 
readily into the “tunnel” of the active site, allowing for positioning of the α-carbon near the C145 
residue, compared to the more strained butylene linker in GpG4. This may account for the 
reason why the heptylene adducts are repaired more efficiently by hAGT. However, the length of 
the linker affected hAGT repair more drastically in the case of ICL DNA (XL7 versus XL4) and 
IaCL lacking the phosphodiester linkage (GG7 versus GG4), with much greater repair efficiency 
observed for the heptylene analogues. Much of our understanding of the AGT repair mechanism 
is derived from crystal structures of hAGT bound to damage-containing DNA (hAGT C145S 
with DNA containing an O
6
-MedG insert and another of hAGT covalently cross-linked with 
DNA containing a N1,O
6
-ethanoxanthosine insert). Both structures reveal conformational 
changes occurring in the DNA during the repair process with minimal changes in the protein 
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structure. Similar findings were observed for E. coli Ada.
329
 The alkylated nucleotide is flipped 
into the protein active site allowing for attack of the activated thiolate anion of Cys145. In the 
case of GpG7 and GpG4, the alkylene linkers could be thought of as part of a larger ring system, 
which may prevent the necessary entry of the alpha carbon into the active site in order for alkyl 
group transfer. This may be a result from rotation of the O
6
-alkylated linked dG residue, which is 
covalently attached to the O
6
-atom of the adjacent dG residue.  
 Time course assays were performed using 60 pmol hAGT and 2 pmol of either GpG4 or 
GpG7 duplex substrates by quantifying the amounts of unrepaired, MP and RP products 
(Figure S4.16). The data, summarized in Figure 4.5, reveals that GpG4 was depleted by hAGT 
at a slower rate with approximately 20% repair occurring in 4 h whereas similar levels of repair 
for GpG7 required 1 h. The formation of the RP reached a plateau after similar reaction times 
for GpG4 and GpG7 with values within 20-25 %. The formation of the MP, on the other hand, 
plateaued at a higher value for duplexes containing GpG7 (14%) compared to GpG4 (3%). The 
faster repair of GpG7 compared to GpG4 is probably due to the added flexibility imparted from 
the longer alkylene linker, which may allow for more optimal rotation of the damaged nucleotide 
into the protein active site. The geometrically optimized molecular models of GpG4, GpG7 and 




 distance of 3.0, 3.2, and 3.5 Å, respectively. An increase 
in base tilting observed for GpG4 relative to GpG7 suggests that the butylene adduct is more 
strained relative to the heptylene adduct, which could account for the greater repair observed for 
GpG7 relative to GpG4. Comparison of the GpG4 and GpG7 structures to GG4 and GG7 
revealed an increase in buckling for IaCL DNA duplexes containing the phosphodiester linkage. 
Greater repair was also observed for XL7 versus XL4 ICL DNA by hAGT.
65
 Repair of GpG4 
duplexes by hAGT proceeded slightly faster compared to XL4, whereas repair of XL7 occurred 
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more quickly compared to GpG7 duplexes, showing a clear distinction in the efficiency of 
hAGT towards processing these forms of DNA modifications despite the alkylene linker of the 
IaCL residing on one strand only.   
 
Figure 4.5. Time course repair assay of GpG4 (left) and GpG7 (right) by hAGT displaying a 
faster repair of GpG7. Graphical illustrations display abundances [%] of MP (- - -), RP (—•—) 
and substrate (—) over time (min). 
 The time course assay revealed reduced reaction rates for processing of GpG4 and GpG7 
IaCL duplexes compared to those containing GG4 and GG7 by hAGT. After a repair reaction 
time of 4 h, 80% and 73% of GpG4 and GpG7 remained, respectively, whereas virtually all of 
GG4 and GG7 substrates were depleted by hAGT (at 30-fold excess of protein). As stated 
previously, this drastic difference imparted by the presence of the phosphodiester linkage may 
likely be the result of the alkylene linkers found in GpG4 and GpG7 adopting less reactive 





 In our previous report of the repair of duplexes containing the GG4 and GG7 IaCL by 
hAGT, we proposed that the phosphorylation of the damaged strand occurred at the 5’-terminal 
of the oligomer. A more-detailed analysis of the repair event revealed that T4 PNK is capable of 
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phosphorylating the internal 5'-hydroxyl group as well (Figure S4.9 – S4.11). To validate that 
T4 PNK could in fact phosphorylate both positions, T4 PNK and a three-fold excess of ATP was 
incubated with either GG4 or GG7. Mass spectral analysis revealed the presence of mono- and 
bis-phosphorylated products (Figure S4.5 – S4.6). To help decipher the repair pathway of GG4 
and GG7, a mixture of γ-[32P]ATP (1 uL, 10 μCi) and non-radioactive ATP (3-fold excess) was 
used to radiolabel the damaged strand DNA. The total repair assay of GG4 and GG7 resulted in 
different ratios of RP and MP, with substrate consumption levels in agreement with those 
previously observed (Figure S4.11). The variance observed in the RP and MP levels may have 
resulted from the mixture of mono- and bis-phosphorylated products of GG4 and GG7.   
 The radioactivity-based assay has the limitation of only monitoring the DNA species, 
which prompted us to perform an SDS-PAGE analysis of the reaction to analyze the various 
proteinaceous products formed (Figure 4.6).
151
 Lane 1 contains the hAGT protein alone, 
whereas lanes 2-6 contains hAGT with unmodified DNA, GG4, GG7, GpG4, and GpG7, 
respectively (600 pmol protein incubated with 600 pmol DNA for 16h at 37 
o
C). Lanes 3 and 4 
both show the presence of two bands, one is minor with a faster migration similar to the 
unreacted hAGT protein. The major, slower migrating band is presumably the AGT-DNA 
covalent complex, and is in agreement with our radioactivity-based repair assay and previous 
preparations of AGT-DNA complexes using ICL DNA.
151
 Interestingly, the reaction between a 1 
: 1 molar equivalence of GG4 or GG7 with hAGT yielded almost quantitative conversion to the 
DNA-protein covalent complex. Lane 5 displays the lack of GpG4 repair by hAGT whereas lane 
6 reveals the appearance of a faint band with lower mobility compared to the hAGT protein 




Figure 4.6. 12% SDS-PAGE of hAGT mediated repair of GG4, GG7, GpG4, and GpG7. 
Repair of 600 pmol IaCL DNA by 600 pmol hAGT for 16 h at 37 °C: lane L, unstained protein 
molecular weight marker; lane 1, hAGT; lane 2 unmodified control DNA + hAGT reaction; lane 
3 GG4 + hAGT reaction; lane 4 GG7 + hAGT reaction; lane 5 GpG4 + hAGT reaction; lane 6 
GpG7 + hAGT reaction. 
 The in vitro assay results demonstrate that IaCL DNA containing butylene and heptylene 
linkers are repaired by hAGT adding to our knowledge of the substrate range that this protein can 
act upon. IaCLs can be introduced in DNA by different bifunctional alkylating agents such as 
busulfan, however the O
6
-position of dG is not the major site of adduct formation. McManus and 
coworkers previously showed that AGT-deficient CHO cells are sensitive to killing by 
hepsulfam. It was also shown that hAGT can protect CHO cells, in part, against hepsulfam 
exposure, but not busulfan. Our preliminary results are consistent with this finding as more 
efficient hAGT repair observed for the heptylene versus butylene IaCL adducts. 
 X-ray crystallography studies of hAGT bound to damaged DNA have shown that Tyr114 
was necessary for flipping of the damaged nucleotide into the active site of the protein.
137
 Y114F 
and Y114A hAGT mutants have reduced activity towards O
6
-alkylated-dG lesions highlighting 
the important role of Tyr114. In the current study, the presence of the phosphodiester linkage 
between the O
6
-linked IaCL (GpG4 and GpG7) reduced the repair efficiency by hAGT 
compared to those lacking the phosphodiester group (GG4 and GG7). The basis for the 







 in nature. The interaction of the phosphate group of GpG4 and 
GpG7 with Tyr114 may be unfavorable, which contributes to lower repair efficiencies observed 




-dG IaCL containing other 
backbone bio-isosteric linkages, such as formacetal group,
330
 may contribute to probing the 
contributions of the sterics and electronics of Tyr114 towards AGT-mediated repair. 
 One highlight feature of this study is the efficient repair of single stranded GG7 by 
hAGT with only 5-fold excess protein (and similar efficiencies for GG4 at 60-fold excess 
hAGT).  Given the lack of the phosphodiester linkage at the cross-link site, repair of the IaCL 
cleaves the DNA into two smaller DNA fragments. This system may be used as a functional 
irreversible switch for novel molecular nanotechnology devices. Recently, there have been a 
number of reports describing the activity of AGT towards various DNA structure and 
applications in protein tagging.
178,307,308
 The integration of these IaCL modifications into a device 
would potentially benefit from orthogonality, and little crosstalk with other switch mechanisms 
such as pH, UV-radiation and toehold-mediated strand displacement mechanisms. Other types of 
flexible IaCL such as those linking the O
6
-atom of dG to the O
4
-atom of dT in DNA sequences 
are currently being investigated for such applications. 
4.3 Conclusions 
 Cyclic nucleoside dimers containing an alkylene linkage between the O
6
-atoms of two 2’-
deoxyguanosines were synthesized and the corresponding phosphoramidites were incorporated 
into DNA by solid-phase synthesis to produce IaCL DNA. Thermal denaturation analysis of 
duplexes containing these butylene and heptylene IaCL were found to result in a reduction in the 
Tm by about 20 
o
C relative to the control. Circular dichroism and molecular modeling suggested 
minimal global perturbation in the duplex structure. Both GpG4 and GpG7 were repaired 
175 
 
moderately by hAGT, with slightly greater efficiency for the heptylene versus butylene linker. 
IaCL DNA lacking the phosphodiester group at the cross-link site (GG4 and GG7) were repaired 
with much greater efficiency. These results contribute an ongoing investigation of AGT to act 
upon modified DNA structures. 
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4.5 Supporting information 
4.5.1 Supporting Methods 
4.5.1.1 General  
 5’-O-(4,4’-dimethoxytrityl)-N2-phenoxyacetyl-2’-deoxyguanosine and  N,N-
diisopropylaminocyanoethylphosphonamidic chloride were purchased from ChemGenes, Inc. 




diisopropyl)phosphoramidites and protected 2’-deoxyribonucleoside-Controlled Pore Glass 
(CPG)  supports were purchased from Glen Research (Sterling, Virginia). All other chemicals 
and solvents were purchased from the Aldrich Chemical Company (Milwaukee, WI) or EMD 
176 
 
Chemicals Inc. (Gibbstown, NJ). Flash column chromatography was performed using silica gel 
60 (230–400 mesh) purchased from Silicycle (Quebec City, QC). Thin layer chromatography 
(TLC) was carried out with precoated TLC plates (Merck, Kieselgel 60 F254, 0.25 mm) 
purchased from EMD Chemicals Inc. (Gibbstown, NJ). NMR spectra were recorded on a Varian 
500 MHz NMR spectrometer at room temperature. 
1
H NMR spectra were recorded at a 
frequency of 500.0 MHz and chemical shifts were reported in parts per million (ppm) downfield 
from tetramethylsilane. 
13
C NMR spectra (
1
H decoupled) were recorded at a frequency of 125.7 





H decoupled) were recorded at a frequency of 202.3 MHz and chemical shifts were 
reported in ppm with H3PO4 used as an external standard. High resolution mass spectrometry of 
modified nucleosides were obtained using a 7T-LTQ FT ICR mass spectrometer (Thermo 
Scientific) at the Concordia University Centre for Structural and Functional Genomics. The mass 
spectrometer was operated in full scan, positive ion or negative ion detection mode. ESI mass 
spectra for oligonucleotides were obtained at the Centre for Biological Applications of Mass 
Spectrometry (Concordia University) using a Micromass Qtof2 mass spectrometer (Waters) 
equipped with a nanospray ion source. The mass spectrometer was operated in full scan, negative 
ion detection mode.  
4.5.1.2 Chemical synthesis of nucleosides 
The synthesis of phosphoramidites 6a and 6b are shown in Scheme 4.1. 
3’,5’-O-bis(tert-butydimethylsilyl)-N2-phenoxyacetyl-2’-deoxyguanosine (4.1):  
 N
2
-phenoxyacetyl-2’-deoxyguanosine (2.0 g, 5.0 mmol) was dried via co-evaporation 
with anhydrous Py (3 x 8 mL) and dissolved in DCM (50 mL). To this solution was added 
177 
 
imidazole (1.7 g, 25 mmol), DMAP (cat.) and TBS-Cl (1.9, 12.5 mmol). A precipitate was 
immediately formed after the addition of the silylating reagent. After 16 h of stirring, the solvent 
was partially evaporated in vacuo (to about 50 mL), washed with a saturated aqueous solution of 
NaHCO3 (2 x 75 mL) and brine (50 mL), dried over anhydrous Na2SO4, decanted and the solvent 
was evaporated in vacuo to produce a yellow gum. The product was purified via flash column 
chromatography using EtOAc : hexanes (1 : 1 to 100% EtOAc) to afford 2.7 g (86 %) Rf (SiO2 
TLC):0.15 EtOAc : hexanes  (1 : 1). λmax(MeCN) = 260 nm and 285 nm. 
1
H NMR (500MHz, 
CDCl3, ppm): 11.77 (s, 1H, NH), 9.19 (s, 1H,NH), 8.00 (s, 1H, H8), 7.39-7.35 (m, 2H, Ar), 7.12-
7.08 (m, 1H, Ar), 7.01-6.99 (m, 2H, Ar), 6.28 (t, 1H, H1’, J = 6.5 Hz), 4.71 (s, 2H,PhOCH2CO), 
4.60 (m, 1H, H3’), 3.90 (m, 1H, H4’), 3.80-3.74 (m, 2H, 2 x H5’), 2.48 (m,1H, H2’), 2.40 (m, 
1H, H2’), 0.92 (s, 9H, (CH3)3CSi), 0.90 (s, 9H, (CH3)3CSi), 0.11 (s, 6H, (CH3)2Si), 0.078 (s, 3H, 
CH3Si), 0.070 (s, 3H, CH3Si).
 13
C NMR (125.7 MHz, CDCl3, ppm):
 
169.5, 156.4, 155.4, 147.5, 
146.1, 137.1, 130.0, 123.0, 122.0, 114.9, 88.0, 83.6, 71.7, 67.0, 62.7, 41.5, 26.0, 25.8, 18.4, 18.0, 
-4.66, -4.77, -5.39, -5.52. IR (thin film); νmax (cm
−1
) = 3220, 2954, 2929, 2857, 1701, 1612, 
1557, 1496, 1472, 1404, 1257, 1070, 837, 780. HRMS (ESI-MS) m/z calculated for 
C30H48N5O6Si2
+









 To a solution of 4.1 (2.1 g, 2.4 mmol), 4.2a (1.4 g, 2.2 mmol) and Ph3P (0.69 g, 2.6 
mmol) in anhydrous dioxane (21.5 mL) was added DIAD (0.52 mL, 2.6 mmol) dropwise while 
stirring. After 16 h, the solvent was evaporated in vacuo and the content taken up in DCM (70 
mL), washed with a saturated aqueous solution of NaHCO3(2 x 75 mL), dried over anhydrous 
Na2SO4, decanted and the solvent was once more evaporated to produce a yellow gum. The 
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product was partially purified via flash column chromatography using EtOAc : hexanes (2 : 3, 3 : 
2) (Rf (SiO2 TLC): 0.66 EtOAc), fractions containing the product were pooled, concentrated in 
vacuo, and used without further purification for the subsequent step. To the residue, Ph3P (0.22 
g, 0.83 mmol) and (Ph3P)4Pd (0.44 g, 0.39 mmol) in anhydrous THF (42 mL) was added in a 
solution of n-BuNH2 (1.5 mL, 15 mmol) and HCOOH (0.58 mL, 15 mmol) in THF (16 mL). 
After 30 min of stirring, the solvent was evaporated in vacuo and the crude taken up in EtOAc 
(75 mL), washed with a saturated aqueous solution of NaHCO3 (2 x 100 mL) and brine (50 mL), 
dried over anhydrous Na2SO4, decanted and the solvent was evaporated in vacuo to produce a 
yellow gum. The product was purified via flash column chromatography using EtOAc : hexanes 
(1 : 1 → 100 % EtOAc) to afford 2.4 g (86 % over 2 steps) of a colorless foam. Rf (SiO2 TLC): 
0.34 EtOAc : hexanes (17 : 1).  λmax(MeCN) = 269 nm. 
1
H NMR (500MHz, CDCl3, ppm): 8.85 (m, 
2H, NH), 8.17 (s, 1H, H8), 8.03 (s, 1H, H8),  7.39-7.12 (m, 13H, Ar), 7.06-6.98 (m, 6H, Ar), 
6.79-6.76 (m, 4H, Ar), 6.58 (dd, 1H, H1’a, J = 6.5 Hz), 6.44 (dd, 1H, H1’b, J = 6.5 Hz),  4.80-
4.78 (m, 3H, PhOCH2CO, H3’a), 4.72-4.67 (m, 6H, PhOCH2CO & ArOCH2(CH2)2CH2OAr), 
4.63 (m, 1H, H3’b), 4.21 (m, 1H, H4’a), 4.01 (m, 1H, H4’b), 3.88 (dd, 1H, H5’b, J = 4.5 & 11.5 
Hz), 3.79 (dd, 1H, H5’’b, J = 3.5 & 11.5 Hz),  3.75 (s, 6H, 2 x OCH3), 3.46 (dd, 1H, H5’a, J = 5 
& 10.5 Hz), 3.34 (dd, 1H, H5’’a, J = 5 & 10 Hz), 2.76 (m, 1H, H2’a), 2.68-2.59 (m, 2H, H2’’a & 
H2’b), 2.44 (m, 1H, H2’’b), 2.13 (m, 4H, CH2CH2), 1.84 (bs, 1H, OH), 0.924 (s, 9H, 
(CH3)3CSi), 0.919 (s, 9H, (CH3)3CSi), 0.119 (s, 3H, (CH3)Si), 0.115 (s, 3H, (CH3)Si), 0.093 (s, 
6H, (CH3)2Si).
 13
C NMR (125.7 MHz, CDCl3, ppm): 161.1, 158.5, 157.3, 152.4, 151.1, 151.0, 
144.6, 140.3, 135.8, 135.7, 132.1, 132.04, 131.96, 131.93, 130.03, 130.01, 129.78, 129.76, 128.6, 
128.5, 128.1, 127.8, 126.9, 122.3, 122.2, 118.9, 114.92, 114.91, 113.1, 88.0, 86.5, 86.4, 84.2, 
84.2, 72.5, 71.9, 68.1, 67.9, 67.12, 67.05, 64.1, 62.8, 55.2, 41.2, 40.6, 26.0, 25.8, 25.40, 25.36, 
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18.4, 18.0, -4.64, -4.78, -5.35, -5.47. IR (thin film); νmax (cm
−1
) = 3410, 3255, 2954, 2929, 2856, 
1700 1607, 1510, 1496, 1249, 1176, 1074, 1033, 836, 780. HRMS (ESI-MS) m/z calculated for 
C73H91N10O14Si2
+
 1387.6249: found 1387.6260 [M+H]
+







 To a solution of 4.1 (2.4 g, 2.7 mmol), 4.2b (1.5 g, 2.4 mmol) and Ph3P (0.77 g, 2.9 
mmol) in anhydrous dioxane (26 mL) was added DIAD (0.58 mL, 2.9 mmol) dropwise while 
stirring. After 16 h, the solvent was evaporated in vacuo and the content taken up in DCM (75 
mL), washed with a saturated aqueous solution of NaHCO3 (2 x 80 mL) and brine (70 mL), dried 
over anhydrous Na2SO4, decanted and the solvent was once more evaporated to produce a yellow 
gum. The product was partially purified via flash column chromatography using EtOAc : 
hexanes (1 : 4 → 3 : 2) (Rf (SiO2 TLC): 0.73 EtOAc), fractions containing the product were 
pooled, concentrated in vacuo, and used without further purification for the subsequent step. To 
the resulting residue, Ph3P (0.24 g, 0.92 mmol) and (Ph3P)4Pd (0.50 g, 0.43 mmol) in anhydrous 
THF (48 mL) was added in a solution of n-BuNH2 (1.7 mL, 17 mmol) and HCOOH (0.65 mL, 
17 mmol) in THF (18 mL). After 15 min of stirring, the solvent was evaporated in vacuo and the 
crude taken up in EtOAc (75 mL), washed with a saturated aqueous solution of NaHCO3 (2 x 80 
mL) and brine (70 mL), dried over anhydrous Na2SO4, decanted and the solvent was evaporated 
in vacuo to produce a yellow gum. The product was purified via flash column chromatography 
using EtOAc : hexanes (1 : 1 → 7 : 3) to afford 2.8 g (82 % over 2 steps) of a colorless foam. Rf 
(SiO2 TLC): 0.54 EtOAc : hexanes (17 : 1). λmax(MeCN) = 269 nm. 
1
H NMR (500MHz, CDCl3, 
ppm): 8.79 (bs, 1H, NH), 8.74 (bs, 1H, NH), 8.15 (s, 1H, H8), 8.03 (s, 1H, H8),  7.42-7.16 (m, 
13H, Ar), 7.05-6.98 (m, 6H, Ar), 6.79-6.76 (m, 4H, Ar), 6.66 (dd, 1H, H1’a, J = 6.5 Hz), 6.44 
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(dd, 1H, H1’b, J = 6.5 Hz),  4.82-4.80 (m, 3H, PhOCH2CO, H3’a), 4.66-4.55 (m, 7H, 
PhOCH2CO, H3’b & ArOCH2(CH2)2CH2OAr), 4.25 (m, 1H, H4’a), 4.02 (m, 1H, H4’b), 3.88 
(dd, 1H, H5’b, J = 4.5 & 11 Hz), 3.79 (dd, 1H, H5’’b, J = 3.5 & 11.5 Hz),  3.75 (s, 6H, 2 x 
OCH3), 3.46 (dd, 1H, H5’a, J = 5 & 10.5 Hz), 3.34 (dd, 1H, H5’’a, J = 4 & 10 Hz), 2.74 (m, 1H, 
H2’a), 2.69-2.63 (m, 2H, H2’’a & H2’b), 2.44 (m, 1H, H2’’b), 1.89 (m, 4H, 
CH2CH2CH2CH2CH2), 1.56-1.44 (m, 6H, CH2CH2CH2CH2CH2), 0.925 (s, 9H, (CH3)3CSi), 
0.920 (s, 9H, (CH3)3CSi), 0.119 (s, 3H, (CH3)Si), 0.115 (s, 3H, (CH3)Si), 0.094 (s, 6H, 
(CH3)2Si).
 13
C NMR (125.7 MHz, CDCl3, ppm):
 
161.1, 158.5, 157.3, 152.4, 151.1, 151.0, 144.6, 
140.3, 135.8, 135.7, 132.1, 132.04, 131.96, 131.93, 130.03, 130.01, 129.78, 129.76, 128.6, 128.5, 
128.1, 127.8, 126.9, 122.3, 122.2, 118.9, 114.92, 114.91, 113.1, 88.0, 86.5, 86.4, 84.23, 84.16, 
72.5, 71.9, 68.1, 68.0, 67.12, 67.05, 64.1, 62.8, 55.2, 41.2, 40.6, 26.0, 25.8, 25.40, 25.36, 18.4, 
18.0, -4.64, -4.78, -5.35, -5.47. IR (thin film); νmax (cm
−1
) = 3410, 3057, 2953, 2931, 2856, 1717, 
1607, 1510, 1496, 1381, 1248, 1175, 1073, 836, 780. HRMS (ESI-MS) m/z calculated for 
C76H97N10O14Si2
+









deoxyguanidinyl]}-butane (4.4a):  
 To a solution of 1,2,4-triazole (0.25 g, 3.6 mmol) and NEt3 (0.50 mL, 3.6 mmol) in 
anhydrous THF (19 mL) was added Cl2(o-ClPhO)PO (0.30 mL, 1.8 mmol) dropwise at room 
temperature. A precipitate was formed immediately, which slightly dissipated over 10 - 20 min. 
After 40 min of vigorous stirring, the reaction was transferred by canula and filtered through a 
sintered glass funnel into another flask containing a solution of 4.3a (0.50 g, 0.36 mmol) in 
anhydrous Py (8 mL). The transfer / filtration was accelerated under reduced pressure. After 1 h 
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of stirring, the reaction was quenched using a saturated solution of NaHCO3 (10 mL), where a 
precipitate was observed to form. The solvent was partially removed in vacuo at 40 
o
C and the 
resulting residue was taken up in DCM (50 mL) containing NEt3 (0.3 mL), washed with water (2 
x 80 mL) followed by a saturated solution of NH4Cl (70 mL) then dried over anhydrous Na2SO4 
(≈ 4 g). A small amount of MeOH (1 mL) was added to the dried organic phase to help with 
solubility. The organic layer was filtered and the solvent was evaporated to produce a yellow 
gum. The product was purified via flash column chromatography using MeOH : DCM (5 %, 9 
%) containing a constant 0.12 % (v/v) of NEt3 to afford 0.53 g (93 %) of a colorless foam. Rf 
(SiO2 TLC): 0.44 MeOH : DCM (10 %).  λmax(MeCN) = 270 nm. 
1
H NMR (500MHz, CDCl3, 
ppm): 8.84 (bs, 1H, NH), 8.81 (bs, 1H, NH), 8.16 (s, 1H, H8), 7.95 (s, 1H, H8),  7.63 (d, 1H, Ar, 
J = 8 Hz), 7.35-7.10 (m, 15H, Ar), 7.01-6.90 (m, 7H, Ar), 6.73-6.70 (m, 4H, Ar), 6.47 (dd, 1H, 
H1’a, J = 7 Hz), 6.42 (dd, 1H, H1’b, J = 6.5 Hz),  5.22 (m, 1H, H3’a), 4.83-4.81 (m, 4H, 2 x 
PhOCH2CO), 4.69 (m, 4H, ArOCH2(CH2)2CH2OAr), 4.62 (m, 1H, H3’b), 4.45 (m, 1H, H4’a), 
3.99 (dd, 1H, H4’b, J = 3.5 & 7.5 Hz), 3.85 (dd, 1H, H5’b, J = 4 & 11.5 Hz), 3.77 (dd, 1H, 
H5’’b, J = 3.5 & 11.5 Hz),  3.73 (s, 6H, 2 x OCH3), 3.39 (dd, 1H, H5’a, J = 5 & 10.5 Hz), 3.29 
(dd, 1H, H5’’a, J = 3 & 10.5 Hz), 2.84-2.81 (m, 2H, H2’a & H2’’a), 2.65 (m, 1H, H2’b), 2.42 
(m, 1H, H2’’b), 2.10 (m, 4H, CH2CH2), 0.902 (s, 9H, (CH3)3CSi), 0.897 (s, 9H, (CH3)3CSi), 
0.098 (s, 3H, (CH3)Si), 0.094 (s, 3H, (CH3)Si), 0.071 (s, 6H, (CH3)2Si). Residual trimethylamine 
peaks are observed at 2.97 ppm and 1.26 ppm. 
 13
C NMR (125.7 MHz, CDCl3, ppm):
 
161.04, 
161.02, 158.4, 157.4, 157.3, 152.6, 152.4, 151.2, 151.1, 149.2, 149.1, 144.5, 140.4, 140.1, 135.7, 
135.5, 130.1, 129.90, 129.85, 129.73, 129.70, 128.2, 127.8, 127.6, 127.5, 126.8, 124.93, 124.87, 
123.8, 123.6, 122.2, 122.0, 121.7, 121.41, 121.39, 118.8, 118.6, 114.90, 114.87, 113.1, 88.0, 
86.5, 85.8, 85.7, 84.2, 84.1, 71.9, 68.1, 68.0, 67.0, 64.2, 62.8, 55.2, 41.2, 39.5, 26.0, 25.8, 25.4, 
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25.3, 18.4, 18.0, -4.65, -4.79, -5.36, -5.48. Residual trimethylamine peaks are observed at 45.8 
ppm and 8.68 ppm. 
31
P NMR (202.3 MHz, CDCl3, ppm): -6.68. IR (thin film); νmax (cm
−1
) = 
3410, 3063, 2954, 2930, 2856, 2635, 2486, 1700, 1606, 1509, 1496, 1383, 1247, 1176, 1081, 
1032, 837, 780. HRMS (ESI-MS) m/z calculated for C79H93ClN10O17PSi2
-











 To a solution of 1,2,4-triazole (0.25 g, 3.6 mmol) and NEt3 (0.50 mL, 3.6 mmol) in 
anhydrous THF (19 mL) was added Cl2(o-ClPhO)PO (0.30 mL, 1.8 mmol) dropwise at room 
temperature. A precipitate was formed immediately, which slightly dissipated over 10 - 20 min. 
After 40 min of vigorous stirring, the reaction was transferred by canula then filtered through a 
sintered glass funnel into another flask containing a solution of 4.3b (0.50 g, 0.36 mmol) in 
anhydrous Py (8 mL). The transfer / filtration was accelerated under reduced pressure. After 1 h 
of stirring, the reaction was quenched using a saturated solution of NaHCO3 (10 mL), where a 
precipitate was observed to form. The solvent was partially removed in vacuo at 40
o
C and the 
resulting residue was taken up in DCM (50 mL) containing NEt3 (0.3 mL), washed with water (2 
x 80 mL) followed by a saturated solution of NH4Cl (70 mL) then dried over anhydrous Na2SO4 
(≈ 4 g). A small amount of MeOH (1 mL) was added to the dried organic phase to help with 
solubility. The organic layer was filtered and the solvent was evaporated to produce a yellow 
gum. The product was purified via flash column chromatography using MeOH : DCM (4 %, 8%) 
containing a constant 0.12 % (v/v) of NEt3 to afford 0.50 g (88 %) of a colorless foam. Rf (SiO2 
TLC):0.46 MeOH : DCM (10 %).  λmax(MeCN) = 269 nm. 
1
H NMR (500MHz, CDCl3, ppm): 8.73 
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(bs, 1H, NH), 8.64 (bs, 1H, NH), 8.15 (s, 1H, H8), 7.96 (s, 1H, H8),  7.64 (d, 1H, Ar, J = 8.5 
Hz), 7.38-7.12 (m, 15H, Ar), 7.05-7.01 (m 6H, Ar), 6.96-6.93 (m, 1H, Ar), 6.74-6.72 (m, 4H, 
Ar), 6.49 (dd, 1H, H1’a, J = 6 & 8.5 Hz), 6.44 (dd, 1H, H1’b, J = 6.5 Hz),  5.22 (m, 1H, H3’a), 
4.83 (m, 4H, 2 x PhOCH2CO), 4.64-4.57 (m, 5H, H3’b & ArOCH2(CH2)5CH2OAr), 4.46 (m, 1H, 
H4’a), 4.01 (dd, 1H, H4’b, J = 3.5 & 7 Hz), 3.87 (dd, 1H, H5’b, J = 4.5 & 11.25 Hz), 3.78 (dd, 
1H, H5’’b, J = 3 & 11.25 Hz),  3.75 (s, 6H, 2 x OCH3), 3.40 (dd, 1H, H5’a, J = 5 & 10 Hz), 3.31 
(dd, 1H, H5’’a, J = 3 & 10 Hz), 2.90-2.80 (m, 2H, H2’a & H2’’a), 2.66 (m, 1H, H2’b), 2.43 (m, 
1H, H2’’b), 1.90 (m, 4H, CH2 & CH2), 1.45 (m, 6H, CH2CH2CH2), 0.915 (s, 9H, (CH3)3CSi), 
0.910 (s, 9H, (CH3)3CSi), 0.112 (s, 3H, (CH3)Si), 0.108 (s, 3H, (CH3)Si), 0.086 (s, 6H, 
(CH3)2Si). Residual trimethylamine peaks are observed at 3.10 ppm and 1.39 ppm
 13
C NMR 
(125.7 MHz, CDCl3, ppm):
 
161.2, 158.4, 152.3, 151.1, 140.2, 135.6, 130.1, 129.8, 128.1, 127.7, 
122.2, 114.9, 113.1, 88.0, 84.2, 71.9, 68.1, 67.8, 62.8, 55.1, 41.2, 29.2, 28.8, 26.0, 25.9, 25.8, 
25.7, 18.4, 18.0, -4.64, -4.78, -5.35, -5.48. Residual trimethylamine peaks are observed at 45.7 
ppm and 8.54 ppm.
 31
P NMR (202.3 MHz, CDCl3, ppm): -6.73. IR (thin film); νmax (cm
−1
) = 
3409, 3057, 2953, 2931, 2856, 2485, 1717, 1607, 1510, 1496, 1443, 1419, 1382, 1247, 1175, 







 To a solution of 4.4a (0.96 g, 0.61 mmol) in THF (61 mL) was added TBAF (1M in 
THF) (6.1 mL, 6.1 mmol) dropwise while stirring. After 1h, the solvent was evaporated and the 
content taken up in DCM (75 mL), washed with a saturated solution of aqueous NaHCO3 (2 x 75 
mL) and brine (50 mL), then dried over anhydrous Na2SO4 (≈ 4 g), decanted and the solvent was 
once more evaporated to produce a yellow gum. The crude intermediate was further dried by co-
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evaporation with anhydrous Py (3 x 10 mL), and then dissolved in anhydrous Py (130 mL) 
followed by the addition of MSNT (0.90 g, 3.0 mmol). After 4 h of stirring, the reaction was 
quenched with H2O (10 mL) and the solvent evaporated in vacuo. The resulting residue was 
taken up in DCM (80 mL), washed with a saturated solution of aqueous NaHCO3 (2 x 80 mL) 
and brine (50 mL), dried over anhydrous Na2SO4 (≈ 4 g), decanted and the solvent was 
evaporated to produce a yellow gum. The product was purified via flash column chromatography 
using MeOH : DCM (2 %→ 4 %)  to afford 0.41 g (51 %) of a colorless solid. Rf (SiO2 
TLC):0.35 MeOH : DCM (6 %). λmax(MeCN) = 265 nm. 
31
P NMR (202.3 MHz, CDCl3, ppm): -
8.51, -9.19. IR (thin film); νmax (cm
−1
) = 3406, 3251, 3058, 2932, 2837, 1700, 1608, 1510, 1496, 
1419, 1384, 1250, 1176, 1085, 1032, 957, 833, 792, 755. HRMS (ESI-MS) m/z calculated for 
C67H65ClN10O16P
+




 To a solution of 4.4b (0.50 g, 0.31 mmol) in THF (31 mL) was added TBAF (1M in 
THF) (3.1 mL, 3.1 mmol) dropwise while stirring. After 6h, the solvent was evaporated and the 
content taken up in DCM (75 mL), washed with a saturated solution of aqueous NaHCO3 (2 x 75 
mL) and brine (50 mL), then dried over anhydrous Na2SO4 (≈ 4 g), decanted and the solvent was 
once more evaporated to produce a yellow gum. The crude intermediate was further dried by co-
evaporation with anhydrous Py (3 x 10 mL), then dissolved in anhydrous Py (65 mL) followed 
by the addition of MSNT (0.48 g, 1.5 mmol). After 16 h of stirring, the reaction was quenched 
with H2O (10 mL), and the solvent evaporated in vacuo. The resulting residue was taken up in 
DCM (70 mL), washed with a saturated solution of aqueous NaHCO3 (2 x 80 mL) and brine (50 
mL), dried over anhydrous Na2SO4 (≈ 4 g), decanted and the solvent was once more evaporated 
to produce a yellow gum. The product was purified via flash column chromatography using 
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MeOH : DCM (2 %→ 3.3 %)  to afford 0.22 g (52 %) of a colorless solid. Rf (SiO2 TLC):0.41 
MeOH : DCM (6 %). λmax(MeCN) = 267 nm. 
31
P NMR (202.3 MHz, CDCl3, ppm): -7.82, -8.50. IR 
(thin film); νmax (cm
−1
) =3407, 3257, 3058, 2930, 2853, 1716, 1607, 1510, 1496, 1443, 1420, 
1383, 1247, 1176, 1084, 1014, 953, 832, 755. HRMS (ESI-MS) m/z calculated for 
C70H70ClN10NaO16P
+




 To a solution of 4.5a (0.28 g, 0.21 mmol) and DIPEA (62 µL, 0.40 mmol) in anhydrous 
THF (2.1 mL) was added Cl-POCENiPr2 (70 μL, 0.32 mmol) dropwise while stirring. After 10 
min, a precipitate was formed and after 30 min the solvent was evaporated in vacuo and the 
crude taken up in EtOAc (70 mL), washed with a saturated solution of aqueous NaHCO3 (2 x 75 
mL) and brine (50 mL), then dried over anhydrous Na2SO4 (≈ 4 g). The organic layer was 
filtered and the solvent was evaporated to produce a yellow gum. The product, a slightly yellow 
oil, taken up in EtOAc (2 mL) and was precipitated from hexanes (1 L) to afford 0.30 g of a 
yellow foam. Rf (SiO2 TLC):0.095, 0.214, 0.310 EtOAc. λmax(MeCN) = 265 nm.
 31
P NMR (202.3 
MHz, d6-acetone, ppm):  149.35, 148.87, 148.81, 148.72, -6.90, -6.93, -9.54, -9.71. IR (thin 
film); νmax (cm
−1
) = 3579, 3410, 2967, 2837, 2253, 1711, 1607, 1511, 1445, 1419, 1383, 1250, 
1177, 1084, 955, 831, 756. HRMS (ESI-MS) m/z calculated for C76H81ClN12NaO17P2
+
 
1553.4899: found 1553.4860 [M+H]
+
.   
Compound 4.6b 
 To a solution of 4.5b (0.22 g, 0.16 mmol) and DIPEA (52 µL, 0.30 mmol) in anhydrous 
THF (2.0 mL) was added Cl-POCENiPr2 (53 μL, 0.24 mmol) dropwise while stirring. After 10 
min, a precipitate was formed and after 30 min the solvent was evaporated in vacuo and the 
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crude taken up in EtOAc (60 mL), washed with a saturated solution of aqueous NaHCO3 (2 x 70 
mL) and brine (50 mL), then dried over anhydrous Na2SO4 (≈ 4 g). The organic layer was 
filtered and the solvent was evaporated to produce a yellow gum. The product, a yellow gum, 
taken up in EtOAc (2 mL) and was precipitated from hexanes (1 L) to afford 0.24 g of a yellow 
foam. Rf (SiO2 TLC):0.354, 0.430 NEt3 : EtOAc (3 %). λmax(MeCN) = 269 nm. 
31
P NMR (202.3 
MHz, d6-acetone, ppm): 148.97, 148.80, 148.74, 148.61, -7.40, -7.48, -8.77, -8.88. IR (thin film); 
νmax (cm
−1
) = 3411, 2965, 1710, 1607, 1510, 1496, 1445, 1421, 1383, 1248, 1177, 1084, 1031, 
957, 831, 756. HRMS (ESI-MS) m/z calculated for C79H87ClN12NaO17P2
+
 1595.5368: found 
1595.5359 [M+H]
+
.   
Abbreviations:  DCM, dichloromethane; DIAD, diisopropyl azodicarboxylate; DMAP, 4-
dimethylaminopyridine; EtOAc, ethyl acetate; MeCN, acetonitrile; MeOH, methanol; MSNT, 1-
(mesitylene-2-sulfonyl)-3-nitro-1,2,4-triazole; Py, pyridine; TBS-Cl, tert-butyldimethylsilyl 
chloride; THF, tetrahydrofuran . 
4.5.1.3 Preparation, purification and characterization of the IaCL 
oligonucleotide 
 The cross-linked duplexes, the sequences for which are shown in Figure 4.1, were 
assembled with an Applied Biosystems Model 3400 synthesizer on a 1.5 mmol scale using β-
cyanoethylphosphoramidite chemistry supplied by the manufacturer with slight modifications to 
coupling times. The nucleoside phosphoramidites protected with "fast-deprotecting" groups were 
prepared in anhydrous MeCN at a concentration of 0.1 M for the 3’-O-deoxyphosphoramidites, 
and 0.15 M for the cross-linked 3’-O-deoxyphosphoramidite. Oligomer sequence assembly was 
carried out as previously described.
323
 The capping step of the assembly was carried out using 
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phenoxyacetic anhydride/pyridine/tetrahydrofuran 1:1:8 (v/v/v; solution A) and 1-methyl-
imidazole/ tetrahydrofuran 16:84 (w/v; solution B). Coupling wait times for phosphoramidites 
4.6a and 4.6b were extended to 10 min (compared to 2 min for the commercially available 
phosphoramidites). Protecting group removal and cleavage from the solid support was carried 
out by treatment with aqueous (28% v/v) ammonium hydroxide for 17 h at room temperature 
with mild rocking in 2 mL screw-cap microfuge tubes fitted with Teflon lined caps, followed by 
an additional 4 h at 55 
o
C. Crude oligomers were transferred and lyophilized in a Speedvac 
concentrator followed by purification by strong anion exchange HPLC using a Dionex DNAPAC 
PA-100 column (0.4 cm x 25 cm) purchased from Dionex Corp, Sunnyvale, CA using a linear 
gradient of 0–52% buffer B over 24 min (buffer A: 100 mm Tris HCl, pH 7.5, 10% MeCN and 
buffer B: 100 mm Tris HCl, pH 7.5, 10% MeCN, 1M NaCl) at 55 
o
C. The columns were 
monitored at 260 nm for analytical runs or 280 nm for preparative runs. The purified oligomers 
were desalted using C-18 SEP PAK cartridges (Waters Inc.) as previously described.
317
 Modified 
oligomers (0.05 A260 units) were characterized by digestion with snake venom phosphodiesterase 
(0.28 units) and calf intestinal phosphatase (5 units) in a buffer containing 10 mM Tris (pH 8.1) 
and 2 mm magnesium chloride for 3 days at 37 
o
C. The resulting mixture of nucleosides was 
analyzed by reversed phase HPLC using a Symmetry C-18 5 mm column (0.46 x 15 cm) 
purchased from Waters Inc., Milford, MA. A linear gradient of 0–30% buffer B over 30 min 
(buffer A, 50 mm sodium phosphate, pH 5.8 and buffer B, 50 mm sodium phosphate, pH 5.8, 
50% MeCN) was used to elute the analytes. The peaks in the elution profile were identified by 
co-injection with the corresponding standards with the following elution times: dC (4.5 min),dG 
(7.4 min), dT (8.0 min), dA (9.0 min), and the ratio of nucleosides was determined. The results 
are given in Table 1 of the main text. The molecular mass of the modified oligomers were 
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identified by ESI-MS and the measured values were in agreement with the expected masses 
(Supporting Information Figure 4.3 and 4.4 for MS spectra). 
4.5.1.4 UV thermal denaturation 
 Molar extinction coefficients for the unmodified and cross-linked oligonucleotides were 





). All duplexes were prepared by mixing equimolar amounts of the 
interacting strands and lyophilizing the mixture to dryness. The resulting pellet was then re-
dissolved in 90mM sodium chloride, 10 mM sodium phosphate, 1 mM EDTA buffer (pH 7.0) to 
give a final concentration of 3.5 μM duplex. Prior to the thermal run, samples were degassed by 
placing them in a speed- vac concentrator for 2 min. Annealing curves were acquired at 260 nm 
starting at 95 
o




 until 15 
o
C, using 
a Varian CARY Model 3E spectrophotometer fitted with a 6-sample thermostated cell block and 
a temperature controller. The samples were then denatured by heating from 15 
o
C to 95 
o
C at an 




 to show reversibility. Denaturing data processing was 
carried out as described by Puglisi and Tinoco
254
 and transferred to Microsoft Excel
TM
 for 
viewing. Thermodynamic parameters of the control duplex and IaCL-containing duplexes were 
obtained by performing thermal denaturation studies in triplicate at concentrations of 0.7, 2.8, 
13.8 and 69 μM duplex DNA in cuvettes with path length of 1, 0.5, 0.2 and 0.1 cm, respectively. 
A plot of ln(Ctot/4) as a function of 1/Tm, used for a non- self-complementary bimolecular 




4.5.1.5 Circular dichroism (CD) spectroscopy 
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 Circular dichroism spectra were obtained on a Jasco J-815 spectropolarimeter equipped 
with a Julaba F25 circulating bath. Samples were allowed to equilibrate for 5 – 10 min at 15 oC 
in 90 mM sodium chloride, 10 mM sodium phosphate, 1 mM EDTA (pH 7.0), at a final 
concentration of 3.5 μM. Each spectrum was an average of 5 scans, collecting at a rate of 50 nm 
min
-1
 , with a bandwidth of 1 nm and sampling wavelength of 0.2 nm using fused quartz cells 
(Starna 29-Q-10). The CD spectra were recorded from 350 to 220 nm at 15 
o
C. The molar 
ellipticity (φ) was calculated from the equation φ = ε/Cl, where ε is the relative ellipticity 
(mdeg), C is the molar concentration of oligonucleotides (moles/L), and l is the path length of the 
cell (cm). The data were processed using software supplied by the manufacturer (JASCO, Inc.) 
and transferred into Microsoft Excel
TM
 for viewing. 
4.5.1.6 Molecular modelling  
 Molecular modeling was performed by using the Hyperchem 7.5 software package from 
Hypercube utilizing the AMBER force field. Hybridized oligomers containing a dGG·dCC, 
dGpG4·dCC, dGpG4·dCC base pair were constructed from the nucleic acid template option 
using a B-form duplex. Sequence contexts were truncated to the following 5’-GGC TXX GAT C 
and 3’-CCG ACC CTA G for proper solvation. Duplexes were solvated with water using a 
periodic box occupying at least 3 times the volume of the duplex alone. Standard Amber99 
parameters were used with the dielectric set to constant. “One to four scale factors” non-bonded 
interactions were set to 0.5 (both electrostatic and van der Waals). Cutoffs were applied to 
“switched” to an outer and inner radius of 15.3 and 11.3 Å. All structures were geometry 
optimized using Polak-Ribiere conjugate gradient until the RMS gradient was less than 0.1 
kcal/(Å mol) using the periodic boundary condition option. 
4.5.1.7 Protein expression and purification  
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 Ampicillin, isopropyl β-D-thiogalactopyranoside (IPTG), and most other biochemical 
reagents as well as polyacrylamide gel materials were purchased from Bioshop Canada Inc 
(Burlington, ON). Ni-NTA Superflow Resin was purchased from Qiagen (Mississauga, ON). 
Complete, Mini, EDTA-free Protease Inhibitor Cocktail Tablets were obtained from Roche 
(Laval, QC). Nitro-cellulose filters (0.20 μm) were obtained from Millipore. XL-10 Gold and 
Bl21(DE3) E. coli cells were obtained from Stratagene (Cedar Creek, TX). T4 polynucleotide 
kinase (PNK) was obtained from Fermentas (Burlington, ON). [γ-32P]ATP was purchased from 
PerkinElmer (Woodbridge, ON). Phusion Polymerase was obtained from New England Biolabs 
(Ipswich, MA). DNA primers for site directed mutagenesis and cloning were purchased from 
Biocorp (Montreal, QC).  All AGT homologues were expressed under the promoter of the 
pQE30 vector in XL-10 Gold E. coli cells, as previously described.
149–151,331
  
4.5.1.8 AGT repair assay of GpG4 and GpG7  
 DNA substrates were labeled at the using γ-[32P]-ATP as previously described.331 Briefly, 
a 20 μM solution of DNA was made in 1X PNK buffer along with 1 μL γ-[ 32P]-ATP (10 μCi 
μL−1 ) and 5 units of T4 PNK. The labelling reaction was conducted for 1 h at 37 °C after which 
the reaction was terminated by boiling the sample for 5 min. 100 pmol of labeled DNA was 
added to 110 pmol of the complement strand in a total volume of 50 μL of water making a 2 μM 
dsDNA solution with 10% excess of the non-damaged strand. The solution was boiled for 2 min, 
cooled slowly to room temperature and kept in a refrigerator at 4 °C overnight to ensure proper 
annealing of the duplex. The repair reaction mixtures were constituted of 2 pmol of the DNA 
duplex and 10 pmol of AGT in a total volume of 15 μL of Activity Buffer [10 mM Tris–HCl (pH 
7.6), 100 mM NaCl and 1 mM DTT] and allowed to react at 37 °C overnight. The reaction was 
terminated by the addition of 18.2 μL of stop buffer [81 mM Tris–HCl, 81 mM boric acid, 1.8 
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mM EDTA and 1% SDS (sodium dodecyl sulfate) (pH 8.0) in 80% formamide] followed by 
boiling for 2 min. Samples (10 μL) were loaded on a 14 cm × 16 cm, 20% 7 M urea denaturing 
polyacrylamide gel (19 : 1) for separation. The gels were run using 1X TBE for 4h at 475 V and 
the gels exposed to a storage phosphor screen. The image was captured on a Typhoon 9400 (GE 
Healthcare, Piscataway, NJ) and the autoradiography counts obtained by Image-Quant™ 
(Amersham Biosciences). For the repair time course assay of GpG4 and GpG7 duplexes, master 
mixes of 120 μL composed of 400 pmol of hAGT and 13.3 pmol of DNA substrate were 
prepared. Each sample was placed at 37 
oC and at each time point, 7.5 μL was removed from the 
master mix and placed in a tube with 9.1 μL of stop reaction buffer and analysis was achieved as 
described above. Repair experiments were repeated with single stranded IaCL DNA GG4 and 
GG7 as previously described with slight modifications.
323
 Labelling of the DNA strands was 
carried out as above with an additional 300 pmol of non-radioactive ATP. All GG4 and GG7 
samples were analyzed on polyacrylamide gel electrophoresis (using 1X TBE for 50 min at 425 











4.5.2 Supporting Figures and Tables 
 
Figure S4.1 -IEX-HPLC profile of GpG4 (A) and GpG7 (B). The column was eluted using a 
linear gradient of 0-52% buffer B over 24 min (buffer A: 100 mM Tris HCl, pH 7.5, 10% MeCN 
and buffer B: 100mM Tris HCl, pH 7.5, 10% MeCN, 1 M NaCl) at 55 
o
C and flow rate of 1 












dC 4 4.0 
dI (dA) 3 2.8 
dG 4 3.6 
dT 2 1.1 
dG-dG 4C  1 1.0 
GpG7 
dC 4 4.0 
dI (dA) 3 2.9 
dG 4 4.0 
dT 2 1.4 
dG-dG 7C 1 1.2 
 
Figure S4.2- C-18 HPLC profile of nuclease digested GpG4 (A) and GpG7 (B). The column 
was eluted with a linear gradient of 0-60% buffer B over 30 min (buffer A: 50 mM sodium 
phosphate, pH 5.8 and buffer B: 50 mM sodium phosphate, pH 5.8, 50% MeCN) at a flow rate of 
1.0 mL/min over 30 min, monitored at 260 nm. The appearance of a new peak which does not 
correlate with elution profiles of corresponding dimers lacking the phosphodiester group, 
suggests incomplete digestion of GpG4 and GpG7.
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Figure S4.3 - Deconvoluted ESI MS spectrum of oligonucleotide GpG4 
 
 








Figure S4.5 - Deconvoluted ESI MS spectrum of oligonucleotide GG4 (400 pmol) 





Figure S4.6 - Deconvoluted ESI MS spectrum of oligonucleotide GG7 (400 pmol) 





Figure S4.7 - UV thermal denaturation experiments for Van’t Hoff experiments for unmodified 
DNA duplex (GG), GG4, GG7, GpG4, and GG7 at 0.69 µM (―), 2.8 µM (•••),  14 µM (– – –), 
69 µM (–•–). Tm values are reported in Table S4.1 and all plots of Tm
-1
 versus ln(Ct/4) exceeded 





Figure S4.8 - Molecular models of unmodified control duplex and duplexes containing GpG4 





Figure S4.9 - Total repair gel of single stranded GG4 and GG7 by AGTs. Lane 1, 2 pmol 
control unmodified DNA; lane 2, 2 pmol GG4; lane 3, 2 pmol GG4 +10 pmol hAGT; lane 4, 2 
pmol GG4 +60 pmol hAGT; lane 5, 2 pmol GG4 +10 pmol OGT; lane 6, 2 pmol GG4 +10 pmol 
Ada-C; lane 7, 2 pmol GG4 +10 pmol OGT S134P; lane 8, 2 pmol 5’-pGGC TG; lane 9, 2 pmol 
5’- pG GAT CAC CAG, lane 10, 2 pmol GG7; lane 11, 2 pmol GG7 +10 pmol hAGT; lane 12, 
2 pmol GG7 +60 pmol hAGT; lane 13, 2 pmol GG7 +10 pmol OGT; lane 14, 2 pmol GG7 +10 















Figure S4.10 - Total repair gel of single stranded GG4 and GG7 by AGTs. Lane 1, 2 pmol 
control unmodified DNA; lane 2, 2 pmol GG4; lane 3, 2 pmol GG4 +10 pmol hAGT; lane 4, 2 
pmol GG4 +60 pmol OGT; lane 5, 2 pmol GG4 + 60 pmol Ada-C; lane 6, 2 pmol GG4 + 60 
pmol OGT S134P; lane 7, 1 pmol 5’-GGC TG; lane 8, 2 pmol 5’- G GAT CAC CAG, lane 9, 2 
pmol GG7; lane 10, 2 pmol GG7 +10 pmol hAGT; lane 11, 2 pmol GG7 +60 pmol OGT; lane 










Figure S4.11 - Total repair gel of double stranded GG4 and GG7, labelled with a mixture of γ-
[
32P]ATP (1 uL, 10 μCi) and non-radioactive ATP (3-fold excess), by AGTs. Lane 1, 2 pmol 
control unmodified DNA; lane 2, 2 pmol GG4; lane 3, 2 pmol GG4 +10 pmol hAGT; lane 4, 2 
pmol GG4 +60 pmol hAGT; lane 5, 2 pmol GG4 + 60 pmol OGT; lane 6, 2 pmol GG4 + 60 
pmol Ada-C; lane 7, 2 pmol GG4 + 60 pmol OGT S134P; lane 8, 2 pmol GG7; lane 9, 2 pmol 
GG7 +10 pmol hAGT; lane 10, 2 pmol GG7 + 60 pmol hAGT; lane 11, 2 pmol GG7 + 60 pmol 
OGT; lane 12, 2 pmol GG7 + 60 pmol Ada-C; lane 13, 2 pmol GG7 + 60 pmol OGT S134P; 




Figure S4.12 - Time course repair gel of single stranded GG4 and GG7 by hAGT. (A) 
Denaturing gel of the repair of 2 pmol of GG4 by 10 pmol hAGT as a function of time: lane 1, 2 
pmol Control; lanes 2-15, 2 pmol GG4 + 10 pmol hAGT incubated for 1, 2.5, 5, 10, 15, 25, 35, 
45, 60, 90, 120, 180, 240, 1020 min, respectively. (B) Denaturing gel of the repair of 2 pmol of 
GG7 by 10 pmol hAGT as a function of time: lane 1, 2 pmol Control; lanes 2-15, 2 pmol GG7 + 







Figure S4.13 - Time course repair assay plots of GG4 (A and B) and GG7 (C and D) by hAGT 
displaying significant faster repair of GG7 as previously observed for repair of corresponding 
duplexes, respectively. Graphs on the left show the full length assay (960 min) whereas those on 
the right are truncated. Graphical illustrations display abundances [%] of MP (- - -), RP (—•—) 









Figure S4.14 - Control experiment displaying feasibility of denaturing gels in resolving repair 
products and substrates: lane 1, 2 pmol control (5’-GGC TGG GAT CAC CAG) ; lane 2, 1 pmol 
control + 1 pmol GpG4; lane 3, 2 pmol GpG4; lane 4, 2 pmol control; lane 5, 1 pmol control + 1 






Figure S4.15 - Graphical representation of the % IaCL (2 pmol) of GG4, GG7, GpG4 and 
GpG7 remaining in the reaction tube after treatment with hAGT (30-fold protein, 60 pmol) for 
16h at 37 
o
C obtained using ImageJ software (National Institutes of Health). 
 
Figure S4.16 - Time course repair gel of GpG4 and GpG7 by hAGT. (A) Denaturing gel of the 
repair of 2 pmol of GpG4 by 60 pmol hAGT as a function of time: lane 1, 2 pmol Control; lanes 
2-11, 2 pmol GpG4 + 60 pmol hAGT incubated for 5, 15, 35, 60, 90, 120, 180, 240, 300 and 960 
min, respectively (B) Denaturing gel of the repair of 2 pmol of GpG7 by 60 pmol hAGT as a 
function of time: lane 1, 2 pmol Control; lanes 2-11, 2 pmol GpG7 + 60 pmol hAGT incubated 





Figure S4.17  - Total repair gel of duplexes containing bicyclic pyrimidine adducts (DFP and 
TPP, structures shown below). The preparation of DNA oligomers containing these 
modifications have been described in CHAPTER II (5`-GGC TX GAT CAC CAG, where X 
denotes the site of modification). Lane 1, 2 pmol DFP; lane 2, 2 pmol DFP + 10 pmol hAGT; 
lane 3, 2 pmol DFP + 10 pmol OGT; lane 4, 2 pmol DFP + 10 pmol Ada-C; Lane 5, 2 pmol 
TPP; lane 6, 2 pmol TPP + 10 pmol hAGT; lane 7, 2 pmol TPP + 10 pmol OGT; lane 8, 2 pmol 
TPP + 10 pmol Ada-C; lane 9, 2 pmol unmodified control DNA. 
 
 
Table S4.1 - Tm values (
o
C) with respect to DNA concentration (µM). All duplexes were 
resuspended in 90mM sodium chloride, 10 mM sodium phosphate, 1 mM EDTA buffer (pH 7.0). 
Annealing curves were acquired at 260 nm starting at 95 
o
C and decreasing temperature at a rate 




 until 15 
o
C. Denaturation curves were acquired in a similar fashion (15 
o





C) in triplicates 
GG GG4 GG7 GpG4 GpG7 
0.69 59.0 60.0 61.0 37.0 38.1 38.0 39.2 40.1 41.0 42.0 43.0 41.0 43.2 44.0 43.0 
2.8 62.0 62.6 64.3 41.0 41.5 41.9 42.0 43.5 43.0 44.1 45.5 43.9 46.1 47.4 46.9 
14 68.0 67.9 69.0 45.4 45.6 46.0 47.5 47.8 48.5 48.9 50.0 49.2 51.0 52.3 52.9 
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Backbone Flexibility Influences Nucleotide Incorporation by 
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 Intrastrand cross-links (IaCL) connecting two purine nucleobases in DNA pose a 
challenge to high fidelity replication in the cell. Various repair pathways or polymerase bypass 
can cope with these lesions. The influence of the phosphodiester linkage between two 
neighbouring 2´-deoxyguanosine (dG) residues attached through the O
6
-atoms by an alkylene 
linker on bypass with human DNA polymerase η (hPol η) was explored in vitro. Steady-state 
kinetics and mass spectrometric analysis of products from nucleotide incorporation revealed that 
although hPol η is capable of bypassing the 3´-dG in a mostly error-free fashion, significant 
misinsertion was observed for the 5´-dG of the IaCL containing a butylene or heptylene linker. 
The lack of the phosphodiester linkage triggered an important increase in frameshift adduct 






 Chemotherapeutic agents such as the platinum-containing drugs used in the treatment of 
cancer exert their therapeutic effect mainly via the formation of cytotoxic DNA damage. The 
lesions that these agents produce have been identified primarily as intrastrand cross-links (IaCL) 
between the N7-atoms of purines with the distribution of these IaCL determined to be 65% 
1,2(GpG), 25% 1,2(ApG), and 5-10% 1,3(GpTpG).
281,332–338
 In addition, formation of minor 
products including interstrand cross-links (ICL), mono-adducts and DNA-protein cross-links 
occur.
281
 The presence of these adducts on the DNA scaffold impedes vital cellular processes 
such as DNA replication and transcription ultimately leading to cell death. Drugs used in cancer 







 have also been shown to introduce IaCL in DNA, in particular between 
adjacent purine nucleobases. Using drugs that act directly on DNA to treat cancer have intrinsic 
and acquired drug resistance as a major limitation, which is mediated by the cellular response 
processes of DNA repair and translesion DNA synthesis (TLS).     
 The four TLS DNA polymerases identified in humans are Pol η, Pol κ, Pol ι, and Rev1. 
The most widely studied of these is Pol η given its crucial involvement in bypassing UV-induced 
intrastrand cross-linked DNA lesions. Disruption in the proper function of the POLH gene leads 
to xeroderma pigmentosum variant (XPV), a disease characterized by hypersensitivity to UV-
radiation and an increased incidence of skin cancer.
207
As suspected, POLH knockout mice 
demonstrated heightened incidences of skin cancer compared to the control group when exposed 
to UV-radiation.
339
 XPV cell extracts displayed replication inhibition of plasmid DNA 
containing a single (6-4) pyrimidone photoproduct lesion.
82
 Moreover, human cells deficient in 





 Exposure of DNA to γ-radiation leads to the formation of a mixture of the 
IaCL lesions G[8,5]C and G[8,5]T, among others, formed via a radical mechanism.
4
 Their 
bypass by yeast and/or human Pol η demonstrated reduced fidelity and processivity, in particular 
across the dG portion of the lesion.
78,223,341
  Accounts of Pol η bypass are numerous and the 
search for other biologically relevant DNA damage, or mimics thereof, is ongoing.   
 DNA alkylating agents such as N-nitroso-N-methylurea readily modify the N7-atom of 
dG and, to a lesser extent, the O
6
-position. Lesions at the O
6
-atom of dG have also been detected 
after exposure to the methylating and chloroethylating chemotherapeutic drugs temozolimide and 
carmustine. Endogenous formation of O
6
-MedG by S-adenosylmethionine is estimated at 10–30 
damage events per cell per day.
14
 The introduction of covalent appendages at the N7-atom of a 
purine nucleotide in DNA reduces chemical stability, leading to modifications such as the 
introduction of abasic sites and/or formation of formamidopyrimidine lesions. Alkyl 
modifications introduced at the O
6
-position of dG are chemically stable and if left uncorrected, 
lead to stalls or significant G:C to A:T transitions by DNA polymerases including those of the Y-
family.
45,342–346
 The importance of this site of alkylation has been demonstrated by in vivo studies 




 The disruption of high 
fidelity DNA polymerase activity in the presence of O
6
-MedG and other O
6
-alkyldG lesions has 
been attributed to disruption of Watson-Crick base pairing.   
Much less is known about the bypass of IaCL containing more flexible lesions such as 
an alkylene linker, in comparison to more rigid systems including platinum-based IaCL DNA. In 
the present study, we investigated whether Pol η was capable of efficiently bypassing an O6-dG-
alkylene-O
6
-dG IaCL containing butylene or heptylene tethers (Figure 5.1A). Our 
phosphoramidite synthetic strategy used to generate such IaCL DNA probes (CHAPTER III 
210 
 
and IV) allowed us to engineer identical sets of adducted DNA lacking the phosphodiester 
linkage at the cross-linked site (Figure 5.1B), which were also evaluated.
323
 The absence of the 
phosphodiester linkage presumably confers increased flexibility to the IaCL DNA. This study set 
out to (i) investigate the ability of hPol η to bypass a malleable IaCL lesion that can disrupt the 
fidelity of Watson-Crick base pairing (at the O
6
-position of dG as opposed to the N7-position). 
The second objective was to (ii) investigate the effect of IaCL linker length (butylene vs. 
heptylene) on the processivity of hPol η. The chain lengths of the IaCL linkers were inspired 
from DNA adducts formed from exposure to the alkyl sulfones busulfan and hepsulfam, known 
to generate butylene and heptylene DNA adducts, respectively.
69,324
 It should be noted, however, 
that a specific IaCL connected at O
6
-atoms of 5’-d(GG) sequences has not been identified to 
date. Our model IaCL DNA serve as chemically stable probes that can be prepared in scales and 
purity amenable for biochemical studies. The final objective of the study was to (iii) investigate 
the effect of phosphodiester linkage deletion on IaCL DNA bypass by hPol η.  
 




-dG IaCL containing (A) and lacking (B) the 






5.2 Materials and Methods 
5.2.1 Steady-state Kinetics 
  All primer extension assays were carried out using a template strand with the sequence 
5´- AC XX CT CAC ACT (where XX denotes the cross linked dGG residues or dGG for the 
unmodified control) and a fluorescently labelled primer 5´-(FAM)TAG TGU GAG (where FAM 
is 6-carboxyfluorescein and U is 2´-deoxyuridine). Steady-state kinetic experiments were 
conducted as previously described.
229,236,347,348
 Briefly, assays were generally performed at 37 °C 
in 40 mM Tris-HCl buffer (pH 7.5) containing 100 mM KCl, 5% glycerol (v/v), 10 mM 
dithiothreitol (DTT), 5 mM MgCl2 and 100 µg mL
-1
 bovine serum albumin (BSA). The 5´- 
fluorescently labelled (FAM) primer-template (9-/13-mer) duplex (5 μM) was extended using 1.9 
to 500 nM concentrations of hPol η in the presence of various concentrations of a single dNTP (0 
to 1 mM, at 7-10 different dNTP concentrations) at 37 °C for 5-20 min. Reactions were 
quenched using a solution containing 20 mM EDTA (pH 8.0), 95% formamide (v/v), 
bromphenol blue, and xylene cyanol dyes. Substrates and products were resolved on 18% (w/v) 
polyacrylamide electrophoresis gels containing 7.5 M urea. Gels were monitored by a Typhoon 
Scanner (GE Healthcare) and analyzed by fluorescence intensity using ImageJ software 
(National Institutes of Health). The values of kcat and Km were estimated by non-linear regression 
analysis (hyperbolic fit) with the program Graphpad Prism (La Jolla, CA).  
5.2.2 LC-MS/MS Analysis of Fully Extended Products 
 All primer extension assays were carried out using identical sequences as described in the 
above section. DNA Primers were extended in the presence of all four dNTP followed by 
analysis via mass spectrometry. Primer sequences were specifically designed to contain a 2´-
deoxyuridine (U) insert in order to produce shorter oligonucleotide fragments that are formed by 
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treatment with uracil DNA glycosylase followed by hot piperidine). These were subsequently 
analyzed by an LC-MS/MS method (ion-trap mass spectrometer), as previously 
described.
229,236,256–258
 DNA primer extension was accomplished by combining hPol η (95 pmol, 
0.95 μM for unmodified duplexes and 340 pmol, 3.4 µM for IaCL-containing duplexes) with 
template-primer duplex (2 nmol, 20 μM) and a mixture of 1 mM each of dATP, dCTP, dGTP, 
and dTTP at 37°C for 0.5-1.5h in 50 mM Tris-HCl buffer (pH 7.5), 50 mM NaCl, 5 mM DTT, 5 
mM MgCl2 and 50 µg/ml bovine serum albumin (BSA). The reactions were terminated by spin 
column separations (Micro Bio-Spin™ 6 Columns from BIO-RAD) to extract the dNTPs and 
Mg
2+
. The extent of the extension was monitored by electrophoresis/fluorography prior to LC-
MS/MS analysis (Figure S5.6). The extension products were treated with 25 units of uracil DNA 
glycosylase followed by 0.25 M piperidine, and subjected to LC-MS/MS analysis using an 
Acquity UPLC system (Waters) interfaced to a Thermo-Finnigan LTQ mass spectrometer 
(Thermo Scientific, San Jose, CA) equipped with a negative ion electrospray source.
229,236,256–258
 
Chromatographic separation was carried out with an Acquity UPLC BEH octadecylsilane (C18) 
column (2.1 x 100 mm, 1.7 μm). The LC solvent system was as follows: Mobile phase A, 10 
mM CH3CO2NH4 in 98% H2O; mobile phase B, 10 mM CH3CO2NH4 in 90% MeCN (v/v). The 
following gradient (v/v) was used with a flow rate of 300 μL min-1 at a temperature of 50 oC: 
Linear gradient from 0-3% B (v/v) in 3 min, followed by a linear increase to 20% B (v/v) from 3-
5 min, then 20-100% B (v/v) from 5-6 min which was held for 2 min. The column was re-
equilibrated for 3 min with 0 % B (v/v) for subsequent analysis. Mass spectrometry conditions 
were as follows: Source voltage, 4 kV; source current 100 μA; capillary voltage,- 49 V; capillary 
temperature, 350 °C; tube lens voltage, -90 V. Product ion spectra were recorded over the range 
m/z 300-2000 and the most abundant species (-2 charge) was used for collision-induced 
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dissociation (CID) analysis. The calculation for the oligonucleotide sequence CID fragmentation 
was carried out using Mongo Oligo Mass Calculator v2.06 from The RNA Institute (College of 
Arts and Science, University at Albany State University of New York). The relative yields of 
various products were calculated based on the peak areas of extracted ion chromatograms from 
LC-MS analyses. The sum of the peak areas was used for multi-charged species. 
5.3 Results and Discussion 
 Bypass studies with hPol η  have revealed its ability to process a wide variety of DNA 











 Bulkier forms of DNA damage including 




 and the dG[8,5-Me]dT IaCL,
223
 
have also been the subject of bypass studies with hPol η (structures of selected examples are 
illustrated in Figure S5.1). Bis-alkylating drugs such as busulfan can introduce IaCL that may 
have increased flexibility at the modified site relative to the bulkier lesions described above. 
Given the versatility of hPol η to bypass a variety of lesions by TLS, we decided to explore the 




-dG IaCL containing either a 
butylene or heptylene linkage between the bases. To further probe the influence of flexibility, 
template strands lacking and containing a phosphodiester linkage between the linked nucleobases 





-dG IaCL and lacking a phosphodiester linkage between the 
tethered nucleotides have been shown to be substrates of the human DNA repair protein O
6
-
alkylguanine DNA alkyltransferase (hAGT), which repairs the linkage restoring dG.
323
 In this 
process, the first reaction with AGT forms two products, a DNA-protein cross-linked (DPC) 
species and a repaired oligonucleotide. The DPC is a very poor substrate for a second repair 
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event which releases the second unmodified (repaired) DNA fragment. Butylene linked IaCL 
were observed to be resistant to the action of hAGT using extended reaction times (8h) and five 
molar equivalents of the protein. However, the heptylene linked IaCL DNA analogues were 
almost completely consumed under these conditions.
323
 The template strands employed in this 




 Steady-state kinetic evaluations of nucleotide incorporations opposite IaCL lacking a 
phosphodiester linkage between the attached nucleobases (GG4 and GG7, where 4 and 7 are 
butylene and heptylene linked), containing a phosphodiester linkage (GpG4 and GpG7) and 
unmodified GG were carried out with the catalytic core construct of hPol η (amino acids 1-432). 
The primer extension assay is illustrated in Figure 5.2. In all cases, the IaCL modification 
blocked DNA synthesis by hPol η relative to the unmodified control. Incorporation of the correct 
dCMP nucleotide by hPol η opposite the first 3´-alkylated dG of GG4, GG7, GpG4, and GpG7 
was reduced by approximately 320-, 280-, 320-, and 320-fold, respectively, relative to GG (see 
Figure 5.3 and Table S5.1). These results differ significantly from the cisplatin-adducted GG 
templates where a 1.2 fold decrease was observed,
227
 which suggests that modification of the 
Watson-Crick hydrogen-bonding face poses a challenge to the  incorporation efficiency of  hPol 
η. Moreover, they correlate with studies of hPol η bypass with an O6-MedG-containing template, 
which demonstrated a significant decrease (10-fold) in efficiency for incorporation of the correct 
dCMP nucleotide.
45
 The reduced efficiency of incorporation may be attributed to hindrance due 
to the presence of the alkylene tether. Bulkier lesions at the O
6
-atom such as the benzyl and 4-
oxo-4-(3-pyridyl)butyl] lesion have been shown to reduce incorporation efficiency by a factor of 
~ 65 and 250, respectively, for hPol η.45 The alkylene linkage to a subsequent nucleotide, found 
215 
 
in IaCL DNA, could also contribute to the reduced relative kinetic efficiencies observed. 
Significant misinsertions by Saccharomyces cerevisiae Pol η have also been observed across the 
dG nucleotide of the dG[8,5-Me]dT IaCL, whereas hPol η mostly incorporated the correct 
dNMPs across both nucleotides of this IaCL.
222,223,341
 Steady-state data for our IaCL DNA 
showed a preference for dCMP insertion across the first 3´-dG alkylated residue. However, an 
overall decrease in selectivity (f coefficients are shown in Figure 5.3 and supplied in  Table 
S5.1) was observed, particularly for the GG4 and GG7 templates. Relative insertions (f 
coefficients) of dAMP, dGMP and dTMP increased to 0.37, 0.34, and 0.24 for GG4 and 0.40, 
0.23, and 0.47 for GG7 compared to 0.001, 0.001, and 0.003 for GG, respectively. Lower f 
coefficients were generally observed for GpG4 and GpG7 compared to GG4 and GG7, 
respectively, suggesting the added flexibility inherent to GG4 and GG7 posed an issue for hPol 
η fidelity. It was interesting to observe an increased efficiency and selectivity for the butylene 
linkers (GG4 and GpG4) in comparison to heptylene linkers (GG7 and GpG7), substantiating 
that increased steric bulk hinders processivity by hPol η. It was noted that in all cases, except 






Figure 5.2: Pictorial representation of primer extension assay using hPol η, where X represents 
the presence, or lack, of a phosphodiester linkage. Frameshift adduct formation (-1), observed 
primarily at the 5'-dG residue for GG4 and GG7, is characterized by hPol η skipping the 
template nucleotide.  
 Post-insertion extension across the second alkylene linked site (5´-dG) using primers that 
contain dC or dT directly across from the 3´-dG of the IaCL containing templates, as well as the 
unmodified GG, was studied. The results are summarized in Figure 5.3 and tabulated in Tables 
S5.2 and S5.3. Extension across the second O
6
-alkylene linked dG was generally slower 
compared to the first regardless of the identity of the additional nucleotide (dC or dT) in the 
primer. An interesting feature for the GG4 and GG7 templates was the apparent proficient 
misinsertion of dGTP across the O
6
-alkylated 5´-dG residue. It was suspected that frameshift 
adduct formation had occurred, which was confirmed by full extension analysis by LC-MS/MS, 
given that dC is the subsequent nucleotide in the template strand. dNTPs other than dGTP were 
not efficiently incorporated in the case of GG4 and GG7. The post-extension profiles for GpG4 
and GpG7 displayed a clear decrease in selectivity compared to that of insertion across the first 
(3´) O
6
-alkylated-dG, with an almost complete loss in dNTP preference for GpG7. To be noted 
is the preference of dTTP over dCTP for GpG4 and GpG7. The 3´-end O
6
-alkylated-dG • dT 
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mismatch significantly lowered incorporation efficiency across the subsequent O
6
-alkylated-dG 
for all IaCL DNA except for insertion of dCMP in the case of GpG4. The steady-state results 
showed an overall reduction in incorporation efficiency and fidelity, particularly across the 5´-
dG of the IaCL. This occurrence is not observed for hPol η bypass of platinum-based dGG 
adducts nor the dG[8,5-Me]dT adduct.
224
 The reduction of incorporation efficiency and fidelity 
across the 5´-dG may be the result of the alkylene linker adopting an orientation that disrupts 








Figure 5.3: Summary of steady-state kinetics of incorporation of dNTP opposite IaCL-
containing template GG4, GG7, GpG4, GpG7  (5´- AC XX CT CAC ACT) and unmodified 
template (GG) by hPol η. DNA primer sequence identity were 3´- GA GUG TGA T(FAM)-5´ 
(Panel A and B), 3´- C GA GUG TGA T(FAM)-5´ (Panel C and D), or 3´- T GA GUG TGA 
T(FAM)-5´ (Panel E and F). Tabulated values are reported in Table S5.1-S5.3. 
 Analysis of single insertions by a DNA polymerase is useful for kinetic analysis in terms 
of identifying the extent of blockage by a given modification in a quantitative manner. However, 
this may not reflect insertion profiles in the presence of all four dNTPs as well as extension past 
the damaged sites. Fidelity of hPol η and processivity across and past the damage site was 
assessed via analysis of extended products by LC-MS/MS, using a reported 
methodology.
45,229,256–258
 This method provides insight regarding hPol η’s preference to 
incorporate dNTP across the IaCL site (Tables S5.4 and S5.5). The PAGE analysis of fully 
extended products (Figure 5.4) revealed blockage of hPol η after insertion across the GG4 and 
GG7 IaCL modification (e.g. extension was stalled after incorporation of the second dNTP). 
Similar results were observed for replication across and past DNA templates containing a single 
abasic site insert and may represent slippage of hPol η during replication.236 Our study suggests 
that hPol η bypass requires an intact phosphodiester DNA backbone for processivity, particularly 
for IaCL. In contrast, hPol η replicated past the IaCL of GpG4 and GpG7 to reach an 
accumulation of the fully extended (13 nt) and over-extended (14 nt) product (Figure 5.4). hPol 
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η exhibited similar bypass extension profiles for other O6-alkyl-dG lesions, which suggested that 
the IaCL containing a phosphodiester linkage may be processed as two adjacent mono-adducted 
dG inserts.  
 
Figure 5.4: Time course assay of primer full extension (25 µM annealed DNA) by hPol η (3.4 
µM for damaged and 1µM undamaged DNA) in presence of all four dNTPs (1 mM mixture). 
DNA duplexes were composed of IaCL-containing template GG4, GG7, GpG4, GpG7 (5´- AC 
XX CT CAC ACT) or unmodified template (GG), annealed with DNA primer (3´- GA GUG 
TGA T(FAM)-5´). DNA template used is indicated at the bottom, product length identified on 
the left-hand side, reaction times are indicated at the top (in minutes unless stated otherwise). 
Note that only the 30 min reaction time is shown for the undamaged control (GG) (data for other 
time points not shown). Extended products were resolved by 17 % denaturing PAGE (19:1) and 
visualized via fluorography.  
 Insertion profiles opposite the 3´-dG and 5´-dG of GG4, GG7, GpG4 and GpG7 and the 





-dG was preferred by hPol η in all cases, which was in agreement with the steady-





, only a slight increase (3 - 12 %) in dTMP insertion by hPol η across 
the 3´-dG relative to the unmodified control was observed. Interestingly, the MS-based analysis 
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revealed that dAMP incorporation occurs at levels of 24% and 14% for GG4 and GG7, 
respectively, and in only negligible amounts for GpG4, GpG7 and the unmodified control. 
Similar erroneous dAMP insertions by hPol η have been observed opposite abasic sites (also 
known as the “purine-rule”) in addition to frameshift adduct formation.236,351–353 Minor products 
(<3 %) corresponded to frameshift adduct formation opposite 3´-dG lesions.  
 
Figure 5.5. Insertion profiles by hPol η opposite the (A) 3´-dG and the (B) 5´-dG of the O6-dG-
alkylene-O
6
-dG IaCL and unmodified control. DNA sequence contexts were as follows: IaCL-
containing template (GG4, GG7, GpG4, GpG7 or unmodified template GG) had sequence 5´- 
AC XX CT CAC ACT), and DNA primer sequence was 3´- GA GUG TGA T(FAM)-5´.  
Tabulated LC-MS extension products and percentages can be found in Table S5.4-S5.5. 
 Nucleotide insertion profiles for the 5´-end of the dG lesion by hPol η revealed proclivity 
for the frameshift adduct formation in the case of GG4 and GG7, whereas a pyrimidine insertion 
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was preferred for GpG4 and GpG7. These results were in agreement with the steady-state 
kinetic evaluation of dGMP insertion across the 5´-end of the dG lesion of GG4 and GG7. We 
suspect that the added flexibility incurred from the lack of a phosphodiester linkage is 
responsible for large discrepancies observed between the IaCL DNA. hPol η incorporated little to 
no purines opposite the 5´-end of the dG lesion in GpG4 and GpG7, but levels of 10 % and 17 
% for dAMP and dGMP, respectively, were measured for GG4. Only 7 % dAMP was detected 
for extension across the O
6
-alkylated 5´-dG in GG7, with no dGMP insertion detected. 
Misinsertion of dTMP was preferred by hPol η in the case of GpG4 and GpG7 (53% and 74%, 
respectively). Correct insertion of dCMP  accounted for 47% and 24% opposite the O
6
-alkylated 
5´-dG in GpG4 and GpG7, respectively, and only a minor dCMP insertion was observed for 
GG4 and GG7 (11% and 1%, respectively).  
5.4 Conclusion 
 In conclusion, both the steady-state primer extension assays and LC-MS analysis of fully 





was more problematic compared to the 3´-end. An increase in frameshift adduct formation by 
hPol η was observed at 5´-dG of IaCL DNA lacking the phosphodiester linkage, compared to 
those IaCL containing this functional group. To be noted was the decrease in selectivity by hPol 
η for longer heptylene IaCL versus the butylene analogue, regardless of the presence of the 
phosphodiester group at the cross-linked site. Structural insights on the ternary complexes (DNA, 
hPol η and incoming nucleoside triphosphate) by X-ray crystallography are being initiated and 
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5.6 Supporting Information 
5.6.1 Supporting methods 
5.6.1.1 Chemical Synthesis and Characterization of Modified DNA 
Oligonucleotides 
 The chemical synthesis of the dimer phosphoramidites required for GG4 and GG7 have 
been described in previously published work.
323
 Those required for GpG4, and GpG7 are 
described CHAPTER IV with syntheses adapted from previously described procedures.
297
 The 
cross-linked duplexes, whose sequences are 5´- AC XX CT CAC ACT (where XX denotes the 
cross linked dGG residues or dGG for the unmodified control), were assembled on an Applied 
Biosystems Model 3400 synthesizer on a 1.5 μmol scale using standard β-
cyanoethylphosphoramidite chemistry supplied by the manufacturer with slight modifications to 
coupling times. The nucleoside phosphoramidites containing fast deprotecting groups were 
prepared in anhydrous MeCN at a concentration of 0.1 M for the 3´-O-deoxyphosphoramidites, 
and 0.15 M for the cross-linked 3´-O-deoxyphosphoramidite. Oligomer sequence assembly was 





 Protecting groups and cleavage from the solid support was carried out by treatment with 
aqueous (28% v/v) NH4OH in EtOH (1 mL of a 3 : 1 v/v solution) for 4h at 55 
o
C in 2 mL screw 
cap microfuge tubes fitted with Teflon lined caps for GG4 and GG7. Modified oligomers GpG4 
and GpG7 were first deprotected for 16 h in aqueous (28% v/v) NH4OH at room temperature 
with gentle rocking, followed by an additional 4 h at 55 
o
C. Crude oligomers were transferred to 
new screw cap microfuge tubes and the solvent removed using a Savant SC110A SpeedVac 
Concentrator (Thermo) followed by purification by strong-anion exchange HPLC with a Dionex 
DNAPAC PA-100 column (0.4 cm × 25 cm) purchased from Dionex, Sunnyvale, CA using a 
linear gradient of 0-52% buffer B (v/v) over 24 min (buffer A: 100 mM Tris HCl, pH 7.5, 10% 
MeCN and buffer B: 100 mM Tris HCl, pH 7.5, 10% MeCN, 1 M NaCl) at 55 
o
C. The columns 
were monitored at 260 nm for analytical runs or 280 nm for preparative runs. The purified 
oligomers were desalted using C-18 SEP PAK cartridges (Waters) as previously described.
317
  
ESI mass spectra for oligonucleotides were obtained at the Concordia University Centre for 
Biological Applications of Mass Spectrometry using a Micromass Qtof2 mass spectrometer 
(Waters) equipped with a nanospray ion source. The mass spectrometer was operated in full 
scan, negative ion detection mode.  The molecular mass of the modified oligomers were 
identifed by ESI-MS and the measured values were in agreement with the expected masses (see 




5.6.2 Supporting Figures and Tables 
Figure S5.1 - Examples of different IaCL DNA adducts mentioned in the main text. A An 
example of an IaCL formed from exposure of DNA to the chemotherapeutic drug cisplatin.
227,350
 
B An example of an IaCL formed from exposure of DNA to the chemotherapeutic drug 
busulfan.
69
 C  An example of a UV-induced (6-4) pyrimidone photoproduct lesion.
82
 D An 
example of a UV-induced cyclubutane pyrimidine dimer. 
207
 E The structure of dG[8,5-Me]dT 
IaCL.
223




















































Figure S5.6 - LC-MS analysis of most abundant full-length extension products opposite GG in 
DNA template by hPol η in the presence of all four dNTPs. (a) Sample reconstructed extracted 
ion chromatogram for m/z 732.80 for product with sequence 5´-pGAGCCGT and (b) mass 
spectrum of peak at retention time 3.11 min. (c) Sample reconstructed extracted ion 
chromatogram for m/z 837.20 for product with sequence 5´-pGAGCCGTA and (d) mass 
spectrum of peak at retention time 3.44 min. See Table S5.4 for full list of products and 











Figure S5.7 - LC-MS analysis of most abundant full-length extension products opposite GG4 in 
DNA template by hPol η in the presence of all four dNTPs. (a) Sample reconstructed extracted 
ion chromatogram for m/z 803.0 for product with sequence 5´-pGAGCG and (b) mass spectrum 
of peak at retention time 1.31 min. (c) Sample reconstructed extracted ion chromatogram for m/z 
746.14 for product with sequence 5´-pGAGC_GTG and (d) mass spectrum of peak at retention 
time 2.64 min. See Table S5.4 for full list of products and respective m/z assignments. See 










Figure S5.8 - LC-MS analysis of most abundant full-length extension products opposite GG7 in 
DNA template by hPol η in the presence of all four dNTPs. (a) Sample reconstructed extracted 
ion chromatogram for m/z 803.0 for product with sequence 5´-pGAGCG and (b) mass spectrum 
of peak at retention time 1.27 min. See Table S5.4 for full list of products and respective m/z 






Figure S5.9 - LC-MS analysis of most abundant full-length extension products opposite GG in 
DNA template by hPol η in the presence of all four dNTPs. (a) Sample reconstructed extracted 
ion chromatogram for m/z 737.80 for product with sequence 5´-pGAGCTGT and (b) mass 
spectrum of peak at retention time 3.38 min. (c) Sample reconstructed extracted ion 
chromatogram for m/z 837.20 for product with sequence 5´-pGAGCCGTA and (d) mass 
spectrum of peak at retention time 3.39 min. (e) Sample reconstructed extracted ion 
chromatogram for m/z 842.21 for product with sequence 5´-pGAGCTGTA and (f) mass 
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spectrum of peak at retention time 3.57 min.  See Table S5.4 for full list of products and 




Figure S5.10 - LC-MS analysis of most abundant full-length extension products opposite GG in 
DNA template by hPol η in the presence of all four dNTPs. (a) Sample reconstructed extracted 
ion chromatogram for m/z 737.80 for product with sequence 5´-pGAGCTGT and (b) mass 
spectrum of peak at retention time 3.37 min. (c) Sample reconstructed extracted ion 
234 
 
chromatogram for m/z 837.20 for product with sequence 5´-pGAGCCGTA and (d) mass 
spectrum of peak at retention time 3.38 min. (e) Sample reconstructed extracted ion 
chromatogram for m/z 842.21 for product with sequence 5´-pGAGCTGTA and (f) mass 
spectrum of peak at retention time 3.58 min.  See Table S5.4 for full list of products and 
respective m/z assignments. See above for methodology. 
 
Table S5.1 - Steady-state kinetics of incorporation of dNTP opposite 3´-end O
6
-alkylated-dG of 
IaCL-containing template GG4, GG7, GpG4, GpG7  (5´- AC XX CT CAC ACT) and 
unmodified template (GG) by hPol η. DNA primer sequence identity was 3´- GA GUG TGA 
T(FAM)-5´. 
Template base dNTP kcat (s
-1
) KM (μM) kcat/KM x 10
-3
 (μM-1s-1) f1 
G dATP 0.045 ± 0.002 62 ± 9 0.7 ± 0.1 0.001 
G dGTP 0.052 ± 0.003 74 ± 13 0.7 ± 0.1 0.001 
G dCTP 2.32 ± 0.09 4.8 ± 0.5 480 ± 60  
G dTTP 0.18 ± 0.01 111 ± 22 1.6 ± 0.3 0.003 
GG4 dATP 0.037 ± 0.001 66 ± 5 0.56 ± 0.05 0.37 
GG4 dGTP 0.029 ± 0.001 56 ± 4 0.52 ± 0.04 0.34 
GG4 dCTP 0.12 ± 0.01 76 ± 17 1.5 ± 0.4  
GG4 dTTP 0.040 ± 0.003 111 ± 22 0.36 ± 0.08 0.24 
GG7 dATP 0.031 ± 0.001 45 ± 5 0.70 ± 0.08 0.40 
GG7 dGTP 0.025 ± 0.001 63 ± 7 0.40 ± 0.05 0.23 
GG7 dCTP 0.12 ± 0.01 69 ± 16 1.7 ± 0.4  
GG7 dTTP 0.07 ± 0.01 92 ± 21 0.8 ± 0.2 0.47 
GpG4 dATP 0.025 ± 0.001 80 ± 11 0.31 ± 0.04 0.20 
GpG4 dGTP 0.0074 ± 0.0002 69 ± 5 0.107 ± 0.009 0.07 
GpG4 dCTP 0.078 ± 0.003  51 ± 5 1.5 ± 0.2   
GpG4 dTTP 0.046 ± 0.006 150 ± 36 0.30 ± 0.08 0.20 
GpG7 dATP 0.021 ± 0.001 83 ± 8 0.25 ± 0.02 0.16 
GpG7 dGTP 0.0103 ± 0.0002 83 ± 5 0.13 ± 0.01 0.08 
GpG7 dCTP 0.066 ± 0.003  43 ± 6  1.5 ± 0.2   
GpG7 dTTP 0.040 ± 0.002 72 ± 9 0.55 ± 0.08 0.36 
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Table S5.2 - Steady-state kinetics of incorporation of dNTP opposite 5´-end O
6
-alkylated-dG of 
IaCL-containing template GG4, GG7, GpG4, GpG7  (5´- AC XX CT CAC ACT) and 
unmodified template (GG) by hPol η. DNA primer sequence identity was 3´- CGA GUG TGA 
T(FAM)-5´. 
Template base dNTP kcat (s
-1
) KM (μM) kcat/KM x 10
-3
 (μM-1s-1) f1 
G dATP 0.028 ± 0.001 76 ± 5 0.36 ± 0.03 0.0009 
G dGTP 0.033 ± 0.001 38 ± 3 0.87 ± 0.07 0.002 
G dCTP 2.19 ± 0.11 5.7 ± 0.8 390 ± 60  
G dTTP 0.09 ± 0.01 260 ± 34 0.35 ± 0.05 0.001 
GG4 dATP 0.0021 ± 0.0001 93 ± 9 0.022 ± 0.002 0.01 
GG4 dGTP 0.059 ± 0.002 32 ± 4 1.9 ± 0.2  
GG4 dCTP 0.0014 ± 0.0001 236 ± 26 0.0059 ± 0.0007 0.003 
GG4 dTTP 0.009 ± 0.001 274 ± 42 0.033 ± 0.006 0.02 
GG7 dATP 0.00176 ± 0.00004 76 ± 6 0.023 ± 0.002 0.02 
GG7 dGTP 0.029 ± 0.001 27 ± 3 1.1 ± 0.1  
GG7 dCTP 0.00075 ± 0.00005 195 ± 35 0.0038 ± 0.0007 0.003 
GG7 dTTP 0.0057 ± 0.0003 177 ± 24 0.032 ± 0.005 0.03 
GpG4 dATP 0.0139 ± 0.0004 81 ± 8 0.17 ± 0.02 0.20 
GpG4 dGTP 0.0057 ± 0.0001 26 ± 2 0.22 ± 0.02 0.25 
GpG4 dCTP 0.060 ± 0.006  103 ± 20 0.6 ± 0.1  0.68 
GpG4 dTTP 0.047 ± 0.003 55 ± 8 0.9 ± 0.1  
GpG7 dATP 0.0070 ± 0.0002 54 ± 5 0.13 ± 0.01 0.75 
GpG7 dGTP 0.0055 ± 0.0001 32 ± 3 0.17 ± 0.02  
GpG7 dCTP 0.025 ± 0.002  375 ± 57 0.07 ± 0.01  0.38 
GpG7 dTTP 0.049 ± 0.006 307 ± 60 0.16 ± 0.04 0.94 
 
1




Table S5.3 - Steady-state kinetics of incorporation of dNTP opposite 5´-end O
6
-alkylated-dG of 
IaCL-containing template GG4, GG7, GpG4, GpG7  (5´- AC XX CT CAC ACT) and 
unmodified template (GG) by hPol η. DNA primer sequence identity was 3´- TGA GUG TGA 
T(FAM)-5´. 
Template base dNTP kcat (s
-1
) KM (μM) kcat/KM x 10
-3
 (μM-1s-1) f1 
G dATP 0.00151 ± 0.00003 43 ± 3 0.035 ± 0.003 0.002 
G dGTP 0.00247 ± 0.00005 49 ± 4 0.051 ± 0.004 0.003 
G dCTP 0.168 ± 0.004 11 ± 1  15 ± 2  
G dTTP 0.0034 ± 0.0003 91 ± 19 0.037 ± 0.008 0.002 
GG4 dATP 0.00218 ± 0.00003 37 ± 2 0.059 ± 0.004 0.25 
GG4 dGTP 0.0168 ± 0.0003 72 ± 5 0.23 ± 0.02  
GG4 dCTP 0.00134 ± 0.00005 196 ± 18 0.0068 ± 0.0007 0.03 
GG4 dTTP 0.0016 ± 0.0001 144 ± 19 0.011 ± 0.001 0.05 
GG7 dATP 0.00155 ± 0.00002 80 ± 4 0.019 ± 0.001 0.12 
GG7 dGTP 0.0092 ± 0.0001 56 ± 2 0.162 ± 0.007  
GG7 dCTP 0.00103 ± 0.00004 198 ± 23 0.0052 ± 0.0006 0.032 
GG7 dTTP 0.0016 ± 0.0001 189 ± 21 0.008 ± 0.001 0.05 
GpG4 dATP 0.0048 ± 0.0002 65 ± 7 0.07 ± 0.01 0.04 
GpG4 dGTP 0.0036 ± 0.0001 34 ± 2 0.104 ± 0.007 0.06 
GpG4 dCTP 0.14 ± 0.01 78 ± 13 1.8 ± 0.3   
GpG4 dTTP 0.066 ± 0.006 98 ± 18 0.7 ± 0.1 0.38 
GpG7 dATP 0.00206 ± 0.00004 57 ± 4 0.036 ± 0.003 0.64 
GpG7 dGTP 0.00259 ± 0.00003 46 ± 2 0.056 ± 0.003  
GpG7 dCTP 0.0053 ± 0.0002  140 ± 13 0.038 ± 0.004  0.68 
GpG7 dTTP 0.0057 ± 0.0003 117 ± 16 0.049 ± 0.007 0.87 
 
1











Table S5.4 - LC-MS analysis of products of hPol η replicating template GG4, GG7, GpG4, GpG7 (5´- AC XX CT CAC ACT) and 
unmodified GG. DNA primer sequence identity was 3´- GA GUG TGA T(FAM)-5´. 
Name Fragment m/z calculated GG GG4 GG7 GpG4 GpG7 
4A GAGA (-2) 650.42  (-2) 650.18 (-2) 650.27   
4G GAGG (-2) 658.42  (-2) 658.27    







(-2) 807.00   





(-2) 814.82  
(-2) 815.36 
(-3) 543.18 5GA GAGGA 





























(-2) 810.36  
 
5__ GAGGT  
5CT GAGCT (-2) 790.51   (-2) 790.27   
6AGG GAGAGG (-2) 979.63  (-2) 979.45    
6TAG GAGTAG (-2) 967.12  (-2) 967.55    
6ATT GAGATT 
 (-2) 954.62     (-2) 954.36 
6TAT GAGTAT 
6C_ GAGCGT (-2) 955.11  (-2) 954.82 (-2) 954.91   




    
(-2) 946.82 
(-3) 631.09 








 (-2) 1099.36 (-3) 733.09 
238 
 
 (-3) 733.00 
7CT GAG CTG T  (-2) 1107.21 
(-3) 737.80 





















































8CCC GAG CCCG T  (-3) 829.19 (-3) 828.82     
8CCT GAG CCG CT 
(-2) 1244.30 
(-3) 829.19 












(-3) 841.82 8TCA GAG TCG TA 
8CTG GAG CTG TG (-2) 1271.81 
(-3) 847.54 




(-3) 847.55 8TCG GAG TCG TG 
8CTC GAG CTG TC  (-2) 1251.80 
(-3) 834.20 




(-3) 834.09 8CCT GAG CCG TT  
8CTT GAG CTG TT 
(-2) 1259.30 
(-3) 839.20 
   (-3) 839.09 (-3) 839.27 8TCT GAG TCG TT 
8TTC GAG TTG TC  
8TTA GAG TTG TA 
(-2) 1271.32 
(-3) 847.21 





8TTT GAG TTG TT 
(-2) 1266.81 
(-3) 844.21 






Table S5.5 - Percentages of full-length extension products determined by LC-MS/MS analysis. 
Name Fragment GG GG4 GG7 GpG4 GpG7 
4A GAGA  3 4   
4G GAGG  1    
4T GAGT   6   
5AA GAGAA  7 3   
5A_G GAGAG  12 6  2 
5GA GAGGA  < 1 < 1   
5CA GAGCA 1 1 < 1   
5AC GAGAC  1 < 1   
5CT GAGCT   2   
5C_G GAGCG < 1 21 64   
5TA GAGTA   4   
5T_G GAGTG   3   
5__ GAGGT  3 3   
6AGG GAGAGG  < 1    
6TAG GAGTAG  1    
6ATT GAGATT     < 1 
6TAT GAGTAT     < 1 
6C_G GAGCGG  5    
6CTA GAGCTA     1 
6C_ GAGCGT  2 5   
6T_ GAGTGT  2    
7CC GAGCCGT 79 8  2 2 
7CT GAG CTG T     21 36 
7TC GAG TCG T     < 1  
7TT GAGTTGT     2 
7C_A GAGC_GTA 1 < 1    
7C_G GAGC_GTG  28    
7AT GAGATGT    1  
8CCA GAG CCG TA 11 2  31 16 
8CCG GAG CCG TG 6 1  9 3 
8CCC GAG CCCG TC < 1     
8CCT GAG CCG CT    1  
8CTA GAG CTG TA < 1   18 24 
8TCA GAG TCG TA    < 1 < 1 
8CTG GAG CTG TG    8 6 
8TCG GAG TCG TG    < 1 < 1 
8CTC GAG CTG TC     1 1 
8CCT GAG CCG TT     1 < 1 
8CTT GAG CTG TT    < 1 1 
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8TCT GAG TCG TT     1 
8TTC GAG TTG TC     < 1  
8TTA GAG TTG TA    2 2 





 Chapter VI 
Site-Specific Conjugation of Human O
6
-Alkylguanine DNA 
Alkyltransferase to DNA Strands Using Intrastrand Cross-Linked 
DNA Mimics 
 
To be submitted as:  
 





A facile methodology is reported to conjugate human O
6
-alkylguanine-DNA-
alkyltransferase to the 3’-end of the DNA strand in excellent yields with short reaction times by 
using intrastrand cross-linked (IaCL) DNA probes. This strategy exploited the substrate 
specificity of hAGT to generate the desired DNA-protein covalent complex. IaCL DNA linking 
two thymidine residues, or linking a thymidine residue to a 2’-deoxyguanosine residue (either in 
a 5’→3’ or 3’→5’ fashion), lacking a phosphodiester linkage at the cross-linked site, were 
prepared using a phosphoramidite strategy followed by solid-phase synthesis. All duplexes 
containing the model IaCL displayed a reduction in thermal denaturation stability relative to 




-thymdine and the (5’→3’) O6-2’-
deoxyguanosine-alkylene-O
4
-thymdine IaCL DNA adducts were unrepaired by any of the AGTs 
tested (human AGT and Escherichia coli homologues, OGT and Ada-C). The (5’→3’)  O4-
thymidine-alkylene-O
6
-2’-deoxyguanosine IaCL DNA containing butylene or heptylene tethers 
were efficiently repaired by the human variant, whereas Ada-C was capable of modestly 
repairing the heptylene IaCL adduct. The IaCL strategy has expanded the toolbox for hAGT 
conjugation to DNA strands. Finally, hAGT was functionalized with a fluorescently-labelled 





Bifunctional alkylating agents have the capability of causing pronounced DNA damage 
by generating inter- (ICL), intrastrand (IaCL) cross-links, mono-adducts, and DNA-protein 
cross-links (DPC).
28,132
 Extensive research has been carried out on ICL given their exceptional 
cytotoxicity.
54
 The introduction of ICL in DNA prevents the unwinding of the DNA strands, a 
necessary step for vital processes such as replication and transcription. IaCL can impede cellular 
proliferation despite residing on only one strand.
69,268
 For instance, cyclobutane pyrimidine 
dimers, pyrimidine (6-4) pyrimidone dimers (and their Dewar isomers) produced by UV-
radiation are prime examples of non-drug-induced IaCL DNA, which can lead to carcinogenesis 
if left unattended.
75,274,354
 Exposure of DNA to gamma radiation produces IaCL DNA between 
neighboring 2'-deoxyguanosine (dG) and thymidine (dT) residues, which accounts at least in 
part, to the cytotoxicity of this type of radiation.
273
 Moreover, certain cancer chemotherapeutic 
regimens exploit the formation of DNA alkyl lesions to treat certain diseases. Platinum-based 
chemotherapeutics such as cisplatin are widely utilized for cancer treatment and exert their 
efficacy mainly via the formation of IaCL DNA lesions.
268
 Understanding the impact of IaCL on 
DNA structure, as well as how cells process such DNA damage is an ongoing investigation. As 
such, it is of values to develop methodologies for the preparation of species resembling 
intermediates, which could provide insights on their exerted cytotoxic effects. 




-dT sites are observed when exposing DNA to 
various alkylating agents, with O
6





 Regardless of their low occurrence, these lesions are chemically stable and are 





Both lesions are presumed to cause misinsertions by disrupting the Watson-Crick H-bonding 
properties with their natural complements leading to misreading by DNA polymerases during 
DNA replication. The O
6
-MedG · dT and O
4
MedT · dG adopt nonwobble base pair motifs, 





-Alkylguanine DNA alkyltransferases (AGTs) proteins of the direct repair pathway are 
found in all kingdoms of life and have shown a large variance in substrate specificity in terms of 
lesion type and site of alkylation.
132
 They play a pivotal role in maintaining genomic integrity by 
removing mutagenic lesions found at the O
6
-position of dG residues, and to a lesser extent the 
O
4




-MedG) lesions are sufficient 







MedT) lesion has superior mutagenic properties in mammalian cell lines, relative to O
6
-
MedG, since this lesion is inefficiently repaired by AGTs or the mismatch repair.
233
 Moreover, 
the increased binding affinity of hAGT to DNA containing O
4
MedT can inhibit NER pathways 
from successfully removing these lesions.
356
 
The human homologue (hAGT) displays superior repair activity against O
6
-alkyl-dG 
lesions, including mono-adducts such as methyl, benzyl, and 4-oxo- 4-(3-pyridyl)butyl, to name 
a few.
132
 AGT-mediated repair has also been associated with cancer resistance mechanisms to a 









 Unveiling the scope of repair 
for AGTs could aid in the development of more potent treatment strategies. Our group has 
reported the repair by hAGT of ICL linking the O
6
-atoms of directly opposing 2'deoxyguanosine 
residues, as well as in a GNC motif.
64,65
 Orientation of the alkylene bridge caused little variance 
in the processing by hAGT. More pronounced repair was observed for ICL DNA with a 
245 
 
heptylene linkage, in comparison to the butylene analogue. OGT, however, was incapable of 
removing the ICL between 2'-deoxyguanosine residues. In addition, no repair was observed with 
cross-links between O
4
-atoms of thymidine residues, despite the preference of OGT for 
alkylation at the O
4




 Recently, we have 
demonstrated the capability of hAGT to efficiently repair IaCL DNA lacking a phosphate group 
at the cross-link site. As with the ICL DNA, hAGT was more efficient in repairing the heptylene 
linkage compared to the butylene IaCL. Repair rates were also superior for the IaCL containing 
the longer heptylene linker compared to the butylene. Interestingly, the IaCL of greater length 
was virtually entirely consumed by hAGT, whereas repair of the heptylene ICL by a larger 
excess of protein amounted to 57% only.
65
  
Despite having the typical role of maintaining the genomic material integrity, hAGT has 
shown to enhance cytotoxicity of certain bifunctional alkylating agents by an efficient production 
of DPC adducts. 1,2-dibromoethane and 1,2,3,4-Diepoxybutane, for instance, are capable of 
inducing AGT-DNA cross-links.
360–362
  The paradoxical cytotoxicity was attributed to the 
formation of either a DNA or protein intermediate, capable of readily reacting with its 
counterpart.
170
 Given the importance of such conjugates, efficient methodologies for the 
production of AGT-mediated DPC warrant further investigation.  
The current understanding of the AGT-mediated repair mechanism involves flipping of 
the damaged nucleotide into the active site, whereby an activated cysteine residue attacks the 






 DPC covalent complexes between DNA and hAGT have 
shown to be especially insightful in providing much of the AGT-mediated repair mechanism. 
The N1,O
6
-ethanoxanthine modification generates a DPC after hAGT repair and crystallographic 





 However, this approach generated a DPC tethered by an ethylene linker and it would 
be of interest to investigate longer linker tethers given that AGTs are capable of repairing a wide 
scope of substrates (butylene and heptylene adducts, for instance).
65,150
 Towards this end, 





-dT by hAGT, whereby repair solely occurred at the dG unit.
151
 
Unfortunately, the repair reaction conversions for the heptylene mixed ICL substrate was fairly 
low (25 %) after 16 h, using a 30-fold excess of hAGT protein, allowing for improvements in the 
methodology of DPC species production. No appreciable amount of DPC was observed for 
repair of the butylene ICL substrate analogue. While hAGT was capable of low repair activity, 
no other AGT variant tested positive for repair, further limiting the versatility of the ICL probe 
repair.  
Reaction of AGTs with an IaCL DNA, lacking the phosphodiester linkage, would 
potentially allow for an efficient production of DPCs tethered at either the 3’- or 5’-end of the 
DNA strand. The overall approach would benefit from improved atom economy and greater 
reaction yields compared to ICL DNA. One main hurdle of this strategy is the ability of a second 





-dG IaCL (CHAPTER IV) and ICL DNA probes.
64,65
 To circumvent this issue, we 
engineered a dT-dG mixed IaCL, where AGT substrate specificity could dictate the products 
generated and potentially provide a versatile and an efficient method to produce DPCs tethered at 





6.2  Results and Discussion 
6.2.1 Synthesis and Characterization of TT, GT, and TG IaCL DNA 
Bis-alkylating agents, busulfan and hepsulfam, are known to generate butylene IaCL and 
heptylene ICL adducts, respectively, between purine residues (Figure S6.1). This served as the 





-alkylene-dT IaCL lesions presented herein have not been identified, formation of other 
various pyrimidine-pyrimidine and pyrimidine-purine adducts in DNA have been previously 
identified. For instance, pyrimidine(6-4)pyrimidone photoproducts (Figure S6.1) are examples 
of lesions linking the C4 position of one pyrimidine residue with a neighbouring pyrimidine 
nucleotide at the 6-position, and is said to play a significant role in mutagenesis and in inducing 
human skin cancer.
91,363
 DNA treated with mechlorethamine has revealed the formation of ICL 
linking the N3-atoms of mispaired dC residues.
364
 γ-radiation is capable of producing IaCL DNA 
between adjacent purine and pyrimidine residues, regardless of their orientation (5’-GT or 5’-
TG, for instance, Figure S6.1).
2,3,77,78,341
 These examples prompted us to engineer biologically 
relevant IaCL mimics to help understand repair by AGTs. Moreover, generating such DNA 
modifications allowed us to study duplexes containing flexible IaCL lesions that interfere with 




















-2’-deoxyguanosine-alkylene-O6-2’-deoxyguanosine IaCL mimics lacking a phosphodiester 
linkage between the two residues. The probes showed in (D) have been investigated by our group 
previously (CHAPTERS III, IV, V)
323
 (E) The position of the IaCL mimics in the DNA 
sequence is shown by the XY (where XY4 has a butylene linker and XY7 a heptylene linker). 
 
The current study aimed (i) at investigating the ability of certain AGTs to repair a variety 
of different IaCL DNA, with structures and corresponding labels shown in Figure 6.1 (6.1A-
6.1C). Since the initial report of IaCL DNA between two dG residues demonstrated efficient 
repair by hAGT (Figure 6.1D),
323
 we envisioned an analogous set of probes suitable for repair 
by other AGTs such as OGT and Ada-C. The second aim of this study (ii) was to generate 
appreciable amounts of DPC species with greater versatility compared to the previously 
generated ICL DNA probes.  
249 
 
The preparation of the modified DNA scaffolds in scales and purity amenable for 
biochemical studies was accomplished by a combination of small molecule and automated solid-
phase synthesis.  The preparation of cross-linked phosphoramidites 6.7a and 6.7b, required for 
the preparation of TT4 and TT7, respectively, is shown in Scheme 6.1. The synthesis was 
adapted from the procedures developed by Swann’s group and our group.150,242 Yet, the 
introduction of an additional protecting group was necessary to engineer TT4 and TT7. The 
levulinyl protecting group was chosen based on its compatibility with various other nucleoside 
constructs.
299
 Protected monomer 6.2 was prepared by selectively introducing the TBS group at 
the 5’-hydroxyl of commercially available thymidine (6.1), followed by esterifcation of the 3’-
hydroxyl with levulinic acid, in good yield over two steps. The preparation of the convertible 
nucleoside required optimization since the previously utilized procedure for 3’-O-(tert-
butyldimethylsilyl)-5’-O-(4,4’-dimethoxytrityl)-thymidine led to a significant production of side-
product, presumably occurring with the carbonyl groups found in the  levulinyl moiety. The 
production of the desired convertible nucleoside was accomplished by the addition of POCl3 in 
two portions (1.5 equivalences followed by another 1.1 after 5 min of stirring on ice). The 
reaction time was not extended beyond 20-30 min to minimize side-product formation and, once 
worked-up, used without further purification for the subsequent step. Dimerization was achieved 
in the presence of DBU and a slight excess of the corresponding alcohol 6.4a and 6.4b, which 
have been synthesized using previously published procedures by our group.
150
 Removal of the 
levulinyl group was achieved using a standard protocol,
299
 with slight modifications, to furnish 




Scheme 6.1: Reagents and conditions where a-compounds are n = 3 and b-compounds are n = 6: 
(i) TBS-Cl (1.1 eq), Py, 0
o
C, 4 h, work up, Levulinic acid (2 eq), EDC (2 eq), dioxane, 21
o
C, 
16h. (ii) Triazole (22.5 eq), NEt3 (23eq), POCl3 (2.1 eq), MeCN:DCM (1:1 v/v), 0
o
C, 2 h. (iii) 
DBU (2.3 eq), MeCN, 21
o
C, 16 h. (iv) N2H4 • H2O (0.5 M) in pyridinium acetate buffer (1:1 
v/v), 21
o
C, 10 min. (v) Cl-P(OCEt)(NiPr2) (1.5 eq), DIPEA (1.9 eq), THF, 21
o
C, 30 min.  
 
The synthesis of cross-linked phosphoramidites 6.11a and 6.11b, required for the 
synthesis of GT4 and GT7, respectively, is shown in Scheme 6.2 and began with the preparation 
of hydroxybutyl and hydroxyheptyl mono-adducts 6.8a and 6.8b, respectively, from intermediate 
protected monomer 6.2. Only a slight excess of the corresponding diol was utilized to minimize 
side-product formation. The Mitsunobu reaction was performed to couple 6.8a or 6.8b with a 
protected dG analogue
65
 to produce dimers 6.9a or 6.9b. The Mitsunobu reaction was selected on 










Scheme 6.2: Reagents and conditions where a-compounds are n = 3 and b-compounds are n = 6: 
(i) 1. Triazole (22.5 eq) NEt3 (23 eq), POCl3 (2.5 eq), DCM : MeCN (1:1 v/v), 0
o
C, 30 min, 2. 
1,4-butanediol or 1,7-heptanediol (1.1 eq), DBU (1.2 eq), MeCN, 21
o
C, 16 h. (ii) 3’-O-(tert-
butyldimethylsilyl)-5’-O-(4,4’-dimethoxytrityl)-N2-phenoxyacetyl-2’-deoxyguanosine (1.1 eq), 
Ph3P (2 eq), DIAD (2.5 eq), 21 
o
C, 18 h. (iii) N2H4 • H2O (0.5 M) in pyridinium acetate buffer 
(1:1 v/v), 21
o
C, 15 min. (iv) Cl-P(OCEt)(NiPr2) (1.5 eq), DIPEA (1.9 eq), THF, 21
o
C, 30 min. 
 
Phosphoramidites 6.16a and 6.16b, required for the preparation of TG4 and TG7, was 
prepared in a similar fashion as described for 6.11a and 6.11b and shown in Scheme 6.3. 
Commercially available N2-phenoxyacetyl-2’-deoxyguanosine was converted to the fully 
protected monomer 6.13 using an analogous procedure to the thymidinyl intermediate 6.2. 
Dimers 6.14a or 6.14b were prepared using the Mitsunobu coupling of 6.4a or 6.4b with 
monomer 6.13. Finally, levulinyl deprotection of 6.14a and 6.14b furnished the corresponding 




Scheme 6.3: Reagents and conditions where a-compounds are n = 3 and b-compounds are n = 6: 
(i) 1. TBS-Cl (1.05 eq), Py, 0
oC →22oC, 16 h, 2. Levulinic acid  (2 eq), EDAC • HCl (2 eq), 
DMAP (cat) dioxane, 22
o
C, 16 h. (ii) 6.4a or 6.4b (1.2 eq), Ph3P (2.2 eq), DIAD (2.6 eq), 
dioxane, 22
o
C, 18 h. (iii) N2H4 • H2O (0.5 M) in pyridinium acetate buffer (1:1 v/v), 21
o
C, 30 
min. (iv) Cl-P(OCEt)(NiPr2) (1.5 eq), DIPEA (1.9 eq), THF, 21
o
C, 30 min. 
 
All phosphoramidites (6.7a, 6.7b, 6.11a, 6.11b, 6.16a, and 6.16b) were prepared in 
moderate to good yield using similar procedures. Purification was achieved using column 
chromatography, which resulted in pure products as demonstrated by 
31
P NMR spectra. In all 
cases, two sharp signature peaks were observed in the region of 147-149 ppm of the 
31
P NMR 
spectra, which are characteristic of phosphoramidites.
65,150,323
  
The IaCL DNA assembly employed either dimer phosphoramidite 6.7a, 6.7b, 6.11a, 
6.11b, 6.16a, or 6.16b, which differed in both their nucleobase composition and linker length 
(butylene compared to heptylene). Linear IaCL DNA assembly was conducted in accordance 
with previous published procedures on duplexes containing similar modifications.
150,151,323
 The 
use of "fast-deprotecting" commercially available 3'-O-phosphoramidites was utilized due to the 




 Coupling times were extended for cross-linked amidites 
253 
 
to 600s as opposed to 120s for standard 3'-O-phosphoramidites, in order to ensure proper 
coupling of the dimers. Importantly, the addition of 20% (v/v) THF was used in order to 
solubilize amidites 6.11a, 6.11b, 6.16a, or 6.16b. IaCL DNA oligomers were deprotected and 
cleaved off the CPG solid support via treatment with an anhydrous solution of 0.05 M K2CO3 in 
methanol for 4 h under gentle rocking. Excess base was neutralized with an equimolar amount of 
acetic acid and lyophilized, without desalting, in a speed-vacuum concentrator. The resulting 
pellets were treated with triethylamine trihydrofluride to remove the remnant silyl protecting 
groups at 40
o
C for 16h. Initial sonication was required to break the pellet apart for two rounds of 
15s. Precipitation of IaCL DNA was achieved with cold n-butanol, as opposed to methanol, and 
allowed to cool at -20 
o
C for 10 min. IaCL oligomers proved slightly soluble in methanol, which 
was generally more-pronounced for heptylene adducts compared to the butylene IaCL DNA 
presumably because of the increase hydrophobicity of longer alkylene linkers. Also, solubility of 




-dT IaCL DNA 
with sequences of 12 nucleotides in length), especially in cases where the modification was 
engineered in the central region of the sequence (data not shown). The precipitated material was 
washed with another cold aliquot of n-butanol before purification by SAX-HPLC. 
Characterization of IaCL DNA by ESI-MS revealed deconvoluted masses in agreement with all 
expected masses (Supporting Figures S6.2-S6.7)  
6.2.2 UV thermal denaturation, circular dichroism, and molecular modeling 
studies of IaCL DNA 
The impact of the different IaCL on DNA duplex stability was assessed by UV thermal 
denaturation experiments. Results of the experiments are summarized in Figure 6.2 (see 







-dG IaCL DNA, a general decrease in Tm value of approximately 16-19 
o
C relative to 
the unmodified control was observed in all cases.
323
 The linker size had little effect on the 
thermal denaturation profiles across the various duplexes containing the IaCL DNA. All curves 
displayed a characteristic sigmoidal transition. Interestingly, we suspect the lack of the 
phosphodiester linkage at the cross-linked site has minimal influence on the duplex stability as 




-dG IaCL (CHAPTER IV).
323
 Yet, the decreased 
stability is likely a result of H-bonding disruption between the alkylated dT (or dG) and its base-
paired 2'-deoxyadenosine (or  2’-deoxycytidines) counterpart. In addition, the decrease in Tm 
may have been a consequence of the bulky alkylene linkers causing local or global perturbations.  
 
Figure 6.2. Tm values (
o
C) of duplexes containing TT, TT4, TT7, GT, GT4, GT7, TG, TG4, 
TG7. Bar in black, colorless and grey represent the unmodified controls, butylene adducts, and 
heptylene adducts, respectively. Hyperchromicity change (A260) versus temperature (
o
C) profiles 
are shown in Supporting Figures S8-S10 
Circular dichroism (CD) spectroscopy was carried out to evaluate the global structural 
influence of the IaCL mimics on the DNA duplexes. CD profiles of duplexes containing TG4, 
TG7 and the unmodified (TG) control is provided in Figure 6.3 as an example (see Figure 
255 
 
S6.11-S6.12 for other CD spectra). In all cases, CD profiles displayed characteristic signatures 
pertaining to the B-DNA family with maxima near 280 nm, cross-overs near 255 nm and minima 
near 240 nm. More importantly, all the CD profiles of duplexes containing the IaCL were similar 
to the corresponding unmodified DNA duplexes, which suggested that the presence of the IaCL 




Figure 6.3. Circular dichroism spectra of IaCL duplexes TG4 (•••), TG7 (— — —) and 
unmodified control TG DNA (—). 
Basic molecular modeling was conducted on duplexes containing the different IaCL 
adducts or the unmodified control nucleotides using AMBER force field (see Figures S6.13-
S6.15). Duplexes containing the various IaCLs displayed the alkylene linkers residing in the 
major groove channel. The presence of the alkylene tethers seemed to generally disrupt the base 
pairing between the alkylated nucleobases' complements, relative to the unmodified controls 
which may account for the decrease in Tm observed. Yet, molecular models suggested minimal 
global distortions induced by the presence of the IaCL tether, which was in agreement with 
observation from CD spectroscopy.   
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6.2.3 AGT repair of IaCL DNA substrates 
Four different AGT variants, hAGT, OGT, Ada-C, and an S134P OGT variant were 
tested for their ability to repair the DNA duplexes containing the different IaCL (TT4, TT7, 
GT4, GT7, TG4, and TG7). The repair assays were conducted as described in a prior report
323
, 
whereby the successful repair of the IaCL mimic generates a smaller DNA repair product (RP) 
species and a DPC median product (MP) (as shown in Figure 6.4). Denaturing PAGE 





Figure 6.4. Repair of (A) TG4 and (B) TG7 by hAGT, OGT, Ada-C, and OGT S134P. 
Denaturing PAGE of repair reactions as described in the experimental section with varying 
protein concentration (either 5- or 30-fold protein). Panel A; Lane 1, 2 pmol control unmodified 
TG DNA; lane 2, 2 pmol TG4; lane3 TG4 + 10 pmol hAGT; lane4 TG4 + 60 pmol hAGT; 
lane5 TG4 + 10 pmol OGT; lane6 TG4 + 60 pmol OGT; lane7 unmodified 5-mer control DNA 
5’-pGGCTT; lane8 unmodified 10-mer control 5’-pGGC ATC ACC AG; lane9 TG4 + 10 pmol 
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Ada-C; lane10 TG4 + 60 pmol Ada-C; lane11 TG4 + 10 pmol OGT S134P; lane12 TG4 + 60 
pmol OGT S134P. Panel B; identical to panel A except with TG7 instead of TG4. 
 
The radioactivity-based repair assay revealed no appreciable repair (< 20 % repair) of 
TT4, TT7, GT4, and GT7 at both five-molar equivalence and thirty-molar equivalence of AGT 
(Supporting Figures S6.16-S6.17). Lack of repair by Ada-C was not surprising as this protein is 




-position of dT 
and dG, respectively.
146,365
  It was, however, surprising to observe the lack of OGT-mediated 
repair of these IaCL DNA, particularly TT4 and TT7, given that OGT is proficient in repairing 





The OGT S134P variant,
149
 which is said to contains a larger active site, was also incapable of 
IaCL repair. Moreover, hAGT proved inefficient at repairing duplexes containing GT4 and GT7 
despite being capable of efficiently repairing GG4 and GG7 (see Figure 6.1D). Our group has 




-dT ICL occurring 
solely at the O
6




 The lack of hAGT 
repair towards GT4 and GT7 could thus suggest that the 3’-phosphodiester linkage is playing a 
critical role in the repair at the dG moiety of the IaCL. This hypothesis is further supported by 
the efficient repair of TG4 and TG7 by hAGT depicted in Figure 6.4, which both possess the 3’-
phosphodiester linkage at the dG residue (Figure 6.1). Crystallographic structures of covalent 
complexes between modified DNA and hAGT, as well as computational approaches, have 





 We suspect that deleting this functional group severely cripples hAGT repair, 
at least for IaCL-type lesions.   
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Repair profiles of TG4 and TG7 are illustrated in the denaturing gel shown in Figure 
6.4. Only hAGT was capable of TG4 repair (lanes 3 and 4 in Figure 6.4A) with almost complete 
substrate consumption at five-fold protein-DNA ratio (10 pmol protein and 2 pmol DNA). As 
suspected, hAGT was also capable of efficiently repairing the heptylene analogue TG7 (lanes 3 
and 4 in Figure 6.4B). We were surprised to observe repair of TG7 by Ada-C at thirty-fold 
protein equivalence (lane 10 in Figure 6.4B). The results revealed repair occurring only at the 
O
6
-alkylene-dG part of the IaCL, due to the production of the larger DNA RP (Figure 6.4B). To 
the extent of our knowledge, this marks the first substrate adduct larger than O
6
-ethyl-dG capable 
of undergoing repair by Ada-C,
146
 albeit at a mediocre efficiency (30 % substrate consumption 
reactions of 16h at 37
o
C). No repair at thymidinyl moiety of TG7 was observed, which was in 
agreement with a lack of repair of larger O
4
-hydroxyalkylene-dT mono-adducts  Ada-C.
150
 The 
IaCL strategy may find applications in efficiently generating DNA-Ada cross-linked species that 
have otherwise been impossible using the ICL avenue.
151
 Our approach would, however, require 
optimization given the large protein excess required to initiate repair of TG7. 
  Time course assays were used to gain insights on the kinetics of the reaction with AGTs 
and the results are summarized in Figure 6.5 (see Supporting Figure S6.18 for gels). Substrate 
TG4 (Figure 6.5A) was processed by hAGT significantly slower compared to TG7 (Figure 
6.5B), which was in agreement with repair trends observed with other IaCL
323
 DNA as well as 
ICL
65
 DNA repair by hAGT. Approximately 25 % of TG4 IaCL substrate remained after a 
reaction period of 60 min with five-fold excess hAGT, whereas similar levels were reached after 
only 10 min for TG7. Interestingly, the TG4 IaCL substrate was repaired with enhanced rates in 
comparison to the GG4 IaCL DNA. For instance, TG4 reached reaction plateau (20 % substrate 
remaining) after approximately 90 min, whereas it took hAGT approximately 480 min to reach 
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similar levels for GG4. 
323
 This trend was not shared for the heptylene analogues (TG7 versus 
GG7), with repair levels reaching approximately 20% after 15 min. This observation may be a 
consequence of the energetic requirement involved in rotating the α-carbon to the O6-alkylted-
dG in a favorable fashion in order to initiate nucleophilic attack by the Cys145 thiolate anion. 
There are a variety of different accounts that suggest orientation of the alkyl group at the O6-
atom of dG influences the repair by hAGT. Perhaps the alkylated dG nucleobase is more easily 
rotated in the case of TG4 compared to GG4. Pyrimidines are capable of adopting a variety of 
different conformations, which may confer added flexbility.
366
 The added flexibility may aid in 
the repair of the more constrained butylene IaCL DNA, consistent with repair kinetics of TG4 
versus GG4. The same effect may not necessarily cause the same benefit for the longer 
heptylene tether, as longer linkers are inherently more flexible (due to the additional rotatable 
bonds groups). This may explain why similar hAGT repair rates are observed for TG7 and GG7. 





2`-deoxyuridine ICL DNA duplex, which revealed that the α-carbon of the O4-alkylated 
pyrimidine adopted an unexpected E conformation between the α-carbon and theC4-O4 bond. 
Perhaps such a conformation is contributing to the effects observed with TG4 versus GG4. We 
were please to observe the formation of a median product (MP) in the case of TG4 and TG7, 
similar to observations previously made for GG4 and GG7. The presence of such species would 




Figure 6.5. Time course repair assay plots of TG4 (A) and TG7 (B) by hAGT, at five molar 
equivalence protein, displaying significant faster repair of TG7 by hAGT. Time course repair 
assay of TG7 by hAGT (C) and Ada-C (D) at thirty molar equivalence protein, displaying 
significant faster repair of TG7 by hAGT compared to Ada-C. Graphical illustrations display 
abundances [%] of MP (———), RP (—•—)and substrate (—) over time (min). 
 
Time course assays revealed that Ada-C repaired TG7 in a much slower fashion relative 
to hAGT (Figure 6.5C and Figure 6.5D, respectively, see Supporting Figure S6.19 for gels). 
At thirty-fold protein equivalences, TG7 levels reached about 70 % after reaction times of 4 h by 
Ada-C, whereas similar amounts were detected after only 15 s with hAGT. These results were 














 Unfortunately, no considerable amounts of MP were detected for Ada-C mediated 
repair (Figure 6.4B and Figure 6.5D). 
Studies from our group and others have suggested that repair by AGTs may be dependent 
on conformations of the alkyl group in order for efficient group transfer.
150,151,228,321
 This effect 
may not be as pronounced in freely rotating adducts or smaller appendages that have a narrower 
range of orientations. The DNA-protein complex must be such that the α-carbon of the DNA 
lesion resides in a favorable orientation to allow attack by the cysteine thiolate anion.
137
 It should 
be noted, however, that substrate discrimination due to conformational factors may be pertaining 
to more than simply the alkyl appendage found in the DNA oligomer. Notably, a prime example 
is that of O
6
-methyl-riboguanosine, which is a poor substrate of hAGT when incorporated into 
DNA oligomers.
367
 The culprit was accredited to a potential clash between the 2'-hydroxyl group 
and an amino acid near the active site of hAGT.
137
 The lack of the phosphodiester group in our 
IaCL mimic presumably confers added flexibility to the nucleobases, sugar moiety and the 
alkylene appendage, which may explain the proficient repair observed by hAGT and mediocre 
repair by Ada-C. Yet, it is clear that the lack of a 3'-phosphodiester linkage prevents efficient 
repair by hAGT of O
6
-alkylene-dG (such as those found in GT4 and GT7). This may simply be 
because  the Tyr114 residue is incapable of efficiently rotating the damaged nucleobase given the 
lack of the 3'-phosphodeister group. Yet, it is unclear if the alkylene linker orientation, 
presumable pointing towards the 3'-end of the sequence, in GT4 and GT7 adopts an adverse 
conformation.     
6.2.4 Identification of GG4, GG7, TG4 and TG7 repair products by SDS-
PAGE and ESI-MS 
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The radioactivity-based assay described above mainly monitors DNA species, thus 
prompting us to monitor proteinaceous species by SDS-PAGE followed by mass spectrometric 
characterization. We conducted repair reactions of AGT protein (600 pmol) and IaCL DNA (600 
pmol), either single-stranded or part of a duplex. GG4 and GG7 were utilized as positive 
controls. As previously demonstrated for GG4 and GG7 (CHAPTER IV), hAGT-mediated 
repair of TG4 and TG7 was not significantly affected by the lack, or presence, of the 
complementary DNA strand (data not shown). The Coomassie blue-stained gel is illustrated in 
Figure 6.6 and displays almost quantitative conversion of hAGT to a slower migrating species 
(presumably the DPC species) when reacted with single-stranded GG4, GG7, TG4, and TG7 
(lane 2, 3, 5, and 6, respectively) for 16h at 37
o
C. Furthermore, we were please to observe 
excellent reaction conversions when shortening the reaction times to only one hour (Figure 
S6.20). DPC formation occurred in a more efficient fashion compared to AGT-cross-linking 
using the N1,O
6
-ethano-2′-deoxyxanthosine modification, which suffered from slower reaction 
kinetics under higher protein-to-DNA ratio.
160
 No appreciable amount of DPC, however, was 
detected by reacting Ada-C (600 pmol) with TG7 (600 pmol) as shown in lane 8 of Figure 6.6.  
 
Figure 6.6. 15% SDS-PAGE (Coomassie stained) of hAGT mediated repair of GG4, GG7, 
TG4, and TG7, and Ada-C mediated repair of TG7. Repair of 600 pmol single-stranded IaCL 
DNA by 600 pmol protein for 16 h at 37 °C: lane L, unstained protein molecular weight marker; 
lane 1 unmodified control (GG) DNA + hAGT; lane 2 GG4 + hAGT reaction; lane 3 GG7 + 
hAGT reaction; lane 4 unmodified control (TG) DNA + hAGT; lane 5 TG4 + hAGT reaction; 
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lane 6 TG7 + hAGT reaction; lane 7 unmodified control (TG) + Ada-C; lane 8 TG7 + Ada-C. 
Note that there is no appreciable amounts of DNA-Ada-C cross-link formation (lane 8). 
The DPC species were characterized by ESI-MS and the spectra of complexes produced 
from reacting hAGT with GG4, GG7, TG4, and TG7 for 30 min at 37
o
C are shown in Figure 
6.7 (Panels A, B, C, and D, respectively). The spectra of butylene products display a minor peak 
attributed to unreacted hAGT (21 876 Da) and major peak corresponding to the butylene DPC. 
The heptylene analogues, on the other hand, reveal the presence of only one major peak 
attributed to the heptylene DPC species. It should be noted that the absence of another peak with 
higher mass values (~ 25 kDa) precludes the efficient formation of the other DPC reaction 
products (i.e. hAGT reacting with the 5’-residue of the IaCL). These results support the 
importance of the 3’-phosphodiester linkage in the repair mechanism by hAGT, as previously 
hypothesized.
137,168
 Moreover, these results are consistent with previous studies that demonstrate 









ICL DNA, by hAGT.
64,65,150




-dT ICL DNA was only repaired by 
hAGT at the dG residue
151
 similarly to TG4 and TG7, but not GT4 and GT7 which both 
remained inert. The repair by hAGT of the novel modification TG4 and TG7 is illustrated in 




Figure 6.7: Identification of hAGT-DNA covalent complex by ESI-MS. Product identified from 
reaction of hAGT with single-stranded (A) GG4, (B) GG7, (C) TG4, (D) TG7. Values in 
brackets represent the calculated masses. 
 
Cellular DPC production has become an increase concern due to their diversity and 
elevated cytotoxicity.
100
 Our IaCL approach has demonstrated a facile methodology to generate 
hAGT cross-linked to the DNA with excellent reaction conversions, particularly compared to 
repair of ICL adducts. We have expanded the versatility of the current method by the 
introduction of different size alkylene tethers in DPCs. In addition, hAGT cross-linking sites 
were possible to either the O
6
-atom of dG or the O
4
-atom of dT, a commodity possible due to the 
necessity of the 3’-phosphodiester group for efficient hAGT-mediated repair of O6-alkyl-dG 
adducts. There are no current methodologies, to the extent of our knowledge, to efficiently 
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generate a DPC between hAGT and an O
6
-alkyl-dG residue. The N1,O6-ethanoxanthosine 
avenue generates an ethylene bridge between Cys145 and the N1-atom of the xanthosine 
nucleotide.
137,160
 As proof-of-concept, we synthesized an oligomer with fluorescein tags at the 
5’- and 3’-end of the GG4 or GG7 DNA oligomer. Cross-linking experiments yielded a 
fluorescently labelled DPC species, generated with similar yields (Figure S6.21). 
 
Figure 6.8: hAGT-mediated repair of TG4 and TG7 IaCL.  
 
The IaCL may find applications in molecular nanotechnology devices as novel functional 
irreversible switches. There has been growing interest in exploiting the activity of AGTs for 




 and molecular 
imaging
176
 to name a few. The proposed IaCL switch, once inserted into a system, would benefit 
from orthogonality with virtually no response to other switching mechanisms like pH, UV-
radiation and toehold-mediated mechanisms. Moreover, we have shown that the kinetics of TG 
IaCL cleavage are fast and reliable in producing only one DNA-protein complex. Our IaCL may 
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be an efficient avenue to conjugate a hAGT molecule to a device or cleaving a particular DNA 
segment part of the system, all depending on the directionality of the TG IaCL.  
6.3 Conclusion 
The introduction of a variety of different IaCL DNA mimics were prepared using a 
straightforward synthetic methodology in purity and scales sufficient for biophysical and 
biochemical studies. Our model IaCL adducts all decreased the thermal stability of duplexes by 
about 15-19 
o
C, relative to unmodified control, as verified by UV thermal denaturation 
experiments. Circular dichroism spectroscopy revealed minimal global perturbation of the DNA 
structure relative to control duplexes. A series of well-defined hAGT-DNA covalent complexes 
were generated via either a butylene or heptylene linker, to either an O
4
-alkylated thymidinyl or 
an O
6
-alkylated 2’-deoxyguanidyl residues. We identified a novel substrate for Ada-C (TG7), 
with no evident amount of DPC observed using the assays described herein. Unfortunately, we 
were unable to generate the 5’-tethered DPC complexes using the engineered GT4 and GT7 
probes with the AGTs tested. The reason for the substrate discrimination by hAGT is 
hypothesized to arise from (1) the lack of the 3’-phosphodiester linkage of the O6-alkylated dG 
residue or (2) the α-carbon adopting a non-favourable conformation hence preventing successful 
repair by hAGT. Nonetheless, the use of IaCL DNA substrates supplies an attractive method for 
the production of site-specific hAGT-DNA covalent complex with increased versatility 
compared to the ICL DNA avenue.       
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6.5 Supporting Information 
6.5.1 Supporting Methods 
6.5.1.1 General  
N2-phenoxyacetyl-2’-deoxyguanosine , 5’-O-(4,4’-dimethoxytrityl)-N2-phenoxyacetyl-
2’-deoxyguanosine, 5’-O-(4,4’-dimethoxytrityl)-thymidine, thymidine, and  N,N-
diisopropylaminocyanoethylphosphonamidic chloride were purchased from ChemGenes, Inc. 
(Wilmington, MA). 3’-O-(tert-butyldimethylsilyl)-5’-O-(4,4’-dimethoxytrityl)-N2-
phenoxyacetyl-2’-deoxyguanosine and was prepared according to previously reported 
procedures.
65




diisopropyl)phosphoramidites and protected 2’-deoxyribonucleoside–CPG supports were 
purchased from Glen Research (Sterling, Virginia). 6-FAM phosphoramidites and 6-FAM lcaa 
CPG (DMT) 500Å was purchased from ChemGenes (Wilmington, MA) and used according to 
the manufacturer’s protocols. All other chemicals and solvents were purchased from the Aldrich 
Chemical Company (Milwaukee, WI) or EMD Chemicals Inc. (Gibbstown, NJ). Flash column 
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chromatography was performed using silica gel 60 (230–400 mesh) purchased from Silicycle 
(Quebec City, QC). Thin layer chromatography (TLC) was carried out with precoated TLC 
plates (Merck, Kieselgel 60 F254, 0.25 mm) purchased from EMD Chemicals Inc. (Gibbstown, 
NJ). NMR spectra were recorded on a Varian 500 MHz NMR spectrometer at room temperature. 
1
H NMR spectra were recorded at a frequency of 500.0 MHz and chemical shifts were reported 
in parts per million (ppm) downfield from tetramethylsilane. 
13
C NMR spectra (
1
H decoupled) 
were recorded at a frequency of 125.7 MHz and chemical shifts were reported in ppm with 
tetramethylsilane as a reference. 
31
P NMR spectra (
1
H decoupled) were recorded at a frequency 
of 202.3 MHz and chemical shifts were reported in ppm with H3PO4 used as an external 
standard. High resolution mass spectrometry of modified nucleosides were obtained using an 7T-
LTQ FT ICR instrument (Thermo Scientific), at the Concordia University Centre for Structural 
and Functional Genomic. The mass spectrometer was operated in full scan, positive ion detection 
mode. ESI mass spectra for oligonucleotides were obtained at the Concordia University Centre 
for Biological Applications of Mass Spectrometry (CBAMS) using a Micromass Qtof2 mass 
spectrometer (Waters) equipped with a nanospray ion source. The mass spectrometer was 
operated in full scan, negative ion detection mode. Ampicillin, isopropyl β-D-
thiogalactopyranoside (IPTG), and most other biochemical reagents as well as polyacrylamide 
gel materials were purchased from Bioshop Canada Inc. (Burlington, ON). Ni-NTA Superflow 
Resin was purchased from Qiagen (Mississauga, ON). Complete, Mini, EDTA-free Protease 
Inhibitor Cocktail Tablets were obtained from Roche (Laval, QC) Nitro- cellulose filters (0.20 
μm) were obtained from Millipore. XL-10 Gold and Bl21(DE3) E. coli cells were obtained from 
Stratagene (Cedar Creek, TX). T4 polynucleotide kinase (PNK) was obtained from Fermentas 
(Burlington, ON). [γ-32P]ATP was purchased from PerkinElmer (Woodbridge, ON). Phusion 
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Polymerase was obtained from New England Biolabs (Ipswich, MA). DNA primers for site 
directed mutagenesis and cloning were purchased from Biocorp (Montreal, QC). 
6.5.1.2 Chemical synthesis of nucleosides 
The synthesis of phosphoramidites 6.7a and 6.7b are shown in Scheme 6.1 
5’-O-tert-butyldimethylsilyl-3’-O-levulinyl- thymidine (6.2) 
Thymidine (2.0 g, 8.3 mmol) was co-evaporated in vacuo with anhydrous Py (2 x 5 mL). 
To a solution of dried thymidine in Py (50 mL) at 0
o
C was added TBS-Cl (1.3 g, 8.6 mmol) and 
allowed to stir. After 3h, the solvent was removed in vacuo and the crude was taken up in DCM 
(50 mL) forming a white precipitate in suspension. The content was washed with aqueous 
NaHCO3 (3% w/ v, 2 x 50 mL) and once with brine (50 mL), which removed the precipitate, 
followed by drying over anhydrous Na2SO4 (~ 4 g). The solvent was removed in vacuo and 
analysis by TLC revealed that the crude product was of sufficient purity to proceed to the 
subsequent step. To a solution of the 5’-O mono-silylated thymidine adduct (~2.9 g, ~8.1 mmol), 
EDC (3.1 g, 16 mmol) and DMAP (cat) in dioxane (64 mL) was added levulinic acid (1.9 g, 16 
mmol) and allowed to stir. After 4h, the solvent was removed in vacuo and the crude was taken 
up in DCM (50 mL), washed with aqueous NaHCO3 (3% w/v, 2 x 50 mL) and once with brine 
(50 mL), and dried over anhydrous Na2SO4 (~ 4 g). The solvent was removed in vacuo and the 
product was purified via flash column chromatography using MeOH : DCM (1% to 2.5%) as 
eluent to afford 3.2 g (85% over two steps) of a slightly beige powder. Rf (SiO2 TLC): 0.53 
MeOH : DCM (5%). λmax(MeCN) = 264 nm. 
1
H NMR (500MHz, CDCl3, ppm): 9.38 (s, 1H, NH), 
7.54 (d, 1H, H6, J = 1 Hz), 6.33 (dd, 1H, H1’, J = 9, 6 Hz), 5.24 (m, 1H, H3’), 4.08 (m, 1H, 
H4’), 2.75 (m, 2H, CH2CO), 2.58 (m, 2H, OOCCH2), 2.39 (m, 1H, H2’), 2.18 (s, 3H, COCH3), 
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2.08 (m, 1H, H2’’), 1.90 (d, 3H, ArCH3, J = 1 Hz), 0.91 (s, 9H, SiC(CH3)3), 0.109 (s, 3H, 
SiCH3), 0.105 (s, 3H, SiCH3). 
13
C NMR (125.7 MHz, CDCl3, ppm): 206.3, 205.7, 176.8, 172.4, 
168.4, 164.0, 150.5, 135.2, 111.1, 85.4, 84.7, 75.6, 63.6, 38.0, 37.7, 29.7, 27.9, 25.9, 18.3, 12.4, , 
-5.42, -5.52. IR (thin film); νmax (cm
−1
) = 3066, 2955, 2929, 2856, 1715, 1471, 1276, 1257, 1073, 
1005, 837. HRMS (ESI-MS) m/z calculated for C21H35N2O7Si
+







butyldimethylsilyl)-3’-O- (levulinyl)-thymidinyl]}-butane (6.5a) 
To a solution of compound 6.2 (1.2 g, 2.6 mmol) , triazole (4.0 g, 58 mmol), NEt3 (8.3 
mL, 59 mmol) in MeCN : DCM (32mL, 1/1 v/v) stirring at 0
o
C for 10 min was added POCl3 
dropwise (0.36 mL, 3.9 mmol). After 5 min, another portion of POCl3 (0.27 mL, 2.9 mmol) was 
added which resulted in the formation of a precipitate.  After 20 min, the solvent was removed in 
vacuo and the crude was taken up in DCM (50 mL). The content was washed with aqueous 
NaHCO3 (3% w/ v, 2 x 50 mL) and once with brine (50 mL), followed by drying over anhydrous 
Na2SO4 (~ 4 g). The solvent was removed in vacuo and crude intermediate 6.3 was used directly 
for the subsequent dimerization reaction. To a solution of 6.3 (~ 1.0 g, ~2.1 mmol) and 6.4a (1.7 
g, 2.3 mmol) in MeCN (15 mL) was added DBU (0.92 mL, 6.2 mmol) and allowed to stir at 21 
o
C. After 20h, the solvent was removed in vacuo and the crude was taken up in DCM (50 mL). 
The content was washed with aqueous NaHCO3 (3% w/ v, 2 x 50 mL), dried over anhydrous 
Na2SO4 (~ 4 g), and concentrated in vacuo. The crude product was purified via flash column 
chromatography using EtOAc : hexanes (7 :3 to 100:0) as eluent to afford 1.2 g (52 %) of a 
colorless foam. Rf (SiO2 TLC): 0.35 EtOAc . λmax(MeCN) =283 nm. 
1
H NMR (500MHz, CDCl3, 
ppm): 7.94 (s, 1H, H6), 7.77 (s, 1H, H6), 7.42-7.40 (m, 2H Ar), 7.31-7.23 (m, 7H, Ar), 6.84-6.81 
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(m, 4H, Ar),  6.41 (dd, 1H, H1’a, J = 9, 5.5 Hz), 6.32 (dd, 1H, H1’b, J = 6 Hz), 5.24 (m, 1H, 
H3’a), 4.48-4.43 (m, 5H, H3’b & 2 x ArOCH2), 4.13 (m, 1H, H4’a), 3.96 (m, 1H, H4’b), 3.91-
3.90 (m, 2H, H5’a & H5’’a), 3.79 (s, 6H, 2 x OCH3), 3.51 (m, 1H, H5’b), 3.25 (m, 1H, H5’’b),  
2.75 (m, 2H, CH2CO), 2.64-2.47 (m, 4H, H2’a, H2’b & OOCCH2), 2.23-2.18 (m, 4H, H2’’b & 
COCH3), 2.04-1.92 (m, 4H, H2’’a & ArCH3), 1.88 (m, 4H, CH2CH2), 1.51 (s, 3H, ArCH3), 0.90 
(s, 9H, SiC(CH3)3), 0.80 (s, 9H, SiC(CH3)3), 0.11- 0.10 (m, 9H, 3 x SiCH3), - 0.08 (s, 3H, 
SiCH3).  
13
C NMR (125.7 MHz, CDCl3, ppm): 206.3, 205.7, 176.8, 172.4, 168.4, 164.0, 150.5, 
135.2, 111.1, 85.3, 84.8, 84.7, 63.6, 38.0, 37.8, 37.7, 37.3, 29.8, 29.7, 29.0, 27.9, 27.7, 25.9, 18.3, 
12.4, -5.42, -5.52. IR (thin film); νmax (cm
−1
) = 3063, 2954, 2928, 2855, 1739, 1720, 1673, 1537, 
1509, 1330, 1253, 1229, 1178, 1033, 835. HRMS (ESI-MS) m/z calculated for C62H87N4O14Si2
+
 






butyldimethylsilyl)-3’-O-(levulinyl)-thymidinyl]}-heptane (6.5b)  
Intermediate 6.3 was prepared according to the procedure for product 6.5a as described 
above. To a solution of 6.3 (~ 0.48 g, ~0.95 mmol) and 6.4b (0.77 g, 1.0 mmol) in MeCN (7.9 
mL) was added DBU (0.81 mL, 5.4 mmol) and allowed to stir at 21 
o
C. After 20h, the solvent 
was removed in vacuo and the crude was taken up in DCM (50 mL). The content was washed 
with aqueous NaHCO3 (3% w/ v, 2 x 50 mL) and once with brine (50 mL), then dried over 
anhydrous Na2SO4 (~ 4 g), and concentrated in vacuo. The crude product was purified via flash 
column chromatography using MeOH : DCM (1% to 3%) as eluent to afford 0.78 g (68 %) of a 
colorless foam. Rf (SiO2 TLC): 0.54 MeOH : DCM (5%). λmax(MeCN) = 283 nm. 
1
H NMR 
(500MHz, CDCl3, ppm): 7.92 (d, 1H, H6, J = 1 Hz), 7.75 (d, 1H, H6, J = 1 Hz), 7.42-7.40 (m, 
2H Ar), 7.31-7.21 (m, 7H, Ar), 6.84-6.81 (m, 4H, Ar),  6.41 (dd, 1H, H1’a, J = 9.0, 5.5 Hz), 6.33 
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(dd, 1H, H1’b, J = 6 Hz), 5.24 (m, 1H, H3’a), 4.47 (m, 1H, H3’b), 4.38-4.35 (m, 4H, 2 x 
ArOCH2), 4.13 (m, 1H, H4’a), 3.96 (m, 1H, H4’b), 3.91-3.90 (m, 2H, H5’a & H5’’a), 3.78 (s, 
6H, 2 x OCH3), 3.51 (m, 1H, H5’b), 3.25 (m, 1H, H5’’b),  2.74 (m, 2H, CH2CO), 2.64-2.46 (m, 
4H, H2’a, H2’b & OOCCH2), 2.22-2.17 (m, 4H, H2’’b & COCH3), 2.00 (m, 1H, H2’’a), 1.93 (d, 
3H, ArCH3, J = 1 Hz), 1.76 (m, 4H, CH2CH2), 1.51 (d, 3H, ArCH3, J = 1 Hz), 1.38 (m, 6H, 
CH2CH2CH2), 0.89 (s, 9H, SiC(CH3)3), 0.80 (s, 9H, SiC(CH3)3),0.11 (s, 3H, SiCH3), 0.10 (s, 3H, 
SiCH3),-0.01 (s, 3H, SiCH3), - 0.08 (s, 3H, SiCH3).  
13
C NMR (125.7 MHz, CDCl3, ppm): 206.3, 
172.4, 170.5, 170.5, 158.7, 156.0, 155.9, 144.4, 139.4, 139.0, 135.5, 130.1, 130.1, 128.2, 127.90, 
127.0, 113.2, 113.2, 104.7, 104.5, 86.6, 86.5, 86.4, 86.2, 85.6, 75.9, 71.1, 67.4, 67.3, 63.6, 62.4, 
55.2, 42.2, 39.0, 37.8, 29.8, 29.0, 28.5, 28.5, 28.0, 25.9, 25.9, 25.7, 18.2, 17.9, 12.3, 11.8, -4.64, -
4.97, -5.45, -5.54. IR (thin film); νmax (cm
−1
) = 3063, 2953, 2928, 2855, 2739, 1720, 1673, 1608, 
1536, 1509, 1329, 1253, 1178, 1122, 1033, 835. HRMS (ESI-MS) m/z calculated for 
C65H93N4O14Si2
+






butyldimethylsilyl)- thymidinyl]}-butane (6.6a) 
A solution (1.5 mL) of 0.5 M N2H4•H2O in pyridinium acetate (1/1, v/v) was added to 
6.5a (0.39 g, 0.33 mmol) and allowed to stir. After 5 min, the reaction was diluted with DCM 
(100 mL) and washed several times with saturated aqueous NaHCO3 (6 x 50 mL), followed by 
water (50 mL) and brine (50 mL). The organic layer was dried over anhydrous Na2SO4 (~ 4 g), 
concentrated in vacuo and purified via flash column chromatography using MeOH : DCM (1% 
to 5%) as eluent to afford 0.3 g (83 %) of a colorless foam. Rf (SiO2 TLC): 0.20 MeOH : DCM 
(3%). λmax(MeCN) =283 nm. 
1
H NMR (500MHz, CDCl3, ppm): 7.94 (d, 1H, H6, J = 1 Hz), 7.79 (d, 
1H, H6, J = 1 Hz), 7.41-7.40 (m, 2H Ar), 7.29-7.21 (m, 7H, Ar), 6.83-6.80 (m, 4H, Ar),  6.38 
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(dd, 1H, H1’a, J = 7.5, 5.5 Hz), 6.32 (dd, 1H, H1’b, J = 6 Hz), 4.49-4.42 (m, 6H, H3’a, H3’b & 2 
x ArOCH2), 4.10 (m, 1H, H4’a), 3.96 (m, 1H, H4’b), 3.91 (m, 1H, H5’a), 3.83 (m, 1H, H5’’a), 
3.78 (s, 6H, 2 x OCH3), 3.51 (m, 1H, H5’b), 3.25 (m, 1H, H5’’b), 3.04 (d, 1H, OH, J = 3.5),  
2.60 (m, 1H, H2’a), 2.47 (m, 1H, H2’b), 2.19 (m, 1H, H2’’b), 2.03 (m, 1H, H2’’a), 1.93 (d, 3H, 
ArCH3, J = 1 Hz), 1.87 (m, 4H, CH2CH2), 1.50 (d, 3H, ArCH3, J = 1Hz), 0.90 (s, 9H, 
SiC(CH3)3), 0.80 (s, 9H, SiC(CH3)3), 0.10 (s, 3H, SiCH3), 0.09 (s, 3H, SiCH3), -0.01 (s, 3H, 
SiCH3), - 0.08 (s, 3H, SiCH3). 
13
C NMR (125.7 MHz, CDCl3, ppm): 170.34, 170.32, 158.7, 
156.0, 155.9, 144.4, 139.5, 135.49, 135.48, 130.08, 130.06, 128.2, 127.9, 127.0, 113.2, 113.2, 
104.50, 104.45, 87.4, 86.6, 86.5, 86.2, 72.3, 71.0, 66.73, 66.65, 63.5, 62.4, 55.2, 42.23, 42.19, 
25.9, 25.7, 25.3, 25.2, 18.3, 17.9, 12.3, 11.7, -4.64, -4.97, -5.42, -5.48. IR (thin film); νmax (cm
−1
) 
=3384, 3061, 2954, 2929, 2855, 1669, 1580, 1509, 1472, 1329, 1121, 835. HRMS (ESI-MS) m/z 
calculated for C57H81N4O12Si2
+






butyldimethylsilyl)- thymidinyl]}-heptane (6.6b) 
A solution (2.9 mL) of 0.5 M N2H4•H2O in pyridinium acetate (1/1, v/v) was added to 
6.5b (1.2 g, 0.98 mmol) and allowed to stir. After 5 min, the reaction was diluted with EtOAc 
(75 mL) and washed several times with saturated aqueous NaHCO3 (6 x 80 mL), followed by 
brine (50 mL). The organic layer was dried over anhydrous Na2SO4 (~ 4 g), concentrated in 
vacuo and purified via flash column chromatography using MeOH : DCM (1.5% to 3.5%) as 
eluent to afford 0.74 g (69 %) of a colorless foam. Rf (SiO2 TLC): 0.10 EtOAc.  λmax(MeCN) = 283 
nm. 
1
H NMR (500MHz, CDCl3, ppm): 7.92 (d, 1H, H6, J = 1 Hz), 7.78 (d, 1H, H6, J = 1 Hz), 
7.41-7.40 (m, 2H Ar), 7.29-7.21 (m, 7H, Ar), 6.83-6.81 (m, 4H, Ar),  6.38 (dd, 1H, H1’a, J = 7.5, 
6.0 Hz), 6.32 (dd, 1H, H1’b, J = 6 Hz), 4.48-4.44 (m, 2H, H3’a & H3’b), 4.37-4.34 (m, 4H, 2 x 
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ArOCH2), 4.09 (m, 1H, H4’a), 3.96 (m, 1H, H4’b), 3.92 (m, 1H, H5’a), 3.84 (m, 2H, H5’’a), 
3.78 (s, 6H, 2 x OCH3), 3.51 (m, 1H, H5’b), 3.25 (m, 1H, H5’’b), 2.99 (d, 1H, OH, J = 3.5 Hz), 
2.60 (m, 1H, H2’a), 2.48 (m, 1H, H2’b), 2.20 (m, 1H, H2’’b), 2.04 (m, 1H, H2’’a), 1.93 (d, 3H, 
ArCH3, J = 1 Hz), 1.73 (m, 4H, CH2CH2), 1.51 (d, 3H, ArCH3, J = 1 Hz), 1.39 (m, 6H, 
CH2CH2CH2), 0.90 (s, 9H, SiC(CH3)3), 0.80 (s, 9H, SiC(CH3)3),0.11 (s, 3H, SiCH3), 0.10 (s, 3H, 
SiCH3),-0.01 (s, 3H, SiCH3), - 0.08 (s, 3H, SiCH3). 
13
C NMR (125.7 MHz, CDCl3, ppm): 
170.47, 170.46, 158.7, 156.1, 156.0, 144.4, 139.4, 139.3, 135.5, 130.08, 130.06, 128.2, 127.9, 
127.0, 113.20, 113.18, 104.6, 104.5, 87.3, 86.6, 86.6, 86.5, 86.2, 72.3, 71.1, 67.3, 67.3, 63.5, 
62.4, 55.2, 42.22, 42.19, 28.9, 28.5, 28.4, 25.9, 25.83, 25.81, 25.7, 18.3, 17.9, 12.3, 11.8, -4.64, -
4.97, -5.42, -5.48. IR (thin film); νmax (cm
−1
) = 3365, 3061, 2953, 2930, 2856, 1671, 1608, 1536, 
1509, 1472, 1430, 1328, 1253, 1178, 1121, 835. HRMS (ESI-MS) m/z calculated 
forC60H87N4O12Si2
+








To a solution of 6.6a (0.30 g, 0.28 mmol) and DIPEA (92 µL, 0.53 mmol) in THF (2.8 
mL) was added Cl-P(OCEt)(NiPr2) (93  µL, 0.42 mmol) and the reaction was allowed to stir at 
room temperature. After 20 min, the solvent was removed in vacuo and the crude was taken up 
in EtOAc (50 mL), washed with aqueous NaHCO3 (3% w/v, 2 x 40mL), followed with brine (40 
mL). The organic layer was dried over anhydrous Na2SO4 (~ 1 g), decanted and then evaporated 
in vacuo. The crude product was purified via flash column chromatography using EtOAc 
(containing 0.1% v/v NEt3) as eluent to afford 0.27 g (74 %) of a colorless foam. Rf (SiO2 TLC): 
0.53, 0.41 EtOAc. λmax(MeCN) = 283 nm. 
1
H NMR (500MHz, d6-acetone, ppm): 7.94 (m, 1H, H6), 
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7.82-7.79 (m, 1H, H6), 7.51-7.48 (m, 2H Ar), 7.39-7.24 (m, 7H, Ar), 6.92-6.89 (m, 4H, Ar), 
6.32-6.25 (m, 2H, H1’a & H1’b), 4.63-4.59 (m, 2H, H3’a & H3’b), 4.41-4.36 (m, 4H, 2 x 
ArCH2), 4.25, 4.16 (m, 1H, H4’a), 4.03-3.82 (m, 5H, POCH2, H4’b, H5’a & H5’’a), 3.79 (s, 6H, 
2 x OCH3), 3.73-3.65 (m, 2H, 2 x NCH),  3.49 (m, 1H, H5’b), 3.35 (m, 1H, H5’’b), 2.81-2.77 
(m, 2H, CH2CN),  2.62-2.51 (m, 1H, H2’a), 2.42-2.37 (m, 1H, H2’b), 2.33-2.27 (m, 1H, H2’’b), 
2.16-2.11 (m, 1H, H2’’a), 1.94-1.92 (m, 7H, ArCH3 & CH2CH2), 1.62-1.61 (m, 3H, ArCH3), 
1.23-1.21 (m, 12H, 4 x CH3), 0.94-0.93 (m, 9H, SiC(CH3)3), 0.86-0.85 (m, 9H, SiC(CH3)3), 0.16-
0.14 (m, 6H, 2 x SiCH3), 0.07 (s, 3H, SiCH3), 0.01 (s, 3H, SiCH3). 
13
C NMR (125.7 MHz, d6-
acetone, ppm): 170.88, 170.87, 159.77, 155.58, 155.57, 155.56, 145.82, 140.87, 140.69, 140.62, 
136.54, 136.50, 131.01, 131.00, 129.01, 128.72, 127.77, 118.93, 114.02, 114.01, 104.12, 104.10, 
104.01, 87.96, 87.92, 87.57, 87.53, 87.46, 87.34, 87.24, 87.04, 86.87, 75.11, 75.06, 74.98, 74.93, 
72.76, 67.10, 64.23, 64.08, 63.80, 59.55, 59.41, 55.57, 44.01, 43.98, 43.91, 43.88, 42.54, 41.49, 
41.45, 41.34, 41.31, 26.35, 26.15, 26.04, 24.92, 24.91, 24.89, 24.87, 24.85, 24.83, 24.81, 20.79, 
20.77, 20.73, 20.72, 18.93, 18.91, 18.50, 12.48, 12.46, 12.12, -4.44, -4.69, -5.17, -5.18, -5.22.
31
P 
NMR (202.3 MHz, d6-acetone, ppm): 148.05, 147.68. IR (thin film); νmax (cm
−1
) = 3064, 2957, 
2929, 2856, 1714, 1673, 1608, 1536, 1509, 1471, 1363, 1329, 1253, 1124, 1035, 1002, 835, 782. 
HRMS (ESI-MS) m/z calculated forC66H98N6O13PSi2
+








To a solution of 6.6b (0.31 g, 0.28 mmol) and DIPEA (91 µL, 0.52 mmol) in THF (2.8 
mL) was added Cl-P(OCEt)(NiPr2) (93  µL, 0.42 mmol) and the reaction was allowed to stir at 
room temperature. After 20 min, the solvent was removed in vacuo and the crude was taken up 
276 
 
in EtOAc (50 mL), washed with aqueous NaHCO3 (3% w/v, 2 x 40mL), followed with brine (40 
mL). The organic layer dried over anhydrous Na2SO4 (~ 1 g), decanted and the solvent 
evaporated in vacuo. The crude product was purified via flash column chromatography using 
EtOAc (containing 0.1% v/v NEt3) as eluent to afford 0.32 g (87 %) of a colorless foam. Rf (SiO2 
TLC): 0.81, 0.70 EtOAc. λmax(MeCN) = 283 nm. 
1
H NMR (500MHz, d6-acetone, ppm): 7.94-7.93 
(m, 1H, H6), 7.81-7.78 (m, 1H, H6), 7.51-7.48 (m, 2H Ar), 7.39-7.24 (m, 7H, Ar), 6.92-6.89 (m, 
4H, Ar), 6.32-6.26 (m, 2H, H1’a & H1’b), 4.63-4.60 (m, 2H, H3’a & H3’b), 4.33-4.30 (m, 4H, 2 
x ArCH2), 4.25, 4.16 (m, 1H, H4’a), 4.02-3.82 (m, 5H, POCH2, H4’b, H5’a & H5’’a), 3.79 (s, 
6H, 2 x OCH3), 3.72-3.65 (m, 2H, 2 x NCH),  3.49 (m, 1H, H5’b), 3.35 (m, 1H, H5’’b), 2.80-
2.78 (m, 2H, CH2CN),  2.63-2.51 (m, 1H, H2’a), 2.42-2.37 (m, 1H, H2’b), 2.33-2.28 (m, 1H, 
H2’’b), 2.18-2.11 (m, 1H, H2’’a), 1.94-1.93 (m, 3H, ArCH3), 1.79-1.75 (m, 4H, 2 x CH2), 1.60 
(m, 3H, ArCH3), 1.50-1.47 (m, 6H, CH2CH2CH2), 1.23-1.21 (m, 12H, 4 x CH3), 0.94-0.93 (m, 
9H, SiC(CH3)3), 0.86-0.84 (m, 9H, SiC(CH3)3), 0.16-0.14 (m, 6H, 2 x SiCH3), 0.06 (s, 3H, 
SiCH3), 0.01 (s, 3H, SiCH3).  
13
C NMR (125.7 MHz, d6-acetone, ppm): 170.04, 170.03, 158.87, 
154.70, 144.91, 139.92, 139.73, 139.66, 135.64, 135.61, 130.11, 130.10, 128.13, 127.81, 126.87, 
118.05, 113.12, 113.10, 103.20, 103.19, 103.09, 87.05, 87.02, 86.66, 86.61, 86.56, 86.41, 86.33, 
86.13, 85.93, 74.21, 74.16, 74.08, 74.03, 71.83, 66.53, 66.51, 63.33, 63.18, 62.88, 58.66, 58.51, 
54.67, 43.11, 43.08, 43.02, 42.98, 41.63, 40.57, 40.54, 40.42, 40.39, 28.77, 28.32, 25.71, 25.46, 
25.26, 24.03, 24.01, 23.99, 23.97, 23.95, 23.94, 23.92, 19.89, 19.88, 19.84, 19.82, 18.03, 18.01, 
17.61, 11.60, 11.57, 11.23, -5.33, -5.59, -6.07, -6.08, -6.12. 
31
P NMR (202.3 MHz, d6-acetone, 
ppm): 148.04, 147.67. IR (thin film); νmax (cm
−1
) = 3064, 2957, 2931, 2857, 1714, 1673, 1608, 
1536, 1430, 1328, 1254, 1223, 1180, 1126, 1034, 1003, 835, 782. HRMS (ESI-MS) m/z 
calculated for C69H104N6O13PSi2
+





The synthesis of phosphoramidites 6.11a and 6.11b are shown in Scheme 6.2 
5’-O-(tert-butyldimethylsilyl)-3’-O-levulinyl-O4-hydroxybutyl-thymidine (6.8a)  
To a solution of 6.2 (1.0 g, 2.2 mmol) and triazole (3.4 g, 50 mmol) in MeCN : DCM (14 
mL : 14 mL) stirring at 0 
o
C was added NEt3 (7.1 mL, 51 mmol) followed by the dropwise 
addition of POCl3 (0.31 mL, 3.3 mmol). Additional POCl3 (0.20 mL, 2.1 mmol) was added 
dropwise after 10 min. After 30 min, the solvent was removed in vacuo and the content taken up 
in DCM (50 mL), then washed with a 3 % (w/v) aqueous solution of NaHCO3 (2 x 50mL). The 
solvent was dried over anhydrous Na2SO4, decanted and evaporated to produce the intermediate 
as a yellow gum. To a solution of this intermediate and 1,4-butanediol (0.22 g, 2.4 mmol) in 
MeCN (13 mL) was added DBU (0.40 mL, 2.6 mmol). After 16h, the solvent was removed in 
vacuo and the content taken up in EtOAc (50 mL), then washed with a 3 % (w/v) aqueous 
solution of NaHCO3 (2 x 50mL) followed with brine (50 mL). The solvent was dried over 
anhydrous Na2SO4 (≈ 4 g), decanted and then evaporated to afford a yellow gum. The product 
was purified via flash column chromatography using MeOH : DCM (1 % → 5 %) as eluent to 
afford 0.50 g (43 % over two steps) of a slightly yellow oil. Rf (SiO2 TLC): 0.10 EtOAc. 
λmax(MeCN) = 287 nm. 
1
H NMR (500MHz, CDCl3, ppm): 7.74 (d, 1H, H6, J = 1 Hz),  6.37 (dd, 
1H, H1’, J = 9 Hz & 5 Hz), 5.22 (m, 1H, H3’), 4.40 (t, 2H, ArOCH2, J = 6.0 Hz), 4.11 (m, 1H, 
H4’), 3.89-3.87 (m, 2H, H5’ & H5’’), 3.68 (m, 2H, CH2OH), 2.75 (m, 2H, COCH2), 2.61-2.55 
(m, 3H, H2’ & OOCCH2), 2.17 (s, 3H, COCH3), 1.99 (m, 1H, H2’’), 1.91-1.81 (m, 6H, ArCH3, 
OH, CH2), 1.67 (m, 2H, CH2), 0.87 (s, 9H, SiC(CH3)3), 0.084 (s, 3H, SiCH3), 0.079 (s, 3H, 
SiCH3). 
13
C NMR (125.7 MHz, CDCl3, ppm): 206.3, 172.4, 170.4, 155.9, 139.1, 104.7, 86.4, 
85.6, 75.9, 67.1, 63.5, 62.2, 39.0, 37.7, 29.8, 29.1, 27.9, 25.8, 25.0, 18.2, 12.2, -5.47, -5.56. IR 
(thin film); νmax (cm
−1
) = 3419, 2958, 2929, 2856, 2362, 2335, 1739, 1719, 1669, 1534, 1475, 
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1432, 1331, 1259, 1231, 1126, 836, 783. HRMS (ESI-MS) m/z calculated for C25H43N2O8Si
+
 




To a solution of 6.2 (2.3 g, 5.1 mmol) and triazole (10.3 g, 148 mmol) in MeCN : DCM 
(41 mL : 41 mL) stirring at 0 
o
C was added NEt3 (21 mL, 151 mmol) followed by the dropwise 
addition of POCl3 (0.92 mL, 9.9 mmol). Additional POCl3 (0.68 mL, 7.3 mmol) was added 
dropwise after 15 min. After 30 min, the solvent was removed in vacuo and the content taken up 
in DCM (50 mL), then washed with a 3 % (w/v) aqueous solution of NaHCO3 (2 x 75mL). The 
solvent was dried over anhydrous Na2SO4 (≈ 4 g), decanted and then evaporated to produce the 
intermediate as a yellow gum. To a solution of this intermediate and 1,7-butanediol (0.84 g, 6.3 
mmol) in MeCN (37 mL) was added DBU (1.14 mL, 7.6 mmol). After 16h, the solvent was 
removed in vacuo and the content taken up in EtOAc (70 mL) then washed with a 3 % (w/v) 
aqueous solution of NaHCO3 (2 x 50mL) and followed with brine (50 mL). The solvent was 
dried over anhydrous Na2SO4 (≈ 4 g), decanted and evaporated to afford a yellow gum. The 
product was purified via flash column chromatography using MeOH : DCM (0.5 % → 2 %) as 
eluent to afford 1.2 g (43 % over two steps) of a slightly yellow oil. Rf (SiO2 TLC): 0.18 
EtOAc:Hex (8 : 2). λmax(MeCN) = 288 nm. 
1
H NMR (500MHz, CDCl3, ppm): 7.72 (d, 1H, H6, J = 
1 Hz),  6.36 (dd, 1H, H1’, J = 9 Hz & 5 Hz), 5.21 (m, 1H, H3’), 4.34 (t, 2H, ArOCH2, J = 6.5 
Hz), 4.10 (m, 1H, H4’), 3.90-3.84 (m, 2H, H5’ & H5’’), 3.60 (m, 2H, CH2OH), 2.73 (m, 2H, 
COCH2), 2.60-2.53 (m, 3H, H2’ & OOCCH2), 2.16 (s, 3H, COCH3), 1.97 (m, 1H, H2’’), 1.89 (d, 
3H, ArCH3, J = 1Hz), 1.74-1.68 (m, 3H, OH & CH2), 1.53 (m, 2H, CH2), 1.40-1.33 (m, 6H, 
CH2CH2CH2) 0.86 (s, 9H, SiC(CH3)3), 0.072 (s, 3H, SiCH3), 0.066 (s, 3H, SiCH3). 
13
C NMR 
(125.7 MHz, CDCl3, ppm): 206.3, 172.4, 170.5, 156.0, 138.9, 104.7, 86.4, 85.6, 75.8, 67.3, 63.5, 
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62.8, 38.9, 37.7, 32.6, 29.7, 28.9, 28.4, 27.9, 25.8, 25.8, 25.8, 25.6, 18.2, 12.2, -5.49, -5.57. IR 
(thin film); νmax (cm
−1
) = 3426, 2961, 2931, 2856, 2362, 2336, 1739, 1721, 1669, 1535, 1473, 
1432, 1331, 1259, 1230, 1126, 837, 783.  HRMS (ESI-MS) m/z calculated for C28H49N2O8Si
+ 








-[5’-O-(tert-butyldimethylsilyl)-3’-O-levulinyl-thymidinyl]}-butane (6.9a)  
To a solution of 6.8a (0.50 g, 0.95 mmol), 3’-O-(tert-butyldimethylsilyl)-5’-O-(4,4’-
dimethoxytrityl)-N2-phenoxyacetyl-2’-deoxyguanosine (0.78 g, 0.95 mmol) and Ph3P (0.50, 1.9 
mmol) in dioxane (2.8 mL) was added DIAD (0.37 mL, 1.9 mmol) dropwise over 5 min while 
stirring. After 16h, additional DIAD (0.1 mL, 0.51 mmol) was added and the reaction was 
allowed to stir for another 2h. The solvent was removed in vacuo and the content taken up in 
DCM (50 mL) and washed with a 3 % (w/v) aqueous solution of NaHCO3 (2 x 50 mL). The 
solvent was dried over anhydrous Na2SO4 (≈ 4 g), decanted and evaporated to produce a yellow 
gum. The product was purified via flash column chromatography using MeOH : DCM (1 % → 2 
%) as eluent to afford 1.2 g of crude material (verified by 
1
H NMR, data not shown). The 
product was repurified via flash column chromatography using EtOAc : hexanes (3 : 2 → 4: 1) 
as eluent to afford 0.59 g (46 %) of a colorless foam. Rf (SiO2 TLC): 0.22 MeOH : DCM (2 %). 
λmax(MeCN) = 271 nm. 
1
H NMR (500MHz, CDCl3, ppm): 8.67 (broad s, 1H, NH), 8.03 (s, 1H, H8), 
7.76 (d, 1H, H6, J = 1 Hz),  7.39-7.17 (m, 11H, Ar), 7.04-6.99 (m, 3H, Ar), 6.78-6.76 (m, 4H, 
Ar), 6.42-6.38 (m, 2H, H1’a & H1’b), 5.24 (m, 1H, H3’b), 4.76 (broad s, 2H, PhOCH2CO), 4.65 
(m, 2H, ArOCH2), 4.57 (m, 1H, H3’a), 4.45 (m, 2H, ArOCH2), 4.13 (m, 1H, H4’b), 4.06 (m, 1H, 
H4’a), 3.92-3.86 (m, 2H, H5’b & H5’’b), 3.75 (s, 6H, 2 x OCH3), 3.32 (m, 2H, H5’a & H5’’a), 
2.78-2.54 (m, 6H, COCH2, OOCCH2, H2’a & H2’b), 2.43 (m, 1H, H2’’a), 2.19 (s, 3H, COCH3), 
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2.02-1.97 (m, 5H, H2’’b & CH2CH2), 1.92 (s, 3H, ArCH3), 0.89 (s, 9H, SiC(CH3)3), 0.85 (s, 9H, 
SiC(CH3)3), 0.10 (m, 6H, 2 x SiCH3), 0.03 (s, 3H, SiCH3), - 0.01 (s, 3H, SiCH3). 
13
C NMR 
(125.7 MHz, CDCl3, ppm): 206.29, 172.40, 170.38, 161.02, 158.48, 157.22, 155.89, 152.39, 
151.08, 144.51, 140.12, 139.12, 135.72, 135.68, 129.98, 129.97, 129.77, 128.09, 127.79, 126.83, 
122.25, 118.89, 114.91, 113.10, 104.66, 86.95, 86.45, 86.41, 85.64, 84.28, 75.91, 72.50, 68.01, 
67.16, 66.84, 63.56, 63.44, 55.17, 40.93, 38.96, 37.75, 29.77, 27.96, 25.85, 25.72, 25.47, 25.21, 
18.23, 17.93, 12.27, -4.70, -4.84, -5.45, -5.54. IR (thin film); νmax (cm
−1
) = 3412, 2956, 2928, 
2856, 2361, 2336, 1735, 1719, 1670, 1607, 1539, 1509, 1472, 1437, 1332, 1251, 1177, 1124, 
835, 782. HRMS (ESI-MS) m/z calculated for C70H92N7O15Si2
+











To a solution of 6.8b (0.75 g, 1.3 mmol), 3’-O-(tert-butyldimethylsilyl)-5’-O-(4,4’-
dimethoxytrityl)-N2-phenoxyacetyl-2’-deoxyguanosine (0.98 g, 1.2 mmol) and Ph3P (0.66, 2.5 
mmol) in dioxane (4.0 mL) was added DIAD (0.50 mL, 2.5 mmol) dropwise over 5 min while 
stirring. After 16h, the solvent was removed in vacuo and the content taken up in EtOAc (50 
mL), then washed with a 3 % (w/v) aqueous solution of NaHCO3 (2 x 50 mL) and followed with 
brine (50 mL). The solvent was dried over anhydrous Na2SO4 (≈ 4 g), decanted and then 
evaporated to produce a yellow gum. The product was purified via flash column chromatography 
using EtOAc : hexanes (3 : 2 → 4 : 1) as eluent to afford 0.98 g (71 %) of a colorless foam. Rf 
(SiO2 TLC): 0.70 EtOAc. λmax(MeCN) = 271 nm. 
1
H NMR (500MHz, CDCl3, ppm): 8.64 (broad s, 
1H, NH), 8.02 (s, 1H, H8), 7.75 (d, 1H, H6, J = 1 Hz),  7.40-7.17 (m, 11H, Ar), 7.05-7.00 (m, 
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3H, Ar), 6.78-6.76 (m, 4H, Ar), 6.42-6.39 (m, 2H, H1’a & H1’b), 5.24 (m, 1H, H3’b), 4.78 
(broad s, 2H, PhOCH2CO), 4.60-4.57 (m, 3H, H3’a & ArOCH2), 4.37 (t, 2H, ArOCH2, J = 7 
Hz), 4.13 (m, 1H, H4’b), 4.07 (m, 1H, H4’a), 3.93-3.87 (m, 2H, H5’b & H5’’b), 3.76 (s, 6H, 2 x 
OCH3), 3.33 (m, 2H, H5’a & H5’’a), 2.79-2.55 (m, 6H, COCH2, OOCCH2, H2’a & H2’b), 2.44 
(H2’’a), 2.19 (s, 3H, COCH3), 2.00 (m, 1H, H2’’b), 1.92-1.86 (m, 5H, ArCH3 & CH2), 1.75 (m, 
2H, CH2), 1.52 (m, 2H, CH2), 1.43-1.42 (m, 4H, CH2CH2), 0.89 (s, 9H, SiC(CH3)3), 0.85 (s, 9H, 
SiC(CH3)3) 0.104 (s, 3H, SiCH3), 0.098(s, 3H, SiCH3), 0.04 (s, 3H, SiCH3), - 0.01 (s, 3H, 
SiCH3). 
13
C NMR (125.7 MHz, CDCl3, ppm): 206.30, 172.41, 170.50, 161.21, 158.47, 155.96, 
152.33, 151.11, 144.51, 140.02, 138.93, 135.72, 135.69, 129.97, 129.76, 128.09, 127.79, 126.83, 
122.23, 118.93, 114.91, 113.10, 113.09, 104.76, 86.94, 86.44, 86.36, 85.60, 84.27, 75.91, 72.52, 
68.04, 67.82, 67.43, 63.57, 63.45, 55.17, 40.90, 38.94, 37.76, 29.77, 29.07, 28.78, 28.50, 27.96, 
25.90, 25.85, 25.72, 18.23, 17.94, 12.29, -4.70, -4.84, -5.45, -5.54. IR (thin film); νmax (cm
−1
) = 
3412, 2956, 2928, 2856, 2362, 2336, 1735, 1719, 1670, 1607, 1533, 1509, 1464, 1437, 1331, 











-[5’-O-(tert-butyldimethylsilyl)-thymidinyl]}-butane (6.10a)  
A solution (2.5 mL) of 0.5 M N2H4•H2O in pyridinium acetate (1/1, v/v) was added to 
6.9a (0.75 g, 0.57 mmol). After 15 min of stirring, the reaction was diluted with EtOAc (75 mL 
added), washed several times with a 3 % (w/v) aqueous solution of NaHCO3 (6 x 75 mL) and 
then with brine (75 mL). The solvent was dried over anhydrous Na2SO4 (≈ 4 g), decanted and 
evaporated to produce a yellow gum. The product was purified via flash column chromatography 
using MeOH : DCM (1.5 % → 3.5 %) as eluent to afford 0.41 g (58 %) of a colorless foam. Rf 
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(SiO2 TLC): 0.23 MeOH : DCM (3 %). λmax(MeCN) = 271 nm. 
1
H NMR (500MHz, CDCl3, ppm): 
8.68 (broad s, 1H, NH), 8.03 (s, 1H, H8), 7.77 (d, 1H, H6, J = 1 Hz),  7.40-7.16 (m, 11H, Ar), 
7.06-6.99 (m, 3H, Ar), 6.78-6.76 (m, 4H, Ar), 6.42 (dd, 1H, H1’a, J = 6.5 Hz), 6.38 (dd, 1H, 
H1’b, J = 7.5 , 6 Hz), 4.76 (broad s, 2H, PhOCH2CO), 4.65 (m, 2H, ArOCH2), 4.57 (m, 1H, 
H3’a), 4.46-4.43 (m, 3H, H3’b & ArOCH2), 4.08-406 (m, 2H, H4’a & H4’b), 3.91 (dd, 1H, 
H5’b, J = 11, 3 Hz), 3.83 (dd, 1H, H5’’b, J = 11, 3 Hz), 3.76 (s, 6H, 2 x OCH3), 3.33-3.32 (m, 
2H, H5’a & H5’’a), 2.83 (d, 1H, OH, J = 4.5 Hz), 2.69 (m, 1H, H2’a), 2.59 (m, 1H, H2’b), 2.44 
(m, 1H, H2’’a), 2.02-1.97 (m, 5H, H2’’b & CH2CH2), 1.92 (d, 3H, ArCH3, J = 1 Hz), 0.89 (s, 
9H, SiC(CH3)3), 0.85 (s, 9H, SiC(CH3)3), 0.09 (s, 3H, SiCH3), 0.08 (s, 3H, SiCH3), 0.04 (s, 3H, 
SiCH3), - 0.01 (s, 3H, SiCH3). 
13
C NMR (125.7 MHz, CDCl3, ppm): 170.38, 161.03, 158.48, 
157.23, 156.01, 152.39, 151.08, 144.51, 140.11, 139.45, 135.73, 135.69, 129.99, 129.97, 129.77, 
128.09, 127.80, 126.83, 122.25, 118.89, 114.92, 113.11, 104.48, 87.31, 86.95, 86.63, 86.45, 
84.28, 72.50, 72.39, 68.01, 67.18, 66.80, 63.47, 55.18, 42.22, 40.94, 25.87, 25.72, 25.48, 25.22, 
18.30, 17.94, 12.29, -4.69, -4.84, -5.42, -5.49. IR (thin film); νmax (cm
−1
) = 3409, 3057, 2954, 
2929, 2857, 2362, 1724, 1663, 1608, 1532, 1509, 1496, 1462, 1441, 1380, 1362, 1251, 1177, 
1067, 940, 835, 782.HRMS (ESI-MS) m/z calculated for C65H86N7O13Si2
+










A solution (3.1 mL) of 0.5 M N2H4•H2O in pyridinium acetate (1/1, v/v) was added to 
6.9b (0.95 g, 0.70 mmol). After 20 min of stirring, the reaction was diluted with EtOAc (70 mL 
added), then washed several times with a 3 % (w/v) aqueous solution of NaHCO3 (6 x 75 mL) 
followed with brine (75 mL). The solvent was dried over anhydrous Na2SO4 (≈ 4 g), decanted 
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and evaporated to produce a yellow gum. The product was purified via flash column 
chromatography using MeOH : DCM (2 % → 3.5 %) as eluent to afford 0.64 g (73 %) of a 
colorless foam. Rf (SiO2 TLC): 0.68 EtOAc. λmax(MeCN) = 271 nm. 
1
H NMR (500MHz, CDCl3, 
ppm): 8.66 (broad s, 1H, NH), 8.02 (s, 1H, H8), 7.78 (d, 1H, H6, J = 1 Hz),  7.39-7.17 (m, 11H, 
Ar), 7.05-6.99 (m, 3H, Ar), 6.78-6.76 (m, 4H, Ar), 6.43-6.37 (m, 2H, H1’a & H1’b), 4.78 (broad 
s, 2H, PhOCH2CO), 4.58-4.56 (m, 3H, H3’a & ArOCH2), 4.44 (m, 1H, H3’b), 4.36 (t, 2H, 
ArOCH2, J = 6.5 Hz), 4.10-406 (m, 2H, H4’a & H4’b), 3.91 (dd, 1H, H5’b, J = 11, 3 Hz), 3.82 
(dd, 1H, H5’’b, J = 11, 3 Hz), 3.76 (s, 6H, 2 x OCH3), 3.33-3.32 (m, 2H, H5’a & H5’’a), 3.26 (d, 
1H, OH, J = 4 Hz), 2.69 (m, 1H, H2’a), 2.61 (m, 1H, H2’b), 2.43 (m, 1H, H2’’a), 2.02 (m, 1H, 
H2’’b), 1.94-1.86 (m, 5H, ArCH3 & CH2), 1.75 (m, 2H, CH2), 1.52 (m, 2H, CH2), 1.43-1.42 (m, 
4H, 2 x CH2),  0.89 (s, 9H, SiC(CH3)3), 0.85 (s, 9H, SiC(CH3)3), 0.09 (s, 3H, SiCH3), 0.08 (s, 
3H, SiCH3), 0.04 (s, 3H, SiCH3), - 0.01 (s, 3H, SiCH3). 
13
C NMR (125.7 MHz, CDCl3, ppm): 
170.5, 161.2, 158.5, 156.1, 152.3, 151.1, 144.5, 140.0, 139.3, 135.73, 135.70, 130.0, 129.8, 
128.1, 127.8, 126.8, 122.2, 118.9, 114.9, 113.1, 113.1, 104.6, 87.4, 86.9, 86.7, 86.4, 84.3, 72.5, 
72.3, 68.1, 67.8, 67.4, 63.50, 63.45, 55.2, 42.2, 40.9, 29.1, 28.8, 28.5, 25.9, 25.7, 18.3, 17.9, 12.3, 
-4.69, -4.84, -5.42, -5.48. IR (thin film); νmax (cm
−1
) = 3409, 3060, 2953, 2930, 2857, 2361, 
2337, 1723, 1663, 1608, 1533, 1508, 1496, 1464, 1437, 1375, 1329, 1250, 1177, 1065, 1034, 
940, 834, 781. HRMS (ESI-MS) m/z calculated for C68H92N7O13Si2
+













To a solution of compound 6.10a (0.20 g, 0.16 mmol) and DIPEA (53 μL, 0.31 mmol) in 
THF (2 mL) was added Cl-POCENiPr2 (54 μL, 0.25 mmol) dropwise while stirring. After 30 
min, the solvent was evaporated in vacuo and the content was diluted with EtOAc (50 mL), then 
washed with NaHCO3 (aq, 3%) (2 x 35 mL) and followed by brine (35 mL). The solvent was 
dried over anhydrous Na2SO4, decanted and then evaporated to produce a yellow gum. 
Purification was achieved via short flash column chromatography using EtOAc (containing 0.1 
% NEt3) as eluent to afford 0.16 g (69 %) of a colorless foam. Rf (SiO2 TLC): 0.86, 0.81 EtOAc. 
λmax(MeCN) = 271 nm. 
1
H NMR (500MHz, d6-acetone, ppm): 9.33 (s, 1H, NH), 8.22 (s, 1H, H8), 
7.82-7.79 (m, 1H, H6),  7.42-7.40 (m, 2H, Ar), 7.35-7.17 (m, 6H, Ar), 7.24-7.16 (m, 3H, Ar), 
7.05-6.98 (m, 3H, Ar), 6.91-6.75 (m, 4H, Ar ), 6.48-6.45 (m, 1H, H1’a), 6.33-6.29 (m, 1H, 
H1’b), 5.04 (bs, 2H, PhOCH2CO), 4.90 (m, 1H, H3’a), 4.68-4.60 (m, 3H, H3’b & ArOCH2), 
4.45-4.42 (m, 2H, ArOCH2), 4.26 & 4.16 (m, 1H, H4’b), 4.06-4.04 (m, 1H, H4’a), 3.99-3.83 (m, 
4H, H5’b, H5’’b & CH2OP), 3.77-3.66 (m, 8H, 2x (CH)N & 2 x OCH3), 3.48-3.44 (m, 1H, 
H5’a), 3.38-3.35 (m, 1H, H5’’a), 3.11-3.08 (m, 1H, H2’a), 2.82-2.79 (m, 2H, CH2CN), 2.64-2.59 
(m, 1H, H2’b), 2.50-2.45 (m, 1H, H2’’a), 2.19-2.12 (m, 1H, H2’’b), 2.08-1.97 (m, 4H, CH2CH2, 
overlapping with acetone solvent residual peak),  1.94 (m, 3H, ArCH3), 1.24-1.21 (m, 12H, 4 x 
CH3), 0.94 (m, 9H, SiC(CH3)3) , 0.87 (m, 9H, SiC(CH3)3), 0.16-0.15 (m, 6H, 2 x SiCH3), 0.09 
(m, 3H, SiCH3), 0.04 (m, 3H, SiCH3) . 
13
C NMR (125.7 MHz, d6-acetone, ppm): 170.0, 160.9, 
158.6, 158.6, 158.2, 154.8, 154.8, 152.7, 151.5, 145.3, 141.2, 139.8, 139.7, 136.0, 135.9, 130.1, 
130.0, 129.5, 128.1, 127.5, 126.5, 121.3, 118.8, 118.1, 114.8, 112.9, 112.8, 103.3, 103.2, 87.1, 
87.0, 86.8, 86.7, 86.6, 86.4, 86.2, 86.1, 84.5, 74.21, 74.16, 74.1, 74.0, 72.5, 67.9, 66.7, 66.1, 64.1, 
63.3, 63.2, 58.7, 58.5, 54.6, 43.1, 43.1, 43.03, 42.99, 40.6, 40.4, 39.5, 25.5, 25.4, 25.3, 25.1, 
24.03, 24.02, 23.98, 23.96, 23.9, 19.90, 19.88, 19.84, 19.83, 18.04, 18.02, 17.6, 11.60, 11.58, -
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5.36, -5.50, -6.07, -6.12. 
 31
P NMR (202.3 MHz, d6-acetone, ppm): 148.03, 147.68. HRMS (ESI-
MS) m/z calculated for C74H103N9O14PSi2
+










To a solution of compound 6.10b (0.20 g, 0.16 mmol) and DIPEA (52 μL, 0.31 mmol) in 
THF (2 mL) was added Cl-POCENiPr2 (52 μL, 0.25 mmol) dropwise while stirring. After 30 
min, the solvent was evaporated in vacuo and the content was diluted with EtOAc (50 mL), then 
washed with NaHCO3 (aq, 3%) (2 x 35 mL) followed with brine (35 mL). The solvent was dried 
over anhydrous Na2SO4, decanted and then evaporated to produce a yellow gum. Purification 
was achieved via short flash column chromatography using EtOAc (containing 0.1 % NEt3) as 
eluent to afford 0.21 g (89 %) of a colorless foam. Rf (SiO2 TLC): 0.92, 0.90 EtOAc. λmax(MeCN) = 
272 nm. 
1
H NMR (500MHz, d6-acetone, ppm): 9.30 (s, 1H, NH), 8.23 (s, 1H, H8), 7.80 & 7.80 
(m, 1H, H6),  7.43-7.40 (m, 2H, Ar), 7.34-7.16 (m, 6H, Ar), 7.24-7.16 (m, 3H, Ar), 7.05-6.98 (m, 
3H, Ar), 6.81-6.75 (m, 4H, Ar ), 6.47-6.45 (m, 1H, H1’a), 6.33-6.29 (m, 1H, H1’b), 5.05 (bs, 2H, 
PhOCH2CO), 4.89 (m, 1H, H3’a), 4.64-4.59 (m, 3H, H3’b & ArOCH2), 4.33-4.31 (m, 2H, 
ArOCH2), 4.26 & 4.16 (m, 1H, H4’b), 4.07-4.04 (m, 1H, H4’a), 3.99-3.81 (m, 4H, H5’b, H5’’b 
& CH2OP), 3.75-3.65 (m, 8H, 2x (CH)N & 2 x OCH3), 3.47-3.44 (m, 1H, H5’a), 3.38-3.35 (m, 
1H, H5’’a), 3.11-3.07 (m, 1H, H2’a), 2.82-2.78 (m, 2H, CH2CN), 2.64-2.53 (m, 1H, H2’b), 2.50-
2.45 (m, 1H, H2’’a), 2.17-2.12 (m, 1H, H2’’b), 1.94 (m, 3H, ArCH3), 1.92-1.89 (m, 2H, CH2), 
1.79-1.77 (m, 2H, CH2), 1.54-1.48 (m, 6H, (CH2)3),  1.24-1.22 (m, 12H, 4 x CH3), 0.95-0.94 (m, 
9H, SiC(CH3)3) , 0.87 (m, 9H, SiC(CH3)3), 0.17-0.15 (m, 6H, 2 x SiCH3), 0.09 (m, 3H, SiCH3), 
0.04 (m, 3H, SiCH3). 
13
C NMR (125.7 MHz, d6-acetone, ppm): 170.1, 161.0, 158.6, 158.6, 
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158.2, 154.8, 152.6, 151.6, 145.3, 141.2, 139.7, 139.7, 136.0, 135.9, 130.1, 130.0, 129.5, 128.1, 
127.5, 126.5, 121.3, 118.7, 114.8, 112.9, 112.8, 103.3, 103.2, 86.8, 86.3, 86.14, 86.06, 84.5, 74.0, 
72.5, 67.9, 67.1, 66.5, 64.1, 63.3, 63.2, 59.6, 58.7, 58.5, 54.6, 43.1, 43.1, 43.02, 42.99, 39.5, 28.3, 
25.7, 25.7, 25.5, 25.3, 24.01, 23.97, 23.95, 19.88, 19.83, 18.0, 17.6, 13.6, 11.6, 11.6, -5.37, -5.51, 
-6.09, -6.13.
 31
P NMR (202.3 MHz, d6-acetone, ppm): 148.03, 147.67. HRMS (ESI-MS) m/z 
calculated for C77H109N9O14PSi2
+
 1470.7365: found 1470.7380 [M+H]
+
.  
The synthesis of phosphoramidites 6.16a and 6.16b are shown in Scheme 6.3 
5’-O-(tert-butyldimethylsilyl)-3’-O-levulinyl-N2-phenoxyacetyl-2’-deoxyguanosine (6.13) 
N2-Phenoxyacetyl-2’-deoxyguanosine (6.12) (3.0 g, 7.5 mmol) was co-evaporated thrice 
with anhydrous pyridine (3 x 10 mL). To a solution of the dried residue in pyridine (45 mL) 
stirring at 0 
o
C was added TBS-Cl (1.2 g, 7.8 mmol) which was then allowed to warm slowly to 
22 
o
C. After 16h, the solvent was removed in vacuo and the content taken up in DCM (100 mL), 
washed with distilled water (50 mL) followed with a saturated solution of NaHCO3(aq) (75 mL). 
A gel-like material formed in the organic layer after the second wash, which was then solubilized 
by the addition of MeOH (5 mL). The solvent was then dried over anhydrous Na2SO4 (≈ 4 g), 
decanted and evaporated to produce a yellow gum. The residue was placed on high vacuum for 
2h before being used for the subsequent step. To a solution of the dried residue, EDAC • HCl 
(2.9 g, 14.9 mmol), and DMAP (cat) in dioxane (54 mL) was added levulinic acid (1.73 g, 14.9 
mmol) and allowed to stir at 22 
o
C. After 16h, the solvent was removed in vacuo and the content 
taken up in DCM (50 mL), washed with a saturated solution of NaHCO3(aq) (2 x 50 mL) followed 
with brine (50 mL). The solvent was dried over anhydrous Na2SO4 (≈ 4 g), decanted and 
evaporated to produce a yellow gum. The product was purified via flash column chromatography 
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using MeOH : DCM (1.0 % → 1.5 %) as eluent to afford 3.1 g (67 % over two steps) of a 
slightly yellow solid. Rf (SiO2 TLC):0.46 MeOH : DCM (5 %). λmax(MeCN) = 285, 259 nm. 
1
H 
NMR (500MHz, CDCl3, ppm): 11.80 (br, 1H, NH), 9.40 (br, 1H, NH), 8.06 (s, 1H, H8), 7.34-
7.31 (m, 2H, Ar), 7.05 (m, 1H, Ar), 6.99-6.97 (m, 2H, Ar), 6.26 (dd, 1H, H1’, J = 8, 6.5 Hz), 
5.38 (m, 1H, H3’), 4.70 (s, 2H, PhOCH2CO), 4.16 (m, 1H, H4’), 3.85-3.78 (m, 2H, H5’ & H5’’), 
2.79-2.77 (m, 2H, COCH2), 2.60-2.55 (m, 2H, OOCCH2), 2.10 (s, 3H, COCH3), 0.86 (s, 9H, 
SiC(CH3)3), 0.059 (s, 3H, SiCH3), 0.057 (s, 3H, SiCH3). 
13
C NMR (125.7 MHz, CDCl3, ppm): 
206.5, 172.3, 169.7, 156.5, 155.3, 147.6, 146.3, 137.0, 129.9, 122.9, 121.6, 114.9, 85.7, 83.8, 
75.5, 67.03, 66.98, 63.6, 38.9, 37.8, 29.8, 27.9, 25.9, 25.8, 18.3, -5.45, -5.61. IR (thin film); νmax 
(cm
−1
) = 3417, 2956, 2928, 2856, 2363, 2335, 1717, 1700, 1616, 1559, 1506, 1496, 1473, 1457, 
1405, 1360, 1258, 1208, 1155, 1075, 1004, 936, 838, 782. HRMS (ESI-MS) m/z calculated for 
C29H40N5O8Si
+






(tert-butyldimethylsilyl)-3’-O-levulinyl-N2-phenoxyacetyl-2'-deoxyguanidyl]}-butane (6.14a)  
To a solution of 6.13 (0.76 g, 1.2 mmol), 6.4a (1.0 g, 1.4 mmol) and Ph3P (0.68, 2.6 
mmol) in dioxane (4.0 mL) was added DIAD (0.51 mL, 2.6 mmol) dropwise over 5 min while 
stirring. After 16h, additional DIAD (0.11 mL, 0.54 mmol) was added and the reaction was 
allowed to stir for another 2h. The solvent was removed in vacuo and the content taken up in 
EtOAc (75 mL) then washed with a 3 % (w/v) aqueous solution of NaHCO3 (2 x 75 mL) 
followed with brine (75 mL). The solvent was dried over anhydrous Na2SO4 (≈ 4 g), decanted 
and evaporated to produce a yellow gum. The product was purified via flash column 
chromatography using EtOAc : hexanes (3 : 2 → 100 % EtOAc) as eluent to afford 0.85 g (52 
%) of a colorless foam. Rf (SiO2 TLC): 0.45 EtOAc. λmax(MeCN) = 270 nm. 
1
H NMR (500MHz, 
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CDCl3, ppm): 8.77 (broad s, 1H, NH), 8.23 (s, 1H, H8), 7.93 (d, 1H, H6, J = 1 Hz),  7.41-7.21 
(m, 11H, Ar), 7.05-7.00 (m, 3H, Ar), 6.84-6.80 (m, 4H, Ar), 6.51 (dd, 1H, H1’a, J = 6 & 8 Hz), 
6.32 (dd, 1H, H1’b, J = 6 Hz), 5.43 (m, 1H, H3’a), 4.77 (broad s, 2H, PhOCH2CO), 4.64 (t, 2H, 
ArOCH2, J = 6 Hz), 4.49-4.43 (m, 3H, ArOCH2 & H3’b), 4.19 (m, 1H, H4’a), 3.96 (m, 1H, 
H4’b), 3.90-3.88 (m, 2H, H5’a & H5’’a), 3.78 (s, 6H, 2 x OCH3), 3.51 (dd, 1H, H5’b, J= 3 & 11 
Hz), 3.25 (d, 1H, H5’’b, J = 3 & 11 Hz), 2.78 (m, 2H, OOCCH2), 2.67-2.61 (m, 4H, CH2CO, 
H2’a & H2’’a), 2.48 (m, 1H, H2’b), 2.22-2.17 (m, 4H, H2’’b & COCH3), 2.04-1.96 (m, 4H, 
CH2CH2), 1.50 (d, 3H, ArCH3, J = 1 Hz), 0.90 (s, 9H, SiC(CH3)3), 0.79 (s, 9H, SiC(CH3)3), 0.10 
(s, 3H, SiCH3), 0.09 (s, 3H, SiCH3), -0.01 (s, 3H, SiCH3), - 0.08 (s, 3H, SiCH3). 
13
C NMR (125.7 
MHz, CDCl3, ppm): 206.3, 172.4, 170.3, 161.0, 158.7, 157.2, 155.9, 152.5, 151.2, 144.4, 139.8, 
139.5, 135.49, 135.47, 130.08, 130.06, 129.8, 128.2, 127.9, 127.0, 122.3, 118.6, 114.9, 113.2, 
113.2, 104.5, 86.6, 86.5, 86.2, 85.7, 84.0, 75.7, 71.0, 68.0, 67.2, 66.7, 63.7, 62.4, 55.2, 42.2, 39.1, 
37.8, 29.8, 28.0, 26.0, 25.7, 25.4, 25.2, 18.4, 17.9, 11.7, -4.64, -4.97, -5.40, -5.56. IR (thin film); 
νmax (cm
−1
) = 3411, 3060, 2956, 2929, 2856, 2362, 2336, 1734, 1718, 1669, 1607, 1532, 1509, 
1472, 1437, 1329, 1301, 1251, 1177, 1154, 1070, 836, 781. HRMS (ESI-MS) m/z calculated for 
C70H92N7O15Si2
+






(tert-butyldimethylsilyl)-3’-O-levulinyl-N2-phenoxyacetyl-2'-deoxyguanidyl]}-heptane (6.14b)  
To a solution of 6.13 (0.71 g, 1.2 mmol), 6.4b (1.0 g, 1.3 mmol) and Ph3P (0.64, 2.5 
mmol) in dioxane (3.8 mL) was added DIAD (0.48 mL, 2.5 mmol) dropwise over 5 min while 
stirring. After 16h, the solvent was removed in vacuo and the content taken up in EtOAc (75 mL) 
then washed with a 3 % (w/v) aqueous solution of NaHCO3 (2 x 75 mL) followed with brine (75 
mL). The solvent was dried over anhydrous Na2SO4 (≈ 4 g), decanted and evaporated to produce 
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a yellow gum. The product was purified via flash column chromatography using EtOAc : 
hexanes (1 : 1 → 4 : 1) as eluent to afford 0.76 g (48 %) of a colorless foam. Rf (SiO2 TLC): 0.70 
EtOAc. λmax(MeCN) = 270 nm. 
1
H NMR (500MHz, CDCl3, ppm): 8.75 (broad s, 1H, NH), 8.22 (s, 
1H, H8), 7.91 (d, 1H, H6, J = 1 Hz),  7.68-7.20 (m, 11H, Ar), 7.04-7.01 (m, 3H, Ar), 6.84-6.80 
(m, 4H, Ar), 6.51 (dd, 1H, H1’a, J = 6 & 9 Hz), 6.32 (dd, 1H, H1’b, J = 6 Hz), 5.42 (m, 1H, 
H3’a), 4.79 (broad s, 2H, PhOCH2CO), 4.58 (t, 2H, ArOCH2, J = 6.5 Hz), 4.47 (m, 1H, H3’b), 
4.35 (t, 2H, ArOCH2, J = 7 Hz), 4.19 (m, 1H, H4’a), 3.95 (m, 1H, H4’b), 3.90-3.88 (m, 2H, 
H5’a & H5’’a), 3.78 (s, 6H, 2 x OCH3), 3.51 (dd, 1H, H5’b, J= 3 & 11 Hz), 3.24 (dd, 1H, H5’’b, 
J = 3 & 11 Hz), 2.78 (m, 2H, OOCCH2), 2.67-2.61 (m, 4H, CH2CO, H2’a & H2’’a), 2.48 (m, 
1H, H2’b), 2.22-2.17 (m, 4H, H2’’b & COCH3), 1.89 (m, 2H, CH2), 1.75-1.71 (m, 4H, 2 x CH2),  
1.50 (d, 3H, ArCH3, J = 1 Hz), 1.43-1.40 (m, 4H, 2 x CH2), 0.90 (s, 9H, SiC(CH3)3), 0.79 (s, 9H, 
SiC(CH3)3), 0.10 (s, 3H, SiCH3), 0.09 (s, 3H, SiCH3), -0.02 (s, 3H, SiCH3), - 0.08 (s, 3H, 
SiCH3). 
13
C NMR (125.7 MHz, CDCl3, ppm):
 
206.3, 172.4, 170.5, 161.2, 158.6, 155.9, 152.5, 
151.2, 144.4, 139.7, 139.3, 135.5, 132.1, 132.0, 130.08, 130.06, 129.8, 128.5, 128.4, 128.2, 
127.9, 127.0, 122.3, 118.6, 114.9, 113.2, 113.2, 104.6, 86.6, 86.5, 86.2, 85.7, 84.0, 75.7, 71.1, 
68.0, 67.8, 67.3, 63.7, 62.4, 55.2, 42.2, 39.1, 37.8, 29.8, 29.1, 28.9, 28.5, 28.0, 26.0, 25.9, 25.7, 
18.4, 17.9, 14.2, 11.8, -4.64, -4.97, -5.40, -5.56. IR (thin film); νmax (cm
−1
) = 3411, 3059, 2954, 
2930, 2856, 2362, 2336, 1734, 1718, 1669, 1607, 1529, 1509, 1472, 1437, 1378, 1328, 1301, 
1252, 1177, 1155, 1071, 836, 782, 734. HRMS (ESI-MS) m/z calculated for C73H98N7O15Si2
+
 









A solution (2.8 mL) of 0.5 M N2H4•H2O in pyridinium acetate (1/1, v/v) was added to 
6.14a (0.85 g, 0.64 mmol). After 30 min of stirring, the reaction was diluted with EtOAc (70 mL 
added), washed several times with a 3 % (w/v) aqueous solution of NaHCO3 (6 x 75 mL) 
followed with brine (75 mL). The solvent was dried over anhydrous Na2SO4 (≈ 4 g), decanted 
and evaporated to produce a yellow gum. The product was purified via flash column 
chromatography using MeOH : DCM (1.5 % → 2.5 %) as eluent to afford 0.57 g (73 %) of a 
colorless foam. Rf (SiO2 TLC):0.17 MeOH : DCM (4 %). λmax(MeCN) = 270 nm.. 
1
H NMR 
(500MHz, CDCl3, ppm): 8.85 (broad s, 1H, NH), 8.23 (s, 1H, H8), 7.95 (d, 1H, H6, J = 1 Hz),  
7.42-7.40 (m, 2H, Ar), 7.36-7.23 (m, 9H, Ar), 7.07-7.01 (m, 3H, Ar), 6.84-6.82 (m, 4H, Ar), 6.70 
(dd, 1H, H1’a, J = 6.8 Hz), 6.33 (dd, 1H, H1’b, J = 6 Hz), 4.77 (m, 3H, H3’a & PhOCH2CO), 
4.62 (t, 2H, ArOCH2, J = 6 Hz), 4.50-4.43 (m, 3H, ArOCH2 & H3’b), 4.17 (m, 1H, H4’a), 3.97 
(m, 1H, H4’b), 3.89-3.88 (m, 2H, H5’a & H5’’a), 3.79 (s, 6H, 2 x OCH3), 3.52 (dd, 1H, H5’b, J= 
3 & 11 Hz), 3.26 (dd, 1H, H5’’b, J = 3 & 11 Hz), 2.64-2.61 (m, 2H, H2’a & H2’’a), 2.49 (m, 
1H, H2’b), 2.20 (m, 1H, H2’’b), 2.03-1.96 (m, 4H, CH2CH2), 1.51 (d, 3H, ArCH3, J = 1 Hz), 
0.91 (s, 9H, SiC(CH3)3), 0.80 (s, 9H, SiC(CH3)3), 0.10 (s, 3H, SiCH3), 0.09 (s, 3H, SiCH3), 0.00 
(s, 3H, SiCH3), - 0.07 (s, 3H, SiCH3). 
13
C NMR (125.7 MHz, CDCl3, ppm): 170.4, 161.0, 158.7, 
157.1, 155.9, 152.4, 150.9, 144.4, 140.4, 139.5, 135.49, 135.47, 130.09, 130.06, 129.8, 128.2, 
127.9, 127.1, 122.4, 118.8, 114.9, 113.21, 113.18, 104.6, 87.8, 86.6, 86.5, 86.2, 84.3, 72.5, 71.0, 
67.9, 67.1, 66.7, 63.9, 62.3, 58.5, 55.2, 42.2, 41.6, 29.7, 26.0, 25.7, 25.4, 25.2, 18.4, 17.9, 11.7, 
8.26, -4.63, -4.96, -5.36, -5.50. IR (thin film); νmax (cm
−1
) = 3411, 3059, 2957, 2928, 2856, 2362, 
2335, 1717, 1663, 1608, 1532, 1509, 1472, 1437, 1381, 1329, 1301, 1251, 1176, 1150, 1064, 
1034, 835, 781, 734. HRMS (ESI-MS) m/z calculated for C65H86N7O13Si2
+










A solution (2.4 mL) of 0.5 M N2H4•H2O in pyridinium acetate (1/1, v/v) was added to 
6.14b (0.74 g, 0.54 mmol). After 30 min of stirring, the reaction was diluted with EtOAc (70 mL 
added), then washed several times with a 3 % (w/v) aqueous solution of NaHCO3 (6 x 75 mL) 
followed with brine (75 mL). The solvent was dried over anhydrous Na2SO4 (≈ 4 g), decanted 
and evaporated to produce a yellow gum. The product was purified via flash column 
chromatography using MeOH : DCM (1.5 % → 2.5 %) as eluent to afford 0.55 g (80 %) of a 
colorless foam. Rf (SiO2 TLC):0.23 MeOH : DCM (4 %). λmax(MeCN) = 270 nm. 
1
H NMR 
(500MHz, CDCl3, ppm): 8.80 (broad s, 1H, NH), 8.21 (s, 1H, H8), 7.92 (d, 1H, H6, J = 1 Hz),  
7.42-7.40 (m, 2H, Ar), 7.36-7.21 (m, 9H, Ar), 7.06-7.01 (m, 3H, Ar), 6.84-6.81 (m, 4H, Ar), 6.66 
(dd, 1H, H1’a, J = 6.5 Hz), 6.33 (dd, 1H, H1’b, J = 6 Hz), 4.75 (m, 3H, H3’a & PhOCH2CO), 
4.57 (t, 2H, ArOCH2, J = 6.5 Hz), 4.47 (m, 1H, H3’b), 4.35 (t, 2H, ArOCH2, J = 7 Hz), 4.15 (m, 
1H, H4’a), 3.96 (m, 1H, H4’b), 3.89-3.88 (m, 2H, H5’a & H5’’a), 3.79 (s, 6H, 2 x OCH3), 3.52 
(dd, 1H, H5’b, J= 3 & 11.5 Hz), 3.26 (dd, 1H, H5’’b, J = 3 & 11.5 Hz), 2.64-2.61 (m, 2H, H2’a 
& H2’’a), 2.49 (m, 1H, H2’b), 2.20 (m, 1H, H2’’b), 1.88 (m, 2H, CH2), 1.74 (m, 2H, CH2), 1.51 
(m, 5H, CH2 & ArCH3), 1.43-1.41 (m, 4H, CH2CH2) 0.91 (s, 9H, SiC(CH3)3), 0.80 (s, 9H, 
SiC(CH3)3), 0.10 (s, 3H, SiCH3), 0.09 (s, 3H, SiCH3), -0.01 (s, 3H, SiCH3), - 0.07 (s, 3H, 
SiCH3). 
13
C NMR (125.7 MHz, CDCl3, ppm): 170.5, 161.2, 158.7, 156.0, 152.3, 151.0, 144.4, 
140.3, 139.3, 135.5, 132.1, 132.0, 130.09, 130.07, 129.8, 128.5, 128.4, 128.2, 127.9, 127.0, 
122.4, 118.8, 114.9, 113.20, 113.18, 104.6, 87.6, 86.6, 86.5, 86.2, 84.2, 72.5, 71.1, 68.0, 67.8, 
67.3, 67.1, 63.8, 62.4, 55.2, 42.2, 41.5, 29.1, 28.8, 28.5, 26.0, 25.9, 25.7, 18.4, 17.9, 11.8, -4.64, -
4.96, -5.36, -5.50. IR (thin film); νmax (cm
−1
) = 3411, 3059, 2953, 2930, 2856, 2362, 2336, 1717, 
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1668, 1607, 1531, 1509, 1471, 1437, 1379, 1328, 1302, 1251, 1176, 1110, 1066, 1034, 835, 781, 
733. HRMS (ESI-MS) m/z calculated for C68H91N7O13Si2Na
+









To a solution of compound 6.15a (0.20 g, 0.16 mmol) and DIPEA (53 μL, 0.31 mmol) in 
THF (2 mL) was added Cl-POCENiPr2 (54 μL, 0.25 mmol) dropwise while stirring. After 35 
min, the solvent was evaporated in vacuo and the content was diluted with EtOAc (50 mL), then 
washed with 3% (w/v) NaHCO3(aq) (2 x 35 mL) followed by brine (35 mL). The solvent was 
dried over anhydrous Na2SO4, decanted and evaporated to produce a yellow gum. Purification 
was achieved via short flash column chromatography using an EtOAc (containing 0.1 % NEt3) as 
eluent to afford 0.19 g (83 %) of a colorless foam. Rf (SiO2 TLC): 0.84, 0.76 EtOAc. λmax(MeCN) = 
271 nm. 
1
H NMR (500MHz, d6-acetone, ppm) ): 9.43 (s, 1H, NH), 8.28-8.27 (s, 1H, H8), 7.94 
(m, 1H, H6),  7.51-7.49 (m, 2H, Ar), 7.40-7.25 (m, 9H, Ar), 7.06-6.97 (m, 3H, Ar), 6.93-6.90 (m, 
4H, Ar ), 6.51-6.47 (m, 1H, H1’a), 6.29-6.27 (m, 1H, H1’b), 5.10 (s, 2H, PhOCH2CO), 4.89-4.83 
(m, 1H, H3’a), 4.69-4.61 (m, 3H, H3’b & ArOCH2), 4.44-4.41 (m, 2H, ArOCH2), 4.26 & 4.17 
(m, 1H, H4’a), 4.03-3.62 (m, 13H, H4’b, H5’a, H5’’a, CH2OP, 2x (CH)N & 2 x OCH3), 3.51-
3.48 (m, 1H, H5’b), 3.37-3.34 (m, 1H, H5’’b), 3.07-2.98 (m, 1H, H2’a), 2.82-2.61 (m, 3H, H2''a 
& CH2CN), 2.43-2.38 (m, 1H, H2’b), 2.34-2.29 (m, 1H, H2’’b) , 2.05-2.02 (m, 2H, CH2, 
overlapping with acetone solvent residual peak), 2.00-1.96 (m, 2H, CH2),  1.61 (m, 3H, ArCH3), 
1.25-1.20 (m, 12H, 4 x CH3), 0.93-0.91 (m, 9H, SiC(CH3)3) , 0.87-0.85 (m, 9H, SiC(CH3)3), 0.10 
(s, 3H, SiCH3), 0.09 (m, 3H, SiCH3), 0.07 (m, 3H, SiCH3), 0.02 (s, 3H, SiCH3). 
13
C NMR (125.7 
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MHz, d6-acetone, ppm): 170.0, 166.92, 160.90, 158.9, 158.2, 154.7, 152.80, 151.79, 144.9, 
140.6, 140.5, 140.0, 135.7, 135.6, 130.1, 129.4, 128.1, 127.8, 126.9, 121.2, 118.4, 118.1, 114.7, 
113.1, 103.3, 87.1, 86.9, 86.8, 86.6, 86.4, 86.0, 84.4, 74.1, 73.9, 73.8, 73.7, 71.8, 67.9, 67.4, 66.7, 
66.1, 65.7, 63.4, 63.2, 62.9, 61.3, 59.6, 58.8, 58.7, 58.5, 54.7, 43.2, 43.12, 43.06, 43.02, 41.6, 
39.1, 38.8, 25.5, 25.4, 25.3, 25.1, 24.1, 24.03, 24.00, 23.98, 19.92, 19.87, 18.1, 17.6, 13.6, 11.2, -
5.33, -5.59, -6.06, -6.09. 
31
P NMR (202.3 MHz, d6-acetone, ppm): 148.24, 148.13. HRMS (ESI-
MS) m/z calculated for C74H103N9O14PSi2
+
 1428.6895: found 1428.6898 [M+H]
+






To a solution of compound 6.15b (0.20 g, 0.16 mmol) and DIPEA (52 μL, 0.31 mmol) in 
THF (2 mL) was added Cl-POCENiPr2 (52 μL, 0.25 mmol) dropwise while stirring. After 30 
min, the solvent was evaporated in vacuo and the content was diluted with EtOAc (50 mL), then 
washed with NaHCO3 (aq, 3%) (2 x 35 mL) followed with brine (35 mL). The solvent was dried 
over anhydrous Na2SO4, decanted and then evaporated to produce a yellow gum. Purification 
was achieved via short flash column chromatography using an EtOAc (containing 0.1 % NEt3) as 
eluent to afford 0.19 g (82 %) of a colorless foam. Rf (SiO2 TLC): 0.87, 0.86 EtOAc. λmax(MeCN) = 
271 nm. 
1
H NMR (500MHz, d6-acetone, ppm) ): 9.42 (s, 1H, NH), 8.28-8.27 (s, 1H, H8), 7.94 
(m, 1H, H6),  7.51-7.50 (m, 2H, Ar), 7.36-7.25 (m, 9H, Ar),  7.05-7.03 (m, 2H, Ar), 7.00-6.97 
(m, 1H, Ar), 6.92-6.91 (m, 4H, Ar ), 6.50-6.47 (m, 1H, H1’a), 6.30-6.27 (m, 1H, H1’b), 5.11 (s, 
2H, PhOCH2CO), 4.88-4.84 (m, 1H, H3’a), 4.64-4.59 (m, 3H, H3’b & ArOCH2), 4.33-4.30 (m, 
2H, ArOCH2), 4.24 & 4.17 (m, 1H, H4’a), 4.09-3.80 (m, 11H, H4’b, H5’a, H5’’a, CH2OP & 2 x 
OCH3), 3.72-3.65 (m, 2H, 2x (CH)N), 3.51-3.48 (m, 1H, H5’b), 3.37-3.34 (m, 1H, H5’’b), 3.07-
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2.98 (m, 1H, H2’a), 2.82-2.76 (m, 2H, CH2CN), 2.74-2.61 (m, 1H, H2''a), 2.43-2.38 (m, 1H, 
H2’b), 2.34-2.29 (m, 1H, H2’’b) , 1.92-1.87 (m, 2H, CH2) 1.78-1.74 (m, 2H, CH2),  1.61 (m, 3H, 
ArCH3), 1.55-1.48 (m, 6H, (CH2)3), 1.26-1.21 (m, 12H, 4 x CH3), 0.92-0.91 (m, 9H, SiC(CH3)3) 
, 0.86-0.85 (m, 9H, SiC(CH3)3), 0.10 (s, 3H, SiCH3), 0.09 (m, 3H, SiCH3), 0.07 (m, 3H, SiCH3), 
0.02 (s, 3H, SiCH3).
13
C NMR (125.7 MHz, d6-acetone, ppm): 170.1, 161.0, 158.9, 158.3, 154.8, 
152.8, 151.8, 144.9, 140.5, 140.4, 139.9, 135.7, 135.6, 130.12, 130.11, 129.4, 128.1, 127.8, 
126.9, 121.2, 118.4, 118.1, 114.7, 113.13, 113.11, 103.3, 87.1, 86.8, 86.6, 86.4, 86.0, 84.4, 84.3, 
74.1, 73.9, 73.8, 73.7, 71.8, 67.9, 67.1, 66.5, 63.4, 63.2, 62.9, 59.6, 58.8, 58.7, 58.5, 54.7, 43.2, 
43.12, 43.06, 43.0, 41.6, 39.1, 38.8, 28.3, 25.72, 25.71, 25.49, 25.48, 25.3, 24.1, 24.04, 24.01, 
23.98, 23.95, 19.93, 19.90, 19.87, 19.85, 18.1, 17.6, 13.6, 11.2, -5.33, -5.58, -6.04, -6.06, -6.08, -
6.10. 
31
P NMR (202.3 MHz, d6-acetone, ppm): 148.23, 148.13. HRMS (ESI-MS) m/z calculated 
for C77H109N9O14PSi2
+
 1470.7365: found 1470.7375 [M+H]
+
.  
6.5.1.3 Preparation, Purification and Characterization of the TT, GT, and TG 
IaCL Oligonucleotide 
The cross-linked duplexes, the sequences for which are shown in Figure 6.1, were 
assembled with an Applied Biosystems Model 3400 synthesizer on a 1.5 mmol scale using β-
cyanoethylphosphoramidite chemistry supplied by the manufacturer with slight modifications to 
coupling times. The nucleoside phosphoramidites protected with "fast-deprotecting" groups were 
prepared in anhydrous MeCN at a concentration of 0.1 M for the 3’-O-deoxyphosphoramidites, 
and 0.13-0.15 M for the cross-linked 3’-O-deoxyphosphoramidite. Oligomer sequence assembly 
was carried out as previously described.
323
 The capping step of the assembly was carried out 
using phenoxyacetic anhydride/pyridine/tetrahydrofuran 1:1:8 (v/v/v; solution A) and 1-methyl-
imidazole/ tetrahydrofuran 16:84 (w/v; solution B). Coupling wait times for phosphoramidites 
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6.7a, 6.7b, 6.11a, 6.11b, 6.16a, and 6.16b were extended to 10 min (compared to 2 min for the 
commercially available phosphoramidites). Protecting group removal and cleavage from the 
solid support was carried out by treatment with 0.05 M K2CO4 in MeOH for 4 h at room 
temperature with mild rocking in 2 mL screw-cap microfuge tubes fitted with Teflon lined caps. 
The base was neutralized with an equimolar amount of AcOH and crude oligomers were 
transferred and lyophilized in a Speedvac concentrator. Silyl protecting groups were removed 
from oligomers by treatment with NEt3•3HF (200 µL, pellet initially sonicated (2 x 15 s)) for 
16h at room temperature under gentle rocking. Oligomers were precipitated using cool n-butanol 
(400 µL) and the resulting mixture was allowed to cool to -20
o
C for 10 min, followed by 
spinning the samples down. The supernatant was removed and the pellet was washed with 
another aliquot of n-butanol (400 µL). Purification was achieved by strong anion exchange 
HPLC using a Dionex DNAPAC PA-100 column (0.4 cm x 25 cm) purchased from Dionex 
Corp, Sunnyvale, CA using a linear gradient of 0–52% buffer B over 24 min (buffer A: 100 mm 
Tris HCl, pH 7.5, 10% MeCN and buffer B: 100 mm Tris HCl, pH 7.5, 10% MeCN, 1M NaCl) 
at 55 
o
C. The columns were monitored at 260 nm for analytical runs or 280 nm for preparative 
runs. The purified oligomers were desalted using C-18 SEP PAK cartridges (Waters Inc.) as 
previously described.
317
 The molecular mass of the modified oligomers were identified by ESI-
MS and the measured values were in agreement with the expected masses (Supporting 
Information Figure S6.2 – S6.7 for MS spectra). 
6.5.1.4 UV thermal denaturation 
Molar extinction coefficients for the unmodified and cross-linked oligonucleotides were 





). All duplexes were prepared by mixing equimolar amounts of the 
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interacting strands and lyophilizing the mixture to dryness. The resulting pellet was then 
dissolved in 90mM sodium chloride, 10 mM sodium phosphate, 1 mM EDTA buffer (pH 7.0) to 
give a final concentration of 3.5 μM duplex. Prior to the thermal run, samples were degassed by 
placing them in a speed- vac concentrator for 2 min. Annealing curves were acquired at 260 nm 
starting at 95 
o




 until 15 
o
C, using 
a Varian CARY Model 3E spectrophotometer fitted with a 6-sample thermostated cell block and 
a temperature controller. The samples were then denatured by heating from 15 
o
C to 95 
o
C at an 




 to show reversibility. Denaturing data processing was 
carried out as described by Puglisi and Tinoco
254




6.5.1.5 Circular dichroism (CD) spectroscopy 
Circular dichroism spectra were obtained on a Jasco J-815 spectropolarimeter equipped 
with a Julaba F25 circulating bath. Samples were allowed to equilibrate for 5 – 10 min at 15 oC 
in 90 mM sodium chloride, 10 mM sodium phosphate, 1 mM EDTA (pH 7.0), at a final 
concentration of 3.4 μM. Each spectrum was an average of 3 scans, collecting at a rate of 50 nm 
min
-1
 , with a bandwidth of 1 nm and sampling wavelength of 0.2 nm using fused quartz cells 
(Starna 29-Q-10). The CD spectra were recorded from 350 to 220 nm at 15 
o
C. The molar 
ellipticity (φ) was calculated from the equation φ = ε/Cl, where ε is the relative ellipticity 
(mdeg), C is the molar concentration of oligonucleotides (moles/L), and l is the path length of the 
cell (cm). The data were processed using software supplied by the manufacturer (JASCO, Inc.) 
and transferred into Microsoft Excel
TM
 for viewing. 
6.5.1.6 Molecular modelling  
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Molecular modeling was performed by using the Hyperchem 7.5 software package from 
Hypercube utilizing the AMBER force field. Hybridized oligomers containing a dGG·dCC, 
dGpG4·dCC, dGpG4·dCC base pair were constructed from the nucleic acid template option 
using a B-form duplex. Sequence contexts were truncated to the following 5’-GGC TXX GAT C 
and 3’-CCG AYY CTA G for proper solvation. Duplexes were solvated with water using a 
periodic box occupying at least 3 times the volume of the duplex alone. Standard Amber99 
parameters were used with the dielectric set to constant. “One to four scale factors” non-bonded 
interactions were set to 0.5 (both electrostatic and van der Waals). Cutoffs were applied to 
“switched” to an outer and inner radius of 14.5 and 10.5 Å. All structures were geometry 
optimized using Polak-Ribiere conjugate gradient until the RMS gradient was less than 0.1 
kcal/(Å mol) using the periodic boundary condition option. 
6.5.1.7 Protein expression and purification  
Ampicillin, isopropyl β-D-thiogalactopyranoside (IPTG), and most other biochemical 
reagents as well as polyacrylamide gel materials were purchased from Bioshop Canada Inc 
(Burlington, ON). Ni-NTA Superflow Resin was purchased from Qiagen (Mississauga, ON). 
Complete, Mini, EDTA-free Protease Inhibitor Cocktail Tablets were obtained from Roche 
(Laval, QC). Nitro-cellulose filters (0.20 μm) were obtained from Millipore. XL-10 Gold and 
Bl21(DE3) E. coli cells were obtained from Stratagene (Cedar Creek, TX). T4 polynucleotide 
kinase (PNK) was obtained from Fermentas (Burlington, ON). [γ-32P]ATP was purchased from 
PerkinElmer (Woodbridge, ON). Phusion Polymerase was obtained from New England Biolabs 
(Ipswich, MA). DNA primers for site directed mutagenesis and cloning were purchased from 
Biocorp (Montreal, QC).  All AGT homologues were expressed under the promoter of the 





6.5.1.8 AGT repair assay of IaCL DNA duplexes  
DNA substrates were labeled at the using γ-[ 32P]-ATP as previously described.65 Briefly, 
a 20 μM solution of DNA was made in 1X PNK buffer along with 1 μL γ-[ 32P]-ATP (10 μCi 
μL−1 ) and 5 units of T4 PNK. The labelling reaction was conducted for 1 h at 37 °C after which 
the reaction was terminated by boiling the sample for 5 min. 100 pmol of labeled DNA was 
added to 110 pmol of the complement strand in a total volume of 50 μL of water making a 2 μM 
dsDNA solution with 10% excess of the non-damaged strand. The solution was boiled for 2 min, 
cooled slowly to room temperature and kept in a refrigerator at 4 °C overnight to ensure proper 
annealing of the duplex. The repair reaction mixtures were constituted of 2 pmol of the DNA 
duplex and 10 pmol or 60 pmol of AGT in a total volume of 15 μL of Activity Buffer [10 mM 
Tris–HCl (pH 7.6), 100 mM NaCl and 1 mM DTT] and allowed to react at 37 °C overnight. The 
reaction was terminated by the addition of 18.2 μL of stop buffer [81 mM Tris–HCl, 81 mM 
boric acid, 1.8 mM EDTA and 1% SDS (sodium dodecyl sulfate) (pH 8.0) in 80% formamide] 
followed by boiling for 2 min. Samples (10 μL) were loaded on a 14 cm × 16 cm, 20% 7 M urea 
denaturing polyacrylamide gel (19 : 1) for separation. The gels were run using 1X TBE for 1h-
1.5h at 400 V and the gels exposed to a storage phosphor screen. The image was captured on a 
Typhoon 9400 (GE Healthcare, Piscataway, NJ) and the autoradiography counts obtained by 
Image-Quant™ (Amersham Biosciences). For the repair time course assays, master mixes of 150 
μL composed of 100 pmol (5-fold) or 600 pmol (30-fold) of AGT and 20 pmol of DNA substrate 
were prepared. Each sample was placed at 37 
oC and at each time point, 7.5 μL was removed 
from the master mix and placed in a tube with 9.1 μL of stop reaction buffer and analysis was 
achieved as described above. All samples were analyzed on polyacrylamide gel electrophoresis 
(using 1X TBE for 1 h-1.5 h at 400 V) and visualized as described above. 
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6.5.1.9 Identification of IaCL Repair Product by SDS-PAGE 
600 pmol of hAGT or Ada-C was incubated with 600 pmol of IaCL (GG4, GG7, TG4 or 
TG7 in 25 μL of Activity Buffer [10 mM Tris–HCl (pH 7.6), 100 mM NaCl and 1 mM DTT] 
overnight at 37 °C. The reaction was terminated by adding 6 μL of SDS Buffer [200 mM Tris-
HCl (pH 7.6), 3.2% SDS, 48% glycerol and 0.4 M DTT], boiling the sample for 2 min, and 
separated on a 15% SDS- PAGE. The gel was stained with Coomassie Blue Stain as per the 
manufacturer’s protocol. Detection and visualization of DPC products was conducted with 
Typhoon Trio Variable Mode Imager in fluorescence mode with the green (532 nm) laser in 
conjunction with the 526-nm short-pass filter.  
6.5.1.10 Identification of Repair Product (DPC) from hAGT-mediated 
Repair of IaCL DNA by LC-MS  
600 pmol of hAGT was incubated with 600 pmol of GG4, GG7, TG4 or TG7 in 25 μL 
of Activity Buffer [10 mM Tris–HCl (pH 7.6), 100 mM NaCl and 1 mM DTT] for 30 min at 37 
°C. A reaction aliquot (5 µL) was diluted in aqueous 0.1 % (v/v) formic acid subject to HPLC 




 C4 (214MS) column (Fisher Scientific) 
(100mm x 2.1 mm) operated at a flow rate of 0.25 mL/min at room temperature (22 
o
C) with the 
following gradient method: 0 - 0.1 min, linear gradient from 10 - 20 % B, 0.1 - 6 min, linear 
gradient from 20 - 95 % B, 6 - 8 min, hold at 95 % B, 8 - 10 min, linear gradient from 95 – 10 % 
B, 10 - 19 min, hold at 10 % B (buffer A, 0.1% formic acid in water and buffer B, 0.1% formic 
acid in acetonitrile). The LC system was interfaced to a Micromass Q-Tof Ultima API equipped 
with an electrospray source set with the following conditions: source voltage 3.5 kV, mass range 
of 700−1999 m/z in positive ion mode. The theoretical mass of the hAGT-DNA species were 
calculated by summing the mass of hAGT (21876 Da), either a butylene linker (54 Da) or 
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heptylene linker (96 Da), and the corresponding fragments GGCTT (1494 Da) or GGCTG (1519 
Da). The expected masses are reported in Figure 6.7 of the main text. If the repair event had 
occurred at 5’-residue of the IaCL adduct, DPC masses would have been significantly different 
since the DNA fragment differed in size and sequence context (GGA TCA CCAG (3037 Da)). 
 
 
Figure S6.1: Examples of different DNA adducts mentioned in the main text. A An example of 
an IaCL formed from exposure of DNA to the chemotherapeutic drug busulfan.
69
 B An example 
of γ-radiation induced IaCL lesion (dG[8,5-Me]dT).3,223 C An example of a UV-induced 
cyclubutane pyrimidine dimer. 
207
 D An example of a UV-induced (6-4) pyrimidone 
photoproduct lesion.
82






























Figure S6.8 - Hyperchromicity change (A260) versus temperature (
o
C) profiles of duplexes 
containing TT4 (•••), TT7 (— — —) and unmodified TT control DNA (—). 
 
 
Figure S6.9 - Hyperchromicity change (A260) versus temperature (
o
C) profiles of duplexes 




Figure S6.10 - Hyperchromicity change (A260) versus temperature (
o
C) profiles of duplexes 
containing TG4 (•••), TG7 (— — —) and unmodified TG control DNA (—). 
 
Figure S6.11 - Circular dichroism spectra of IaCL duplexes TT4 (•••), TT7 (— — —) and 





Figure S6.12 - Circular dichroism spectra of IaCL duplexes GT4 (•••), GT7 (— — —) and 





Figure S6.13 - Molecular models of unmodified control (TT) duplex and duplexes containing 




Figure S6.14 - Molecular models of unmodified control (GT) duplex and duplexes containing 




Figure S6.15 - Molecular models of unmodified control (TG) duplex and duplexes containing 





Figure S6.16 - Repair of (A) TT4 and (B) TT7 by hAGT, OGT, Ada-C, and OGT S134P for 
16h at 37
o
C. Denaturing PAGE of repair reactions as described in the experimental section with 
varying protein concentration (either 5- or 30-fold protein). Panel A; Lane 1, 2 pmol control 
unmodified TT DNA; lane 2, 2 pmol TT4; lane 3, TT4 + 10 pmol hAGT; lane 4 TT4 + 60 pmol 
hAGT; lane 5 TT4 + 10 pmol OGT; lane 6 TT4 + 60 pmol OGT; lane 7 unmodified 5-mer 
control DNA 5’-pTGCTT; lane 8 unmodified 10-mer control 5’-pTGC ATC ACC AG; lane 9 
TT4 + 10 pmol Ada-C; lane 10 TT4 + 60 pmol Ada-C; lane 11 TT4 + 10 pmol OGT S134P; 














Figure S6.17 - Repair of (A) GT4 and (B) GT7 by hAGT, OGT, Ada-C, and OGT S134P for 
16h at 37
o
C. Denaturing PAGE of repair reactions as described in the experimental section with 
varying protein concentration (either 5- or 30-fold protein). Panel A; Lane 1, 2 pmol control 
unmodified GT DNA; lane 2, 2 pmol GT4; lane 3, GT4 + 10 pmol hAGT; lane 4 GT4 + 60 
pmol hAGT; lane 5 GT4 + 10 pmol OGT; lane 6 GT4 + 60 pmol OGT; lane 7 unmodified 5-mer 
control DNA 5’-pTGCTT; lane 8 unmodified 10-mer control 5’-pTGC ATC ACC AG; lane 9 
GT4 + 10 pmol Ada-C; lane 10 GT4 + 60 pmol Ada-C; lane 11 GT4 + 10 pmol OGT S134P; 






Figure S6.18 - Time course repair gel of duplexes containing (A) TG4 or (B) TG7 by hAGT. 
(A) Denaturing gel of the repair of 2 pmol of TG4 by 10 pmol hAGT as a function of time: lane 
1, 2 pmol Control; lanes 2-15, 2 pmol TG4 + 10 pmol hAGT incubated for 1, 2.5, 5, 10, 15, 25, 
35, 45, 60, 90, 120, 180, 240, 1020 min, respectively. (B) Denaturing gel of the repair of 2 pmol 
of TG7 by 10 pmol hAGT as a function of time: lane 1, 2 pmol Control; lanes 2-15, 2 pmol TG7 






Figure S6.19 - Time course repair gel of duplexes containing TG7 by 30-fold protein (A) Ada-C 
and (B) hAGT. (A) Denaturing gel of the repair of 2 pmol of TG4 by 60 pmol Ada-C as a 
function of time: lane 1, 2 pmol Control; lanes 2-15, 2 pmol TG4 + 60 pmol hAGT incubated for 
1, 2.5, 5, 10, 15, 25, 35, 45, 60, 90, 120, 180, 240, 1020 min, respectively. (B) Denaturing gel of 
the repair of 2 pmol of TG7 by 60 pmol hAGT as a function of time: lane 1, 2 pmol Control; 
lanes 2-13, 2 pmol TG7 + 60 pmol hAGT incubated for 0.25, 0.5, 0.75, 1, 1.5, 2.5, 5, 10, 15, 25, 






Figure S6.20 - 15% SDS-PAGE (Coomassie stained) of repair reaction between hAGT (300 
pmol) and IaCL DNA (300 pmol) for either 1h (lanes 2-5) or 3.5 h (lanes 6-9) at 37
o
C. Lane L, 
molecular weight marker (ladder); lane 1, hAGT control; lane 2, hAGT + GG4; lane 3, hAGT + 
GG7; lane 4, hAGT + TG4; lane 5, hAGT + TG7; lane 6, hAGT + GG4; lane 7, hAGT + GG7; 
lane 8, hAGT + TG4; lane 9, hAGT + TG7. Results demonstrate virtually quantitative 
conversion to the DPC after only 1h of reaction time.   
 
 
Figure S6.21 - 15% SDS-PAGE of repair reaction between hAGT (300 pmol) and fluorescently 
labelled GG4 or GG7 (300 pmol) for 1h at 37
o
C showing the feasibility of the hAGT protein-
tagging with a functionalized DNA fragment. (A) Coomassie Blue stained. (B)  Fluorescence 
monitoring of the fluorescein tag. Lane L, molecular weight marker (ladder); lane 1, hAGT 
control; lane 2, hAGT + GG4; lane 3, hAGT + GG7.   
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 CHAPTER VII 




7.1 General Conclusions 
 The work presented in this thesis has enabled the introduction of a number of site-specific 
chemical modifications in DNA. This was accomplished using small molecule synthesis to 
generate the nucleoside(tide) phosphoramidite already containing the chemical alterations. These 
building blocks were incorporated into DNA oligomer sequences via automated solid-phase 
synthesis. The developed approach enabled a versatile methodology to incorporate different 
chemical modifications that were subsequently utilized for biochemical purposes.  
 First, DNA containing bicyclic pyrimidine analogues (DFP and TPP) were prepared as 




-EtdT DNA damage. The synthesis of  C5-
modified pyrimidines was accomplished by the use of different size lactone starting materials. 
Once inserted in DNA oligomers, the conformationally restricted analogues behaved similarly to 
the open-chain modifications in terms of biophysical characterization (thermal stability, circular 
dichroism and basic molecular modeling). Although these probes remained inert towards AGT-
mediated repair (hAGT, OGT and Ada-C), they provided critical insights in the bypass 





-EtdT were significantly different in comparison to their respective 
conformationally locked mimics. All adducts causes blockage of hPol η, with stronger blockage 
observed for the open-chain analogues relative to the mimics, respectively. All adducts caused 
error-prone hPol η activity, with the major product containing the dGMP error. The 





MedT. Full extension assays revealed a noteworthy stall at the n+1 primer product 




-EtdT, but not for DFP and TPP, with a larger 
accumulation observed for in the case of O
4
-MedT. Also, a significant increase in frameshift 
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adduct formation (-1) was observed across O
4
-MedT, relative to other adducts and the 
unmodified control. Crystal structures of ternary complexes revealed that the O
4
-MedT 
nucleobase adopted a unique (and undocumented) conformation, not engaging with the incoming 
nucleotide, but rather, engaged in a hydrophobic pocket located at the top of the hPol η active 
site. Interestingly, a similar conformation was not shared for the larger O
4
-EtdT nucleobase in its 
ternary complex crystal structure. The investigation provided mechanistic insights about the 
bypass mechanism of hPol η. That is, perhaps hPol η makes use of the conformational liberty of 
the O
4
-MedT to aid in its nucleotide discrimination (e.g. slowing the extension step by allowing 
different conformational populations inside the active site). This may explain why the fidelity 
decreases with the conformationally locked analogue.   
 Previous investigation from our group has demonstrated the potential involvement of 





ICL DNA with butylene or heptylene linkers, for which hAGT demonstrated repair.
64,65
 In light 
of these results, we questioned whether AGTs were capable of acting on IaCL substrates. As an 
initial study, IaCL mimics lacking the phosphodiester linkage were prepared since these were 
less synthetically challenging and could provide insights on the processing of such substrates by 
AGTs. The key intermediate step in the synthesis of the target dG-dG dimer was the Mitsunobu 
reaction, known for its regioselectivity towards the O
6
-atom of (5', 3'-protected) dG, which has 
previously been used for the introduction of ICL in DNA.
311,312,368
 Our initial findings unveiled 
the potential participation of hAGT in the restoration of IaCL DNA damage. The in vitro assays 
demonstrated efficient repair of the model IaCL (GG4 and GG7). These were processed in 
superior levels compared to their respective ICL DNA versions (even at lower protein : DNA 
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ratios). Furthermore, the heptylene adducted DNA (GG7) was consumed at a faster rate 
compared to the butylene analogue (GG4).  
 The latter study prompted us to develop the next generation of IaCL DNA, which 
contained the phosphodiester linkage (GpG4 and GpG7). Albeit more synthetically challenging 
than the previous mimics, these DNA probes were prepared by first synthesizing the dG-dG 
dimer phosphoramidite containing the alkylene cross-link and intradimer phosphodiester 
backbone. Ring closing of the medium size ring was achieved using methodology developed by 
Begley's group, by means of the MSNT condensing reagent.
325
 Interestingly, UV thermal 
denaturation experiments of DNA duplexes containing the IaCL were in agreement regardless of 
the presence, or lack, of the internucleotide linkage. Surprisingly, duplexes containing GpG4 and 
GpG7 were only modestly repaired by hAGT, with greater efficiency towards GpG7. The 
decrease in repair efficiency, relative to GG4 and GG7, was potentially attributed to: (i) the 
lesion restriction prevented optimal α-carbon orientation necessary for Cys145 to attack, (ii) 
linkage to the neighboring nucleotide prevents efficient flipping of the nucleotide undergoing 
repair, (iii) other vital interactions such as Tyr114 cannot be accomplished correctly. 
Nonetheless, repair of the IaCL DNA were in agreement with previous in vivo experiments, 
which showed that hAGT contributes to cell survival upon exposure to hepsulfam, but not 
busulfan.
65
 Whether this resistance effect was due to removal of IaCL DNA, or adducts other 
than mono-adducts, remains to be determined.         
 Results from CHAPTER II to IV highlighted a few aspects that would warrant 
investigating bypass experiments of GG4, GG7, GpG4, and GpG7 using hPol η. 
Conformationally restricted analogues tested in CHAPTER II displayed enhanced rates of 
bypass compared to the freely rotating lesions, although erroneous. Perhaps reduced flexibility 
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allows for more efficient bypass by hPol η. Adducts such as CPD and Pt-GG lesions are 
proficiently bypassed by hPol η while being relatively rigid in nature. It was also noted that the 
increased conformational rigidity seemed to have a negative impact on hAGT-mediated repair. 
Our hPol η bypass investigation supported the rigidity hypothesis. As expected, all alkylene 
IaCL blocked hPol η bypass relative to the unmodified control. This was observed across both 
residues part of the IaCL. Steady-state experiments revealed that although hPol η increases 
promiscuity across the first O
6
-alkylene-dG residue (3'-dG), the preferred nucleotide was the 
correct dCMP. The same was not said for the second O
6
-alkylene-dG (5'-dG), where an  error-
prone behavior prevailed in all cases. This was, however, more pronounced for GG4 and GG7, 
relative to GpG4 and GpG7, respectively. Full extension assays revealed an accumulation of 
unextended primers in the case of GG4 and GG7 (n+2 products), but not in the case of GpG4 
and GpG7. IaCL containing the intradimer phosphodiester were extended to the full length, with 
the majority containing nucleotides dCMP and dTMP across the 3'-dG and 5'-dG, respectively. 
This brought about the conception that lesion orientation may play a critical role in bypass 
mechanism since the linker of the 3'-O
6
-alkylene-dG is permanently pointing towards the 5'-end 
of the DNA template, whereas the 5'-O
6
-alkylene-dG is oriented in the opposite 3'-direction. 
 Longer extension times of GG4 and GG7 caused uncontrollable extension by hPol η with 
no defined "fully" extended product. This inaccurate behavior has been observed for extension 
across and past abasic sites, regardless of 5'-nucleotide next to the damaged site.
202,236
 Moreover, 
frameshift adduct formation accounted for about 65-80 % of the total products, and the 
remaining was largely attributed to dAMP or dGMP. The study on abasic sites supported the so-
called purine-rule, where purines are most-frequently inserted across the abasic site. Structural 
investigation suggested that a network of water molecules mediate the necessary interactions for 
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the purine rule (previously described as the A-rule).
236
 In the case of GG4 and GG7, the major 
product across the 5'-dG residue is a frameshift adduct which may be mediated by water as well. 
However, structural investigations are required to support this hypothesis.  
 Each nucleotide unit can be divided into a nucleobase, a sugar and a phosphodiester 
group. As expected, the abasic site can mislead DNA Pols given that the identity of the 
nucleotide is defined by its nucleobase moiety (and abasic sites lack the nucleobase).  It was 
interesting to observe similar profiles for GG4 / GG7 where the intradimer phosphodiester 
linkage was deleted, and revealed the direct importance of the phosphodiester group in the 
bypass of IaCL DNA (those linking the O
6
-atoms of dG, at least). The effect may be an artifact 
of the alkylene tether acting as the sugar-phosphate backbone, given that the alkylene moiety 
does not have electrostatic character and is inherently more flexible, whereas the latter has 
anionic character. As a result, it would be of interest to test whether altering the tether size (e.g. 
ethylene) or its character (e.g. diethylamine) would have an effect on hPol η bypass. 
 DNA repair and TLS mechanisms must be orchestrated in the cell.
369,370
 The results 
acquired throughout this research potentially suggest a synergy between hAGT-repair and TLS, 
particularly for IaCL DNA. That is, hAGT repair is efficient for the flexible IaCL analogues, 
whereas TLS is relatively efficient for the more-rigid IaCL DNA. To further probe AGT direct 
repair pathway, we developed a series of three novel sets of IaCL DNA lacking the intradimer 
phosphodiester. The IaCLs linking two O
4
-atoms of dT nucleotides were prepared using the 
convertible nucleoside methodology developed by Swann's group, and procedures developed by 
our group.
150,242,371
 The mixed IaCL dimers between the O
4
-position of dT and the O
6
-position of 
dG were prepared from the dT mono-adducts and dG monomers via the Mitsunobu reaction. 
Using different protecting groups on the 5'-O and 3'-O sugar functionalities of either dT or dG 
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allowed us to generate IaCL DNA with different orientations (5'-TG and 5'-GT). Ultra-mild 
deprotection strategies were employed for the DNA containing the novel IaCL. Biophysical 
studies of duplexes containing the various IaCLs displayed similar behavior relative to GG4 and 
GG7. Repair assay profiles of the different IaCLs (TT4, TT7, GT4, GT7, TG4, and TG7) 
showcased only efficient repair of TG4 and TG7 by hAGT, and low-moderate repair of TG7 by 
Ada-C, with repair occurring only at the dG moiety. Interestingly, repair of TG4 and TG7 by 





-dU ICL revealed higher mobility of the cross-linked site compared to identical 




-dG ICL adduct (unpublished data). The TG IaCL 
hybrid may have higher mobility (flexibility) compared to the GG series, which could account 
for the enhanced repair rates observed. The lack of repair of GT IaCL DNA by hAGT suggests 
that the 3'-phosphodiester may be necessary for efficient repair of O
6
-alkyl-dG adducts, which 
was in agreement with minimal repair of the 5'-dG residue of GG4 and GG7 by hAGT at 
elevated protein : DNA ratio. In addition, the free nucleoside O
6
-MedG is repaired very slowly 
by hAGT, which may be partly due to the lack of the 3'-phosphodiester linkage. Alternatively, it 
may simply be that the linker orientation is not favourable for repair. The preference of the 3'-dG 
residue of GG4, GG7, TG4, and TG7 was important in supporting the necessity of the 3'-
phosphodiester group in order for efficient repair by hAGT. Our investigation revealed an insight 
pertinent to the mechanism of repair, whether the interaction occurs with Tyr114 (or not), via 
sterics or electronics.
137,168
 Deleting this group prevents proficient repair of the 5'-O
6
-alkylene-
dG residue part of two IaCL DNA types (GG4, GG7, GT4, and GT7). More research must be 
conducted to elucidate reasons as to why the 5'-dG remains inert against hAGT activity.  
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 The substrate discrimination based on the phosphodiester linkage allows for the 
production of site-specific DPC with excellent conversions in relatively short times 
(approximately 1h). The procedure can be applied to single stranded IaCL DNA to generate 
hAGT-DNA covalent complexes, making this approach "greener" compared to ICL DNA in 
terms of atom economy. The DPC is tethered between the Cys145 of hAGT and the 3'-
nucleoside of a DNA fragment. The IaCL approach is versatile in producing DPC linked to either 
the O
6
-atom of dG or the O
4
-atom of dT, by either a butylene or heptylene linker. A feature to be 
noted of this DPC is the linear connectivity between the DNA and the protein (Figure 7.1). 
CHAPTER VI showcases an example of functionalizing hAGT with fluorescently-labelled 
DNA (5'-fluorescein). The DPC product was, as expected, fluorescent. This new technology can 
be envisioned as having a DNA spacer between the hAGT molecule and any label compatible 
with DNA and protein (bio)chemistry. The programmability of DNA allows for added versatility 
as well. For instance, the distance between the label and the hAGT molecule can easily be 
tailored by synthesizing longer initial IaCL DNA substrates. Many DNA sequences are known to 
fold into specific secondary structures, which may be of interest to position the tag in a particular 
orientation with respect to the protein. Lastly, the fact that hAGT cleaves the single stranded 




Figure 7.1: General hAGT-mediated repair of IaCL lacking the intradimer phosphodiester 
linkage. The presence of a 5'-tag is optional but may find use in hAGT tagging experiments. 




-alkylene dG as X. 
 
7.2 Future Work 
7.2.1 The Ethylene IaCL DNA Probe for AGT-Repair 
 The work presented herein opens a new area of bifunctional intrastrand adduct repair by 
AGTs. Substrate discrimination of AGT homologues is an ongoing investigation. For instance, 
why hAGT is capable of proficient repair of many O
6
-dG adducts, but limited solely to O
4
-MedT 
adducts. McManus and co-workers demonstrated a method to generate DPC with hAGT 
covalently bound to a DNA strand via a heptylene linker to the thymidinyl residue at the O
4
-
atom. The tether may be too long to verify the interaction of the hAGT active site with the 
thymidine nucleotide, especially because highly mobile ("disordered") regions may not be visible 
in crystallographic structures. Although the new procedure described herein allows for a DPC 
with a shorter, butylene-linked thymidinyl adduct, an even shorter length such as an ethylene 
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bridge may be more suitable. The proposed synthesis the cross-linked dimer is shown in Scheme 
7.1 to prepare TG2. This probe would also be relevant to various chloroethylating agents used in 
the clinic, which are known to generate hydroxyethylene mono-adducts, IaCL, and ICL DNA. In 
addition, exposure to 1,2-dibromoethane generates ethylene DPCs with all four nucleotides.
372,373
 
An assortment of ethylene-linked hAGT-DNA complexes could be devised by modifying the 
synthesis shown in Scheme 7.1 (e.g. changing the mono-adduct from a thymidinyl derivative to 
a 2'-deoxycytidinyl or 2'-deoxyadenosyl). It should be noted, however, that the synthesis of O
6
-
dG-ethylene- dG has been previously attempted by our group (unpublished data) with no success 
to date.      
 
Scheme 7.1: Reagents and conditions: (i) ethylene glycol, DBU, MeCN, 21
oC, 4 h. (ii) 1) 5’-O-
(tert-butyldimethylsilyl)-3’-O-levulinyl-N2-phenoxyacetyl-2’-deoxyguanosine, Ph3P, DIAD, 
dioxane, 21
o
C, 16 h. 2) N2H4•H2O, pyridinium acetate (1:1, v/v), 21
o
C, 30 min. (iii) Cl-
P(OCEt)N(iPr)2, NEt3, THF, 21
o
C, 30 min.  
 
7.2.2 Synthesis of IaCL Adducts with Diverse Tethers for AGT-Repair 
 Our group has mainly focused on generating IaCL and ICL DNA containing alkylene 
tethers. However, certain chemotherapeutic agents such as mechlorethamine generate IaCL and 
ICL with tethers containing a central amino functionality (at the γ-position of the linker Scheme 
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7.2). This central amino functionality would aid in probing the sterics of the linker (by using the 
tertiary amine N-methyldiethanolamine) as well as probing for the electronics as this 
functionality would most-likely be charged at physiological pH. Investigating the O
6
-alkylene-
dG mono-adduct and IaCL lacking the intradimer phosphodiester group (Scheme 7.3) may serve 
as a valuable starting point, since these generally undergo better repair by AGTs compared to 
ICL DNA and the O
4
-alkylene-dT adducts. Depending on the results, expansion to the other 
types of cross-links would definitely be warranted.   
 
Scheme 7.2: Diethanolamine and N-methyldiethanolamine are commercially available (Sigma 
Aldrich, for instance). Note the central nitrogen in the linker (at the γ-position).  
Reagents and conditions: (i) 1) HMDS, TMS-Cl, Py, reflux, 1h. 2) isobutyryl chloride (Cl-iBu), 
NEt3, THF, 21
o
C, 4 h. 3) saturated aqueous solution of NH3, 0
o
C, 30 min. (ii) TBDPS-Cl, Im, 
CH2Cl2, 21
o
C, 4 h. (iii) Pac-Cl, NEt3, THF, 0
o





Scheme 7.3: Reagents and conditions for a-series: (i) Lev-OH, EDAC•HCl, dioxane, 21oC, 4 h. 
(ii) N-(isobutyryl)-N-(2-((tert-butyldiphenylsilyl)oxy)ethyl)-ethanolamine, Ph3P, DIAD, dioxane, 
21
o
C, 16h. (iii) TBAF, THF, 21
o
C, 30 min. (iv) 1. TBS-Cl (2.2 eq), Im (4.4 eq), DMF, 21
o
C, 30 
min, 2. p-TsOH•H2O (1.2 eq), MeOH/DCM (1:4), 21
o
C, 30 min. (v) Lev-OH, EDAC•HCl, 
dioxane, 21
o
C, 4 h. (vi) 6, Ph3P, DIAD, dioxane, 21
o
C,  16h. (vii) TBAF (1M in THF), THF, 
21
o
C, 30 min. (viii) Cl-P(OCEt)N(iPr)2, DIPEA, THF, 21
o
C, 30 min. (ix) N-(isobutyryl)-N-(2-
((phenoxyacetyl)oxy)ethyl)-ethanolamine, Ph3P, DIAD, dioxane, 21
o
C, 16h. (x) Cl-
P(OCEt)N(iPr)2, DIPEA, THF, 21
o
C, 30 min. 
Reagents and conditions for b-series: Identical to a-series except steps (ii) N-(methyl)-N-(2-
((tert-butyldiphenylsilyl)oxy)ethyl)-ethanolamine, Ph3P, DIAD, dioxane, 21
o
C, 16h. (ix) N-
(methyl)-N-(2-((phenoxyacetyl)oxy)ethyl)-ethanolamine, Ph3P, DIAD, dioxane, 21
o
C, 16h.   
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7.2.3 Probing the TLS Pathway Further 
 Our study on TLS revealed a potential dependence on lesion rigidity for efficient 
processivity from hPol η. This hypothesis is drawn from a limited amount of data. To make such 
claims gain more credibility, other Y-family DNA polymerases would have to be investigated 
such as hPol κ, hPol ι, Rev1, yPol η, yRev1, Dpo4 (from Sulfolobus Solfataricus). Moreover, 
DNA Pol bypass seems to be dependent on the DNA sequence identity, and thus, it would be of 
interest to incorporate the adducts described in CHAPTER II and CHAPTER V into other 
DNA sequences to identify if hPol η (and other Pols) behave similarly or differently. For 
CHAPTER II, crystal structures are required for the bicyclicpyrimidine (DFP and TPP) inserts 
to acquire additional insights on the bypass by hPol η. Similarly, structural investigations for the 
IaCL DNA described in CHAPTER V may illuminate why the lack of a phosphodiester linkage 
promotes error-prone behavior by hPol η.       
 The d(TT) CPD adducts is a naturally occurring lesion and is one of the substrates 
bypassed efficiently by hPol η. On the other hand the pyrimidine (6-4) pyrimidone adducts is 
poorly bypassed by hPol η. To further probe this substrate discrimination, a flexible N3-dT-
alkylene-N3-dT IaCL crosslink is proposed (Scheme 7.4 - 7.5). The methodology to generate 
N3-adducted thymidine has been developed previously.
299,374,375
 The presence or lack of the 
intradimer phosphate group allows for a similar comparison as those drawn in CHAPTER V for 
hPol η (or any other Pol tested for that matter). Moreover, the linker protrudes the Watson-Crick 
face and would disrupt H-bonding with the incoming nucleotide. The N3-atom of dT was 





 The N3-alkylene-dT adducts have, also, previously served as mimics of the N3-
alkylene-dC adducts,
298,374,376
 which may aid in deciphering whether hPol η is proficient in 
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bypassing N3-alkylene-pyrimidines in general. Finally, comparison of this study with the 
investigation presented in CHAPTER V would supply insights on the substrate discrimination 
of hPol η towards flexible pyrimidine-pyrimidine and purine-purine IaCL DNA.    
 
Scheme 7.4: Mono-adducts 7.16 a,b,c have been prepared previously.
374
 Reagents and 
conditions: (i) 5’-O-(tert-butyldimethylsilyl)-3’-O-levulinyl-thymidine, DBU, MeCN, 21oC, 16 
h. (ii) Cl-P(OCEt)N(iPr)2, DIPEA, THF, 21
o




Scheme 7.5: Reagents and conditions for a-series: (i) TBS-Cl, Im, CH2Cl2, 21
o
C, 4 h. (ii) 2-
iodoethyl-1-phenoxyacetate, DBU, MeCN, 21
o
C, 4 h. (iii) n-butylamine, THF, 45
o
C, 4h. (iv) I2, 
Ph3P, Im, THF, 21
oC, 1 h. (v) 1) 5’-O-(4,4'-dimethoxytrityl)-3’-O-levulinyl-thymidine, DBU, 
MeCN, 21
o
C, 16 h. 2) N2H4•H2O, pyridinium acetate (1:1, v/v), 21
o
C, 30 min. (vi)  2-
chlorophenyl dichlorophosphate, 1,2,4-triazole, NEt3, THF, Py, 21
o
C, 2 h. (vii) 1. TBAF, THF, 
21
o
C, 1 h. 2. MSNT, Py, 21
o
C, 4 h. (viii) Cl-P(OCEt)N(iPr)2, DIPEA, THF, 21
o
C, 30 min.  
Reagents and conditions for b-series: Same as a-series except step (ii) 4-iodobutyl-1-
phenoxyacetate, DBU, MeCN, 21
o
C, 4 h.  
Reagents and conditions for c-series: Same as a-series except step (ii) 7-iodoheptyl-1-
phenoxyacetate, DBU, MeCN, 21
o
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